data_2cpx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2cpx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--O 1.23 0.105 0 CA-C-O 120.798 0.249 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -126.15 179.18 5.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.464 ' CE ' HG21 ' A' ' 356' ' ' THR . 3.8 ptmt -81.5 -30.86 33.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 86.4 t -99.18 132.89 43.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.452 HD11 ' CE1' ' A' ' 357' ' ' PHE . 79.1 mt -112.29 152.74 28.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.96 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.788 ' CD1' ' CE2' ' A' ' 354' ' ' PHE . 10.3 t80 -124.22 101.76 7.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.948 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.451 HD11 ' N ' ' A' ' 313' ' ' LEU . 6.1 mp -90.63 139.73 30.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.939 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -137.36 -179.53 5.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 63.73 54.06 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.81 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 12.8 mt -116.26 127.09 54.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.968 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 45.1 t -65.56 143.88 98.76 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.643 0.735 . . . . 0.0 110.831 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.16 -22.14 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.7 2.266 . . . . 0.0 112.345 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 37.6 mtt-85 -77.07 -38.86 51.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 69.5 t -46.1 140.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.095 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 75.1 p -140.96 168.41 19.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.199 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -41.21 -47.37 3.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -41.52 -52.24 3.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.88 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.42 -48.43 68.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 18.9 mt -58.2 -47.0 84.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.946 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 86.0 t -53.26 -56.06 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.138 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 7.5 t -60.19 -43.38 95.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.829 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.7 mt -52.12 -48.59 64.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.561 ' CE1' HG21 ' A' ' 370' ' ' VAL . 42.9 m-85 -118.35 42.1 2.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -78.96 -43.55 24.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.073 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -49.48 -34.0 15.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 366' ' ' ALA . 21.9 m-85 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 67.1 mt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.817 0.342 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -97.71 137.8 36.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -123.81 140.27 53.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -136.35 132.94 36.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.805 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 12.4 ttm -112.22 135.9 52.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' MET . . . . . 0.412 ' HE1' ' CE1' ' A' ' 354' ' ' PHE . 29.4 ttm . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.908 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.424 ' C ' ' OE1' ' A' ' 352' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.424 ' OE1' ' C ' ' A' ' 351' ' ' GLY . 2.9 mp0 -147.31 152.73 38.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.851 0.358 . . . . 0.0 110.862 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -158.55 167.09 30.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.788 ' CE2' ' CD1' ' A' ' 312' ' ' TYR . 14.4 m-85 -136.6 138.38 41.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.893 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.463 HG22 ' CE1' ' A' ' 357' ' ' PHE . 85.2 mt -126.68 132.88 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.464 HG21 ' CE ' ' A' ' 309' ' ' LYS . 25.7 m -108.26 118.1 35.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.097 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.463 ' CE1' HG22 ' A' ' 355' ' ' ILE . 47.1 m-85 -99.84 158.91 31.23 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.639 0.733 . . . . 0.0 110.903 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.88 -35.3 13.68 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.623 2.216 . . . . 0.0 112.348 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -157.83 174.8 14.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.977 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . 0.453 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 21.5 pttp -65.89 -45.35 82.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . 0.453 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 48.1 mt-10 -46.21 -65.17 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 60.5 mt -53.28 -54.17 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -43.59 -59.32 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.081 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . 0.495 ' O ' ' N ' ' A' ' 367' ' ' LEU . 11.4 t90 -50.44 -62.87 1.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.0 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -37.25 -50.78 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 332' ' ' PHE . . . -60.17 -37.17 79.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.12 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.531 HD11 ' CE1' ' A' ' 384' ' ' PHE . 6.3 tt -62.37 -62.54 1.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.976 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -53.18 -29.2 30.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.842 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 44.9 mt -76.24 -48.36 20.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . 0.561 HG21 ' CE1' ' A' ' 329' ' ' PHE . 5.4 t -98.41 33.0 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.101 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.36 96.27 7.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 93.32 43.9 3.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.531 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -84.8 109.16 17.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 0.0 110.922 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -62.95 119.31 9.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.935 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.4 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 19.4 tp -133.54 128.68 35.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.851 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . 0.4 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 25.2 m-85 45.81 41.24 7.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.999 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 66.8 41.3 93.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -142.32 141.13 32.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 49.2 mm -90.56 92.73 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.182 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . 0.467 HD22 ' N ' ' A' ' 381' ' ' VAL . 7.2 tt -61.51 129.82 43.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.467 ' N ' HD22 ' A' ' 380' ' ' LEU . 48.0 t -117.22 111.91 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.187 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.41 ' CD1' ' O ' ' A' ' 370' ' ' VAL . 29.2 mt -93.97 137.89 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -133.73 179.21 6.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.531 ' CE1' HD11 ' A' ' 367' ' ' LEU . 27.7 m-85 -109.11 140.79 42.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.413 -179.908 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo . . . . . 0 C--O 1.231 0.163 0 CA-C-O 120.685 0.202 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -118.29 172.67 7.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.463 ' HD2' ' CG2' ' A' ' 310' ' ' VAL . 0.0 OUTLIER -89.91 25.98 1.95 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.949 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . 0.463 ' CG2' ' HD2' ' A' ' 309' ' ' LYS . 89.2 t -143.17 123.22 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.139 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.519 HD13 ' CE1' ' A' ' 357' ' ' PHE . 63.0 mt -116.66 125.62 52.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.969 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.674 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 7.8 t80 -105.1 103.88 13.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.512 ' CD1' ' N ' ' A' ' 313' ' ' LEU . 3.0 mp -87.31 144.68 26.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -140.57 178.69 7.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.928 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.0 m120 59.5 46.09 12.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.855 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.2 mt -105.7 112.5 25.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 37.5 t -54.34 144.54 41.0 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.747 0.784 . . . . 0.0 110.796 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -45.02 -32.16 6.3 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.685 2.257 . . . . 0.0 112.328 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -66.57 -39.82 88.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 84.9 t -46.75 113.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 82.1 p -108.88 165.81 11.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.136 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -42.05 -50.28 4.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 72.9 mtt85 -43.29 -50.48 6.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -49.52 -44.28 46.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.61 -51.87 60.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 91.8 t -48.27 -51.94 8.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.203 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.2 t -62.9 -40.52 97.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.935 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.444 HD21 ' CE2' ' A' ' 373' ' ' TYR . 23.0 mt -55.69 -42.83 75.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.879 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -121.18 41.62 3.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -82.54 -35.7 26.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . 0.527 ' HG3' ' CE2' ' A' ' 332' ' ' PHE . 6.3 ptp180 -55.98 -23.69 34.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.855 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.527 ' CE2' ' HG3' ' A' ' 331' ' ' ARG . 9.0 m-85 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 341' ' ' GLN . 75.6 mt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.724 0.297 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . 0.454 ' N ' HG23 ' A' ' 340' ' ' ILE . 75.3 mm-40 -91.04 117.25 29.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . 0.553 ' CD1' HG22 ' A' ' 355' ' ' ILE . 92.7 m-85 -105.92 146.02 30.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -141.26 126.51 18.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 33.4 tpp -117.18 135.01 54.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' MET . . . . . 0.502 ' HE1' ' CE2' ' A' ' 354' ' ' PHE . 31.0 mtm . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.497 ' C ' ' CD ' ' A' ' 352' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 112.409 -0.276 . . . . 0.0 112.409 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.497 ' CD ' ' C ' ' A' ' 351' ' ' GLY . 23.8 mp0 -154.38 130.31 10.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.857 0.361 . . . . 0.0 110.953 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -153.76 141.89 20.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.129 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.674 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 43.4 m-85 -103.34 152.62 21.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.553 HG22 ' CD1' ' A' ' 342' ' ' PHE . 45.3 mt -148.79 134.75 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.0 m -118.14 127.49 53.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.569 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 42.2 m-85 -104.41 157.8 33.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.641 0.734 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.83 -47.63 9.74 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.668 2.245 . . . . 0.0 112.31 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -141.96 138.7 32.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.82 -27.5 0.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.896 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.28 -58.6 7.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 332' ' ' PHE . 72.6 mt -57.67 -58.8 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.569 ' HB3' ' CD1' ' A' ' 357' ' ' PHE . . . -46.34 -46.5 18.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.12 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -54.73 -61.58 2.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.999 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -50.25 -37.35 35.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.81 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . 0.443 ' HB3' ' CE2' ' A' ' 332' ' ' PHE . . . -69.24 -45.62 69.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.46 HD22 ' N ' ' A' ' 368' ' ' HIS . 6.6 tt -55.94 -51.04 69.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . 0.46 ' N ' HD22 ' A' ' 367' ' ' LEU . 30.6 t60 -63.95 -36.02 82.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 39.9 mt -74.38 -28.01 60.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 17.2 t -102.01 -4.47 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 367' ' ' LEU . 1.4 p-10 -55.21 127.32 28.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 63.72 49.48 68.35 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.448 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.444 ' CE2' HD21 ' A' ' 328' ' ' LEU . 82.3 t80 -93.81 112.49 24.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 110.902 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -67.81 105.96 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 37.3 tp -118.75 118.03 30.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 55.47 35.12 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 73.4 29.52 63.9 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -133.29 129.41 37.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.78 0.324 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 51.0 mm -77.51 90.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . 0.421 ' CD2' ' CG1' ' A' ' 382' ' ' ILE . 8.0 tt -59.6 117.56 5.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 97.0 t -102.68 122.99 55.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.14 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.457 ' C ' ' OE1' ' A' ' 383' ' ' GLU . 15.3 mt -109.26 139.19 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.113 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . 0.457 ' OE1' ' C ' ' A' ' 382' ' ' ILE . 4.9 mp0 -138.65 124.86 20.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.459 ' CE1' HD12 ' A' ' 367' ' ' LEU . 27.9 m-85 -52.45 158.11 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.894 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.439 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo . . . . . 0 C--O 1.229 0.07 0 CA-C-O 120.868 0.278 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -153.64 165.79 34.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.835 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.441 ' CD ' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -84.97 -14.6 47.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . 0.441 HG23 ' CD ' ' A' ' 309' ' ' LYS . 54.4 t -111.32 134.43 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.135 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.563 HD22 ' CD1' ' A' ' 384' ' ' PHE . 29.0 mt -119.04 120.67 37.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.897 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.792 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 13.9 t80 -106.41 102.69 12.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 313' ' ' LEU . 6.2 mp -88.88 149.55 23.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.551 ' HE2' ' CD2' ' A' ' 312' ' ' TYR . 22.5 mttt -137.56 -176.73 4.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 55.35 53.9 9.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.2 mt -109.32 117.68 34.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.898 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 38.6 t -61.34 139.91 94.67 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.675 0.75 . . . . 0.0 110.874 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -43.2 -27.63 1.17 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.703 2.268 . . . . 0.0 112.256 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.494 ' HB3' ' CE2' ' A' ' 376' ' ' TYR . 23.0 mmt85 -69.73 -42.85 73.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.857 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 93.5 t -44.31 136.34 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.13 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.8 p -135.88 166.54 23.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.101 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -41.64 -52.45 3.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -40.94 -41.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.69 -46.72 86.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.33 -44.8 95.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.928 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 95.0 t -55.12 -60.54 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 4.8 t -54.12 -40.63 67.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.904 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 28.7 mt -56.74 -44.9 82.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -120.54 45.76 2.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -84.06 -39.55 19.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -45.26 -37.36 4.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 366' ' ' ALA . 11.9 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.422 HG23 ' CZ ' ' A' ' 342' ' ' PHE . 59.5 mt . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.78 0.324 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -93.83 116.52 28.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . 0.422 ' CZ ' HG23 ' A' ' 340' ' ' ILE . 97.6 m-85 -103.49 149.07 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -141.19 125.25 17.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.849 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 41.7 tpp -114.57 135.63 53.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 9.1 ttm . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.842 179.96 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.405 ' C ' ' CD ' ' A' ' 352' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.405 ' CD ' ' C ' ' A' ' 351' ' ' GLY . 3.2 mp0 -148.37 141.38 24.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 110.861 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -150.05 151.58 33.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.099 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.792 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 58.0 m-85 -116.05 143.73 45.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.825 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.437 HG22 ' CE2' ' A' ' 357' ' ' PHE . 77.4 mt -136.0 139.2 46.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.144 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 83.3 m -124.41 117.41 24.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.13 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.437 ' CE2' HG22 ' A' ' 355' ' ' ILE . 84.0 m-85 -96.75 158.08 34.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.649 0.738 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.7 -35.39 23.21 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.739 2.293 . . . . 0.0 112.307 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -149.71 178.68 8.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.84 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -74.58 -49.93 19.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -41.13 -63.62 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 46.6 mt -51.68 -61.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -38.86 -60.81 0.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.138 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 14.0 t90 -48.42 -56.81 7.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -50.54 -47.09 57.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . 0.446 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . . . -58.28 -32.18 68.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.079 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.561 HD12 ' CZ ' ' A' ' 384' ' ' PHE . 7.2 tt -70.42 -69.94 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.916 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -48.01 -32.68 6.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 41.7 mt -74.32 -41.53 60.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 370' ' ' VAL . 47.3 t -104.04 33.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.187 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.34 139.7 37.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.901 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 52.42 40.02 53.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.442 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -80.2 120.04 23.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.013 0.435 . . . . 0.0 110.917 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -63.68 112.1 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 29.4 tp -121.67 127.27 50.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . 0.494 ' CE2' ' HB3' ' A' ' 319' ' ' ARG . 31.5 m-85 41.27 46.32 2.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 59.97 44.68 96.96 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.443 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -156.03 114.56 3.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.717 0.294 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 17.2 mm -50.62 111.03 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . 0.419 HD21 ' C ' ' A' ' 380' ' ' LEU . 8.3 tt -80.39 120.16 24.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.64 118.18 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.445 ' CD1' ' O ' ' A' ' 370' ' ' VAL . 29.4 mt -99.04 136.83 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.098 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.49 177.66 7.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.921 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.563 ' CD1' HD22 ' A' ' 311' ' ' LEU . 41.3 m-85 -109.98 135.23 51.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.51 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo . . . . . 0 N--CA 1.467 -0.086 0 CA-C-O 120.813 0.256 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -117.92 175.29 5.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -86.96 -36.78 18.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 83.9 t -96.08 125.48 48.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.105 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.528 HD13 ' CE1' ' A' ' 357' ' ' PHE . 34.5 mt -108.64 112.17 24.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.738 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 14.6 t80 -83.6 104.24 13.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.943 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 8.1 mp -90.66 136.71 32.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -132.24 -177.08 4.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 58.72 47.44 12.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.6 mt -106.61 111.54 24.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.441 ' N ' HG21 ' A' ' 320' ' ' VAL . 1.4 t -45.77 142.06 3.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.701 0.762 . . . . 0.0 110.847 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.04 -19.37 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.66 2.24 . . . . 0.0 112.343 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -82.73 -37.98 23.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . 0.441 HG21 ' N ' ' A' ' 317' ' ' SER . 60.8 t -40.77 137.17 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.176 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 4.5 p -135.77 168.25 19.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -45.99 -45.28 15.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -45.38 -59.26 2.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.876 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -44.36 -50.49 9.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 28.8 mt -55.18 -41.94 72.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.979 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 98.3 t -56.69 -57.44 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.151 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 4.5 t -59.86 -24.16 64.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 33.3 mt -76.07 -40.33 53.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.934 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -123.69 39.71 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -88.25 -38.71 15.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -55.61 -17.28 5.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 57.9 m-85 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.503 HD11 ' CE2' ' A' ' 357' ' ' PHE . 43.9 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.77 0.319 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . 0.45 ' N ' HG21 ' A' ' 340' ' ' ILE . 69.0 mt-30 -93.01 127.77 38.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -118.56 142.39 47.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.866 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -141.27 126.18 18.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 11.4 ttm -115.4 125.79 53.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.945 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 9.8 ptp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.886 179.998 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -129.5 150.86 50.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.329 . . . . 0.0 110.945 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -154.71 152.15 29.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.738 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 41.5 m-85 -121.14 126.43 49.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.455 HG23 ' CE1' ' A' ' 357' ' ' PHE . 95.6 mt -118.29 142.79 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.8 m -123.53 121.56 35.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.157 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.528 ' CE1' HD13 ' A' ' 311' ' ' LEU . 37.5 m-85 -99.69 159.05 30.98 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.663 0.744 . . . . 0.0 110.864 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.48 -42.46 18.11 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.688 2.259 . . . . 0.0 112.302 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -153.89 156.44 37.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . 0.425 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 13.7 ptpt -48.6 -45.98 38.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.915 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . 0.425 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 20.1 mm-40 -41.24 -65.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.857 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' A' ' 363' ' ' ALA . 79.1 mt -54.08 -64.73 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 362' ' ' ILE . . . -36.09 -57.6 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.062 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -49.05 -58.75 4.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -50.01 -48.19 52.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -57.66 -38.84 75.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.427 ' CD2' ' C ' ' A' ' 367' ' ' LEU . 5.2 tt -64.38 -60.7 2.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . 0.401 ' N ' HD23 ' A' ' 367' ' ' LEU . 32.8 t60 -56.19 -27.55 54.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 30.2 mt -79.83 -37.11 35.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 13.7 t -110.14 35.92 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.172 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -87.65 106.82 18.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.831 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 90.42 31.61 10.33 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.434 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -76.19 119.06 19.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.834 0.35 . . . . 0.0 110.991 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -66.71 107.28 2.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 15.0 tp -111.93 114.51 27.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.985 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 53.94 40.02 31.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 69.91 29.73 70.68 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.459 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -143.26 113.41 7.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.845 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 19.9 mm -53.88 128.06 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.09 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . 0.413 ' CD2' ' C ' ' A' ' 380' ' ' LEU . 5.5 tt -94.18 117.29 29.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 86.5 t -98.5 128.9 49.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.163 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 24.3 mt -110.58 132.22 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -134.03 124.02 25.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.922 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.446 ' CE1' ' CD2' ' A' ' 311' ' ' LEU . 39.8 m-85 -55.46 151.29 10.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.824 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.487 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.784 0.243 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -110.35 177.01 4.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.846 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -88.16 -25.17 23.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 23.5 t -97.89 128.68 49.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.088 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.569 HD12 ' CE1' ' A' ' 357' ' ' PHE . 48.7 mt -115.63 118.31 32.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.012 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.769 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 15.0 t80 -98.23 102.34 14.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.404 HD11 ' CD1' ' A' ' 355' ' ' ILE . 5.1 mp -88.5 146.54 25.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -138.06 -176.35 4.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 59.7 53.6 4.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.5 mt -115.65 122.84 46.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 18.0 t -64.5 143.87 98.59 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.68 0.753 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.72 -19.5 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.695 2.264 . . . . 0.0 112.386 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 -77.11 -35.16 56.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 97.6 t -48.53 146.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 12.2 p -145.24 175.33 10.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.113 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -48.38 -47.02 37.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -44.47 -54.37 6.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.24 -51.52 25.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 57.2 mt -57.31 -47.53 81.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 330' ' ' ALA . 96.5 t -55.08 -61.78 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.184 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 11.6 t -53.09 -37.59 61.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.411 HD21 ' CE2' ' A' ' 373' ' ' TYR . 32.6 mt -63.23 -40.26 96.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.897 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -120.79 40.54 3.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -82.64 -21.17 35.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.08 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -69.66 -36.99 76.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 -179.87 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.414 HD12 ' CE2' ' A' ' 357' ' ' PHE . 85.4 mt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.726 0.298 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -100.88 117.77 35.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -102.34 138.8 38.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -134.35 129.29 35.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 40.5 tpp -112.87 145.14 41.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 18.6 mmt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 179.995 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -139.87 166.75 23.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 110.882 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -158.6 149.26 20.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.769 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 12.9 m-85 -119.39 121.82 40.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.836 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.404 ' CD1' HD11 ' A' ' 313' ' ' LEU . 61.9 mt -110.14 144.47 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.15 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 17.2 m -120.89 117.76 28.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.132 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 311' ' ' LEU . 53.6 m-85 -98.94 155.76 36.25 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.625 0.726 . . . . 0.0 110.857 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.57 -42.0 18.61 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.75 2.3 . . . . 0.0 112.324 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.75 171.55 17.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.78 -48.94 72.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -39.99 -63.17 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 363' ' ' ALA . 90.6 mt -53.27 -65.82 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 362' ' ' ILE . . . -36.98 -55.49 0.92 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -48.3 -63.47 1.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -45.29 -48.89 13.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -60.17 -33.74 72.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.091 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.56 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.4 tt -68.01 -63.29 1.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -50.65 -34.21 25.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 24.9 mt -75.34 -57.66 3.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.961 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 5.9 t -84.1 31.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.115 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -87.27 103.85 15.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 90.77 37.45 6.43 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.411 ' CE2' HD21 ' A' ' 328' ' ' LEU . 73.9 t80 -82.38 107.64 15.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 0.0 110.961 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -59.09 126.96 29.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.64 124.97 18.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 49.41 34.68 6.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.946 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 73.44 38.03 52.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.438 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.15 150.48 47.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.784 0.325 . . . . 0.0 110.839 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 43.1 mm -97.17 87.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . 0.415 ' CD2' HG13 ' A' ' 382' ' ' ILE . 7.2 tt -52.07 133.63 32.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.957 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 85.0 t -120.62 122.95 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.415 HG13 ' CD2' ' A' ' 380' ' ' LEU . 21.5 mt -104.81 132.43 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.129 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -139.99 119.17 12.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.56 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 58.1 m-85 -51.33 151.59 2.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo . . . . . 0 N--CA 1.466 -0.102 0 CA-C-O 120.766 0.236 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -138.43 160.06 40.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -68.94 -28.42 66.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.94 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 73.9 t -95.85 134.32 33.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.564 HD11 ' CE1' ' A' ' 357' ' ' PHE . 45.4 mt -123.5 121.7 36.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.696 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 10.3 t80 -96.94 113.42 24.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 313' ' ' LEU . 5.3 mp -103.26 145.98 29.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -144.68 -179.7 6.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.955 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.4 m120 60.77 51.48 4.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.5 mt -113.23 115.97 29.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 21.3 t -50.29 146.28 8.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.647 0.737 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.86 -26.37 7.12 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.656 2.237 . . . . 0.0 112.291 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.434 ' HB3' ' NH1' ' A' ' 319' ' ' ARG . 7.5 mtp-105 -72.04 -31.7 66.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.27 132.34 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.166 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 322' ' ' GLU . 41.9 p -139.25 168.36 19.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.091 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 321' ' ' THR . 26.0 tt0 -37.06 -46.72 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.924 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 324' ' ' ASP . 70.7 mtm180 -47.36 -62.24 1.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 323' ' ' ARG . 4.7 m-20 -37.8 -50.92 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 22.6 mt -59.64 -47.71 84.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.962 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 330' ' ' ALA . 94.9 t -46.6 -52.23 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 47.0 t -64.09 -42.39 96.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.436 HD21 ' CD2' ' A' ' 373' ' ' TYR . 78.3 mt -56.28 -49.33 74.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.986 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -113.72 35.04 4.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -70.58 -42.79 70.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.095 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . 0.463 ' HG3' ' CD1' ' A' ' 332' ' ' PHE . 11.4 ptm180 -40.85 -52.53 3.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.81 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.463 ' CD1' ' HG3' ' A' ' 331' ' ' ARG . 16.2 m-85 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.936 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.56 HG23 ' CE1' ' A' ' 342' ' ' PHE . 96.2 mt . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.802 0.334 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -121.88 127.74 50.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . 0.56 ' CE1' HG23 ' A' ' 340' ' ' ILE . 2.4 m-85 -111.61 139.57 46.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 31.3 ttt85 -135.4 123.22 22.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.425 ' C ' ' HE1' ' A' ' 345' ' ' MET . 17.7 ttm -116.9 129.56 56.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' MET . . . . . 0.468 ' HE1' ' N ' ' A' ' 345' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.877 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -107.89 139.97 41.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.96 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -148.46 158.75 44.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.118 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.696 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 47.7 m-85 -132.27 130.26 40.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 85.7 mt -118.68 140.52 42.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.092 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 26.1 m -113.19 105.57 13.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.564 ' CE1' HD11 ' A' ' 311' ' ' LEU . 44.0 m-85 -90.03 158.81 43.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.672 0.749 . . . . 0.0 110.889 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -42.31 -55.52 2.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.605 2.203 . . . . 0.0 112.402 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.0 -176.49 5.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -67.57 -51.17 53.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -39.16 -66.13 0.31 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . 0.44 ' O ' ' C ' ' A' ' 363' ' ' ALA . 61.1 mt -55.27 -65.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.193 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 362' ' ' ILE . . . -34.67 -56.33 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.143 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -50.63 -56.17 13.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 369' ' ' LEU . 30.4 mt-30 -50.97 -43.19 60.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -62.7 -41.48 99.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.07 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.568 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 6.5 tt -62.95 -63.55 1.17 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.972 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -55.92 -31.87 63.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.868 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.422 ' CG ' ' O ' ' A' ' 365' ' ' GLN . 37.0 mt -74.32 -33.02 63.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 370' ' ' VAL . 23.0 t -113.6 25.56 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 367' ' ' LEU . 1.6 p30 -69.43 138.15 53.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.883 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 46.35 49.12 15.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.493 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.436 ' CD2' HD21 ' A' ' 328' ' ' LEU . 89.3 t80 -83.29 118.44 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.03 0.443 . . . . 0.0 110.949 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -68.63 109.95 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.928 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.507 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 45.5 tp -126.42 126.07 43.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.832 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . 0.507 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 39.4 m-85 51.16 38.5 21.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 68.19 35.5 83.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.468 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -140.87 133.74 29.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.74 0.305 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 16.9 mm -79.39 88.45 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.154 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . 0.456 ' CD2' HG13 ' A' ' 382' ' ' ILE . 6.3 tt -58.87 127.49 32.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.884 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.8 t -107.74 130.58 59.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.456 HG13 ' CD2' ' A' ' 380' ' ' LEU . 55.1 mt -112.6 139.68 36.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.14 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -135.45 178.98 6.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.568 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 50.3 m-85 -111.75 129.53 56.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.946 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 -179.938 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.824 0.26 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -103.2 175.8 5.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.419 ' NZ ' ' HB2' ' A' ' 309' ' ' LYS . 0.0 OUTLIER -91.49 5.85 47.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . 0.41 ' CG2' ' HD3' ' A' ' 309' ' ' LYS . 93.5 t -129.91 135.26 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.15 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.525 HD12 ' CE1' ' A' ' 357' ' ' PHE . 96.5 mt -116.11 120.72 39.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.658 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 9.4 t80 -101.68 101.86 12.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.93 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 313' ' ' LEU . 5.7 mp -92.96 146.79 23.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 -176.26 4.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 61.38 49.1 5.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.6 mt -115.51 137.44 52.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 38.7 t -70.67 140.02 86.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.654 0.74 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -43.61 -21.64 0.33 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.732 2.288 . . . . 0.0 112.291 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 11.4 mtp85 -76.65 -41.29 46.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 70.7 t -42.52 123.69 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.149 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 40.7 p -123.08 171.99 8.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.174 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -44.56 -51.25 9.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.885 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -40.83 -50.25 3.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -53.67 -44.25 69.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 32.5 mt -64.7 -48.51 74.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 89.3 t -49.82 -54.51 7.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.157 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 22.8 t -59.15 -41.79 89.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.859 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 44.0 mt -57.52 -45.86 84.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.405 ' CD1' ' HB3' ' A' ' 366' ' ' ALA . 36.2 m-85 -120.49 49.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -91.41 -51.42 5.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -42.74 -49.54 5.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.53 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 40.0 m-85 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.548 HG22 ' CZ ' ' A' ' 342' ' ' PHE . 57.4 mt . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.827 0.346 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -90.76 132.92 35.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.946 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . 0.548 ' CZ ' HG22 ' A' ' 340' ' ' ILE . 33.8 m-85 -125.1 138.36 54.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -139.08 128.91 24.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.5 tpp -112.93 141.65 46.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' MET . . . . . 0.468 ' HE3' ' CE2' ' A' ' 354' ' ' PHE . 7.3 mtm . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -132.28 152.55 51.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.871 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.55 150.06 35.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.658 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 39.2 m-85 -116.47 121.31 41.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.818 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.559 HG21 ' CE1' ' A' ' 357' ' ' PHE . 61.7 mt -114.4 133.29 60.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.192 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.2 m -114.58 114.2 25.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.129 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.559 ' CE1' HG21 ' A' ' 355' ' ' ILE . 37.4 m-85 -91.95 157.94 40.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.722 0.772 . . . . 0.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.4 -47.82 12.48 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.647 2.232 . . . . 0.0 112.371 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -138.83 174.42 10.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -69.92 -44.15 70.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -50.97 -58.21 6.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 97.3 mt -53.15 -52.67 28.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.13 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -45.99 -61.35 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -45.79 -55.56 6.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -43.8 -53.93 5.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . 0.53 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -60.31 -28.43 68.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.13 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.504 HD13 ' CE1' ' A' ' 384' ' ' PHE . 7.2 tt -70.15 -65.99 0.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.921 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -53.75 -28.67 35.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 30.1 mt -78.44 -48.88 14.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 12.1 t -97.37 30.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . 0.42 ' O ' ' CG ' ' A' ' 371' ' ' ASN . 2.0 t30 -82.83 85.97 7.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.956 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 108.9 52.22 0.66 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.436 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -99.51 110.06 22.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.975 0.417 . . . . 0.0 110.898 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -61.47 125.7 24.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 30.3 tp -138.27 128.37 25.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.92 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 48.17 42.69 17.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 61.52 37.06 93.53 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.562 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -148.35 114.44 5.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 110.974 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 34.9 mm -58.4 130.51 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.099 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 7.6 tt -90.93 135.92 33.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.916 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 50.8 t -121.67 125.76 73.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 12.8 mt -111.65 137.91 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.118 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -145.78 122.09 10.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.504 ' CE1' HD13 ' A' ' 367' ' ' LEU . 38.7 m-85 -47.15 151.74 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.507 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo . . . . . 0 N--CA 1.465 -0.154 0 CA-C-O 120.828 0.262 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -107.9 172.64 6.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 7.57 32.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 98.0 t -126.82 123.64 63.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 57.0 mt -109.69 129.2 55.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.802 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 10.3 t80 -110.32 101.62 10.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.475 ' CD1' HD12 ' A' ' 355' ' ' ILE . 5.7 mp -86.43 144.37 27.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.426 ' HG3' ' C ' ' A' ' 313' ' ' LEU . 3.2 mtpm? -142.56 179.11 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . 0.4 HD21 ' CG2' ' A' ' 381' ' ' VAL . 20.2 m-20 60.93 54.72 3.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 16.3 mt -119.6 109.46 15.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 42.8 t -45.71 145.37 2.26 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.708 0.766 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -46.44 -20.65 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.359 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -73.22 -37.67 66.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.971 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 84.4 t -52.55 126.06 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.08 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 37.4 p -121.36 171.72 8.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.136 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -45.07 -42.39 8.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -49.87 -46.98 52.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -52.69 -49.39 65.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.895 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 30.4 mt -59.31 -54.45 46.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 99.9 t -45.89 -52.82 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 1.4 t -61.62 -43.73 98.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.545 HD22 ' CE2' ' A' ' 373' ' ' TYR . 36.9 mt -54.2 -40.37 67.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.932 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 329' ' ' PHE . 6.6 m-85 -125.93 44.48 2.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -89.57 -51.25 5.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.073 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . 0.419 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 15.9 ptm180 -44.43 -46.54 9.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.419 ' N ' ' HG3' ' A' ' 331' ' ' ARG . 24.0 m-85 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.53 HD11 ' CE2' ' A' ' 357' ' ' PHE . 74.6 mt . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 120.725 0.297 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -88.95 136.97 32.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -123.82 139.55 53.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -141.29 135.18 30.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 12.2 ttm -112.93 140.09 48.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.88 179.972 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -99.23 158.13 15.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 0.0 110.925 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -151.23 147.57 27.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.802 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 39.0 m-85 -113.73 119.15 36.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' A' ' 313' ' ' LEU . 75.5 mt -114.14 140.89 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.124 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.443 ' N ' HG21 ' A' ' 355' ' ' ILE . 44.0 m -118.54 130.96 56.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.53 ' CE2' HD11 ' A' ' 340' ' ' ILE . 18.4 m-85 -109.01 155.83 40.2 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.688 0.756 . . . . 0.0 110.909 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.9 -39.56 32.1 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.711 2.274 . . . . 0.0 112.392 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -144.53 179.45 7.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.2 ptmm? -80.12 -31.89 39.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.8 -64.53 0.87 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 75.4 mt -47.69 -65.28 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.124 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -38.15 -55.92 1.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -49.08 -60.95 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -45.01 -54.67 6.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -57.91 -42.83 85.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.067 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.556 HD12 ' CE2' ' A' ' 384' ' ' PHE . 4.5 tt -58.58 -55.47 34.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 14.0 t60 -58.42 -28.63 65.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.882 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 29.5 mt -79.87 -36.76 36.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 19.1 t -91.26 -6.29 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.143 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 371' ' ' ASN . 0.0 OUTLIER -49.6 122.3 6.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.864 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 67.32 48.0 60.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.494 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.545 ' CE2' HD22 ' A' ' 328' ' ' LEU . 76.0 t80 -90.11 110.13 21.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.932 0.396 . . . . 0.0 110.891 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -68.48 114.09 6.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 33.2 tp -121.94 125.0 45.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.926 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 48.72 41.41 17.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 66.29 37.87 93.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.417 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -148.85 114.69 5.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.802 0.334 . . . . 0.0 110.916 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 32.9 mm -57.8 122.26 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . 0.433 HD22 ' N ' ' A' ' 381' ' ' VAL . 7.4 tt -85.13 129.02 34.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.433 ' N ' HD22 ' A' ' 380' ' ' LEU . 76.6 t -103.53 119.91 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 16.3 mt -109.05 130.03 62.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -139.67 131.34 27.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.556 ' CE2' HD12 ' A' ' 367' ' ' LEU . 81.7 m-85 -59.05 123.28 16.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.481 -179.97 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.729 0.22 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 49.1 m-20 -101.11 172.35 7.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.85 1.94 56.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 68.7 t -121.4 128.61 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.473 HD21 ' CD1' ' A' ' 384' ' ' PHE . 28.1 mt -114.29 120.34 40.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.779 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 13.0 t80 -105.62 106.05 16.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.585 ' CD1' ' N ' ' A' ' 313' ' ' LEU . 1.1 mp -91.43 156.19 17.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.932 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.541 ' HE2' ' CD2' ' A' ' 312' ' ' TYR . 41.1 mttt -144.22 -176.59 5.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 15.2 m120 56.76 52.61 9.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.6 mt -115.88 113.21 23.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 40.1 t -55.8 145.15 53.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.752 0.787 . . . . 0.0 110.842 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -46.07 -25.74 3.12 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.725 2.284 . . . . 0.0 112.349 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 10.9 mtp85 -69.61 -41.96 75.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.829 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 66.6 t -44.18 134.65 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.15 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 35.9 p -135.66 169.06 18.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -41.15 -48.57 3.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -40.42 -54.43 2.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -48.75 -59.99 3.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 36.8 mt -49.25 -52.31 27.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 330' ' ' ALA . 80.6 t -46.27 -58.23 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 2.2 t -57.75 -43.64 85.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 41.9 mt -56.08 -41.61 75.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -125.83 45.98 2.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -88.0 -41.87 12.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -52.05 -18.54 1.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.807 -179.867 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.554 HD13 ' CE2' ' A' ' 357' ' ' PHE . 60.8 mt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.831 0.348 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -100.93 116.08 31.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.938 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -103.09 142.8 33.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -141.07 129.75 22.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.3 ttm -108.88 145.44 35.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 27.9 ttm . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.853 179.955 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 29.3 mp0 -152.31 133.03 14.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.888 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -135.59 147.23 48.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.079 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.779 ' CE2' ' CE1' ' A' ' 312' ' ' TYR . 42.6 m-85 -115.32 130.14 56.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.564 HG21 ' CE1' ' A' ' 357' ' ' PHE . 69.7 mt -121.5 141.72 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.188 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.403 ' N ' HG22 ' A' ' 355' ' ' ILE . 39.7 m -121.21 108.61 13.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.564 ' CE1' HG21 ' A' ' 355' ' ' ILE . 51.3 m-85 -88.5 156.67 50.59 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 0.0 110.897 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -47.03 -47.52 16.52 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.695 2.263 . . . . 0.0 112.304 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -148.78 146.3 27.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.912 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -40.42 -41.6 1.43 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -44.49 -65.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 75.2 mt -57.55 -57.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.078 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -40.81 -49.07 3.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -58.56 -62.57 1.76 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -47.92 -45.6 31.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.939 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.36 85.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.164 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.549 HD12 ' CZ ' ' A' ' 384' ' ' PHE . 5.5 tt -63.36 -65.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . 0.425 ' N ' ' CD2' ' A' ' 367' ' ' LEU . 2.4 t60 -46.5 -33.58 4.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 37.3 mt -69.9 -53.0 19.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.952 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.36 36.59 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -83.54 85.77 7.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 106.55 46.18 1.16 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.491 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -89.95 120.52 31.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.008 0.433 . . . . 0.0 110.898 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -70.18 135.4 49.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 28.6 tp -148.29 116.33 6.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.955 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 53.59 42.1 31.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 66.69 30.65 76.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.47 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . 0.421 ' NZ ' ' HA ' ' A' ' 378' ' ' LYS . 0.0 OUTLIER -134.26 124.24 25.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.74 0.305 . . . . 0.0 110.888 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 33.8 mm -74.55 107.76 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 7.3 tt -70.16 127.84 34.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.57 126.44 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.148 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 15.0 mt -106.52 137.59 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.161 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -146.39 121.45 10.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.549 ' CZ ' HD12 ' A' ' 367' ' ' LEU . 54.2 m-85 -52.64 140.0 24.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.853 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.493 -179.937 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 384' ' ' PHE . 59.3 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 CA-C-O 120.916 0.298 . . . . 0.0 112.27 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -130.92 -179.07 5.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -84.91 -26.75 27.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 18.3 t -102.72 145.32 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.628 ' CD1' ' CE1' ' A' ' 357' ' ' PHE . 77.0 mt -125.92 135.23 51.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.549 ' CD1' ' HE2' ' A' ' 314' ' ' LYS . 0.7 OUTLIER -102.86 101.46 11.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.866 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.493 HD21 ' CE1' ' A' ' 329' ' ' PHE . 5.7 mp -91.12 140.96 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.905 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.549 ' HE2' ' CD1' ' A' ' 312' ' ' TYR . 14.6 mttm -139.38 -178.8 5.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 60.53 47.59 8.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 317' ' ' SER . 10.8 mt -105.59 99.61 9.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 316' ' ' LEU . 28.9 t -38.08 144.02 0.38 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.642 0.734 . . . . 0.0 110.924 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -44.54 -33.75 7.0 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.673 2.249 . . . . 0.0 112.382 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 16.6 mtp85 -68.5 -39.26 81.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 97.5 t -41.23 138.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 68.9 p -138.0 176.1 9.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -45.13 -54.23 7.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 324' ' ' ASP . 9.4 mmm180 -42.0 -64.99 0.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.94 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 323' ' ' ARG . 40.3 m-20 -35.92 -47.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 76.0 mt -65.45 -49.39 69.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.923 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 330' ' ' ALA . 55.3 t -48.7 -59.39 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 43.8 t -56.13 -42.73 77.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.558 HD23 ' CD2' ' A' ' 373' ' ' TYR . 29.3 mt -57.16 -31.41 65.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.902 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.493 ' CE1' HD21 ' A' ' 313' ' ' LEU . 64.2 m-85 -129.45 36.8 4.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -85.56 -48.69 8.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -42.54 -41.76 3.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 366' ' ' ALA . 36.9 m-85 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.762 0.315 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -109.54 127.47 54.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -115.56 141.58 47.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.863 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -137.11 127.21 26.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 30.0 tpp -117.15 136.97 52.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 3.2 ptp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.838 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -116.61 151.47 36.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 0.0 110.965 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -163.97 157.2 18.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.094 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.481 ' CE2' ' CE2' ' A' ' 312' ' ' TYR . 8.8 m-85 -118.44 158.42 25.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.815 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.467 HG22 ' CZ ' ' A' ' 357' ' ' PHE . 24.3 mt -144.89 117.25 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.187 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 13.3 m -97.55 131.53 44.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.1 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.628 ' CE1' ' CD1' ' A' ' 311' ' ' LEU . 7.7 m-85 -111.46 155.39 42.95 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.639 0.733 . . . . 0.0 110.892 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -44.26 -31.35 4.23 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.267 . . . . 0.0 112.379 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.1 177.29 11.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . 0.435 ' NZ ' ' O ' ' A' ' 307' ' ' PRO . 0.1 OUTLIER -72.33 -49.92 30.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -43.85 -63.94 0.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 79.3 mt -50.85 -59.03 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.418 ' HB1' ' CD1' ' A' ' 357' ' ' PHE . . . -44.54 -46.13 9.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.095 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -59.04 -67.84 0.33 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -37.5 -52.02 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 332' ' ' PHE . . . -55.94 -43.95 77.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.05 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.535 HD11 ' CE1' ' A' ' 384' ' ' PHE . 7.9 tt -58.17 -55.24 37.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.894 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . 0.448 ' N ' HD21 ' A' ' 367' ' ' LEU . 15.7 m80 -67.45 -13.19 61.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 33.5 mt -93.01 -29.57 15.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 6.2 t -109.21 17.2 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 371' ' ' ASN . 0.5 OUTLIER -75.08 117.13 16.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 81.39 36.5 20.31 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.487 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.558 ' CD2' HD23 ' A' ' 328' ' ' LEU . 65.0 t80 -81.79 114.08 20.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 0.0 110.917 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -70.07 104.4 2.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.959 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 51.2 tp -121.57 125.23 46.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 57.38 27.02 13.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.959 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 78.71 25.28 60.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.514 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -132.57 139.95 48.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 36.2 mm -84.17 94.6 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.126 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . 0.459 ' CD2' HG13 ' A' ' 382' ' ' ILE . 5.2 tt -57.54 130.11 44.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 39.3 t -110.69 124.39 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.459 HG13 ' CD2' ' A' ' 380' ' ' LEU . 14.8 mt -109.03 143.73 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -148.26 121.32 8.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.535 ' CE1' HD11 ' A' ' 367' ' ' LEU . 26.1 m-85 -46.69 149.2 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.83 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.458 -179.968 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 N--CA 1.466 -0.099 0 CA-C-O 120.791 0.246 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -153.47 166.29 33.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.463 ' HD2' ' CG2' ' A' ' 310' ' ' VAL . 0.0 OUTLIER -84.4 29.88 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.867 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . 0.463 ' CG2' ' HD2' ' A' ' 309' ' ' LYS . 90.8 t -146.9 123.21 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.178 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.556 HD13 ' CE1' ' A' ' 357' ' ' PHE . 20.4 mt -116.82 126.51 53.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.785 ' CE1' ' CZ ' ' A' ' 354' ' ' PHE . 18.0 t80 -103.94 101.56 11.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.411 ' CD1' HD13 ' A' ' 355' ' ' ILE . 6.5 mp -89.45 140.52 29.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.958 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -131.9 -176.06 3.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.839 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 55.61 52.98 10.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.919 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.5 mt -111.53 113.04 25.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.952 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 46.6 t -54.2 139.53 55.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.651 0.739 . . . . 0.0 110.867 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -42.37 -28.11 0.89 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.714 2.276 . . . . 0.0 112.35 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 26.4 mmt-85 -68.5 -40.4 80.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.852 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 40.8 t -46.16 123.7 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.106 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 18.3 p -122.05 168.49 11.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -40.81 -51.75 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -43.39 -50.11 6.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -50.04 -47.41 53.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 45.7 mt -61.46 -53.04 61.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 99.7 t -48.11 -49.56 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.182 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 5.8 t -63.46 -40.42 97.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.823 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.406 HD22 ' CD1' ' A' ' 373' ' ' TYR . 40.8 mt -58.46 -40.03 81.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.856 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -123.79 40.29 3.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -86.33 -34.28 20.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.075 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . 0.412 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 9.9 ptp85 -55.51 -39.77 70.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.442 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 23.3 m-85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.554 HG23 ' CZ ' ' A' ' 342' ' ' PHE . 79.4 mt . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.764 0.316 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -82.95 139.98 33.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . 0.554 ' CZ ' HG23 ' A' ' 340' ' ' ILE . 79.8 m-85 -125.37 136.18 53.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -135.69 135.35 40.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.417 ' C ' ' CE ' ' A' ' 345' ' ' MET . 10.6 ttm -116.71 144.19 44.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' MET . . . . . 0.417 ' CE ' ' C ' ' A' ' 344' ' ' MET . 22.5 mmt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -122.62 154.6 37.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.785 0.326 . . . . 0.0 110.978 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -149.59 144.5 26.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.055 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.785 ' CZ ' ' CE1' ' A' ' 312' ' ' TYR . 70.1 m-85 -120.23 119.0 31.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.473 HG22 ' CE1' ' A' ' 357' ' ' PHE . 65.7 mt -108.25 142.61 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.122 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 26.4 m -122.96 103.91 8.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.556 ' CE1' HD13 ' A' ' 311' ' ' LEU . 26.9 m-85 -83.57 156.16 65.37 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.703 0.763 . . . . 0.0 110.858 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -45.21 -52.91 5.91 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.702 2.268 . . . . 0.0 112.287 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -133.92 162.37 32.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -61.14 -42.6 98.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -51.8 -58.23 7.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 72.2 mt -53.08 -61.03 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -42.84 -59.78 1.84 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -43.05 -60.38 1.66 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -43.57 -45.83 6.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.951 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -64.14 -33.66 76.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.15 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.574 HD13 ' CE1' ' A' ' 384' ' ' PHE . 7.1 tt -63.91 -61.65 2.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.923 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.05 -35.67 69.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.11 -42.95 68.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 11.7 t -105.12 41.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -92.21 94.49 9.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 100.64 40.76 2.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.521 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.406 ' CD1' HD22 ' A' ' 328' ' ' LEU . 54.9 t80 -87.63 108.96 19.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.954 0.406 . . . . 0.0 110.928 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -60.38 123.25 16.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 26.0 tp -135.97 132.82 36.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 48.35 45.75 20.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 57.51 34.19 68.52 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.51 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -150.56 114.13 4.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.339 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 45.7 mm -51.04 146.01 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . 0.427 HD21 ' C ' ' A' ' 380' ' ' LEU . 8.3 tt -104.7 140.39 38.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 78.9 t -123.93 125.04 70.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 11.8 mt -109.84 132.57 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.149 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -137.01 119.83 16.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.574 ' CE1' HD13 ' A' ' 367' ' ' LEU . 16.9 m-85 -48.67 114.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.478 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo . . . . . 0 N--CA 1.465 -0.153 0 CA-C-O 120.762 0.234 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -126.58 178.59 5.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -81.62 -28.09 33.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 81.7 t -95.0 138.68 20.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.202 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.519 HD12 ' CE1' ' A' ' 357' ' ' PHE . 77.7 mt -125.31 114.18 18.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.788 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 11.7 t80 -88.62 104.08 16.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.939 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 6.4 mp -92.52 150.84 20.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -140.84 -175.0 4.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 57.75 48.31 14.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 12.1 mt -104.09 124.89 49.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.9 t -67.6 145.05 98.09 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.659 0.742 . . . . 0.0 110.828 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.55 -27.41 3.48 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.705 2.27 . . . . 0.0 112.307 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 32.5 mtp85 -74.25 -38.33 63.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 93.2 t -41.36 146.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 44.6 p -148.73 159.38 44.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.152 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.426 ' C ' ' OE1' ' A' ' 322' ' ' GLU . 1.2 tm-20 -41.02 -32.27 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . 0.414 ' NH1' ' HB2' ' A' ' 323' ' ' ARG . 17.7 ttm105 -60.66 -58.12 9.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.956 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -45.8 -48.55 15.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 36.1 mt -57.84 -51.64 68.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 69.4 t -45.83 -47.34 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 8.8 t -67.28 -37.73 83.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.831 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 51.0 mt -56.52 -34.35 66.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.934 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -127.9 32.85 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -71.24 -52.14 20.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.099 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -40.06 -49.77 2.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.834 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.919 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 83.9 mt . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.913 0.387 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -92.32 138.36 31.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . 0.432 ' CD2' HG21 ' A' ' 355' ' ' ILE . 80.2 m-85 -127.72 136.1 51.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.841 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -134.32 122.78 23.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.873 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 45.4 tpp -110.07 133.29 53.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 26.5 ttm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 179.906 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.431 ' N ' ' CD ' ' A' ' 352' ' ' GLN . 3.0 mp0 -112.18 141.74 45.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.816 0.341 . . . . 0.0 110.891 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.59 153.63 41.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.033 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.788 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 50.7 m-85 -125.24 124.19 41.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.511 HG22 ' CE1' ' A' ' 357' ' ' PHE . 71.3 mt -117.75 137.65 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.136 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 83.4 m -113.9 128.68 56.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.519 ' CE1' HD12 ' A' ' 311' ' ' LEU . 69.8 m-85 -109.46 157.05 38.43 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 0.0 110.875 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -42.8 -34.97 3.91 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.62 2.213 . . . . 0.0 112.398 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . 0.448 ' ND2' ' H ' ' A' ' 362' ' ' ILE . 0.7 OUTLIER -159.44 -177.34 6.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -71.96 -45.62 60.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -43.12 -66.04 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . 0.448 ' H ' ' ND2' ' A' ' 359' ' ' ASN . 58.1 mt -51.1 -69.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.152 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 362' ' ' ILE . . . -36.3 -57.36 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -48.43 -57.28 6.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -50.28 -41.86 51.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.95 90.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.009 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.551 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 4.8 tt -60.75 -60.65 3.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 110.932 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -62.08 -35.18 77.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 32.2 mt -67.46 -40.48 85.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 10.5 t -107.18 32.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.71 125.41 29.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 64.88 38.31 95.37 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.445 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -78.65 124.93 28.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.877 0.37 . . . . 0.0 110.958 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -78.41 121.21 24.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 29.8 tp -125.77 143.97 50.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 38.46 33.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 72.13 47.81 28.82 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.433 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 378' ' ' LYS . 2.4 ptmt -165.92 120.49 1.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.825 0.345 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 46.6 mm -51.49 142.6 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.138 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . 0.468 ' CD2' HG13 ' A' ' 382' ' ' ILE . 5.6 tt -110.4 143.38 40.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 11.7 t -112.78 142.42 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.071 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.468 HG13 ' CD2' ' A' ' 380' ' ' LEU . 27.5 mt -134.56 136.14 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.153 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . 0.45 ' OE1' ' C ' ' A' ' 382' ' ' ILE . 4.8 mp0 -138.63 178.93 6.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.968 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.551 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 48.7 m-85 -105.04 133.93 49.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.93 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.462 -179.92 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo . . . . . 0 N--CA 1.466 -0.113 0 CA-C-O 120.808 0.254 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -130.09 -177.79 4.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.425 ' C ' ' HD3' ' A' ' 309' ' ' LYS . 0.0 OUTLIER -99.12 -14.13 19.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.972 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 69.2 t -111.79 115.07 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.051 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.473 HD21 ' CE1' ' A' ' 384' ' ' PHE . 58.8 mt -100.32 140.23 34.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.849 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.752 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 10.6 t80 -122.27 102.88 8.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.964 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 6.6 mp -86.04 150.98 24.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.552 ' HE2' ' CD2' ' A' ' 312' ' ' TYR . 41.3 mttt -139.79 -175.9 4.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.919 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 54.59 52.35 12.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.0 mt -110.21 104.6 13.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 36.2 t -47.22 143.98 4.59 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.728 0.775 . . . . 0.0 110.823 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.37 -19.01 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.69 2.26 . . . . 0.0 112.335 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 30.5 mtt180 -77.38 -36.39 53.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . 0.443 HG13 ' N ' ' A' ' 321' ' ' THR . 95.9 t -44.88 152.15 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 322' ' ' GLU . 35.3 p -158.78 166.52 31.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.164 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 321' ' ' THR . 7.3 mt-10 -34.78 -55.57 0.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.79 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 322' ' ' GLU . 60.3 mtp180 -37.45 -46.49 0.81 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -56.35 -59.71 4.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 23.1 mt -57.05 -51.2 70.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.926 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 92.6 t -53.11 -56.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.131 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 25.4 t -58.85 -39.51 81.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.9 mt -60.37 -40.52 91.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.402 ' CE1' HG22 ' A' ' 370' ' ' VAL . 28.9 m-85 -124.2 48.27 1.95 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.879 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -83.73 -57.45 3.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.992 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . 0.413 ' HB3' ' NH1' ' A' ' 331' ' ' ARG . 3.4 ptp180 -42.73 -46.1 5.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.891 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.439 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 74.3 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 71.0 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.766 0.317 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -96.18 137.15 35.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -120.08 151.65 38.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -141.27 125.24 17.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 40.4 tpp -112.94 133.63 54.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 11.9 ttm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.879 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 312' ' ' TYR . 2.8 mp0 -132.75 151.37 52.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 110.87 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -153.28 150.37 28.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.089 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.752 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 46.5 m-85 -114.64 152.72 31.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.456 HG23 ' CE1' ' A' ' 357' ' ' PHE . 94.7 mt -139.16 142.84 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.102 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 49.7 m -124.86 121.73 35.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.141 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.456 ' CE1' HG23 ' A' ' 355' ' ' ILE . 62.2 m-85 -104.57 157.2 34.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.666 0.746 . . . . 0.0 110.802 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -46.29 -37.1 18.35 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.626 2.217 . . . . 0.0 112.368 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -149.12 174.44 12.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -71.19 -28.71 64.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -60.13 -63.33 1.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 59.2 mt -50.48 -57.53 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -40.95 -61.49 0.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.082 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -48.09 -63.07 1.17 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -43.48 -41.73 4.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.928 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -63.05 -42.51 99.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.064 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.02 -58.41 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -55.39 -31.28 61.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 51.3 mt -78.02 -37.32 47.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . 0.402 HG22 ' CE1' ' A' ' 329' ' ' PHE . 16.4 t -111.27 37.27 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.74 124.72 29.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 63.08 43.01 99.41 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.483 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' A' ' 374' ' ' LYS . 13.9 t80 -78.61 134.79 37.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 0.0 110.952 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.434 ' O ' ' CE1' ' A' ' 373' ' ' TYR . 21.1 ttmt -86.33 119.48 26.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 18.1 tp -133.83 120.7 20.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 53.34 41.17 32.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 67.21 31.29 77.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.451 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . 0.414 ' NZ ' ' HA ' ' A' ' 378' ' ' LYS . 0.0 OUTLIER -134.83 130.05 35.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.749 0.309 . . . . 0.0 110.829 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 33.7 mm -76.92 92.19 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 8.1 tt -61.16 114.69 3.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 34.1 t -101.05 127.98 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.107 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 32.5 mt -104.79 126.8 59.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -128.65 125.73 38.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.835 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.473 ' CE1' HD21 ' A' ' 311' ' ' LEU . 44.8 m-85 -59.25 158.51 9.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.841 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 384' ' ' PHE . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo . . . . . 0 N--CA 1.466 -0.141 0 CA-C-O 120.782 0.242 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -115.73 176.75 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.43 5.24 48.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 60.5 t -127.72 129.75 70.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 49.3 mt -116.42 121.45 41.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.795 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 17.5 t80 -105.14 104.84 14.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.933 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.451 HD11 ' N ' ' A' ' 313' ' ' LEU . 3.2 mp -91.31 144.02 26.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.942 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -133.44 179.46 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.3 m120 57.23 51.83 9.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.8 mt -108.96 107.57 17.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.5 t -40.48 144.7 0.56 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.702 0.763 . . . . 0.0 110.893 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -47.16 -28.35 7.61 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.66 2.24 . . . . 0.0 112.336 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 24.2 mtt85 -73.51 -30.84 63.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 84.9 t -51.26 119.34 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.125 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 17.2 p -124.72 172.77 9.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -44.37 -44.0 7.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 64.9 mtt-85 -48.56 -54.73 13.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -49.13 -45.03 42.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 57.6 mt -62.63 -53.52 53.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 330' ' ' ALA . 81.6 t -44.36 -49.35 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 47.2 t -65.4 -45.64 83.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.833 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 57.8 mt -52.55 -36.8 56.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.949 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.522 ' CE1' HG21 ' A' ' 370' ' ' VAL . 25.4 m-85 -132.36 44.35 2.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.857 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -80.35 -52.82 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.051 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -37.32 -32.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.84 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 330' ' ' ALA . 86.6 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 64.3 mt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.768 0.318 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -96.31 127.85 42.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -117.66 142.42 47.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.427 ' HD3' ' N ' ' A' ' 344' ' ' MET . 0.8 OUTLIER -140.9 132.12 26.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.854 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.427 ' N ' ' HD3' ' A' ' 343' ' ' ARG . 39.7 tpp -113.83 143.43 44.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 21.3 ttm . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.916 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.404 ' C ' ' NE2' ' A' ' 352' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.426 ' HB3' ' CE1' ' A' ' 312' ' ' TYR . 10.1 mp0 -142.41 143.53 32.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 0.0 110.887 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.87 152.78 40.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.795 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 82.5 m-85 -120.27 132.67 55.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.557 HG22 ' CE1' ' A' ' 357' ' ' PHE . 78.4 mt -124.14 138.02 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.118 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 17.1 m -117.09 117.8 30.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.19 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.557 ' CE1' HG22 ' A' ' 355' ' ' ILE . 50.1 m-85 -98.86 158.17 32.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.696 0.76 . . . . 0.0 110.861 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.19 -35.59 15.44 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.661 2.241 . . . . 0.0 112.355 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -158.42 166.77 31.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 361' ' ' GLU . 8.7 pttt -58.0 -49.71 75.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 360' ' ' LYS . 2.2 tt0 -36.7 -63.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.878 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 55.0 mt -56.13 -62.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.131 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -38.6 -59.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.087 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -47.38 -58.16 4.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.404 ' O ' ' CG ' ' A' ' 369' ' ' LEU . 6.6 mm100 -53.76 -35.39 61.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -68.12 -38.42 82.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.14 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.539 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.4 tt -66.54 -56.79 9.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . 0.421 ' N ' HD21 ' A' ' 367' ' ' LEU . 9.3 t-80 -60.96 -38.02 84.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.776 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.404 ' CG ' ' O ' ' A' ' 365' ' ' GLN . 37.3 mt -65.72 -40.91 92.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . 0.522 HG21 ' CE1' ' A' ' 329' ' ' PHE . 7.3 t -106.15 28.96 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . 0.451 ' CG ' ' O ' ' A' ' 371' ' ' ASN . 0.8 OUTLIER -76.43 116.23 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 73.46 45.94 27.71 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.501 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.431 ' CE1' ' O ' ' A' ' 374' ' ' LYS . 38.6 t80 -85.32 138.07 32.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.912 0.386 . . . . 0.0 110.901 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.431 ' O ' ' CE1' ' A' ' 373' ' ' TYR . 22.4 ttmt -89.26 124.89 34.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 376' ' ' TYR . 60.7 tp -135.88 150.42 49.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.952 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 375' ' ' LEU . 25.2 m-85 35.57 35.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.953 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 375' ' ' LEU . . . 66.73 53.06 29.71 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.51 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -171.83 126.46 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.757 0.313 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 41.9 mm -56.28 144.71 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.161 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . 0.423 ' C ' ' CD2' ' A' ' 380' ' ' LEU . 3.6 tt -112.34 140.37 47.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 23.6 t -110.51 144.48 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 370' ' ' VAL . 23.6 mt -131.42 151.88 36.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.086 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -148.56 175.42 11.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.539 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 29.5 m-85 -104.51 154.2 20.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.472 -179.963 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 C--O 1.23 0.124 0 CA-C-O 120.74 0.225 . . . . 0.0 112.389 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -106.52 172.09 7.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.4 ' HZ1' ' CG2' ' A' ' 356' ' ' THR . 0.0 OUTLIER -84.64 9.89 12.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.824 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 70.5 t -130.94 128.43 62.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.572 HD13 ' CE1' ' A' ' 357' ' ' PHE . 41.5 mt -114.33 122.29 46.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.788 ' CE1' ' CZ ' ' A' ' 354' ' ' PHE . 17.2 t80 -101.77 107.02 18.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.931 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 8.8 mp -87.37 142.93 27.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -138.68 175.33 9.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 60.54 53.43 4.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.2 mt -113.42 109.97 19.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.2 t -47.49 143.92 5.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.722 0.773 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.12 -19.08 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -78.23 -39.83 39.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 87.7 t -49.78 133.83 8.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 55.2 p -133.54 170.0 16.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -43.69 -47.32 7.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -45.0 -57.65 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -49.01 -43.09 40.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 21.3 mt -62.69 -48.56 78.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 62.4 t -51.86 -52.36 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.1 m -61.49 -37.39 83.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.794 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.55 HD22 ' CE2' ' A' ' 373' ' ' TYR . 31.0 mt -59.15 -37.65 77.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.949 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.475 ' CE2' HG21 ' A' ' 370' ' ' VAL . 12.0 m-85 -126.27 42.15 3.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -81.2 -47.42 13.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 331' ' ' ARG . 3.5 ptm85 -46.38 -34.94 5.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 -179.934 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.479 HG21 ' CE1' ' A' ' 342' ' ' PHE . 66.9 mt . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.747 0.308 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -87.54 142.41 27.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . 0.479 ' CE1' HG21 ' A' ' 340' ' ' ILE . 7.5 m-85 -126.73 144.26 50.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.816 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.2 ttt-85 -141.08 132.67 27.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.2 ttm -115.4 147.34 40.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.877 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 22.2 ttm . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.894 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -137.07 142.3 42.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.892 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -148.59 153.26 38.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.09 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.788 ' CZ ' ' CE1' ' A' ' 312' ' ' TYR . 77.9 m-85 -124.78 129.65 50.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.83 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.471 HG21 ' N ' ' A' ' 356' ' ' THR . 56.8 mt -123.65 140.35 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.165 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.471 ' N ' HG21 ' A' ' 355' ' ' ILE . 55.8 m -114.91 129.37 56.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.572 ' CE1' HD13 ' A' ' 311' ' ' LEU . 23.7 m-85 -106.2 156.57 36.63 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.682 0.753 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -46.11 -40.66 21.31 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.755 2.303 . . . . 0.0 112.337 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -141.26 -176.62 4.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.83 -37.0 19.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.36 -56.37 20.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 60.0 mt -54.36 -56.05 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.089 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -44.95 -59.26 2.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.075 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . 0.409 ' O ' ' N ' ' A' ' 367' ' ' LEU . 4.8 t90 -48.42 -66.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -40.1 -41.61 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -71.66 -39.67 70.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.079 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.57 HD11 ' CZ ' ' A' ' 384' ' ' PHE . 5.3 tt -55.88 -50.39 70.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -69.21 -35.8 76.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 31.2 mt -62.91 -47.95 81.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . 0.475 HG21 ' CE2' ' A' ' 329' ' ' PHE . 25.2 t -82.71 -28.33 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.057 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 370' ' ' VAL . 0.3 OUTLIER -36.01 120.77 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.936 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 83.28 36.29 15.11 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.414 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.55 ' CE2' HD22 ' A' ' 328' ' ' LEU . 61.0 t80 -91.79 103.43 15.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.943 0.401 . . . . 0.0 110.946 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm -71.2 101.85 2.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 26.5 tp -114.62 125.47 53.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.952 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 49.51 38.24 14.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 70.01 37.24 73.6 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.503 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -141.03 121.61 14.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 38.8 mm -76.02 86.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . 0.464 ' CD2' HG13 ' A' ' 382' ' ' ILE . 7.5 tt -47.76 135.09 12.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 76.4 t -117.15 111.49 35.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.079 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.464 HG13 ' CD2' ' A' ' 380' ' ' LEU . 43.1 mt -98.64 119.2 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -130.14 127.36 39.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.57 ' CZ ' HD11 ' A' ' 367' ' ' LEU . 48.0 m-85 -54.27 140.71 32.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.928 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.544 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . 0.422 ' HA ' ' CE2' ' A' ' 384' ' ' PHE . 61.2 Cg_endo . . . . . 0 C--O 1.231 0.134 0 CA-C-O 120.805 0.252 . . . . 0.0 112.348 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -128.96 164.23 23.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.26 9.46 6.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 74.3 t -130.68 129.31 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.112 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.452 HD11 ' CE1' ' A' ' 357' ' ' PHE . 64.4 mt -115.96 118.61 33.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.669 ' CE1' ' CZ ' ' A' ' 354' ' ' PHE . 8.0 t80 -102.13 111.36 23.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 313' ' ' LEU . 4.8 mp -96.58 147.66 23.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.932 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -141.16 -175.52 4.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 5.0 m120 56.19 54.97 7.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.4 mt -114.78 109.66 18.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.941 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 17.8 t -50.88 144.05 14.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.661 0.743 . . . . 0.0 110.89 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -46.53 -20.73 1.07 Allowed 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.735 2.29 . . . . 0.0 112.286 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 47.1 mmt-85 -75.13 -35.34 61.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . 0.418 HG11 ' CG ' ' A' ' 324' ' ' ASP . 66.1 t -45.68 137.58 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 322' ' ' GLU . 39.0 p -132.12 150.77 52.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 321' ' ' THR . 5.4 tp10 -33.56 -41.34 0.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -46.72 -55.37 7.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.836 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . 0.418 ' CG ' HG11 ' A' ' 320' ' ' VAL . 0.2 OUTLIER -46.72 -44.41 18.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 36.2 mt -63.09 -47.45 82.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 67.5 t -57.09 -49.93 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 1.8 m -65.56 -42.44 91.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 23.2 mt -52.37 -41.17 62.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -125.38 40.8 3.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -74.82 -40.8 60.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.091 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . 0.464 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 10.2 ptt-85 -50.47 -45.56 56.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.464 ' N ' ' HG3' ' A' ' 331' ' ' ARG . 25.5 m-85 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.521 HD12 ' CE2' ' A' ' 357' ' ' PHE . 70.2 mt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.833 0.349 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -90.2 120.27 31.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -105.85 138.99 41.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -136.87 129.81 30.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 35.5 tpp -111.1 146.32 37.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 20.0 ttm . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.833 179.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -133.37 145.48 50.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.834 0.349 . . . . 0.0 110.952 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -147.23 145.43 29.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.669 ' CZ ' ' CE1' ' A' ' 312' ' ' TYR . 71.2 m-85 -116.76 123.95 48.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 83.8 mt -114.19 141.24 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.084 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 85.1 m -117.88 114.74 23.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.145 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.521 ' CE2' HD12 ' A' ' 340' ' ' ILE . 38.6 m-85 -97.47 158.62 32.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.636 0.732 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -43.89 -43.99 11.98 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.739 2.292 . . . . 0.0 112.337 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.13 -175.29 5.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.952 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -74.65 -39.33 62.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -47.75 -66.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 57.2 mt -55.03 -55.72 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.107 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -43.12 -60.89 1.48 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -46.74 -59.63 2.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.835 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -45.84 -43.86 13.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.972 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.1 95.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.08 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.569 HD11 ' CE1' ' A' ' 384' ' ' PHE . 7.1 tt -63.82 -51.8 63.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.916 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . 0.454 ' N ' HD23 ' A' ' 367' ' ' LEU . 11.7 t60 -62.77 -33.75 75.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 25.3 mt -72.11 -42.07 66.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.971 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 11.2 t -105.64 31.75 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.145 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.73 127.77 33.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 58.79 45.0 95.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.497 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -84.06 113.32 20.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.903 0.383 . . . . 0.0 110.958 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 28.0 tttt -66.25 104.31 1.16 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 10.6 tp -118.56 135.91 54.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 42.43 50.45 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 53.84 41.19 66.5 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.505 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -156.45 110.26 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.781 0.324 . . . . 0.0 110.854 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 31.8 mm -51.44 118.71 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.084 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . 0.416 ' C ' HD23 ' A' ' 380' ' ' LEU . 7.9 tt -77.52 114.9 16.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.941 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 45.4 t -94.59 118.93 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.151 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.411 ' CG1' ' CD2' ' A' ' 380' ' ' LEU . 36.9 mt -107.53 127.8 63.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -139.32 130.55 26.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 367' ' ' LEU . 28.0 m-85 -57.71 132.56 53.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.452 -179.946 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 384' ' ' PHE . 61.4 Cg_endo . . . . . 0 N--CA 1.466 -0.122 0 CA-C-O 120.741 0.225 . . . . 0.0 112.404 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -139.65 162.03 36.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.937 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.408 ' CE ' HG23 ' A' ' 356' ' ' THR . 11.9 ptmt -70.87 -25.06 62.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.939 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 94.9 t -106.14 143.24 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.502 HD12 ' CE1' ' A' ' 357' ' ' PHE . 52.7 mt -124.35 121.42 34.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.974 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.756 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 9.4 t80 -95.4 102.61 14.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.952 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 7.5 mp -85.99 134.09 33.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -133.43 -177.07 4.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 60.22 52.17 5.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.8 mt -113.96 122.49 47.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 13.7 t -61.8 143.77 93.9 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.655 0.741 . . . . 0.0 110.821 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.44 -25.12 2.0 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.682 2.255 . . . . 0.0 112.306 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -74.34 -39.57 62.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.831 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 99.4 t -39.33 134.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 322' ' ' GLU . 35.2 p -126.89 150.5 49.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.136 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 321' ' ' THR . 7.9 tp10 -34.36 -41.54 0.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -45.33 -55.93 5.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . 0.489 ' CG ' ' N ' ' A' ' 325' ' ' LEU . 0.3 OUTLIER -44.12 -51.76 7.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.924 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.489 ' N ' ' CG ' ' A' ' 324' ' ' ASP . 39.0 mt -56.33 -48.38 76.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.934 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 84.7 t -55.7 -53.09 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.146 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 31.2 t -64.51 -33.61 76.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.422 HD22 ' CD2' ' A' ' 373' ' ' TYR . 21.6 mt -65.65 -35.09 79.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.53 ' CE2' HG22 ' A' ' 370' ' ' VAL . 38.6 m-85 -128.04 44.73 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.892 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -82.48 -58.69 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . 0.447 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 15.6 ptp180 -41.1 -42.09 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.561 ' CE2' ' HB1' ' A' ' 366' ' ' ALA . 31.4 m-85 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 341' ' ' GLN . 73.0 mt . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.805 0.336 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . 0.465 ' N ' HG22 ' A' ' 340' ' ' ILE . 7.5 mm-40 -97.7 136.25 38.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . 0.47 ' CE2' HD13 ' A' ' 355' ' ' ILE . 29.6 m-85 -123.51 142.09 51.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -140.62 128.14 21.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 14.9 ttm -110.22 146.38 35.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.823 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.882 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -137.97 156.57 47.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.738 0.304 . . . . 0.0 110.92 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -157.57 155.82 30.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.756 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 46.0 m-85 -127.01 126.0 42.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.498 HG23 ' CE1' ' A' ' 357' ' ' PHE . 97.6 mt -119.18 145.54 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.408 HG23 ' CE ' ' A' ' 309' ' ' LYS . 69.6 m -121.31 129.66 53.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.502 ' CE1' HD12 ' A' ' 311' ' ' LEU . 48.9 m-85 -109.97 158.46 34.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.694 0.759 . . . . 0.0 110.85 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.61 -52.05 7.29 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.685 2.256 . . . . 0.0 112.334 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -138.73 170.61 15.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -66.81 -38.62 86.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -49.78 -65.8 0.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 97.0 mt -51.92 -57.5 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.091 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -41.05 -53.02 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.107 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 12.9 t90 -54.68 -65.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -36.93 -46.71 0.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . 0.561 ' HB1' ' CE2' ' A' ' 332' ' ' PHE . . . -66.58 -49.95 64.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.094 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.461 ' CD2' ' C ' ' A' ' 367' ' ' LEU . 4.5 tt -49.66 -50.31 43.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.853 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -65.42 -36.09 82.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 31.6 mt -64.63 -60.02 3.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . 0.53 HG22 ' CE2' ' A' ' 329' ' ' PHE . 20.4 t -68.45 -33.02 57.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 370' ' ' VAL . 1.5 t-20 -35.14 107.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.965 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 99.18 33.14 5.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.422 ' CD2' HD22 ' A' ' 328' ' ' LEU . 31.8 t80 -96.14 108.28 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.994 0.426 . . . . 0.0 110.97 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -78.75 105.22 9.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.928 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.559 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 21.5 tp -108.76 135.38 50.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.916 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . 0.559 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 57.9 m-85 52.85 27.16 5.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 79.44 34.34 32.47 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.483 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -149.9 122.07 8.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.741 0.305 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 20.5 mm -63.54 136.49 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.167 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . 0.426 ' CD2' HG13 ' A' ' 382' ' ' ILE . 8.2 tt -96.73 132.96 41.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 55.9 t -113.84 119.86 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.426 HG13 ' CD2' ' A' ' 380' ' ' LEU . 18.3 mt -103.96 139.47 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -136.86 120.08 16.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 307' ' ' PRO . 35.8 m-85 -48.89 118.12 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.505 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . 0.565 ' HA ' ' CE1' ' A' ' 384' ' ' PHE . 72.6 Cg_exo . . . . . 0 C--O 1.231 0.141 0 CA-C-O 120.838 0.266 . . . . 0.0 112.335 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . 0.415 ' C ' ' HA ' ' A' ' 360' ' ' LYS . 76.0 m-20 -124.87 164.87 19.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.61 13.86 3.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.59 129.41 40.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.119 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 76.9 mt -120.25 117.87 28.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.983 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.789 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 7.4 t80 -93.97 105.72 17.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.467 ' CD2' HD12 ' A' ' 355' ' ' ILE . 4.4 mp -88.28 145.02 26.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.909 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.43 ' HG3' ' C ' ' A' ' 313' ' ' LEU . 16.6 mtpp -143.31 170.89 14.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 67.46 54.92 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 12.9 mt -114.77 120.9 41.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 22.6 t -57.33 143.84 72.53 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.674 0.75 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -43.94 -27.2 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.671 2.247 . . . . 0.0 112.385 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -71.16 -38.73 72.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 66.0 t -47.05 122.44 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 44.8 p -127.31 168.67 14.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.18 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -39.22 -48.79 1.83 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.913 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . 0.436 ' NH1' ' HB2' ' A' ' 323' ' ' ARG . 0.0 OUTLIER -44.52 -49.87 9.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -53.7 -50.99 64.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 76.4 mt -55.33 -51.93 65.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.965 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 330' ' ' ALA . 97.5 t -46.98 -59.54 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.094 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 2.6 t -54.0 -47.51 71.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 31.9 mt -49.62 -46.27 49.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -119.9 41.8 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -85.15 -25.16 27.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.035 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -64.79 -37.14 86.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.92 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 71.1 mt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.767 0.317 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -89.68 116.12 27.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.49 130.49 54.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -129.94 117.89 20.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.832 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.1 ttm -103.95 146.85 28.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 34.3 mtm . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -152.91 142.49 21.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.49 142.87 29.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.076 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.789 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 53.0 m-85 -105.45 115.79 30.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.557 HG21 ' CE1' ' A' ' 357' ' ' PHE . 64.2 mt -108.39 129.42 62.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.12 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 27.1 m -109.53 116.06 31.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.557 ' CE1' HG21 ' A' ' 355' ' ' ILE . 36.9 m-85 -94.46 159.17 34.33 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.728 0.775 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -44.85 -47.55 11.67 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.242 . . . . 0.0 112.372 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -142.67 176.47 9.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . 0.415 ' HA ' ' C ' ' A' ' 308' ' ' ASN . 0.0 OUTLIER -74.78 -29.21 61.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . 0.411 ' N ' ' HG2' ' A' ' 360' ' ' LYS . 77.8 mt-10 -62.33 -56.95 13.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 68.5 mt -56.09 -56.39 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.077 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -49.86 -48.62 51.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -51.22 -49.12 61.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -60.96 -52.72 63.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.942 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.25 67.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.049 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.553 HD11 ' CE2' ' A' ' 384' ' ' PHE . 5.9 tt -65.02 -67.04 0.47 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . 0.465 ' N ' HD23 ' A' ' 367' ' ' LEU . 10.3 t-80 -46.35 -36.1 6.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.84 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.5 mt -71.61 -58.3 3.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.862 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . 0.458 ' O ' ' CD1' ' A' ' 382' ' ' ILE . 9.3 t -82.59 37.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.099 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -84.94 136.2 33.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 49.28 38.42 26.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.519 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.549 ' CE1' ' O ' ' A' ' 374' ' ' LYS . 33.4 t80 -78.21 130.39 36.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.951 0.405 . . . . 0.0 110.905 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.549 ' O ' ' CE1' ' A' ' 373' ' ' TYR . 17.5 tttm -71.14 129.79 39.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.881 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 19.1 tp -143.56 124.47 14.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 43.77 48.25 6.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 59.89 42.46 98.2 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.499 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -155.47 119.25 4.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.338 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 48.3 mm -61.51 107.59 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.119 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . 0.414 ' C ' HD22 ' A' ' 380' ' ' LEU . 8.4 tt -71.33 115.63 10.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 382' ' ' ILE . 90.6 t -99.74 136.4 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.141 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.458 ' CD1' ' O ' ' A' ' 370' ' ' VAL . 57.5 mt -113.39 135.15 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -137.45 118.8 14.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.565 ' CE1' ' HA ' ' A' ' 307' ' ' PRO . 59.9 m-85 -47.97 151.54 0.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.509 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 384' ' ' PHE . 61.3 Cg_endo . . . . . 0 C--O 1.23 0.105 0 CA-C-O 120.783 0.243 . . . . 0.0 112.334 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -137.76 168.64 19.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 310' ' ' VAL . 13.1 ptmt -72.79 -33.61 66.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.907 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . 0.423 ' N ' ' HG3' ' A' ' 309' ' ' LYS . 55.6 t -98.22 145.92 8.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.143 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.565 HD13 ' CE1' ' A' ' 357' ' ' PHE . 56.9 mt -127.63 114.43 17.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.573 ' CZ ' ' CG ' ' A' ' 314' ' ' LYS . 6.4 t80 -89.31 105.94 18.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.933 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.462 ' N ' HD13 ' A' ' 313' ' ' LEU . 6.3 mp -93.22 148.05 22.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.573 ' CG ' ' CZ ' ' A' ' 312' ' ' TYR . 0.0 OUTLIER -144.5 177.12 8.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 378' ' ' LYS . 1.6 t30 67.49 53.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 15.6 mt -118.03 112.07 19.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.2 t -38.63 154.29 0.14 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.65 0.738 . . . . 0.0 110.855 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.62 1.96 3.3 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.679 2.253 . . . . 0.0 112.363 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -108.43 -24.83 11.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . 0.42 HG22 ' CG ' ' A' ' 376' ' ' TYR . 95.5 t -50.98 142.65 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.131 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 64.6 p -133.89 162.85 30.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 323' ' ' ARG . 6.2 tt0 -38.81 -53.76 1.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.909 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 322' ' ' GLU . 56.7 ttt180 -34.78 -42.71 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -62.66 -50.71 70.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 322' ' ' GLU . 15.6 mt -60.04 -48.51 81.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 78.9 t -49.33 -60.46 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.066 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 23.8 t -53.62 -38.58 64.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.9 mt -62.4 -41.24 98.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -119.56 46.02 2.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -92.31 -58.26 2.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.09 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -38.37 -47.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.899 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.503 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 49.0 m-85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.437 ' CD1' ' CE2' ' A' ' 357' ' ' PHE . 73.6 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.808 0.337 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -87.65 133.56 33.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -118.62 140.16 50.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -137.97 123.51 19.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 46.6 tpp -103.26 133.3 48.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 20.0 tpp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.936 179.92 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -146.83 147.08 30.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 0.0 110.939 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -154.99 142.44 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.081 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 312' ' ' TYR . 50.8 m-85 -120.2 121.95 39.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.825 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 80.6 mt -115.22 145.15 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.11 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 25.9 m -122.22 117.75 26.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.565 ' CE1' HD13 ' A' ' 311' ' ' LEU . 63.4 m-85 -99.73 157.39 34.01 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.606 0.717 . . . . 0.0 110.88 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -42.33 -40.11 6.76 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.652 2.235 . . . . 0.0 112.372 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.52 171.04 20.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 361' ' ' GLU . 11.0 pttm -58.08 -53.99 52.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 360' ' ' LYS . 45.7 mt-10 -36.52 -64.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.45 -56.93 9.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.136 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -42.27 -60.62 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.089 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 367' ' ' LEU . 13.5 t90 -47.63 -64.61 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.938 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -37.67 -46.15 0.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -64.76 -38.13 89.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.037 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.567 HD12 ' CZ ' ' A' ' 384' ' ' PHE . 7.7 tt -62.04 -61.31 2.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.883 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -56.24 -30.12 61.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 28.9 mt -72.94 -50.94 20.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.955 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 370' ' ' VAL . 25.4 t -98.74 37.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.142 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . 0.421 ' O ' ' CG ' ' A' ' 371' ' ' ASN . 0.7 OUTLIER -88.12 87.65 7.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 111.44 42.55 1.05 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -89.27 125.99 35.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.988 0.423 . . . . 0.0 110.917 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -74.29 94.0 2.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 16.2 tp -104.3 132.0 51.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.99 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . 0.42 ' CG ' HG22 ' A' ' 320' ' ' VAL . 5.3 m-85 46.09 42.46 9.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 64.64 40.63 97.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . 0.465 ' HB3' ' ND2' ' A' ' 315' ' ' ASN . 81.4 mttt -152.57 149.25 28.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.757 0.313 . . . . 0.0 110.953 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 15.8 mm -84.26 107.41 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.116 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . 0.466 ' CD2' HG13 ' A' ' 382' ' ' ILE . 8.2 tt -72.76 131.21 42.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.847 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.463 ' N ' HD22 ' A' ' 380' ' ' LEU . 41.0 t -113.1 114.45 46.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.087 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.466 HG13 ' CD2' ' A' ' 380' ' ' LEU . 31.6 mt -98.32 129.87 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -126.82 168.02 15.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.567 ' CZ ' HD12 ' A' ' 367' ' ' LEU . 26.3 m-85 -94.76 137.08 34.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.457 -179.94 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo . . . . . 0 N--CA 1.465 -0.156 0 CA-C-O 120.81 0.254 . . . . 0.0 112.272 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -107.09 175.63 5.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -85.8 -26.59 25.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.936 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 88.2 t -97.53 124.36 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.48 HD13 ' CE1' ' A' ' 357' ' ' PHE . 66.5 mt -113.05 115.06 27.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.934 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.795 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 16.4 t80 -87.85 104.06 16.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 8.3 mp -85.84 138.17 32.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.918 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -134.06 177.03 8.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . 0.436 ' ND2' ' HB3' ' A' ' 378' ' ' LYS . 1.7 t30 61.89 54.71 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.845 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.4 mt -111.0 127.71 55.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.456 ' HB2' ' CD ' ' A' ' 378' ' ' LYS . 29.4 t -61.91 143.35 94.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.648 0.737 . . . . 0.0 110.903 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -47.12 -19.47 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.604 2.203 . . . . 0.0 112.418 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -82.47 -33.29 28.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . 0.418 HG12 ' CG ' ' A' ' 324' ' ' ASP . 99.4 t -44.1 133.04 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 322' ' ' GLU . 68.8 p -129.63 151.56 50.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 321' ' ' THR . 9.3 tt0 -34.55 -38.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -48.16 -56.21 8.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . 0.418 ' CG ' HG12 ' A' ' 320' ' ' VAL . 0.3 OUTLIER -46.46 -45.05 17.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 42.3 mt -61.62 -46.22 90.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 65.8 t -56.32 -53.08 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 38.8 t -63.15 -41.67 99.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.851 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 24.0 mt -55.26 -41.48 72.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.971 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.411 ' CD1' ' HB3' ' A' ' 366' ' ' ALA . 19.0 m-85 -122.23 40.85 3.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -79.2 -54.76 5.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.135 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -39.76 -33.34 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 179.996 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.418 HG21 ' N ' ' A' ' 341' ' ' GLN . 71.6 mt . . . . . 0 N--CA 1.458 -0.038 0 CA-C-O 120.834 0.349 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . 0.418 ' N ' HG21 ' A' ' 340' ' ' ILE . 60.9 mt-30 -98.52 123.38 42.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -114.4 140.26 48.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -141.23 124.31 16.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.891 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 41.2 tpp -108.63 137.58 46.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.813 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' MET . . . . . 0.471 ' HE3' ' N ' ' A' ' 345' ' ' MET . 1.4 mpp? . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -144.41 142.89 30.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 0.0 110.919 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.74 146.01 31.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.795 ' CE2' ' CE1' ' A' ' 312' ' ' TYR . 39.9 m-85 -111.72 124.02 51.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.502 HG23 ' CE1' ' A' ' 357' ' ' PHE . 79.0 mt -117.12 141.13 36.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.105 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.463 ' N ' HG21 ' A' ' 355' ' ' ILE . 35.8 m -119.84 118.47 30.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.502 ' CE1' HG23 ' A' ' 355' ' ' ILE . 32.5 m-85 -94.1 155.34 40.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.612 0.72 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.1 -32.23 18.2 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.241 . . . . 0.0 112.359 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -152.19 -179.42 7.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 8.6 pttm -78.07 -41.28 35.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . 0.435 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 36.1 mt-10 -54.04 -63.2 1.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 80.4 mt -47.17 -61.44 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 364' ' ' TRP . . . -44.36 -65.26 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.019 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' TRP . . . . . 0.408 ' C ' ' O ' ' A' ' 363' ' ' ALA . 6.1 t90 -36.46 -51.09 0.81 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.938 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -54.47 -53.29 56.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . 0.411 ' HB3' ' CD1' ' A' ' 329' ' ' PHE . . . -53.08 -40.66 64.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.53 HD11 ' CZ ' ' A' ' 384' ' ' PHE . 6.3 tt -59.57 -68.23 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . 0.431 ' N ' ' CD2' ' A' ' 367' ' ' LEU . 4.4 t60 -49.79 -33.79 17.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 35.3 mt -72.59 -39.14 67.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.967 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' VAL . . . . . 0.414 ' O ' ' CD1' ' A' ' 382' ' ' ILE . 31.3 t -109.81 40.57 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.74 141.58 32.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 48.37 30.36 8.01 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.451 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -70.46 108.82 4.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.933 0.397 . . . . 0.0 110.853 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -71.45 97.41 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.458 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 31.6 tp -101.46 131.6 47.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.915 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' TYR . . . . . 0.458 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 57.1 m-85 53.5 31.93 13.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 73.6 34.8 56.4 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . 0.456 ' CD ' ' HB2' ' A' ' 317' ' ' SER . 21.2 mtpp -142.77 112.37 6.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.697 0.284 . . . . 0.0 110.93 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 14.6 mm -52.83 100.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.166 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . 0.481 ' C ' HD22 ' A' ' 380' ' ' LEU . 7.8 tt -69.35 120.57 15.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.5 t -104.04 120.46 54.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.414 ' CD1' ' O ' ' A' ' 370' ' ' VAL . 65.6 mt -99.34 138.46 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.099 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -140.32 120.54 13.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.912 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.53 ' CZ ' HD11 ' A' ' 367' ' ' LEU . 42.7 m-85 -54.69 147.45 14.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.453 -179.949 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 98.7 p -84.43 168.57 15.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.368 . . . . 0.0 110.828 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 20.0 m -53.51 158.16 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 166.8 -54.6 0.24 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.531 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 8.3 m -62.33 128.25 35.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 0.0 110.924 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 23.8 t -160.94 132.24 5.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.967 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 95.79 74.09 1.2 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -76.74 -48.73 17.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 0.0 110.862 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.3 -45.79 11.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 5.4 pt -72.81 123.3 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -85.98 42.66 0.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm 61.91 50.29 4.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.5 128.97 89.32 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.56 0.695 . . . . 0.0 111.14 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -43.16 -31.89 2.76 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.709 2.272 . . . . 0.0 112.317 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 4.5 ptt? -153.34 105.53 2.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -76.43 51.98 0.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.875 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.9 m -86.64 139.09 31.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.854 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.9 -177.17 0.32 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.834 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.541 ' CE2' HG13 ' A' ' 381' ' ' VAL . 10.1 p90 -41.3 158.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.921 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -116.03 138.75 24.34 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.583 0.706 . . . . 0.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.47 -35.66 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.679 2.252 . . . . 0.0 112.293 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 86.77 -127.27 8.31 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.528 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.465 ' CG ' ' HD2' ' A' ' 307' ' ' PRO . 27.9 tt0 -93.74 140.52 23.07 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.679 0.752 . . . . 0.0 110.856 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 306' ' ' GLU . 60.8 Cg_endo -75.33 126.87 10.04 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 0.0 112.33 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -126.15 179.18 5.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.464 ' CE ' HG21 ' A' ' 356' ' ' THR . 3.8 ptmt -81.5 -30.86 33.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 86.4 t -99.18 132.89 43.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.452 HD11 ' CE1' ' A' ' 357' ' ' PHE . 79.1 mt -112.29 152.74 28.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.96 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.788 ' CD1' ' CE2' ' A' ' 354' ' ' PHE . 10.3 t80 -124.22 101.76 7.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.948 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.451 HD11 ' N ' ' A' ' 313' ' ' LEU . 6.1 mp -90.63 139.73 30.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.939 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -137.36 -179.53 5.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 63.73 54.06 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.81 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 12.8 mt -116.26 127.09 54.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.968 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 45.1 t -65.56 143.88 98.76 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.643 0.735 . . . . 0.0 110.831 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.16 -22.14 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.7 2.266 . . . . 0.0 112.345 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 37.6 mtt-85 -77.07 -38.86 51.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 69.5 t -46.1 140.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.095 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 75.1 p -140.96 168.41 19.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.199 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -41.21 -47.37 3.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -41.52 -52.24 3.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.88 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.42 -48.43 68.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 18.9 mt -58.2 -47.0 84.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.946 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 86.0 t -53.26 -56.06 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.138 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 7.5 t -60.19 -43.38 95.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.829 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.7 mt -52.12 -48.59 64.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.561 ' CE1' HG21 ' A' ' 370' ' ' VAL . 42.9 m-85 -118.35 42.1 2.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -78.96 -43.55 24.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.073 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -49.48 -34.0 15.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 366' ' ' ALA . 21.9 m-85 -73.98 -38.16 64.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 15.3 tm0? -43.43 -64.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.933 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.29 -44.76 88.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.825 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -38.47 150.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -42.64 133.35 3.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 123.6 143.79 6.38 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.496 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -47.37 154.44 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.686 2.258 . . . . 0.0 112.402 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.03 138.2 16.25 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.637 2.224 . . . . 0.0 112.375 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 67.1 mt -79.6 135.07 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.134 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -97.71 137.8 36.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -123.81 140.27 53.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -136.35 132.94 36.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.805 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 12.4 ttm -112.22 135.9 52.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' MET . . . . . 0.412 ' HE1' ' CE1' ' A' ' 354' ' ' PHE . 29.4 ttm -99.25 130.63 45.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.908 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 40.9 p -134.15 58.52 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.098 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 349' ' ' MET . . . -95.81 -170.84 35.63 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.497 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.24 -25.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 110.879 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' MET . . . . . 0.428 ' N ' ' O ' ' A' ' 347' ' ' GLY . 13.6 tpp -130.8 99.0 4.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.796 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 33.6 mtt180 -75.97 171.28 14.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.424 ' C ' ' OE1' ' A' ' 352' ' ' GLN . . . 106.14 28.66 5.16 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.463 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.424 ' OE1' ' C ' ' A' ' 351' ' ' GLY . 2.9 mp0 -147.31 152.73 38.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.851 0.358 . . . . 0.0 110.862 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -158.55 167.09 30.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.788 ' CE2' ' CD1' ' A' ' 312' ' ' TYR . 14.4 m-85 -136.6 138.38 41.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.893 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.463 HG22 ' CE1' ' A' ' 357' ' ' PHE . 85.2 mt -126.68 132.88 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.464 HG21 ' CE ' ' A' ' 309' ' ' LYS . 25.7 m -108.26 118.1 35.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.097 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.463 ' CE1' HG22 ' A' ' 355' ' ' ILE . 47.1 m-85 -99.84 158.91 31.23 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.639 0.733 . . . . 0.0 110.903 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.88 -35.3 13.68 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.623 2.216 . . . . 0.0 112.348 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -157.83 174.8 14.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.977 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.453 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 21.5 pttp -65.89 -45.35 82.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . 0.453 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 48.1 mt-10 -46.21 -65.17 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 60.5 mt -53.28 -54.17 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -43.59 -59.32 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.081 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . 0.495 ' O ' ' N ' ' A' ' 367' ' ' LEU . 11.4 t90 -50.44 -62.87 1.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.0 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -37.25 -50.78 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 332' ' ' PHE . . . -60.17 -37.17 79.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.12 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.531 HD11 ' CE1' ' A' ' 384' ' ' PHE . 6.3 tt -62.37 -62.54 1.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.976 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -53.18 -29.2 30.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.842 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 44.9 mt -76.24 -48.36 20.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . 0.561 HG21 ' CE1' ' A' ' 329' ' ' PHE . 5.4 t -98.41 33.0 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.101 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.36 96.27 7.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 93.32 43.9 3.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.531 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -84.8 109.16 17.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 0.0 110.922 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -62.95 119.31 9.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.935 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.4 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 19.4 tp -133.54 128.68 35.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.851 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . 0.4 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 25.2 m-85 45.81 41.24 7.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.999 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 66.8 41.3 93.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -142.32 141.13 32.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 49.2 mm -90.56 92.73 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.182 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.467 HD22 ' N ' ' A' ' 381' ' ' VAL . 7.2 tt -61.51 129.82 43.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.541 HG13 ' CE2' ' A' ' 302' ' ' TYR . 48.0 t -117.22 111.91 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.187 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.41 ' CD1' ' O ' ' A' ' 370' ' ' VAL . 29.2 mt -93.97 137.89 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -133.73 179.21 6.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.531 ' CE1' HD11 ' A' ' 367' ' ' LEU . 27.7 m-85 -109.11 140.79 42.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -65.46 -142.94 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.413 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.83 174.74 7.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.783 0.325 . . . . 0.0 110.885 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -99.56 113.0 25.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.09 155.12 46.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.868 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 24.7 tptt 59.95 45.17 12.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.88 155.92 16.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.06 146.52 31.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 56.5 p -105.12 45.91 0.94 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.4 t -127.56 159.27 35.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.79 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -175.17 95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.527 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.83 -8.88 19.41 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.731 2.288 . . . . 0.0 112.305 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 44.4 m -40.0 156.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 1.2 t -136.44 170.43 16.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.86 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.526 -179.94 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 41.2 m -79.91 172.64 13.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.958 0.409 . . . . 0.0 110.83 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 3.5 m -159.25 129.66 5.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.847 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 142.65 115.44 1.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 4.3 t -116.65 45.94 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.866 0.365 . . . . 0.0 110.855 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 3.4 m -41.0 160.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 96.61 50.98 1.75 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.508 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.49 -49.6 75.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.783 0.325 . . . . 0.0 110.863 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -118.11 -15.03 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.15 160.45 12.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.093 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.05 75.55 1.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 35.1 tttm 55.88 35.77 26.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 14.6 mm -106.91 135.85 19.51 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.635 0.731 . . . . 0.0 111.104 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -78.66 -39.82 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.664 2.243 . . . . 0.0 112.351 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -122.88 92.93 3.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.857 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -129.14 42.38 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.8 m -97.09 -56.6 2.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 6.0 m -128.22 175.16 8.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.849 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -51.38 169.77 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.884 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -101.16 103.37 25.43 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.66 0.743 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.26 -50.54 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.695 2.264 . . . . 0.0 112.336 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 116.1 -172.55 14.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.468 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.47 ' CG ' ' HD2' ' A' ' 307' ' ' PRO . 39.0 tt0 -77.49 141.38 65.44 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.573 0.701 . . . . 0.0 110.946 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 306' ' ' GLU . 73.1 Cg_exo -47.15 103.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.701 2.268 . . . . 0.0 112.367 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -118.29 172.67 7.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.463 ' HD2' ' CG2' ' A' ' 310' ' ' VAL . 0.0 OUTLIER -89.91 25.98 1.95 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.949 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . 0.463 ' CG2' ' HD2' ' A' ' 309' ' ' LYS . 89.2 t -143.17 123.22 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.139 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.519 HD13 ' CE1' ' A' ' 357' ' ' PHE . 63.0 mt -116.66 125.62 52.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.969 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.674 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 7.8 t80 -105.1 103.88 13.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.512 ' CD1' ' N ' ' A' ' 313' ' ' LEU . 3.0 mp -87.31 144.68 26.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -140.57 178.69 7.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.928 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.0 m120 59.5 46.09 12.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.855 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.2 mt -105.7 112.5 25.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 37.5 t -54.34 144.54 41.0 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.747 0.784 . . . . 0.0 110.796 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -45.02 -32.16 6.3 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.685 2.257 . . . . 0.0 112.328 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -66.57 -39.82 88.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 84.9 t -46.75 113.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 82.1 p -108.88 165.81 11.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.136 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -42.05 -50.28 4.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 72.9 mtt85 -43.29 -50.48 6.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -49.52 -44.28 46.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.61 -51.87 60.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 91.8 t -48.27 -51.94 8.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.203 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.2 t -62.9 -40.52 97.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.935 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.444 HD21 ' CE2' ' A' ' 373' ' ' TYR . 23.0 mt -55.69 -42.83 75.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.879 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -121.18 41.62 3.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -82.54 -35.7 26.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.527 ' HG3' ' CE2' ' A' ' 332' ' ' PHE . 6.3 ptp180 -55.98 -23.69 34.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.855 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.527 ' CE2' ' HG3' ' A' ' 331' ' ' ARG . 9.0 m-85 -105.93 36.64 2.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . 0.416 ' C ' ' HD2' ' A' ' 335' ' ' LYS . 5.2 tp60 -129.71 -42.11 1.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -73.4 82.78 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.416 ' HD2' ' C ' ' A' ' 333' ' ' GLN . 0.0 OUTLIER -172.89 -175.96 1.35 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . 0.434 ' O ' ' C ' ' A' ' 337' ' ' GLY . 9.8 mptt -52.66 -55.81 19.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.941 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 336' ' ' LYS . . . -35.62 153.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.524 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.38 153.39 39.96 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.322 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -46.32 125.01 8.44 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 341' ' ' GLN . 75.6 mt -60.11 137.46 22.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . 0.454 ' N ' HG23 ' A' ' 340' ' ' ILE . 75.3 mm-40 -91.04 117.25 29.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . 0.553 ' CD1' HG22 ' A' ' 355' ' ' ILE . 92.7 m-85 -105.92 146.02 30.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -141.26 126.51 18.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 33.4 tpp -117.18 135.01 54.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' MET . . . . . 0.502 ' HE1' ' CE2' ' A' ' 354' ' ' PHE . 31.0 mtm -116.98 158.12 24.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 347' ' ' GLY . 34.2 p -127.81 -63.11 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.15 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 346' ' ' THR . . . 34.65 -118.85 0.29 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.491 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -76.38 -47.75 22.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 110.852 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 34.3 mtp -124.92 135.08 52.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -83.87 -1.58 54.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.497 ' C ' ' CD ' ' A' ' 352' ' ' GLN . . . -83.87 46.03 3.58 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.409 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.497 ' CD ' ' C ' ' A' ' 351' ' ' GLY . 23.8 mp0 -154.38 130.31 10.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.857 0.361 . . . . 0.0 110.953 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -153.76 141.89 20.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.129 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.674 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 43.4 m-85 -103.34 152.62 21.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.553 HG22 ' CD1' ' A' ' 342' ' ' PHE . 45.3 mt -148.79 134.75 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.0 m -118.14 127.49 53.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.569 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 42.2 m-85 -104.41 157.8 33.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.641 0.734 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.83 -47.63 9.74 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.668 2.245 . . . . 0.0 112.31 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -141.96 138.7 32.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.82 -27.5 0.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.896 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.28 -58.6 7.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 332' ' ' PHE . 72.6 mt -57.67 -58.8 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.569 ' HB3' ' CD1' ' A' ' 357' ' ' PHE . . . -46.34 -46.5 18.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.12 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -54.73 -61.58 2.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.999 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -50.25 -37.35 35.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.81 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . 0.443 ' HB3' ' CE2' ' A' ' 332' ' ' PHE . . . -69.24 -45.62 69.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.46 HD22 ' N ' ' A' ' 368' ' ' HIS . 6.6 tt -55.94 -51.04 69.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . 0.46 ' N ' HD22 ' A' ' 367' ' ' LEU . 30.6 t60 -63.95 -36.02 82.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 39.9 mt -74.38 -28.01 60.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 17.2 t -102.01 -4.47 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 367' ' ' LEU . 1.4 p-10 -55.21 127.32 28.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 63.72 49.48 68.35 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.448 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.444 ' CE2' HD21 ' A' ' 328' ' ' LEU . 82.3 t80 -93.81 112.49 24.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 110.902 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -67.81 105.96 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 37.3 tp -118.75 118.03 30.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 55.47 35.12 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 73.4 29.52 63.9 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -133.29 129.41 37.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.78 0.324 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 51.0 mm -77.51 90.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.421 ' CD2' ' CG1' ' A' ' 382' ' ' ILE . 8.0 tt -59.6 117.56 5.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 97.0 t -102.68 122.99 55.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.14 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.457 ' C ' ' OE1' ' A' ' 383' ' ' GLU . 15.3 mt -109.26 139.19 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.113 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . 0.457 ' OE1' ' C ' ' A' ' 382' ' ' ILE . 4.9 mp0 -138.65 124.86 20.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.459 ' CE1' HD12 ' A' ' 367' ' ' LEU . 27.9 m-85 -52.45 158.11 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.894 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -84.09 -178.37 51.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.439 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -109.34 149.48 29.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.757 0.313 . . . . 0.0 110.87 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -117.09 135.96 53.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -110.26 -38.43 5.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -67.96 107.38 2.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -87.05 88.1 7.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.915 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -47.01 130.45 12.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 78.5 p -85.75 136.5 33.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.876 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 30.3 t -142.87 152.56 42.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.806 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.29 97.22 0.12 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.502 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.84 157.0 43.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.724 2.283 . . . . 0.0 112.311 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 20.8 t -92.4 -63.9 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 22.6 t -99.78 159.05 15.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.5 179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 49.8 m 54.44 41.76 31.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.89 0.376 . . . . 0.0 110.863 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 39.8 m -48.7 170.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.794 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 38.1 -147.01 0.11 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.54 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 1.8 t 66.94 39.49 3.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 0.0 110.782 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 3.1 m -82.8 140.48 32.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -177.74 105.61 0.2 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.515 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -67.09 -54.27 23.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.76 -48.35 77.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.502 ' CD1' ' O ' ' A' ' 293' ' ' ILE . 2.7 pp -83.61 33.76 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.161 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -89.22 -53.64 4.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.867 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -72.32 -59.18 2.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 32.8 mt -124.97 104.3 29.96 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.576 0.703 . . . . 0.0 111.134 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -45.5 -37.71 15.27 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.668 2.245 . . . . 0.0 112.279 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 9.1 mmt -87.97 55.11 3.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.879 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -86.11 -44.96 11.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 63.8 p -129.14 103.06 6.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.88 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.8 m -67.57 -56.27 10.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.847 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.418 ' CZ ' ' O ' ' A' ' 303' ' ' ASN . 0.8 OUTLIER -158.74 151.67 22.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.995 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.418 ' O ' ' CZ ' ' A' ' 302' ' ' TYR . 15.2 m120 -113.44 138.03 22.34 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.612 0.72 . . . . 0.0 110.912 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.92 -40.27 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.753 2.302 . . . . 0.0 112.253 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 120.49 -114.75 2.74 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.466 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -106.91 134.95 19.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 110.917 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -47.48 148.98 4.82 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.62 2.214 . . . . 0.0 112.304 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -153.64 165.79 34.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.835 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.441 ' CD ' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -84.97 -14.6 47.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . 0.441 HG23 ' CD ' ' A' ' 309' ' ' LYS . 54.4 t -111.32 134.43 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.135 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.563 HD22 ' CD1' ' A' ' 384' ' ' PHE . 29.0 mt -119.04 120.67 37.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.897 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.792 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 13.9 t80 -106.41 102.69 12.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 313' ' ' LEU . 6.2 mp -88.88 149.55 23.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.551 ' HE2' ' CD2' ' A' ' 312' ' ' TYR . 22.5 mttt -137.56 -176.73 4.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 55.35 53.9 9.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.2 mt -109.32 117.68 34.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.898 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 38.6 t -61.34 139.91 94.67 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.675 0.75 . . . . 0.0 110.874 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -43.2 -27.63 1.17 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.703 2.268 . . . . 0.0 112.256 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.494 ' HB3' ' CE2' ' A' ' 376' ' ' TYR . 23.0 mmt85 -69.73 -42.85 73.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.857 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 93.5 t -44.31 136.34 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.13 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.8 p -135.88 166.54 23.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.101 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -41.64 -52.45 3.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -40.94 -41.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.69 -46.72 86.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.33 -44.8 95.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.928 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 95.0 t -55.12 -60.54 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 4.8 t -54.12 -40.63 67.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.904 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 28.7 mt -56.74 -44.9 82.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -120.54 45.76 2.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 333' ' ' GLN . . . -84.06 -39.55 19.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -45.26 -37.36 4.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 366' ' ' ALA . 11.9 m-85 -94.22 32.1 1.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 330' ' ' ALA . 8.3 tp60 -116.72 -57.83 2.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -57.89 -34.03 69.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -50.4 155.35 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -57.41 92.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -176.51 151.48 11.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.425 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -45.23 165.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.662 2.242 . . . . 0.0 112.35 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.61 102.93 1.66 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.755 2.304 . . . . 0.0 112.299 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.422 HG23 ' CZ ' ' A' ' 342' ' ' PHE . 59.5 mt -41.73 131.18 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.157 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -93.83 116.52 28.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . 0.422 ' CZ ' HG23 ' A' ' 340' ' ' ILE . 97.6 m-85 -103.49 149.07 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -141.19 125.25 17.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.849 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 41.7 tpp -114.57 135.63 53.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 9.1 ttm -90.1 167.8 12.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.842 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 9.9 t -172.68 156.01 3.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.09 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 124.67 -157.75 19.03 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.484 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . 0.429 ' HG3' ' N ' ' A' ' 349' ' ' MET . 11.4 ptm180 -46.95 -43.3 18.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 0.0 110.808 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' MET . . . . . 0.429 ' N ' ' HG3' ' A' ' 348' ' ' ARG . 3.2 ttt -111.9 106.71 15.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.419 ' NE ' ' C ' ' A' ' 350' ' ' ARG . 0.0 OUTLIER -110.16 174.27 5.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.405 ' C ' ' CD ' ' A' ' 352' ' ' GLN . . . 96.69 31.29 7.13 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.533 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.405 ' CD ' ' C ' ' A' ' 351' ' ' GLY . 3.2 mp0 -148.37 141.38 24.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 110.861 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -150.05 151.58 33.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.099 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.792 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 58.0 m-85 -116.05 143.73 45.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.825 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.437 HG22 ' CE2' ' A' ' 357' ' ' PHE . 77.4 mt -136.0 139.2 46.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.144 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 83.3 m -124.41 117.41 24.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.13 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.437 ' CE2' HG22 ' A' ' 355' ' ' ILE . 84.0 m-85 -96.75 158.08 34.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.649 0.738 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.7 -35.39 23.21 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.739 2.293 . . . . 0.0 112.307 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -149.71 178.68 8.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.84 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -74.58 -49.93 19.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -41.13 -63.62 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 46.6 mt -51.68 -61.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -38.86 -60.81 0.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.138 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 14.0 t90 -48.42 -56.81 7.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -50.54 -47.09 57.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . 0.446 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . . . -58.28 -32.18 68.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.079 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.561 HD12 ' CZ ' ' A' ' 384' ' ' PHE . 7.2 tt -70.42 -69.94 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.916 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -48.01 -32.68 6.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 41.7 mt -74.32 -41.53 60.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 370' ' ' VAL . 47.3 t -104.04 33.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.187 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.34 139.7 37.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.901 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 52.42 40.02 53.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.442 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -80.2 120.04 23.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.013 0.435 . . . . 0.0 110.917 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -63.68 112.1 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 29.4 tp -121.67 127.27 50.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . 0.494 ' CE2' ' HB3' ' A' ' 319' ' ' ARG . 31.5 m-85 41.27 46.32 2.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 59.97 44.68 96.96 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.443 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -156.03 114.56 3.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.717 0.294 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 17.2 mm -50.62 111.03 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.419 ' C ' HD21 ' A' ' 380' ' ' LEU . 8.3 tt -80.39 120.16 24.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.64 118.18 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.445 ' CD1' ' O ' ' A' ' 370' ' ' VAL . 29.4 mt -99.04 136.83 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.098 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.49 177.66 7.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.921 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.563 ' CD1' HD22 ' A' ' 311' ' ' LEU . 41.3 m-85 -109.98 135.23 51.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -53.58 145.83 22.68 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.51 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -111.58 -39.16 4.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.768 0.318 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -109.12 138.47 45.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -137.34 145.32 43.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -117.53 159.98 21.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -48.93 -59.24 3.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.007 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 57.66 43.21 22.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.846 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 4.4 m -118.73 136.26 54.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.6 m -107.34 -45.0 4.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.837 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 89.99 67.21 1.22 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.56 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.92 169.76 21.07 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.746 2.297 . . . . 0.0 112.331 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 34.4 t -66.33 156.38 34.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 46.0 t -148.36 136.75 21.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.791 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.437 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.456 -0.257 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.1 m -99.39 115.16 28.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 110.813 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 46.7 t -111.88 93.31 4.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.86 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -163.2 -95.68 0.11 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.441 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 1.7 t 48.88 42.35 20.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.358 . . . . 0.0 110.847 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 4.9 t -96.31 75.95 2.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.835 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . 0.436 ' CA ' HD11 ' A' ' 293' ' ' ILE . . . 119.75 113.87 2.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.421 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -49.53 -64.68 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.327 . . . . 0.0 110.906 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -96.05 -39.2 9.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.436 HD11 ' CA ' ' A' ' 290' ' ' GLY . 0.2 OUTLIER -80.44 14.01 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.083 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -37.58 -68.25 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -88.06 62.77 6.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.856 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.435 ' CG2' ' HB3' ' A' ' 299' ' ' PHE . 47.4 mt -152.71 105.01 2.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.625 0.726 . . . . 0.0 111.152 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.9 -34.55 3.87 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.703 2.269 . . . . 0.0 112.382 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 8.5 mmt -133.38 105.57 7.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . 0.435 ' HB3' ' CG2' ' A' ' 296' ' ' ILE . 25.3 p90 -120.36 104.34 9.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 5.8 t -159.18 141.77 14.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 27.1 m -168.21 159.33 10.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.557 ' CD2' HG13 ' A' ' 381' ' ' VAL . 29.1 p90 -49.3 170.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.93 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -122.74 137.99 28.8 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.62 0.724 . . . . 0.0 110.9 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -79.52 -40.68 0.24 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.737 2.291 . . . . 0.0 112.324 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 108.25 -118.86 5.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.455 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -122.36 142.06 36.18 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.659 0.742 . . . . 0.0 110.873 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.21 107.02 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.663 2.242 . . . . 0.0 112.316 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -117.92 175.29 5.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -86.96 -36.78 18.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 83.9 t -96.08 125.48 48.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.105 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.528 HD13 ' CE1' ' A' ' 357' ' ' PHE . 34.5 mt -108.64 112.17 24.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.738 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 14.6 t80 -83.6 104.24 13.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.943 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 8.1 mp -90.66 136.71 32.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -132.24 -177.08 4.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 58.72 47.44 12.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.6 mt -106.61 111.54 24.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.441 ' N ' HG21 ' A' ' 320' ' ' VAL . 1.4 t -45.77 142.06 3.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.701 0.762 . . . . 0.0 110.847 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.04 -19.37 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.66 2.24 . . . . 0.0 112.343 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -82.73 -37.98 23.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . 0.441 HG21 ' N ' ' A' ' 317' ' ' SER . 60.8 t -40.77 137.17 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.176 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 4.5 p -135.77 168.25 19.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -45.99 -45.28 15.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -45.38 -59.26 2.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.876 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -44.36 -50.49 9.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 28.8 mt -55.18 -41.94 72.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.979 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 98.3 t -56.69 -57.44 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.151 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 4.5 t -59.86 -24.16 64.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 33.3 mt -76.07 -40.33 53.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.934 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -123.69 39.71 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -88.25 -38.71 15.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -55.61 -17.28 5.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 57.9 m-85 -84.56 -56.27 3.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . 0.456 ' HB2' ' CD1' ' A' ' 340' ' ' ILE . 5.4 tm0? -65.66 -48.52 71.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -52.01 -42.92 63.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.924 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -68.95 -71.52 0.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 22.3 mmtm -145.55 174.57 11.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 82.14 134.36 1.9 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.533 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -48.08 157.58 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.628 2.218 . . . . 0.0 112.43 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.1 105.93 0.09 OUTLIER 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.664 2.242 . . . . 0.0 112.381 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.503 HD11 ' CE2' ' A' ' 357' ' ' PHE . 43.9 mt -54.23 138.97 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.183 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . 0.45 ' N ' HG21 ' A' ' 340' ' ' ILE . 69.0 mt-30 -93.01 127.77 38.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -118.56 142.39 47.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.866 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -141.27 126.18 18.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 11.4 ttm -115.4 125.79 53.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.945 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 9.8 ptp -104.31 157.93 16.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 26.4 p -145.18 159.91 42.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.156 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 151.89 -164.64 30.44 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -43.81 -50.51 7.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.874 0.369 . . . . 0.0 110.923 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' MET . . . . . 0.464 ' O ' ' NE2' ' A' ' 352' ' ' GLN . 2.4 ttm -102.27 42.95 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.51 177.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.929 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 93.86 23.14 23.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.464 ' NE2' ' O ' ' A' ' 349' ' ' MET . 23.8 mt-30 -129.5 150.86 50.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.329 . . . . 0.0 110.945 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -154.71 152.15 29.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.738 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 41.5 m-85 -121.14 126.43 49.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.455 HG23 ' CE1' ' A' ' 357' ' ' PHE . 95.6 mt -118.29 142.79 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.8 m -123.53 121.56 35.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.157 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.528 ' CE1' HD13 ' A' ' 311' ' ' LEU . 37.5 m-85 -99.69 159.05 30.98 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.663 0.744 . . . . 0.0 110.864 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.48 -42.46 18.11 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.688 2.259 . . . . 0.0 112.302 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -153.89 156.44 37.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.425 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 13.7 ptpt -48.6 -45.98 38.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.915 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . 0.425 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 20.1 mm-40 -41.24 -65.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.857 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' A' ' 363' ' ' ALA . 79.1 mt -54.08 -64.73 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 362' ' ' ILE . . . -36.09 -57.6 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.062 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -49.05 -58.75 4.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -50.01 -48.19 52.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -57.66 -38.84 75.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.427 ' CD2' ' C ' ' A' ' 367' ' ' LEU . 5.2 tt -64.38 -60.7 2.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . 0.401 ' N ' HD23 ' A' ' 367' ' ' LEU . 32.8 t60 -56.19 -27.55 54.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 30.2 mt -79.83 -37.11 35.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 13.7 t -110.14 35.92 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.172 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -87.65 106.82 18.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.831 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 90.42 31.61 10.33 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.434 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -76.19 119.06 19.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.834 0.35 . . . . 0.0 110.991 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -66.71 107.28 2.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 15.0 tp -111.93 114.51 27.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.985 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 53.94 40.02 31.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 69.91 29.73 70.68 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.459 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -143.26 113.41 7.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.845 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 19.9 mm -53.88 128.06 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.09 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.413 ' C ' ' CD2' ' A' ' 380' ' ' LEU . 5.5 tt -94.18 117.29 29.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.557 HG13 ' CD2' ' A' ' 302' ' ' TYR . 86.5 t -98.5 128.9 49.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.163 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 24.3 mt -110.58 132.22 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -134.03 124.02 25.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.922 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.446 ' CE1' ' CD2' ' A' ' 311' ' ' LEU . 39.8 m-85 -55.46 151.29 10.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.824 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -50.86 172.01 0.16 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -122.54 101.98 7.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.768 0.318 . . . . 0.0 110.811 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -126.62 100.04 6.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.946 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -103.83 59.84 0.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -121.22 94.45 4.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -82.15 110.33 17.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.961 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -65.32 149.14 50.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.902 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 7.5 t -65.69 91.43 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 7.1 t -50.94 169.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.887 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 100.97 91.87 2.12 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.446 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.0 121.61 5.89 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.753 2.302 . . . . 0.0 112.373 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 3.8 m -67.49 112.75 4.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.907 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 22.2 m -88.86 154.99 19.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.806 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.511 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 33.7 p -133.42 -62.22 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.936 0.398 . . . . 0.0 110.904 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 71.6 p -48.39 145.15 3.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.871 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -155.14 -151.49 5.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.481 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.7 p -119.41 133.52 55.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.775 0.321 . . . . 0.0 110.941 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 11.1 m -57.92 100.06 0.05 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.842 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -153.22 110.61 0.46 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.538 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -62.46 -43.74 98.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.841 0.353 . . . . 0.0 110.913 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -84.48 -47.85 10.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 6.1 pt -99.3 137.95 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . 0.415 ' HD3' ' C ' ' A' ' 294' ' ' ARG . 2.6 tmt_? -133.5 -63.79 0.74 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.834 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -73.49 -64.57 0.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.471 ' CG2' ' HD2' ' A' ' 297' ' ' PRO . 5.2 mp -107.09 139.23 20.23 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.606 0.717 . . . . 0.0 111.174 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . 0.471 ' HD2' ' CG2' ' A' ' 296' ' ' ILE . 63.7 Cg_endo -78.76 151.07 24.53 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.674 2.25 . . . . 0.0 112.343 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 23.2 ttp 56.95 43.82 24.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -105.93 172.89 6.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.6 t 64.44 43.08 4.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.845 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 66.9 m -152.31 166.36 32.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.567 ' CD2' HG12 ' A' ' 381' ' ' VAL . 5.3 p90 -49.36 161.64 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.941 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -124.16 139.51 32.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.659 0.742 . . . . 0.0 110.851 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.49 -41.16 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.268 . . . . 0.0 112.355 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 98.48 -144.65 17.35 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.426 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.425 ' CD ' ' HD2' ' A' ' 307' ' ' PRO . 9.0 tp10 -96.72 138.57 21.39 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.575 0.702 . . . . 0.0 110.897 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . 0.425 ' HD2' ' CD ' ' A' ' 306' ' ' GLU . 73.5 Cg_exo -47.14 99.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.668 2.246 . . . . 0.0 112.329 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -110.35 177.01 4.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.846 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -88.16 -25.17 23.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 23.5 t -97.89 128.68 49.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.088 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.569 HD12 ' CE1' ' A' ' 357' ' ' PHE . 48.7 mt -115.63 118.31 32.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.012 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.769 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 15.0 t80 -98.23 102.34 14.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.404 HD11 ' CD1' ' A' ' 355' ' ' ILE . 5.1 mp -88.5 146.54 25.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -138.06 -176.35 4.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 59.7 53.6 4.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.5 mt -115.65 122.84 46.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 18.0 t -64.5 143.87 98.59 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.68 0.753 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.72 -19.5 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.695 2.264 . . . . 0.0 112.386 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 -77.11 -35.16 56.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 97.6 t -48.53 146.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 12.2 p -145.24 175.33 10.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.113 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -48.38 -47.02 37.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -44.47 -54.37 6.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.24 -51.52 25.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 57.2 mt -57.31 -47.53 81.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 330' ' ' ALA . 96.5 t -55.08 -61.78 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.184 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 11.6 t -53.09 -37.59 61.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.411 HD21 ' CE2' ' A' ' 373' ' ' TYR . 32.6 mt -63.23 -40.26 96.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.897 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -120.79 40.54 3.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -82.64 -21.17 35.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.08 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -69.66 -36.99 76.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -91.85 14.57 15.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . 0.41 ' NE2' ' H ' ' A' ' 340' ' ' ILE . 24.3 tp60 -75.55 -46.04 34.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.886 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -99.52 88.21 3.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -155.94 161.1 40.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -38.48 102.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 130.22 144.64 5.6 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.486 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.52 156.5 1.07 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.651 2.234 . . . . 0.0 112.353 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -45.92 164.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 0.0 112.392 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.414 HD12 ' CE2' ' A' ' 357' ' ' PHE . 85.4 mt -89.44 140.36 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.184 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -100.88 117.77 35.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -102.34 138.8 38.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -134.35 129.29 35.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 40.5 tpp -112.87 145.14 41.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 18.6 mmt -80.7 143.55 32.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 22.9 p -113.73 -62.59 1.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.189 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 348' ' ' ARG . . . -53.12 -170.62 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.48 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 347' ' ' GLY . 6.6 ptp85 -34.55 150.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.755 0.312 . . . . 0.0 110.892 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 4.4 mtt 54.99 50.84 14.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.02 -0.04 8.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -82.28 31.48 2.9 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.486 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -139.87 166.75 23.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 110.882 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -158.6 149.26 20.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.769 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 12.9 m-85 -119.39 121.82 40.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.836 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.404 ' CD1' HD11 ' A' ' 313' ' ' LEU . 61.9 mt -110.14 144.47 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.15 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 17.2 m -120.89 117.76 28.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.132 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 311' ' ' LEU . 53.6 m-85 -98.94 155.76 36.25 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.625 0.726 . . . . 0.0 110.857 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.57 -42.0 18.61 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.75 2.3 . . . . 0.0 112.324 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.75 171.55 17.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.78 -48.94 72.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -39.99 -63.17 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 363' ' ' ALA . 90.6 mt -53.27 -65.82 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 362' ' ' ILE . . . -36.98 -55.49 0.92 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -48.3 -63.47 1.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -45.29 -48.89 13.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -60.17 -33.74 72.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.091 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.56 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.4 tt -68.01 -63.29 1.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -50.65 -34.21 25.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 24.9 mt -75.34 -57.66 3.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.961 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 5.9 t -84.1 31.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.115 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -87.27 103.85 15.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 90.77 37.45 6.43 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.411 ' CE2' HD21 ' A' ' 328' ' ' LEU . 73.9 t80 -82.38 107.64 15.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 0.0 110.961 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -59.09 126.96 29.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.64 124.97 18.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 49.41 34.68 6.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.946 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 73.44 38.03 52.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.438 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.15 150.48 47.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.784 0.325 . . . . 0.0 110.839 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 43.1 mm -97.17 87.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.415 ' CD2' HG13 ' A' ' 382' ' ' ILE . 7.2 tt -52.07 133.63 32.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.957 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.567 HG12 ' CD2' ' A' ' 302' ' ' TYR . 85.0 t -120.62 122.95 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.415 HG13 ' CD2' ' A' ' 380' ' ' LEU . 21.5 mt -104.81 132.43 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.129 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -139.99 119.17 12.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.56 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 58.1 m-85 -51.33 151.59 2.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -64.99 -161.75 0.64 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -123.97 87.49 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -107.36 93.48 4.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -130.22 95.83 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.1 149.07 22.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -106.15 100.29 9.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -170.18 159.24 7.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.836 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 16.7 t -134.52 119.07 18.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 27.9 t -152.05 119.96 6.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.941 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -167.84 104.47 0.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.463 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.25 -175.45 2.41 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.649 2.233 . . . . 0.0 112.369 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 22.0 t -104.4 131.38 51.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 66.4 m -99.26 125.95 44.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.902 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 -179.939 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 73.9 m -152.69 156.39 39.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.847 0.356 . . . . 0.0 110.861 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 44.7 m -123.26 154.33 38.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 163.51 -141.43 7.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.472 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 2.3 t 55.42 37.9 29.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.858 0.361 . . . . 0.0 110.832 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 40.1 p -114.01 148.37 37.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.816 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -48.87 145.08 7.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.499 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -64.99 -44.47 89.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.864 0.364 . . . . 0.0 110.872 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -101.93 -56.5 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.883 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 2.9 pt -75.29 78.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.218 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -91.08 -60.08 2.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -42.44 -56.91 2.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.94 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.46 ' CG2' ' HD2' ' A' ' 297' ' ' PRO . 48.5 mt -123.44 138.38 30.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.625 0.726 . . . . 0.0 111.13 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . 0.46 ' HD2' ' CG2' ' A' ' 296' ' ' ILE . 63.7 Cg_endo -77.89 -48.63 0.1 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.67 2.247 . . . . 0.0 112.392 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 23.2 mtp -88.92 84.07 6.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.92 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -119.68 117.92 29.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 36.9 t -140.46 146.61 38.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 5.3 t -87.52 -58.86 2.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -125.88 165.77 18.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.954 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -123.95 99.77 37.66 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.604 0.716 . . . . 0.0 110.916 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.18 -32.1 7.06 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.718 2.279 . . . . 0.0 112.352 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 96.9 -126.5 8.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.41 ' O ' ' CG ' ' A' ' 384' ' ' PHE . 4.6 pm0 -121.01 151.27 54.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.667 0.746 . . . . 0.0 110.906 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.15 117.56 3.23 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.711 2.274 . . . . 0.0 112.309 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -138.43 160.06 40.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -68.94 -28.42 66.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.94 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 73.9 t -95.85 134.32 33.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.564 HD11 ' CE1' ' A' ' 357' ' ' PHE . 45.4 mt -123.5 121.7 36.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.696 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 10.3 t80 -96.94 113.42 24.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 313' ' ' LEU . 5.3 mp -103.26 145.98 29.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -144.68 -179.7 6.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.955 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.4 m120 60.77 51.48 4.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.5 mt -113.23 115.97 29.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 21.3 t -50.29 146.28 8.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.647 0.737 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.86 -26.37 7.12 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.656 2.237 . . . . 0.0 112.291 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.434 ' HB3' ' NH1' ' A' ' 319' ' ' ARG . 7.5 mtp-105 -72.04 -31.7 66.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.27 132.34 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.166 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 322' ' ' GLU . 41.9 p -139.25 168.36 19.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.091 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 321' ' ' THR . 26.0 tt0 -37.06 -46.72 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.924 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 324' ' ' ASP . 70.7 mtm180 -47.36 -62.24 1.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 323' ' ' ARG . 4.7 m-20 -37.8 -50.92 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 22.6 mt -59.64 -47.71 84.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.962 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 330' ' ' ALA . 94.9 t -46.6 -52.23 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 47.0 t -64.09 -42.39 96.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.436 HD21 ' CD2' ' A' ' 373' ' ' TYR . 78.3 mt -56.28 -49.33 74.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.986 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -113.72 35.04 4.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -70.58 -42.79 70.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.095 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.463 ' HG3' ' CD1' ' A' ' 332' ' ' PHE . 11.4 ptm180 -40.85 -52.53 3.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.81 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.463 ' CD1' ' HG3' ' A' ' 331' ' ' ARG . 16.2 m-85 -68.96 -29.01 67.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.936 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 330' ' ' ALA . 9.2 tp60 -44.94 -31.08 1.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.95 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -51.56 -176.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -80.91 46.61 0.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.904 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -93.42 36.1 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 123.34 -165.24 16.1 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.541 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . 0.419 ' CG ' ' HB3' ' A' ' 358' ' ' PRO . 72.1 Cg_exo -43.79 162.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.709 2.272 . . . . 0.0 112.36 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.8 143.34 29.65 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.648 2.232 . . . . 0.0 112.347 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.56 HG23 ' CE1' ' A' ' 342' ' ' PHE . 96.2 mt -92.28 140.6 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -121.88 127.74 50.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . 0.56 ' CE1' HG23 ' A' ' 340' ' ' ILE . 2.4 m-85 -111.61 139.57 46.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 31.3 ttt85 -135.4 123.22 22.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.425 ' C ' ' HE1' ' A' ' 345' ' ' MET . 17.7 ttm -116.9 129.56 56.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' MET . . . . . 0.468 ' HE1' ' N ' ' A' ' 345' ' ' MET . 0.0 OUTLIER -87.01 133.26 33.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.877 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 12.6 t -150.22 155.84 40.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.164 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 87.01 -37.36 3.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.462 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -123.24 -46.26 2.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.768 0.318 . . . . 0.0 110.846 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 17.6 mmt -126.36 87.82 2.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.424 ' C ' ' HD2' ' A' ' 350' ' ' ARG . 7.5 tmm_? -86.99 145.72 26.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.912 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 93.58 -17.24 58.94 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.51 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -107.89 139.97 41.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.96 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -148.46 158.75 44.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.118 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.696 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 47.7 m-85 -132.27 130.26 40.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 85.7 mt -118.68 140.52 42.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.092 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 26.1 m -113.19 105.57 13.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.564 ' CE1' HD11 ' A' ' 311' ' ' LEU . 44.0 m-85 -90.03 158.81 43.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.672 0.749 . . . . 0.0 110.889 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . 0.419 ' HB3' ' CG ' ' A' ' 338' ' ' PRO . 74.3 Cg_exo -42.31 -55.52 2.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.605 2.203 . . . . 0.0 112.402 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.0 -176.49 5.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -67.57 -51.17 53.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -39.16 -66.13 0.31 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . 0.44 ' O ' ' C ' ' A' ' 363' ' ' ALA . 61.1 mt -55.27 -65.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.193 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 362' ' ' ILE . . . -34.67 -56.33 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.143 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -50.63 -56.17 13.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 369' ' ' LEU . 30.4 mt-30 -50.97 -43.19 60.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -62.7 -41.48 99.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.07 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.568 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 6.5 tt -62.95 -63.55 1.17 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.972 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -55.92 -31.87 63.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.868 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.422 ' CG ' ' O ' ' A' ' 365' ' ' GLN . 37.0 mt -74.32 -33.02 63.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 370' ' ' VAL . 23.0 t -113.6 25.56 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 367' ' ' LEU . 1.6 p30 -69.43 138.15 53.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.883 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 46.35 49.12 15.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.493 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.436 ' CD2' HD21 ' A' ' 328' ' ' LEU . 89.3 t80 -83.29 118.44 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.03 0.443 . . . . 0.0 110.949 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -68.63 109.95 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.928 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.507 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 45.5 tp -126.42 126.07 43.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.832 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . 0.507 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 39.4 m-85 51.16 38.5 21.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 68.19 35.5 83.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.468 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -140.87 133.74 29.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.74 0.305 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 16.9 mm -79.39 88.45 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.154 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.456 ' CD2' HG13 ' A' ' 382' ' ' ILE . 6.3 tt -58.87 127.49 32.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.884 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.8 t -107.74 130.58 59.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.456 HG13 ' CD2' ' A' ' 380' ' ' LEU . 55.1 mt -112.6 139.68 36.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.14 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -135.45 178.98 6.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.568 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 50.3 m-85 -111.75 129.53 56.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.946 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -45.44 157.89 0.28 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -102.06 101.64 12.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 110.845 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -139.18 132.34 29.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -107.6 -53.43 2.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -60.09 136.37 58.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -92.11 -64.13 1.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.889 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 11.3 mmm-85 -141.09 178.13 7.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.442 ' O ' ' C ' ' A' ' 393' ' ' SER . 1.2 t -115.2 119.88 37.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.798 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 392' ' ' SER . 84.8 p -35.05 130.35 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.832 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -143.0 147.9 19.46 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.484 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -46.44 130.45 14.5 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.702 2.268 . . . . 0.0 112.334 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 75.4 p -38.71 -46.41 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 15.9 t -121.46 131.86 54.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.867 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.535 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 95.7 p -127.44 173.86 9.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 0.0 110.804 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 29.7 t -135.25 137.35 42.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 56.9 -117.81 10.49 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.541 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 46.8 t 59.9 43.47 14.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.878 0.37 . . . . 0.0 110.861 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 41.1 t -67.71 -61.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 82.47 175.82 50.98 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.474 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -121.68 106.93 11.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.826 0.346 . . . . 0.0 110.823 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 54.64 44.66 28.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 2.5 pp -104.55 143.02 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -102.29 63.99 0.9 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.877 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? 54.37 39.55 31.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.49 125.6 17.74 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.643 0.735 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.75 -55.11 3.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.595 2.197 . . . . 0.0 112.383 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 21.5 ttp -115.7 106.38 13.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -128.25 41.41 3.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 5.8 t -123.49 127.43 48.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 72.0 m -149.4 174.36 12.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.813 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.536 ' CE2' HG11 ' A' ' 381' ' ' VAL . 14.6 p90 -67.56 172.57 4.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -130.07 142.04 43.99 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.552 0.691 . . . . 0.0 110.922 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.87 -51.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.706 2.27 . . . . 0.0 112.345 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.93 -163.03 30.41 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.498 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.51 ' O ' ' CD2' ' A' ' 384' ' ' PHE . 37.2 mt-10 -51.06 143.16 16.61 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.709 0.766 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.97 110.3 3.09 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.733 2.289 . . . . 0.0 112.351 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -103.2 175.8 5.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.419 ' NZ ' ' HB2' ' A' ' 309' ' ' LYS . 0.0 OUTLIER -91.49 5.85 47.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . 0.41 ' CG2' ' HD3' ' A' ' 309' ' ' LYS . 93.5 t -129.91 135.26 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.15 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.525 HD12 ' CE1' ' A' ' 357' ' ' PHE . 96.5 mt -116.11 120.72 39.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.658 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 9.4 t80 -101.68 101.86 12.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.93 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 313' ' ' LEU . 5.7 mp -92.96 146.79 23.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 -176.26 4.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 61.38 49.1 5.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.6 mt -115.51 137.44 52.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 38.7 t -70.67 140.02 86.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.654 0.74 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -43.61 -21.64 0.33 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.732 2.288 . . . . 0.0 112.291 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 11.4 mtp85 -76.65 -41.29 46.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 70.7 t -42.52 123.69 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.149 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 40.7 p -123.08 171.99 8.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.174 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -44.56 -51.25 9.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.885 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -40.83 -50.25 3.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -53.67 -44.25 69.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 32.5 mt -64.7 -48.51 74.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 89.3 t -49.82 -54.51 7.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.157 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 22.8 t -59.15 -41.79 89.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.859 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 44.0 mt -57.52 -45.86 84.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.405 ' CD1' ' HB3' ' A' ' 366' ' ' ALA . 36.2 m-85 -120.49 49.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -91.41 -51.42 5.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -42.74 -49.54 5.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.53 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 40.0 m-85 -46.13 -38.94 8.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -80.6 75.04 7.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.896 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 335' ' ' LYS . 5.7 pt-20 -122.61 89.51 3.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 334' ' ' GLU . 14.0 pttp 34.49 41.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -106.21 -51.79 2.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.884 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -144.33 -155.0 6.29 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.489 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.28 147.26 29.11 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.736 2.29 . . . . 0.0 112.342 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -47.44 111.2 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.7 2.267 . . . . 0.0 112.315 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.548 HG22 ' CZ ' ' A' ' 342' ' ' PHE . 57.4 mt -46.71 136.68 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.106 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -90.76 132.92 35.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.946 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . 0.548 ' CZ ' HG22 ' A' ' 340' ' ' ILE . 33.8 m-85 -125.1 138.36 54.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -139.08 128.91 24.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.5 tpp -112.93 141.65 46.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' MET . . . . . 0.468 ' HE3' ' CE2' ' A' ' 354' ' ' PHE . 7.3 mtm -103.39 163.11 12.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 27.4 p -157.95 156.84 31.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.143 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 111.19 -141.55 16.55 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -55.13 130.05 40.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.808 0.337 . . . . 0.0 110.931 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 42.1 mmm 48.66 51.26 15.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -71.97 -176.63 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 101.73 21.49 11.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.482 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -132.28 152.55 51.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.871 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.55 150.06 35.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.658 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 39.2 m-85 -116.47 121.31 41.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.818 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.559 HG21 ' CE1' ' A' ' 357' ' ' PHE . 61.7 mt -114.4 133.29 60.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.192 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.2 m -114.58 114.2 25.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.129 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.559 ' CE1' HG21 ' A' ' 355' ' ' ILE . 37.4 m-85 -91.95 157.94 40.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.722 0.772 . . . . 0.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.4 -47.82 12.48 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.647 2.232 . . . . 0.0 112.371 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -138.83 174.42 10.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -69.92 -44.15 70.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -50.97 -58.21 6.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 97.3 mt -53.15 -52.67 28.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.13 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -45.99 -61.35 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -45.79 -55.56 6.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -43.8 -53.93 5.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . 0.53 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -60.31 -28.43 68.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.13 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.504 HD13 ' CE1' ' A' ' 384' ' ' PHE . 7.2 tt -70.15 -65.99 0.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.921 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -53.75 -28.67 35.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 30.1 mt -78.44 -48.88 14.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 12.1 t -97.37 30.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . 0.42 ' O ' ' CG ' ' A' ' 371' ' ' ASN . 2.0 t30 -82.83 85.97 7.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.956 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 108.9 52.22 0.66 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.436 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -99.51 110.06 22.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.975 0.417 . . . . 0.0 110.898 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -61.47 125.7 24.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 30.3 tp -138.27 128.37 25.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.92 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 48.17 42.69 17.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 61.52 37.06 93.53 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.562 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -148.35 114.44 5.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 110.974 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 34.9 mm -58.4 130.51 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.099 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 7.6 tt -90.93 135.92 33.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.916 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.536 HG11 ' CE2' ' A' ' 302' ' ' TYR . 50.8 t -121.67 125.76 73.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 12.8 mt -111.65 137.91 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.118 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -145.78 122.09 10.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.51 ' CD2' ' O ' ' A' ' 306' ' ' GLU . 38.7 m-85 -47.15 151.74 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -51.3 129.72 32.82 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.507 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? -80.39 -48.54 12.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.32 . . . . 0.0 110.869 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -51.77 130.14 28.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.09 111.31 16.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.939 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -67.05 142.13 57.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.942 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -61.54 -59.91 4.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.918 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -128.64 135.23 49.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 82.6 p -50.68 148.54 3.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 60.5 m -60.08 159.07 10.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.879 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 145.26 99.06 0.25 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.448 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.14 167.91 25.88 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.643 2.229 . . . . 0.0 112.366 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 94.5 p -116.11 -50.78 2.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.837 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 88.4 p -73.41 118.71 16.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.415 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.479 -0.249 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 53.3 p -156.82 152.53 26.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.878 0.37 . . . . 0.0 110.866 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 88.1 p -126.74 -44.17 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 118.67 -153.4 16.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.477 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 85.4 p -165.58 118.62 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 110.908 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 66.0 p -164.58 112.18 1.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.833 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 95.41 47.79 2.5 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.522 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -40.9 -49.07 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 0.0 110.884 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -112.65 -49.11 2.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.932 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 2.8 pp -70.85 161.8 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.173 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -116.47 179.66 3.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.812 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -47.47 97.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.474 ' CG2' ' HD2' ' A' ' 297' ' ' PRO . 59.8 mt -146.21 139.15 14.23 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.63 0.729 . . . . 0.0 111.17 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . 0.474 ' HD2' ' CG2' ' A' ' 296' ' ' ILE . 62.4 Cg_endo -77.27 -50.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.686 2.257 . . . . 0.0 112.379 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -121.78 78.78 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -80.64 -43.82 19.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.856 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 91.6 p -87.12 90.01 8.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.88 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 3.1 m -152.62 175.19 13.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -46.43 155.03 0.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.956 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -130.11 100.13 19.09 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.623 0.725 . . . . 0.0 110.831 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -44.38 -45.34 12.68 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.631 2.22 . . . . 0.0 112.413 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 103.92 -124.0 7.93 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.455 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -110.67 134.85 20.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.689 0.757 . . . . 0.0 110.868 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.21 96.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.683 2.256 . . . . 0.0 112.347 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -107.9 172.64 6.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 7.57 32.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 98.0 t -126.82 123.64 63.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 57.0 mt -109.69 129.2 55.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.802 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 10.3 t80 -110.32 101.62 10.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.475 ' CD1' HD12 ' A' ' 355' ' ' ILE . 5.7 mp -86.43 144.37 27.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.426 ' HG3' ' C ' ' A' ' 313' ' ' LEU . 3.2 mtpm? -142.56 179.11 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . 0.4 HD21 ' CG2' ' A' ' 381' ' ' VAL . 20.2 m-20 60.93 54.72 3.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 16.3 mt -119.6 109.46 15.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 42.8 t -45.71 145.37 2.26 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.708 0.766 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -46.44 -20.65 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.359 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -73.22 -37.67 66.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.971 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 84.4 t -52.55 126.06 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.08 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 37.4 p -121.36 171.72 8.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.136 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -45.07 -42.39 8.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -49.87 -46.98 52.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -52.69 -49.39 65.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.895 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 30.4 mt -59.31 -54.45 46.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 99.9 t -45.89 -52.82 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 1.4 t -61.62 -43.73 98.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.545 HD22 ' CE2' ' A' ' 373' ' ' TYR . 36.9 mt -54.2 -40.37 67.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.932 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 329' ' ' PHE . 6.6 m-85 -125.93 44.48 2.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -89.57 -51.25 5.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.073 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.419 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 15.9 ptm180 -44.43 -46.54 9.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.419 ' N ' ' HG3' ' A' ' 331' ' ' ARG . 24.0 m-85 -59.93 -45.14 93.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -59.86 106.28 0.47 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.862 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -138.31 179.78 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.459 ' HG2' ' N ' ' A' ' 336' ' ' LYS . 0.0 OUTLIER -66.77 -28.31 68.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . 0.459 ' N ' ' HG2' ' A' ' 335' ' ' LYS . 34.4 mmtm -46.33 -47.9 18.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.952 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -126.99 159.86 21.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.41 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -44.65 168.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.637 2.225 . . . . 0.0 112.343 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.1 114.78 3.86 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.639 2.226 . . . . 0.0 112.384 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.53 HD11 ' CE2' ' A' ' 357' ' ' PHE . 74.6 mt -52.68 131.38 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.178 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -88.95 136.97 32.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -123.82 139.55 53.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -141.29 135.18 30.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 12.2 ttm -112.93 140.09 48.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 25.4 mmt -79.26 131.64 36.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 29.1 p -134.83 -44.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.121 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 348' ' ' ARG . . . -51.43 111.83 1.54 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.436 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 347' ' ' GLY . 5.9 ptm180 34.38 35.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.789 0.328 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 347' ' ' GLY . 30.3 ttp -173.82 125.92 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.71 161.74 35.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 104.45 -31.69 8.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.438 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -99.23 158.13 15.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 0.0 110.925 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -151.23 147.57 27.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.802 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 39.0 m-85 -113.73 119.15 36.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' A' ' 313' ' ' LEU . 75.5 mt -114.14 140.89 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.124 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.443 ' N ' HG21 ' A' ' 355' ' ' ILE . 44.0 m -118.54 130.96 56.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.53 ' CE2' HD11 ' A' ' 340' ' ' ILE . 18.4 m-85 -109.01 155.83 40.2 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.688 0.756 . . . . 0.0 110.909 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.9 -39.56 32.1 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.711 2.274 . . . . 0.0 112.392 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -144.53 179.45 7.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.2 ptmm? -80.12 -31.89 39.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.8 -64.53 0.87 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 75.4 mt -47.69 -65.28 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.124 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -38.15 -55.92 1.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -49.08 -60.95 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -45.01 -54.67 6.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -57.91 -42.83 85.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.067 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.556 HD12 ' CE2' ' A' ' 384' ' ' PHE . 4.5 tt -58.58 -55.47 34.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 14.0 t60 -58.42 -28.63 65.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.882 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 29.5 mt -79.87 -36.76 36.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 19.1 t -91.26 -6.29 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.143 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 371' ' ' ASN . 0.0 OUTLIER -49.6 122.3 6.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.864 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 67.32 48.0 60.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.494 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.545 ' CE2' HD22 ' A' ' 328' ' ' LEU . 76.0 t80 -90.11 110.13 21.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.932 0.396 . . . . 0.0 110.891 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -68.48 114.09 6.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 33.2 tp -121.94 125.0 45.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.926 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 48.72 41.41 17.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 66.29 37.87 93.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.417 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -148.85 114.69 5.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.802 0.334 . . . . 0.0 110.916 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 32.9 mm -57.8 122.26 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.433 HD22 ' N ' ' A' ' 381' ' ' VAL . 7.4 tt -85.13 129.02 34.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.433 ' N ' HD22 ' A' ' 380' ' ' LEU . 76.6 t -103.53 119.91 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 16.3 mt -109.05 130.03 62.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -139.67 131.34 27.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.556 ' CE2' HD12 ' A' ' 367' ' ' LEU . 81.7 m-85 -59.05 123.28 16.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -50.54 166.86 0.49 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.481 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -86.01 138.11 32.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.37 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -174.92 125.6 0.27 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -72.93 -50.5 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -170.72 149.72 3.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -92.73 113.69 26.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.974 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 18.6 ptt85 -148.21 105.02 3.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 47.9 t -111.96 91.2 3.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 3.8 t -40.89 147.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 162.58 92.95 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.519 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.41 14.64 1.36 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.253 . . . . 0.0 112.33 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.2 t -44.72 139.44 2.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 26.0 p -148.35 149.68 32.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.823 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.485 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 65.3 m -159.42 126.15 4.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.808 0.337 . . . . 0.0 110.841 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 52.9 p -117.27 167.42 11.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.817 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 165.48 173.04 33.61 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.397 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 66.8 m -149.99 125.34 10.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.785 0.326 . . . . 0.0 110.847 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 67.2 p -145.42 133.14 21.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.802 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -45.4 153.33 0.67 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.455 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -70.29 -40.85 74.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.349 . . . . 0.0 110.898 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -96.11 -44.85 7.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.913 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 39.9 pt -83.73 41.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.153 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -58.66 -65.78 0.6 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -77.31 -71.93 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.864 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 2.9 mp -78.8 119.07 75.93 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.644 0.735 . . . . 0.0 111.108 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.55 -51.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.694 2.262 . . . . 0.0 112.316 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 22.0 mmm -54.47 -59.37 4.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.849 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 6.1 t80 40.95 43.19 1.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.5 t -174.69 164.5 3.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.895 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 67.5 m -80.24 -73.32 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.523 ' CE1' ' O ' ' A' ' 382' ' ' ILE . 11.9 p90 -161.46 -178.45 6.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.937 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -105.31 96.37 11.45 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.643 0.735 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.75 -44.37 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.68 2.253 . . . . 0.0 112.337 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 101.41 -177.72 27.36 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.491 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.79 140.0 97.74 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.681 0.753 . . . . 0.0 110.818 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.29 93.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.7 2.267 . . . . 0.0 112.321 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 49.1 m-20 -101.11 172.35 7.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.85 1.94 56.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 68.7 t -121.4 128.61 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.473 HD21 ' CD1' ' A' ' 384' ' ' PHE . 28.1 mt -114.29 120.34 40.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.779 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 13.0 t80 -105.62 106.05 16.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.585 ' CD1' ' N ' ' A' ' 313' ' ' LEU . 1.1 mp -91.43 156.19 17.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.932 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.541 ' HE2' ' CD2' ' A' ' 312' ' ' TYR . 41.1 mttt -144.22 -176.59 5.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 15.2 m120 56.76 52.61 9.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.6 mt -115.88 113.21 23.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 40.1 t -55.8 145.15 53.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.752 0.787 . . . . 0.0 110.842 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -46.07 -25.74 3.12 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.725 2.284 . . . . 0.0 112.349 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 10.9 mtp85 -69.61 -41.96 75.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.829 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 66.6 t -44.18 134.65 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.15 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 35.9 p -135.66 169.06 18.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -41.15 -48.57 3.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -40.42 -54.43 2.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -48.75 -59.99 3.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 36.8 mt -49.25 -52.31 27.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 330' ' ' ALA . 80.6 t -46.27 -58.23 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 2.2 t -57.75 -43.64 85.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 41.9 mt -56.08 -41.61 75.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -125.83 45.98 2.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -88.0 -41.87 12.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -52.05 -18.54 1.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -94.2 -45.2 7.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.807 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -50.15 -42.33 50.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -97.0 33.58 1.88 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -106.7 -68.57 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -156.73 165.45 36.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 64.0 171.98 2.39 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.498 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -46.16 170.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.627 2.218 . . . . 0.0 112.339 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 340' ' ' ILE . 62.9 Cg_endo -78.9 109.65 2.63 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.635 2.223 . . . . 0.0 112.388 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.554 HD13 ' CE2' ' A' ' 357' ' ' PHE . 60.8 mt -34.14 137.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.113 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -100.93 116.08 31.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.938 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -103.09 142.8 33.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -141.07 129.75 22.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.3 ttm -108.88 145.44 35.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 27.9 ttm -98.22 154.46 17.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.853 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 13.9 t -154.64 156.99 37.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.206 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 116.55 -104.2 1.21 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.518 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 349' ' ' MET . 10.4 ptm180 -100.03 158.16 16.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.8 0.333 . . . . 0.0 110.849 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' MET . . . . . 0.436 ' C ' ' O ' ' A' ' 348' ' ' ARG . 21.3 mmm 35.41 45.37 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.417 ' C ' ' OE1' ' A' ' 352' ' ' GLN . 5.9 ppt_? -49.76 179.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 91.96 42.07 4.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.467 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.417 ' OE1' ' C ' ' A' ' 350' ' ' ARG . 29.3 mp0 -152.31 133.03 14.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.888 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -135.59 147.23 48.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.079 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.779 ' CE2' ' CE1' ' A' ' 312' ' ' TYR . 42.6 m-85 -115.32 130.14 56.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.564 HG21 ' CE1' ' A' ' 357' ' ' PHE . 69.7 mt -121.5 141.72 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.188 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.403 ' N ' HG22 ' A' ' 355' ' ' ILE . 39.7 m -121.21 108.61 13.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.564 ' CE1' HG21 ' A' ' 355' ' ' ILE . 51.3 m-85 -88.5 156.67 50.59 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 0.0 110.897 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -47.03 -47.52 16.52 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.695 2.263 . . . . 0.0 112.304 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -148.78 146.3 27.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.912 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -40.42 -41.6 1.43 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -44.49 -65.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 75.2 mt -57.55 -57.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.078 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -40.81 -49.07 3.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -58.56 -62.57 1.76 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -47.92 -45.6 31.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.939 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.36 85.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.164 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.549 HD12 ' CZ ' ' A' ' 384' ' ' PHE . 5.5 tt -63.36 -65.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . 0.425 ' N ' ' CD2' ' A' ' 367' ' ' LEU . 2.4 t60 -46.5 -33.58 4.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 37.3 mt -69.9 -53.0 19.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.952 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.36 36.59 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -83.54 85.77 7.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 106.55 46.18 1.16 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.491 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -89.95 120.52 31.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.008 0.433 . . . . 0.0 110.898 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -70.18 135.4 49.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 28.6 tp -148.29 116.33 6.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.955 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 53.59 42.1 31.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 66.69 30.65 76.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.47 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . 0.421 ' NZ ' ' HA ' ' A' ' 378' ' ' LYS . 0.0 OUTLIER -134.26 124.24 25.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.74 0.305 . . . . 0.0 110.888 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 33.8 mm -74.55 107.76 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 7.3 tt -70.16 127.84 34.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.57 126.44 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.148 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.523 ' O ' ' CE1' ' A' ' 302' ' ' TYR . 15.0 mt -106.52 137.59 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.161 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -146.39 121.45 10.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.549 ' CZ ' HD12 ' A' ' 367' ' ' LEU . 54.2 m-85 -52.64 140.0 24.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.853 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -39.59 113.13 0.31 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.493 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -77.05 -43.84 32.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.803 0.335 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -126.2 159.45 32.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -104.5 131.62 51.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.864 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -100.2 124.21 45.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.449 ' HA ' ' NE2' ' A' ' 390' ' ' GLN . 8.3 mm-40 -103.99 103.35 13.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.943 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -162.08 145.95 12.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.949 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 16.6 m -141.51 150.09 41.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.803 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 78.4 p -63.37 159.84 17.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.91 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 150.04 71.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.481 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.93 132.03 13.82 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.723 2.282 . . . . 0.0 112.375 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 13.6 t -80.55 105.52 11.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.931 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.7 t -57.6 -50.58 72.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.89 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.558 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.2 m -157.32 140.59 15.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.363 . . . . 0.0 110.858 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 69.5 m -83.73 169.23 15.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -105.6 44.56 1.45 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.451 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 61.5 p -174.44 120.28 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 110.794 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 17.2 p -74.48 110.18 8.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 74.9 134.65 0.37 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.492 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -84.72 -22.92 29.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.777 0.322 . . . . 0.0 110.869 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -122.72 -39.74 2.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.515 ' CD1' ' O ' ' A' ' 293' ' ' ILE . 2.7 pp -81.35 39.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.123 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -74.97 -44.24 49.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.823 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -132.8 72.15 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.471 ' O ' ' CE1' ' A' ' 299' ' ' PHE . 71.1 mt -141.19 121.16 8.48 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.593 0.711 . . . . 0.0 111.093 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.9 -39.3 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.67 2.247 . . . . 0.0 112.356 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 11.7 mtm -123.82 89.51 3.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.82 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . 0.471 ' CE1' ' O ' ' A' ' 296' ' ' ILE . 1.2 m-85 -69.25 -45.48 69.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 30.5 t -122.39 102.58 8.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.845 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 19.2 m -76.81 -53.37 8.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.855 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -174.98 164.29 3.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.953 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -138.64 143.34 37.59 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.591 0.71 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.61 -51.9 0.08 OUTLIER 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.759 2.306 . . . . 0.0 112.329 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 99.03 -161.12 20.06 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.503 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -57.16 144.65 69.07 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.625 0.726 . . . . 0.0 110.869 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 384' ' ' PHE . 59.3 Cg_endo -73.36 129.73 14.24 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.7 2.267 . . . . 0.0 112.27 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -130.92 -179.07 5.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -84.91 -26.75 27.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 18.3 t -102.72 145.32 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.628 ' CD1' ' CE1' ' A' ' 357' ' ' PHE . 77.0 mt -125.92 135.23 51.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.549 ' CD1' ' HE2' ' A' ' 314' ' ' LYS . 0.7 OUTLIER -102.86 101.46 11.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.866 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.493 HD21 ' CE1' ' A' ' 329' ' ' PHE . 5.7 mp -91.12 140.96 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.905 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.549 ' HE2' ' CD1' ' A' ' 312' ' ' TYR . 14.6 mttm -139.38 -178.8 5.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 60.53 47.59 8.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 317' ' ' SER . 10.8 mt -105.59 99.61 9.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 316' ' ' LEU . 28.9 t -38.08 144.02 0.38 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.642 0.734 . . . . 0.0 110.924 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -44.54 -33.75 7.0 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.673 2.249 . . . . 0.0 112.382 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 16.6 mtp85 -68.5 -39.26 81.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 97.5 t -41.23 138.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 68.9 p -138.0 176.1 9.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -45.13 -54.23 7.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 324' ' ' ASP . 9.4 mmm180 -42.0 -64.99 0.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.94 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 323' ' ' ARG . 40.3 m-20 -35.92 -47.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 76.0 mt -65.45 -49.39 69.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.923 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 330' ' ' ALA . 55.3 t -48.7 -59.39 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 43.8 t -56.13 -42.73 77.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.558 HD23 ' CD2' ' A' ' 373' ' ' TYR . 29.3 mt -57.16 -31.41 65.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.902 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.493 ' CE1' HD21 ' A' ' 313' ' ' LEU . 64.2 m-85 -129.45 36.8 4.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -85.56 -48.69 8.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -42.54 -41.76 3.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 366' ' ' ALA . 36.9 m-85 -64.77 -35.58 81.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 330' ' ' ALA . 23.0 tt0 -44.26 -58.37 2.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -67.13 72.34 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 336' ' ' LYS . 1.5 tmtp? -164.86 148.51 8.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . 0.449 ' N ' ' HD3' ' A' ' 335' ' ' LYS . 44.5 tttm -41.23 110.84 0.18 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 145.81 142.02 3.73 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.24 152.46 3.62 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.637 2.225 . . . . 0.0 112.38 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.11 137.98 28.75 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.643 2.229 . . . . 0.0 112.363 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 97.2 mt -68.44 142.91 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.129 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -109.54 127.47 54.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -115.56 141.58 47.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.863 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -137.11 127.21 26.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 30.0 tpp -117.15 136.97 52.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 3.2 ptp -109.3 128.55 55.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.838 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 31.9 p -124.95 118.79 27.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.083 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 168.38 -138.45 5.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.547 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 35.7 ptt85 -59.38 -42.61 92.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.755 0.312 . . . . 0.0 110.802 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' MET . . . . . 0.416 ' HG3' ' NE2' ' A' ' 352' ' ' GLN . 2.5 tpp -102.21 47.99 0.88 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -59.65 170.55 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 81.8 5.68 89.62 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.48 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.416 ' NE2' ' HG3' ' A' ' 349' ' ' MET . 80.8 mt-30 -116.61 151.47 36.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 0.0 110.965 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -163.97 157.2 18.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.094 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.481 ' CE2' ' CE2' ' A' ' 312' ' ' TYR . 8.8 m-85 -118.44 158.42 25.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.815 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.467 HG22 ' CZ ' ' A' ' 357' ' ' PHE . 24.3 mt -144.89 117.25 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.187 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 13.3 m -97.55 131.53 44.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.1 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.628 ' CE1' ' CD1' ' A' ' 311' ' ' LEU . 7.7 m-85 -111.46 155.39 42.95 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.639 0.733 . . . . 0.0 110.892 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -44.26 -31.35 4.23 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.267 . . . . 0.0 112.379 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.1 177.29 11.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.435 ' NZ ' ' O ' ' A' ' 307' ' ' PRO . 0.1 OUTLIER -72.33 -49.92 30.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -43.85 -63.94 0.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 79.3 mt -50.85 -59.03 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.418 ' HB1' ' CD1' ' A' ' 357' ' ' PHE . . . -44.54 -46.13 9.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.095 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -59.04 -67.84 0.33 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -37.5 -52.02 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 332' ' ' PHE . . . -55.94 -43.95 77.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.05 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.535 HD11 ' CE1' ' A' ' 384' ' ' PHE . 7.9 tt -58.17 -55.24 37.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.894 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . 0.448 ' N ' HD21 ' A' ' 367' ' ' LEU . 15.7 m80 -67.45 -13.19 61.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 33.5 mt -93.01 -29.57 15.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 6.2 t -109.21 17.2 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 371' ' ' ASN . 0.5 OUTLIER -75.08 117.13 16.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 81.39 36.5 20.31 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.487 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.558 ' CD2' HD23 ' A' ' 328' ' ' LEU . 65.0 t80 -81.79 114.08 20.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 0.0 110.917 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -70.07 104.4 2.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.959 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 51.2 tp -121.57 125.23 46.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 57.38 27.02 13.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.959 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 78.71 25.28 60.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.514 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -132.57 139.95 48.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 36.2 mm -84.17 94.6 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.126 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.459 ' CD2' HG13 ' A' ' 382' ' ' ILE . 5.2 tt -57.54 130.11 44.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 39.3 t -110.69 124.39 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.459 HG13 ' CD2' ' A' ' 380' ' ' LEU . 14.8 mt -109.03 143.73 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -148.26 121.32 8.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.535 ' CE1' HD11 ' A' ' 367' ' ' LEU . 26.1 m-85 -46.69 149.2 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.83 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -64.97 -163.1 0.78 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.458 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -118.75 106.38 12.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.34 . . . . 0.0 110.863 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -76.25 150.22 37.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -100.62 -68.8 0.8 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -141.47 117.45 10.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.847 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -57.34 164.18 1.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -144.68 179.19 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 6.5 t -117.79 116.79 27.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 11.5 t -116.47 155.44 28.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 164.49 160.93 12.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.457 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.06 117.9 4.58 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.707 2.271 . . . . 0.0 112.38 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 10.9 t -89.21 96.55 10.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.826 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 45.7 m -47.72 154.53 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.519 -179.947 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 4.7 m -132.2 157.16 45.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.865 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.7 t -53.22 150.77 5.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.78 120.7 0.36 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.434 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 47.7 m -92.23 -60.12 1.92 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 110.914 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 53.3 m -60.81 129.1 39.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.817 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 55.84 95.49 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.48 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.73 -35.45 79.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 0.0 110.898 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -131.86 -41.08 1.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.444 ' O ' ' CE1' ' A' ' 299' ' ' PHE . 11.9 pt -52.41 -20.92 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.106 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 51.1 ptt85 -59.98 -28.35 67.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.824 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -85.29 -51.81 6.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 4.5 mp -56.1 109.33 1.59 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.531 0.681 . . . . 0.0 111.204 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.55 -42.12 29.35 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.702 2.268 . . . . 0.0 112.327 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.426 ' O ' ' C ' ' A' ' 299' ' ' PHE . 4.0 mpp? -118.53 77.5 1.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 293' ' ' ILE . 0.7 OUTLIER -34.48 -64.3 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 41.8 t -166.29 143.58 5.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 302' ' ' TYR . 51.2 m -154.96 165.23 37.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.894 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.503 ' CD1' ' C ' ' A' ' 302' ' ' TYR . 1.6 p90 -36.03 144.09 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.17 140.07 23.16 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.655 0.74 . . . . 0.0 110.852 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -78.69 -48.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.75 2.3 . . . . 0.0 112.337 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 87.26 -168.39 38.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.493 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.425 ' CD ' ' HD2' ' A' ' 307' ' ' PRO . 7.9 tp10 -39.75 137.63 1.1 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.646 0.736 . . . . 0.0 110.919 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . 0.425 ' HD2' ' CD ' ' A' ' 306' ' ' GLU . 60.4 Cg_endo -73.78 147.36 39.58 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.727 2.285 . . . . 0.0 112.337 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -153.47 166.29 33.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.463 ' HD2' ' CG2' ' A' ' 310' ' ' VAL . 0.0 OUTLIER -84.4 29.88 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.867 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . 0.463 ' CG2' ' HD2' ' A' ' 309' ' ' LYS . 90.8 t -146.9 123.21 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.178 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.556 HD13 ' CE1' ' A' ' 357' ' ' PHE . 20.4 mt -116.82 126.51 53.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.785 ' CE1' ' CZ ' ' A' ' 354' ' ' PHE . 18.0 t80 -103.94 101.56 11.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.411 ' CD1' HD13 ' A' ' 355' ' ' ILE . 6.5 mp -89.45 140.52 29.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.958 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -131.9 -176.06 3.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.839 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 55.61 52.98 10.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.919 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.5 mt -111.53 113.04 25.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.952 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 46.6 t -54.2 139.53 55.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.651 0.739 . . . . 0.0 110.867 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -42.37 -28.11 0.89 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.714 2.276 . . . . 0.0 112.35 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 26.4 mmt-85 -68.5 -40.4 80.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.852 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 40.8 t -46.16 123.7 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.106 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 18.3 p -122.05 168.49 11.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -40.81 -51.75 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -43.39 -50.11 6.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -50.04 -47.41 53.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 45.7 mt -61.46 -53.04 61.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 99.7 t -48.11 -49.56 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.182 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 5.8 t -63.46 -40.42 97.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.823 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.406 HD22 ' CD1' ' A' ' 373' ' ' TYR . 40.8 mt -58.46 -40.03 81.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.856 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -123.79 40.29 3.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -86.33 -34.28 20.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.075 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.412 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 9.9 ptp85 -55.51 -39.77 70.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.442 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 23.3 m-85 -67.72 -34.84 77.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -52.56 94.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.97 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -141.32 168.7 19.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -71.06 81.84 0.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.855 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.48 -65.72 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -138.13 -157.24 7.4 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.477 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -43.15 162.84 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.77 2.313 . . . . 0.0 112.357 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -79.13 121.56 4.93 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.712 2.274 . . . . 0.0 112.307 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.554 HG23 ' CE1' ' A' ' 342' ' ' PHE . 79.4 mt -50.74 109.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.113 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -82.95 139.98 33.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . 0.554 ' CE1' HG23 ' A' ' 340' ' ' ILE . 79.8 m-85 -125.37 136.18 53.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -135.69 135.35 40.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.417 ' C ' ' CE ' ' A' ' 345' ' ' MET . 10.6 ttm -116.71 144.19 44.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' MET . . . . . 0.417 ' CE ' ' C ' ' A' ' 344' ' ' MET . 22.5 mmt -87.93 162.75 16.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 10.2 t -174.0 143.8 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.165 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 88.11 -102.76 2.86 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.5 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -45.82 -61.82 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.313 . . . . 0.0 110.84 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 7.2 mtp -127.6 94.62 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 -84.82 163.92 18.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 82.09 10.04 84.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -122.62 154.6 37.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.785 0.326 . . . . 0.0 110.978 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -149.59 144.5 26.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.055 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.785 ' CZ ' ' CE1' ' A' ' 312' ' ' TYR . 70.1 m-85 -120.23 119.0 31.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.473 HG22 ' CE1' ' A' ' 357' ' ' PHE . 65.7 mt -108.25 142.61 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.122 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 26.4 m -122.96 103.91 8.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.556 ' CE1' HD13 ' A' ' 311' ' ' LEU . 26.9 m-85 -83.57 156.16 65.37 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.703 0.763 . . . . 0.0 110.858 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -45.21 -52.91 5.91 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.702 2.268 . . . . 0.0 112.287 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -133.92 162.37 32.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -61.14 -42.6 98.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -51.8 -58.23 7.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 72.2 mt -53.08 -61.03 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -42.84 -59.78 1.84 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -43.05 -60.38 1.66 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -43.57 -45.83 6.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.951 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -64.14 -33.66 76.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.15 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.574 HD13 ' CE1' ' A' ' 384' ' ' PHE . 7.1 tt -63.91 -61.65 2.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.923 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.05 -35.67 69.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.11 -42.95 68.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 11.7 t -105.12 41.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -92.21 94.49 9.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 100.64 40.76 2.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.521 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.406 ' CD1' HD22 ' A' ' 328' ' ' LEU . 54.9 t80 -87.63 108.96 19.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.954 0.406 . . . . 0.0 110.928 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -60.38 123.25 16.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 26.0 tp -135.97 132.82 36.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 48.35 45.75 20.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 57.51 34.19 68.52 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.51 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -150.56 114.13 4.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.339 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 45.7 mm -51.04 146.01 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.427 ' C ' HD21 ' A' ' 380' ' ' LEU . 8.3 tt -104.7 140.39 38.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 78.9 t -123.93 125.04 70.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 11.8 mt -109.84 132.57 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.149 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -137.01 119.83 16.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.574 ' CE1' HD13 ' A' ' 367' ' ' LEU . 16.9 m-85 -48.67 114.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 386' ' ' LYS . . . -40.22 110.11 0.16 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.478 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 385' ' ' GLY . 0.0 OUTLIER -36.06 151.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.952 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -110.63 112.04 23.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -99.05 42.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -124.72 39.56 3.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -116.04 124.52 50.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 5.3 tpp85 -171.15 133.69 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 32.1 t -84.71 -41.9 15.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 65.4 p -116.44 150.14 38.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.832 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -172.9 88.37 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.41 125.44 7.7 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.65 2.233 . . . . 0.0 112.336 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 28.4 p -109.39 145.57 35.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.9 t -127.76 -55.47 1.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.531 179.969 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.6 t -73.64 140.79 46.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.836 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 35.8 t -108.2 88.22 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.801 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -177.08 113.94 0.45 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.479 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 54.7 m -116.34 126.26 53.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 110.86 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 23.6 t -115.8 145.25 42.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 98.67 139.26 10.73 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.511 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -107.94 152.06 24.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 0.0 110.863 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 44.6 38.85 2.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.959 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 15.3 pt -90.56 40.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.106 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -52.47 -43.09 64.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -121.41 -60.9 1.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 47.0 mt -88.25 133.34 37.0 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.625 0.726 . . . . 0.0 111.108 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.03 -50.68 0.09 OUTLIER 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.698 2.265 . . . . 0.0 112.338 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 29.4 mmt -58.74 -70.05 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.855 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 4.5 t80 56.37 34.61 24.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 2.4 t -159.25 112.86 2.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.796 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 36.1 m -129.01 171.77 12.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -53.07 166.74 0.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.957 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -120.07 111.17 35.69 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.638 0.733 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.64 -39.98 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.621 2.214 . . . . 0.0 112.424 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 96.52 -129.83 10.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -107.58 134.67 19.92 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.748 0.785 . . . . 0.0 110.824 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.8 113.69 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.777 2.318 . . . . 0.0 112.317 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -126.58 178.59 5.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -81.62 -28.09 33.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 81.7 t -95.0 138.68 20.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.202 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.519 HD12 ' CE1' ' A' ' 357' ' ' PHE . 77.7 mt -125.31 114.18 18.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.788 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 11.7 t80 -88.62 104.08 16.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.939 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 6.4 mp -92.52 150.84 20.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -140.84 -175.0 4.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 57.75 48.31 14.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 12.1 mt -104.09 124.89 49.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.9 t -67.6 145.05 98.09 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.659 0.742 . . . . 0.0 110.828 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.55 -27.41 3.48 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.705 2.27 . . . . 0.0 112.307 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 32.5 mtp85 -74.25 -38.33 63.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 93.2 t -41.36 146.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 44.6 p -148.73 159.38 44.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.152 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.426 ' C ' ' OE1' ' A' ' 322' ' ' GLU . 1.2 tm-20 -41.02 -32.27 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . 0.414 ' NH1' ' HB2' ' A' ' 323' ' ' ARG . 17.7 ttm105 -60.66 -58.12 9.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.956 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -45.8 -48.55 15.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 36.1 mt -57.84 -51.64 68.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 69.4 t -45.83 -47.34 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 8.8 t -67.28 -37.73 83.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.831 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 51.0 mt -56.52 -34.35 66.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.934 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -127.9 32.85 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -71.24 -52.14 20.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.099 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -40.06 -49.77 2.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.834 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -54.07 -57.54 10.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -43.48 99.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.93 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -112.15 -175.48 2.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -56.96 -46.53 82.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -69.01 174.81 4.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 57.01 156.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.98 146.42 32.72 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.726 2.284 . . . . 0.0 112.35 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 340' ' ' ILE . 71.2 Cg_exo -45.94 106.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.675 2.25 . . . . 0.0 112.352 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 339' ' ' PRO . 83.9 mt -34.14 129.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -92.32 138.36 31.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . 0.432 ' CD2' HG21 ' A' ' 355' ' ' ILE . 80.2 m-85 -127.72 136.1 51.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.841 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -134.32 122.78 23.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.873 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 45.4 tpp -110.07 133.29 53.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 26.5 ttm -83.68 119.05 24.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 9.7 t -141.38 144.77 34.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 119.62 -83.39 0.35 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.505 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -68.97 -53.51 20.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.83 0.348 . . . . 0.0 110.858 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 8.2 ttt -155.24 118.97 4.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.923 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -87.52 175.67 7.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 107.14 -21.5 31.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.536 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.431 ' N ' ' CD ' ' A' ' 352' ' ' GLN . 3.0 mp0 -112.18 141.74 45.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.816 0.341 . . . . 0.0 110.891 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.59 153.63 41.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.033 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.788 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 50.7 m-85 -125.24 124.19 41.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.511 HG22 ' CE1' ' A' ' 357' ' ' PHE . 71.3 mt -117.75 137.65 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.136 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 83.4 m -113.9 128.68 56.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.519 ' CE1' HD12 ' A' ' 311' ' ' LEU . 69.8 m-85 -109.46 157.05 38.43 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 0.0 110.875 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -42.8 -34.97 3.91 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.62 2.213 . . . . 0.0 112.398 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . 0.448 ' ND2' ' H ' ' A' ' 362' ' ' ILE . 0.7 OUTLIER -159.44 -177.34 6.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -71.96 -45.62 60.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -43.12 -66.04 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . 0.448 ' H ' ' ND2' ' A' ' 359' ' ' ASN . 58.1 mt -51.1 -69.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.152 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 362' ' ' ILE . . . -36.3 -57.36 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -48.43 -57.28 6.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -50.28 -41.86 51.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.95 90.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.009 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.551 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 4.8 tt -60.75 -60.65 3.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 110.932 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -62.08 -35.18 77.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 32.2 mt -67.46 -40.48 85.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 10.5 t -107.18 32.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.71 125.41 29.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 64.88 38.31 95.37 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.445 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -78.65 124.93 28.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.877 0.37 . . . . 0.0 110.958 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -78.41 121.21 24.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 29.8 tp -125.77 143.97 50.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 38.46 33.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 72.13 47.81 28.82 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.433 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 378' ' ' LYS . 2.4 ptmt -165.92 120.49 1.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.825 0.345 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 46.6 mm -51.49 142.6 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.138 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.468 ' CD2' HG13 ' A' ' 382' ' ' ILE . 5.6 tt -110.4 143.38 40.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 11.7 t -112.78 142.42 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.071 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.468 HG13 ' CD2' ' A' ' 380' ' ' LEU . 27.5 mt -134.56 136.14 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.153 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . 0.45 ' OE1' ' C ' ' A' ' 382' ' ' ILE . 4.8 mp0 -138.63 178.93 6.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.968 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.551 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 48.7 m-85 -105.04 133.93 49.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.93 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -110.29 143.4 16.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.462 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -127.93 154.87 45.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.907 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -110.25 -47.6 3.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -154.51 126.73 7.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -81.76 45.06 0.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.892 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -118.98 150.96 39.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -121.52 -44.82 2.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.857 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 73.1 m 46.78 44.4 14.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.892 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 83.1 p -68.77 127.28 32.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.925 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 141.53 91.66 0.18 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.487 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.84 112.68 3.49 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.636 2.224 . . . . 0.0 112.367 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 66.8 m -53.0 109.59 0.44 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.93 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 11.9 t -93.46 139.65 30.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.5 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 10.2 m -65.91 95.81 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 0.0 110.849 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 4.4 m -143.67 162.55 35.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 140.35 154.71 6.33 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.466 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 30.8 m -139.42 157.07 46.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.4 t -147.43 116.49 6.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 139.5 111.0 0.93 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.463 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -93.45 -38.01 11.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.792 0.33 . . . . 0.0 110.876 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -94.05 -20.25 20.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.818 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.422 HD13 ' C ' ' A' ' 293' ' ' ILE . 2.2 pp -103.16 161.07 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.097 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 56.9 mtp85 -111.72 -56.79 2.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 28.7 mmtt -113.95 -55.57 2.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 58.4 mt -97.96 132.59 24.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.594 0.711 . . . . 0.0 111.149 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.99 -42.05 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.266 . . . . 0.0 112.253 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 16.8 mmt -81.5 43.18 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -81.58 -51.78 7.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 75.3 m -107.67 85.65 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 22.6 m -70.91 -52.47 19.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.884 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.449 ' CG ' HG11 ' A' ' 381' ' ' VAL . 4.1 p90 -132.01 136.42 47.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -103.8 136.92 19.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.652 0.739 . . . . 0.0 110.853 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.0 -52.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.621 2.214 . . . . 0.0 112.363 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 113.82 -159.94 13.43 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.534 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -81.3 135.22 50.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.732 0.777 . . . . 0.0 110.867 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.93 122.54 6.26 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.653 2.235 . . . . 0.0 112.35 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -130.09 -177.79 4.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.425 ' C ' ' HD3' ' A' ' 309' ' ' LYS . 0.0 OUTLIER -99.12 -14.13 19.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.972 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 69.2 t -111.79 115.07 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.051 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.473 HD21 ' CE1' ' A' ' 384' ' ' PHE . 58.8 mt -100.32 140.23 34.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.849 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.752 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 10.6 t80 -122.27 102.88 8.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.964 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 6.6 mp -86.04 150.98 24.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.552 ' HE2' ' CD2' ' A' ' 312' ' ' TYR . 41.3 mttt -139.79 -175.9 4.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.919 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 54.59 52.35 12.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.0 mt -110.21 104.6 13.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 36.2 t -47.22 143.98 4.59 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.728 0.775 . . . . 0.0 110.823 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.37 -19.01 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.69 2.26 . . . . 0.0 112.335 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 30.5 mtt180 -77.38 -36.39 53.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . 0.443 HG13 ' N ' ' A' ' 321' ' ' THR . 95.9 t -44.88 152.15 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 322' ' ' GLU . 35.3 p -158.78 166.52 31.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.164 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 321' ' ' THR . 7.3 mt-10 -34.78 -55.57 0.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.79 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 322' ' ' GLU . 60.3 mtp180 -37.45 -46.49 0.81 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -56.35 -59.71 4.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 23.1 mt -57.05 -51.2 70.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.926 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 92.6 t -53.11 -56.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.131 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 25.4 t -58.85 -39.51 81.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.9 mt -60.37 -40.52 91.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.402 ' CE1' HG22 ' A' ' 370' ' ' VAL . 28.9 m-85 -124.2 48.27 1.95 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.879 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -83.73 -57.45 3.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.992 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.413 ' HB3' ' NH1' ' A' ' 331' ' ' ARG . 3.4 ptp180 -42.73 -46.1 5.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.891 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.439 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 74.3 m-85 -46.21 -41.97 13.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -58.62 92.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -105.67 179.5 4.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -69.14 -51.99 32.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -52.42 -58.73 5.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.24 114.0 3.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.533 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -44.93 157.09 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.712 2.275 . . . . 0.0 112.367 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -45.44 121.56 4.01 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.669 2.246 . . . . 0.0 112.316 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 71.0 mt -65.35 140.48 19.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.115 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -96.18 137.15 35.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -120.08 151.65 38.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -141.27 125.24 17.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 40.4 tpp -112.94 133.63 54.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 11.9 ttm -86.76 158.72 19.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.879 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.27 140.11 8.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.207 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 142.56 -154.83 25.42 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.518 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . 0.412 ' HG3' ' N ' ' A' ' 349' ' ' MET . 30.1 ptt180 -53.3 -54.03 42.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 110.87 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' MET . . . . . 0.412 ' N ' ' HG3' ' A' ' 348' ' ' ARG . 17.7 ttm -101.06 81.74 2.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.849 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -91.25 176.98 6.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 102.38 15.87 24.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.502 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 312' ' ' TYR . 2.8 mp0 -132.75 151.37 52.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 110.87 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -153.28 150.37 28.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.089 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.752 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 46.5 m-85 -114.64 152.72 31.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.456 HG23 ' CE1' ' A' ' 357' ' ' PHE . 94.7 mt -139.16 142.84 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.102 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 49.7 m -124.86 121.73 35.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.141 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.456 ' CE1' HG23 ' A' ' 355' ' ' ILE . 62.2 m-85 -104.57 157.2 34.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.666 0.746 . . . . 0.0 110.802 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -46.29 -37.1 18.35 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.626 2.217 . . . . 0.0 112.368 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -149.12 174.44 12.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -71.19 -28.71 64.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -60.13 -63.33 1.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 59.2 mt -50.48 -57.53 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -40.95 -61.49 0.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.082 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -48.09 -63.07 1.17 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -43.48 -41.73 4.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.928 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -63.05 -42.51 99.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.064 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.02 -58.41 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -55.39 -31.28 61.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 51.3 mt -78.02 -37.32 47.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . 0.402 HG22 ' CE1' ' A' ' 329' ' ' PHE . 16.4 t -111.27 37.27 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.74 124.72 29.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 63.08 43.01 99.41 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.483 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' A' ' 374' ' ' LYS . 13.9 t80 -78.61 134.79 37.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 0.0 110.952 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.434 ' O ' ' CE1' ' A' ' 373' ' ' TYR . 21.1 ttmt -86.33 119.48 26.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 18.1 tp -133.83 120.7 20.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 53.34 41.17 32.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 67.21 31.29 77.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.451 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . 0.414 ' NZ ' ' HA ' ' A' ' 378' ' ' LYS . 0.0 OUTLIER -134.83 130.05 35.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.749 0.309 . . . . 0.0 110.829 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 33.7 mm -76.92 92.19 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 8.1 tt -61.16 114.69 3.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.449 HG11 ' CG ' ' A' ' 302' ' ' TYR . 34.1 t -101.05 127.98 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.107 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 32.5 mt -104.79 126.8 59.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -128.65 125.73 38.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.835 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.473 ' CE1' HD21 ' A' ' 311' ' ' LEU . 44.8 m-85 -59.25 158.51 9.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.841 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 384' ' ' PHE . . . -37.67 109.13 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -47.31 -45.36 24.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 110.899 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -110.0 148.63 31.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 389' ' ' LYS . 19.6 ptmt -120.74 -44.01 2.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 388' ' ' LYS . 12.3 tmtt? -36.35 119.09 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.955 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -149.28 143.83 26.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -115.31 132.46 56.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 79.4 p -97.54 165.39 12.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.825 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 86.4 p -120.08 131.71 55.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.837 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -86.93 158.77 30.84 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.477 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.02 123.56 6.82 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.685 2.257 . . . . 0.0 112.387 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 12.0 t -132.85 134.18 44.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 13.7 m -76.61 121.74 23.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.797 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.49 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 1.2 t -146.56 161.67 40.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.896 0.379 . . . . 0.0 110.835 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 93.1 p -116.69 152.8 33.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.811 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 169.71 75.28 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.494 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.9 p -124.43 87.99 2.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.862 0.363 . . . . 0.0 110.873 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 4.6 t -113.51 129.4 56.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.848 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . 0.437 ' HA3' ' CD1' ' A' ' 293' ' ' ILE . . . 82.47 108.43 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.475 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.28 -59.38 4.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 110.889 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -99.97 -47.15 5.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.437 ' CD1' ' HA3' ' A' ' 290' ' ' GLY . 2.7 pp -59.12 165.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 25.4 ttt-85 -124.19 -47.48 1.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -127.3 -47.42 1.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 50.9 mt -104.31 101.29 26.06 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.631 0.729 . . . . 0.0 111.126 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -44.23 -21.13 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.769 2.313 . . . . 0.0 112.27 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 6.2 tpp -107.92 45.05 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.829 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -95.45 -43.87 7.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.813 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.1 t -112.4 90.58 3.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.85 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 54.5 m -120.14 -50.43 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.816 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.561 ' CE2' HG12 ' A' ' 381' ' ' VAL . 15.1 p90 -155.61 165.49 36.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -123.74 138.59 30.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.558 0.694 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.21 -48.44 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.624 2.216 . . . . 0.0 112.287 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 113.71 -150.67 18.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.467 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -96.49 139.0 21.45 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.592 0.71 . . . . 0.0 110.9 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.46 102.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.694 2.263 . . . . 0.0 112.313 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -115.73 176.75 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.43 5.24 48.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 60.5 t -127.72 129.75 70.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 49.3 mt -116.42 121.45 41.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.795 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 17.5 t80 -105.14 104.84 14.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.933 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.451 HD11 ' N ' ' A' ' 313' ' ' LEU . 3.2 mp -91.31 144.02 26.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.942 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -133.44 179.46 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.3 m120 57.23 51.83 9.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.8 mt -108.96 107.57 17.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.5 t -40.48 144.7 0.56 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.702 0.763 . . . . 0.0 110.893 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -47.16 -28.35 7.61 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.66 2.24 . . . . 0.0 112.336 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 24.2 mtt85 -73.51 -30.84 63.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 84.9 t -51.26 119.34 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.125 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 17.2 p -124.72 172.77 9.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -44.37 -44.0 7.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 64.9 mtt-85 -48.56 -54.73 13.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -49.13 -45.03 42.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 57.6 mt -62.63 -53.52 53.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 330' ' ' ALA . 81.6 t -44.36 -49.35 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 47.2 t -65.4 -45.64 83.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.833 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 57.8 mt -52.55 -36.8 56.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.949 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.522 ' CE1' HG21 ' A' ' 370' ' ' VAL . 25.4 m-85 -132.36 44.35 2.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.857 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 333' ' ' GLN . . . -80.35 -52.82 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.051 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -37.32 -32.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.84 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 330' ' ' ALA . 86.6 m-85 -73.97 -45.76 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.924 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 330' ' ' ALA . 57.8 tt0 -50.49 -43.98 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.905 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.76 44.6 1.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -129.33 160.53 32.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.875 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -38.02 -56.7 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.96 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -43.34 138.47 3.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.473 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -47.9 160.48 0.46 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.654 2.236 . . . . 0.0 112.372 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.25 153.58 1.03 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.688 2.259 . . . . 0.0 112.324 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.462 HD13 ' N ' ' A' ' 333' ' ' GLN . 64.3 mt -100.68 137.57 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -96.31 127.85 42.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -117.66 142.42 47.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.427 ' HD3' ' N ' ' A' ' 344' ' ' MET . 0.8 OUTLIER -140.9 132.12 26.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.854 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.427 ' N ' ' HD3' ' A' ' 343' ' ' ARG . 39.7 tpp -113.83 143.43 44.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 21.3 ttm -86.65 157.89 19.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.916 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 34.4 p -142.11 151.31 42.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.138 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 348' ' ' ARG . . . 126.24 -156.71 19.87 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 347' ' ' GLY . 6.6 tpm_? -35.51 -70.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.854 0.359 . . . . 0.0 110.931 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 11.5 mmt -112.02 91.23 3.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.16 28.04 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.404 ' C ' ' NE2' ' A' ' 352' ' ' GLN . . . -90.07 32.78 4.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.475 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.426 ' HB3' ' CE1' ' A' ' 312' ' ' TYR . 10.1 mp0 -142.41 143.53 32.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 0.0 110.887 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.87 152.78 40.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.795 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 82.5 m-85 -120.27 132.67 55.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.557 HG22 ' CE1' ' A' ' 357' ' ' PHE . 78.4 mt -124.14 138.02 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.118 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 17.1 m -117.09 117.8 30.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.19 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.557 ' CE1' HG22 ' A' ' 355' ' ' ILE . 50.1 m-85 -98.86 158.17 32.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.696 0.76 . . . . 0.0 110.861 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.19 -35.59 15.44 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.661 2.241 . . . . 0.0 112.355 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -158.42 166.77 31.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 361' ' ' GLU . 8.7 pttt -58.0 -49.71 75.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 360' ' ' LYS . 2.2 tt0 -36.7 -63.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.878 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 55.0 mt -56.13 -62.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.131 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -38.6 -59.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.087 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -47.38 -58.16 4.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.404 ' O ' ' CG ' ' A' ' 369' ' ' LEU . 6.6 mm100 -53.76 -35.39 61.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -68.12 -38.42 82.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.14 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.539 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.4 tt -66.54 -56.79 9.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . 0.421 ' N ' HD21 ' A' ' 367' ' ' LEU . 9.3 t-80 -60.96 -38.02 84.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.776 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.404 ' CG ' ' O ' ' A' ' 365' ' ' GLN . 37.3 mt -65.72 -40.91 92.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . 0.522 HG21 ' CE1' ' A' ' 329' ' ' PHE . 7.3 t -106.15 28.96 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . 0.451 ' CG ' ' O ' ' A' ' 371' ' ' ASN . 0.8 OUTLIER -76.43 116.23 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 73.46 45.94 27.71 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.501 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.431 ' CE1' ' O ' ' A' ' 374' ' ' LYS . 38.6 t80 -85.32 138.07 32.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.912 0.386 . . . . 0.0 110.901 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.431 ' O ' ' CE1' ' A' ' 373' ' ' TYR . 22.4 ttmt -89.26 124.89 34.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 376' ' ' TYR . 60.7 tp -135.88 150.42 49.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.952 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 375' ' ' LEU . 25.2 m-85 35.57 35.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.953 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 375' ' ' LEU . . . 66.73 53.06 29.71 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.51 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -171.83 126.46 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.757 0.313 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 41.9 mm -56.28 144.71 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.161 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.423 ' C ' ' CD2' ' A' ' 380' ' ' LEU . 3.6 tt -112.34 140.37 47.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.561 HG12 ' CE2' ' A' ' 302' ' ' TYR . 23.6 t -110.51 144.48 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 370' ' ' VAL . 23.6 mt -131.42 151.88 36.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.086 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -148.56 175.42 11.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.539 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 29.5 m-85 -104.51 154.2 20.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -97.41 119.92 6.56 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.472 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -70.27 173.37 6.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.761 0.315 . . . . 0.0 110.958 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -128.83 166.57 18.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.896 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 109.71 15.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.89 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -65.67 101.9 0.68 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -137.2 121.87 18.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -53.0 175.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.836 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.6 t -139.49 108.75 6.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 48.2 t -137.91 141.72 40.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.78 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 168.67 97.67 0.11 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.517 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -43.74 160.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.666 2.244 . . . . 0.0 112.354 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 21.1 t -139.47 168.86 18.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.818 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 10.6 t -171.66 177.37 3.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.839 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.468 -179.982 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 53.4 p 44.13 42.54 5.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.362 . . . . 0.0 110.858 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 20.7 t -62.51 134.18 56.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.35 134.82 1.1 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.449 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 1.4 t -109.72 151.17 27.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.952 0.406 . . . . 0.0 110.852 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 39.0 m -120.31 43.06 2.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.899 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 78.94 140.67 1.9 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.488 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -100.56 -49.46 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.0 110.876 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -108.02 -32.36 7.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.802 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.422 ' C ' ' CD1' ' A' ' 293' ' ' ILE . 2.3 pp -62.32 146.04 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.106 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 294' ' ' ARG . 0.0 OUTLIER -143.15 140.55 30.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 51.89 40.0 27.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 74.4 mt -125.44 119.62 24.76 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.623 0.725 . . . . 0.0 111.106 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.87 -43.77 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.629 2.219 . . . . 0.0 112.333 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 31.5 mtt -143.92 113.08 6.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -96.3 114.14 25.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.822 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.6 m -122.8 -52.06 1.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.899 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 41.4 p -158.72 174.64 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.842 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.437 ' CD1' ' O ' ' A' ' 302' ' ' TYR . 18.5 p90 -45.19 135.39 5.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -103.78 99.81 17.46 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.636 0.731 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -41.93 -37.59 4.36 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.699 2.266 . . . . 0.0 112.276 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 99.64 -110.97 4.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.461 ' CG ' ' HD2' ' A' ' 307' ' ' PRO . 25.9 tt0 -99.19 140.45 21.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.695 0.759 . . . . 0.0 110.862 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 306' ' ' GLU . 59.8 Cg_endo -73.04 105.95 2.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.661 2.241 . . . . 0.0 112.389 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -106.52 172.09 7.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.4 ' HZ1' ' CG2' ' A' ' 356' ' ' THR . 0.0 OUTLIER -84.64 9.89 12.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.824 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 70.5 t -130.94 128.43 62.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.572 HD13 ' CE1' ' A' ' 357' ' ' PHE . 41.5 mt -114.33 122.29 46.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.788 ' CE1' ' CZ ' ' A' ' 354' ' ' PHE . 17.2 t80 -101.77 107.02 18.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.931 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 8.8 mp -87.37 142.93 27.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -138.68 175.33 9.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 60.54 53.43 4.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.2 mt -113.42 109.97 19.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.2 t -47.49 143.92 5.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.722 0.773 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.12 -19.08 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -78.23 -39.83 39.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 87.7 t -49.78 133.83 8.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 55.2 p -133.54 170.0 16.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -43.69 -47.32 7.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -45.0 -57.65 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -49.01 -43.09 40.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 21.3 mt -62.69 -48.56 78.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 62.4 t -51.86 -52.36 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.1 m -61.49 -37.39 83.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.794 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.55 HD22 ' CE2' ' A' ' 373' ' ' TYR . 31.0 mt -59.15 -37.65 77.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.949 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.475 ' CE2' HG21 ' A' ' 370' ' ' VAL . 12.0 m-85 -126.27 42.15 3.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -81.2 -47.42 13.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 331' ' ' ARG . 3.5 ptm85 -46.38 -34.94 5.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -74.16 -46.29 43.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . 0.409 ' CA ' HD12 ' A' ' 340' ' ' ILE . 23.9 tm0? -53.75 -36.84 62.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.17 49.1 1.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -119.12 -177.85 3.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -83.62 49.33 1.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -152.11 168.35 31.32 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.84 165.11 0.07 OUTLIER 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.671 2.247 . . . . 0.0 112.348 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.95 140.43 20.3 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.614 2.209 . . . . 0.0 112.372 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.479 HG21 ' CE1' ' A' ' 342' ' ' PHE . 66.9 mt -80.84 125.53 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.133 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -87.54 142.41 27.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . 0.479 ' CE1' HG21 ' A' ' 340' ' ' ILE . 7.5 m-85 -126.73 144.26 50.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.816 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.2 ttt-85 -141.08 132.67 27.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.2 ttm -115.4 147.34 40.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.877 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 22.2 ttm -95.24 163.36 13.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 39.5 p -136.89 167.91 20.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.203 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 348' ' ' ARG . . . 113.89 176.65 19.21 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.483 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' A' ' 349' ' ' MET . 0.0 OUTLIER -37.61 -32.73 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.341 . . . . 0.0 110.865 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' MET . . . . . 0.411 ' N ' ' HD2' ' A' ' 348' ' ' ARG . 46.3 ttm -127.27 84.27 2.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.28 26.97 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -89.26 30.96 5.31 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.474 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -137.07 142.3 42.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.892 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -148.59 153.26 38.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.09 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.788 ' CZ ' ' CE1' ' A' ' 312' ' ' TYR . 77.9 m-85 -124.78 129.65 50.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.83 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.471 HG21 ' N ' ' A' ' 356' ' ' THR . 56.8 mt -123.65 140.35 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.165 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.471 ' N ' HG21 ' A' ' 355' ' ' ILE . 55.8 m -114.91 129.37 56.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.572 ' CE1' HD13 ' A' ' 311' ' ' LEU . 23.7 m-85 -106.2 156.57 36.63 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.682 0.753 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -46.11 -40.66 21.31 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.755 2.303 . . . . 0.0 112.337 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -141.26 -176.62 4.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.83 -37.0 19.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.36 -56.37 20.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 60.0 mt -54.36 -56.05 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.089 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -44.95 -59.26 2.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.075 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . 0.409 ' O ' ' N ' ' A' ' 367' ' ' LEU . 4.8 t90 -48.42 -66.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -40.1 -41.61 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -71.66 -39.67 70.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.079 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.57 HD11 ' CZ ' ' A' ' 384' ' ' PHE . 5.3 tt -55.88 -50.39 70.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -69.21 -35.8 76.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 31.2 mt -62.91 -47.95 81.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . 0.475 HG21 ' CE2' ' A' ' 329' ' ' PHE . 25.2 t -82.71 -28.33 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.057 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 370' ' ' VAL . 0.3 OUTLIER -36.01 120.77 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.936 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 83.28 36.29 15.11 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.414 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.55 ' CE2' HD22 ' A' ' 328' ' ' LEU . 61.0 t80 -91.79 103.43 15.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.943 0.401 . . . . 0.0 110.946 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm -71.2 101.85 2.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 26.5 tp -114.62 125.47 53.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.952 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 49.51 38.24 14.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 70.01 37.24 73.6 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.503 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -141.03 121.61 14.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 38.8 mm -76.02 86.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.464 ' CD2' HG13 ' A' ' 382' ' ' ILE . 7.5 tt -47.76 135.09 12.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 76.4 t -117.15 111.49 35.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.079 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.464 HG13 ' CD2' ' A' ' 380' ' ' LEU . 43.1 mt -98.64 119.2 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . 0.422 ' OE1' ' CD1' ' A' ' 302' ' ' TYR . 6.3 mm-40 -130.14 127.36 39.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.57 ' CZ ' HD11 ' A' ' 367' ' ' LEU . 48.0 m-85 -54.27 140.71 32.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.928 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -48.96 103.5 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.544 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -66.75 -54.77 19.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -42.23 139.16 1.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -109.4 108.46 19.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -128.61 87.75 2.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -43.56 145.42 0.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.928 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -140.29 115.11 9.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 6.7 t -168.98 116.91 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 36.8 p -114.04 155.33 26.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 169.18 95.55 0.1 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -44.58 126.87 7.37 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.699 2.266 . . . . 0.0 112.334 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 39.8 m -63.14 107.91 1.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.865 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 85.5 p 41.28 42.59 1.8 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.853 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.516 179.999 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 1.4 t -133.66 139.25 46.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.359 . . . . 0.0 110.869 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 35.9 t -39.09 -53.0 1.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.841 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 93.76 144.2 15.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.52 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 23.0 t -75.48 150.59 38.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.392 . . . . 0.0 110.814 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 4.6 t -109.11 42.46 1.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.873 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . 0.452 ' HA3' ' CD1' ' A' ' 293' ' ' ILE . . . 167.15 138.07 2.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.454 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -92.86 -56.95 2.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.838 0.352 . . . . 0.0 110.88 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -62.11 -50.4 72.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.452 ' CD1' ' HA3' ' A' ' 290' ' ' GLY . 14.5 pt -57.98 144.85 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.139 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 294' ' ' ARG . 22.3 mtm105 -133.83 84.12 2.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 56.31 43.17 26.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 47.4 mt -90.37 112.03 50.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.626 0.727 . . . . 0.0 111.14 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -44.74 -44.97 13.92 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.696 2.264 . . . . 0.0 112.364 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.12 141.3 28.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -132.99 -43.27 0.88 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 66.0 m -71.79 111.74 7.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.853 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 3.8 m -161.33 -178.57 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -51.21 151.46 2.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -128.83 121.95 21.22 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.653 0.74 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.32 -38.32 2.08 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.583 2.189 . . . . 0.0 112.324 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 68.14 -161.7 49.76 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.463 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -41.45 142.3 1.01 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.663 0.744 . . . . 0.0 110.855 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . 0.422 ' HA ' ' CE2' ' A' ' 384' ' ' PHE . 61.2 Cg_endo -75.73 137.68 20.44 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.714 2.276 . . . . 0.0 112.348 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -128.96 164.23 23.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.26 9.46 6.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 74.3 t -130.68 129.31 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.112 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.452 HD11 ' CE1' ' A' ' 357' ' ' PHE . 64.4 mt -115.96 118.61 33.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.669 ' CE1' ' CZ ' ' A' ' 354' ' ' PHE . 8.0 t80 -102.13 111.36 23.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 313' ' ' LEU . 4.8 mp -96.58 147.66 23.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.932 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -141.16 -175.52 4.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 5.0 m120 56.19 54.97 7.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.4 mt -114.78 109.66 18.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.941 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 17.8 t -50.88 144.05 14.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.661 0.743 . . . . 0.0 110.89 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -46.53 -20.73 1.07 Allowed 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.735 2.29 . . . . 0.0 112.286 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 47.1 mmt-85 -75.13 -35.34 61.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . 0.418 HG11 ' CG ' ' A' ' 324' ' ' ASP . 66.1 t -45.68 137.58 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 322' ' ' GLU . 39.0 p -132.12 150.77 52.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 321' ' ' THR . 5.4 tp10 -33.56 -41.34 0.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -46.72 -55.37 7.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.836 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . 0.418 ' CG ' HG11 ' A' ' 320' ' ' VAL . 0.2 OUTLIER -46.72 -44.41 18.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 36.2 mt -63.09 -47.45 82.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 67.5 t -57.09 -49.93 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 1.8 m -65.56 -42.44 91.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 23.2 mt -52.37 -41.17 62.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -125.38 40.8 3.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -74.82 -40.8 60.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.091 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.464 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 10.2 ptt-85 -50.47 -45.56 56.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.464 ' N ' ' HG3' ' A' ' 331' ' ' ARG . 25.5 m-85 -64.46 -47.32 79.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 332' ' ' PHE . 38.6 tt0 -35.01 -40.23 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -92.85 69.01 4.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -149.49 177.0 10.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.841 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -61.53 110.92 1.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 139.69 173.97 13.45 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.465 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.01 147.57 34.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.738 2.292 . . . . 0.0 112.294 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.69 119.17 2.6 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.613 2.209 . . . . 0.0 112.403 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.521 HD12 ' CE2' ' A' ' 357' ' ' PHE . 70.2 mt -49.03 127.45 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -90.2 120.27 31.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -105.85 138.99 41.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -136.87 129.81 30.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 35.5 tpp -111.1 146.32 37.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 20.0 ttm -83.73 163.21 20.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.833 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 1.3 t -133.22 143.5 49.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.114 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 348' ' ' ARG . . . 128.73 164.34 11.5 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.51 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 347' ' ' GLY . 9.1 ptm180 -34.48 -37.25 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' MET . . . . . 0.416 ' N ' ' O ' ' A' ' 347' ' ' GLY . 7.8 mtm -110.51 61.39 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.34 30.07 0.56 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -90.08 26.83 9.11 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.453 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -133.37 145.48 50.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.834 0.349 . . . . 0.0 110.952 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -147.23 145.43 29.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.669 ' CZ ' ' CE1' ' A' ' 312' ' ' TYR . 71.2 m-85 -116.76 123.95 48.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 83.8 mt -114.19 141.24 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.084 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 85.1 m -117.88 114.74 23.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.145 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.521 ' CE2' HD12 ' A' ' 340' ' ' ILE . 38.6 m-85 -97.47 158.62 32.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.636 0.732 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -43.89 -43.99 11.98 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.739 2.292 . . . . 0.0 112.337 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.13 -175.29 5.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.952 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -74.65 -39.33 62.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -47.75 -66.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 57.2 mt -55.03 -55.72 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.107 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -43.12 -60.89 1.48 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -46.74 -59.63 2.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.835 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -45.84 -43.86 13.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.972 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.1 95.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.08 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.569 HD11 ' CE1' ' A' ' 384' ' ' PHE . 7.1 tt -63.82 -51.8 63.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.916 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . 0.454 ' N ' HD23 ' A' ' 367' ' ' LEU . 11.7 t60 -62.77 -33.75 75.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 25.3 mt -72.11 -42.07 66.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.971 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 11.2 t -105.64 31.75 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.145 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.73 127.77 33.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 58.79 45.0 95.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.497 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -84.06 113.32 20.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.903 0.383 . . . . 0.0 110.958 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 28.0 tttt -66.25 104.31 1.16 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 10.6 tp -118.56 135.91 54.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 42.43 50.45 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 53.84 41.19 66.5 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.505 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -156.45 110.26 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.781 0.324 . . . . 0.0 110.854 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 31.8 mm -51.44 118.71 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.084 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.416 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.9 tt -77.52 114.9 16.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.941 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 45.4 t -94.59 118.93 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.151 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.411 ' CG1' ' CD2' ' A' ' 380' ' ' LEU . 36.9 mt -107.53 127.8 63.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -139.32 130.55 26.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 367' ' ' LEU . 28.0 m-85 -57.71 132.56 53.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -41.6 107.99 0.11 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.452 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -50.18 154.43 1.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -134.43 -60.12 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.908 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 22.7 tptt -148.54 149.8 32.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.943 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 13.2 pttm -85.47 -29.21 24.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.913 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -142.75 108.4 5.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -87.86 137.52 32.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.831 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 7.7 m -76.41 165.51 24.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.3 t 57.08 42.18 26.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -150.95 144.22 11.51 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.487 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -78.4 122.58 5.66 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.691 2.26 . . . . 0.0 112.369 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 46.6 p -88.73 126.68 35.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 4.8 m -68.93 -57.98 4.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.523 -179.936 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 93.9 p -158.24 149.19 20.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 0.0 110.895 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.1 t -115.93 -58.13 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 117.72 134.84 5.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 60.0 m -68.08 85.59 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.882 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 27.7 t -120.58 153.64 36.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -45.57 147.99 1.94 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.463 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -65.26 -53.35 45.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 110.885 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -111.33 -49.8 2.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.44 ' CD1' ' O ' ' A' ' 296' ' ' ILE . 21.3 pt -48.18 -38.49 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.194 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 39.38 29.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.824 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 293' ' ' ILE . 2.8 mmmm -122.71 -45.15 2.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.44 ' O ' ' CD1' ' A' ' 293' ' ' ILE . 97.9 mt -136.14 128.87 17.71 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.605 0.716 . . . . 0.0 111.142 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.02 -36.7 3.23 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.67 2.247 . . . . 0.0 112.348 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 6.2 mmm -92.96 73.84 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -113.7 -58.53 2.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.5 t -80.77 96.24 6.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.871 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 54.0 m -77.89 -53.25 7.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.24 127.01 1.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.92 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -75.32 115.92 49.8 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.675 0.75 . . . . 0.0 110.903 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.77 -50.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.687 2.258 . . . . 0.0 112.298 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 109.24 -136.81 13.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.468 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.595 ' O ' ' CD2' ' A' ' 384' ' ' PHE . 12.0 tt0 -69.06 141.13 91.52 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.661 0.743 . . . . 0.0 110.917 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 384' ' ' PHE . 61.4 Cg_endo -76.1 144.96 27.31 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.693 2.262 . . . . 0.0 112.404 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -139.65 162.03 36.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.937 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.408 ' CE ' HG23 ' A' ' 356' ' ' THR . 11.9 ptmt -70.87 -25.06 62.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.939 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 94.9 t -106.14 143.24 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.502 HD12 ' CE1' ' A' ' 357' ' ' PHE . 52.7 mt -124.35 121.42 34.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.974 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.756 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 9.4 t80 -95.4 102.61 14.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.952 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 7.5 mp -85.99 134.09 33.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -133.43 -177.07 4.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 60.22 52.17 5.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.8 mt -113.96 122.49 47.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 13.7 t -61.8 143.77 93.9 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.655 0.741 . . . . 0.0 110.821 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.44 -25.12 2.0 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.682 2.255 . . . . 0.0 112.306 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -74.34 -39.57 62.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.831 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 99.4 t -39.33 134.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 322' ' ' GLU . 35.2 p -126.89 150.5 49.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.136 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 321' ' ' THR . 7.9 tp10 -34.36 -41.54 0.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -45.33 -55.93 5.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . 0.489 ' CG ' ' N ' ' A' ' 325' ' ' LEU . 0.3 OUTLIER -44.12 -51.76 7.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.924 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.489 ' N ' ' CG ' ' A' ' 324' ' ' ASP . 39.0 mt -56.33 -48.38 76.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.934 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 84.7 t -55.7 -53.09 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.146 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 31.2 t -64.51 -33.61 76.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.422 HD22 ' CD2' ' A' ' 373' ' ' TYR . 21.6 mt -65.65 -35.09 79.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.53 ' CE2' HG22 ' A' ' 370' ' ' VAL . 38.6 m-85 -128.04 44.73 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.892 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 333' ' ' GLN . . . -82.48 -58.69 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.447 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 15.6 ptp180 -41.1 -42.09 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.561 ' CE2' ' HB1' ' A' ' 366' ' ' ALA . 31.4 m-85 -60.63 -38.67 85.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 330' ' ' ALA . 1.0 OUTLIER -35.56 -52.2 0.66 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.34 87.36 6.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.964 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 337' ' ' GLY . 12.1 tptp -161.54 149.38 15.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 335' ' ' LYS . 49.8 mtpt -37.09 95.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.888 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 335' ' ' LYS . . . 142.37 145.22 4.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.485 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -47.41 156.14 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.723 2.282 . . . . 0.0 112.387 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.94 158.47 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.654 2.236 . . . . 0.0 112.372 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 341' ' ' GLN . 73.0 mt -88.4 138.8 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.11 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . 0.465 ' N ' HG22 ' A' ' 340' ' ' ILE . 7.5 mm-40 -97.7 136.25 38.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . 0.47 ' CE2' HD13 ' A' ' 355' ' ' ILE . 29.6 m-85 -123.51 142.09 51.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -140.62 128.14 21.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 14.9 ttm -110.22 146.38 35.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.823 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.62 169.85 10.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 5.9 t -147.65 153.67 39.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 126.6 -174.64 18.03 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.456 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -42.28 -41.08 2.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.319 . . . . 0.0 110.839 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.34 71.59 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.1 29.49 0.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -93.46 32.82 5.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.457 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -137.97 156.57 47.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.738 0.304 . . . . 0.0 110.92 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -157.57 155.82 30.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.756 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 46.0 m-85 -127.01 126.0 42.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.498 HG23 ' CE1' ' A' ' 357' ' ' PHE . 97.6 mt -119.18 145.54 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.408 HG23 ' CE ' ' A' ' 309' ' ' LYS . 69.6 m -121.31 129.66 53.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.502 ' CE1' HD12 ' A' ' 311' ' ' LEU . 48.9 m-85 -109.97 158.46 34.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.694 0.759 . . . . 0.0 110.85 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.61 -52.05 7.29 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.685 2.256 . . . . 0.0 112.334 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -138.73 170.61 15.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -66.81 -38.62 86.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -49.78 -65.8 0.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 97.0 mt -51.92 -57.5 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.091 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -41.05 -53.02 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.107 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 12.9 t90 -54.68 -65.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -36.93 -46.71 0.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . 0.561 ' HB1' ' CE2' ' A' ' 332' ' ' PHE . . . -66.58 -49.95 64.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.094 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.461 ' CD2' ' C ' ' A' ' 367' ' ' LEU . 4.5 tt -49.66 -50.31 43.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.853 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -65.42 -36.09 82.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 31.6 mt -64.63 -60.02 3.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . 0.53 HG22 ' CE2' ' A' ' 329' ' ' PHE . 20.4 t -68.45 -33.02 57.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 370' ' ' VAL . 1.5 t-20 -35.14 107.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.965 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 99.18 33.14 5.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.422 ' CD2' HD22 ' A' ' 328' ' ' LEU . 31.8 t80 -96.14 108.28 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.994 0.426 . . . . 0.0 110.97 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -78.75 105.22 9.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.928 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.559 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 21.5 tp -108.76 135.38 50.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.916 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . 0.559 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 57.9 m-85 52.85 27.16 5.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 79.44 34.34 32.47 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.483 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -149.9 122.07 8.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.741 0.305 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 20.5 mm -63.54 136.49 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.167 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.426 ' CD2' HG13 ' A' ' 382' ' ' ILE . 8.2 tt -96.73 132.96 41.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 55.9 t -113.84 119.86 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.426 HG13 ' CD2' ' A' ' 380' ' ' LEU . 18.3 mt -103.96 139.47 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -136.86 120.08 16.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 306' ' ' GLU . 35.8 m-85 -48.89 118.12 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.23 140.04 40.24 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.505 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 29.5 mttp -128.59 91.7 3.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.84 0.352 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.31 145.81 7.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.826 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? 56.69 48.73 15.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.84 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -69.92 -43.03 72.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -89.73 114.08 25.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.965 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.433 ' HD3' ' N ' ' A' ' 392' ' ' SER . 0.4 OUTLIER -112.77 175.48 5.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.433 ' N ' ' HD3' ' A' ' 391' ' ' ARG . 1.2 t -174.72 146.27 0.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 29.2 t -140.08 147.68 40.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -174.07 139.22 4.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.519 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.44 177.1 8.92 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.644 2.229 . . . . 0.0 112.331 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 22.9 t -125.35 96.49 4.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.7 m -115.4 162.89 16.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.444 179.94 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.3 t -122.41 130.15 52.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.866 0.365 . . . . 0.0 110.879 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 3.8 m -80.62 149.23 29.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.862 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 45.72 -114.62 1.35 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.475 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 71.8 m 42.44 36.72 0.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.963 0.411 . . . . 0.0 110.868 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.1 t -81.36 145.87 30.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.899 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 152.48 81.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.465 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -103.33 135.95 44.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 110.891 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 45.41 45.07 10.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.884 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 2.7 pp -95.7 -38.35 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.068 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -62.16 -47.55 84.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.59 -52.45 13.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.925 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 5.4 mp -112.34 101.69 52.72 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.65 0.738 . . . . 0.0 111.12 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -44.32 -41.88 13.5 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 0.0 112.292 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.19 -40.82 5.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.914 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -64.84 -41.67 95.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 86.8 p -69.66 -38.87 77.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.836 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 3.0 m -41.36 -62.0 0.94 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.848 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -173.02 152.0 2.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.971 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -112.68 102.32 54.26 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.556 0.693 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -42.35 -55.57 2.49 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.713 2.275 . . . . 0.0 112.336 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 136.82 -142.51 13.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.443 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -103.42 138.71 19.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.61 0.719 . . . . 0.0 110.895 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . 0.565 ' HA ' ' CE1' ' A' ' 384' ' ' PHE . 72.6 Cg_exo -46.38 106.85 0.1 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.662 2.241 . . . . 0.0 112.335 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . 0.415 ' C ' ' HA ' ' A' ' 360' ' ' LYS . 76.0 m-20 -124.87 164.87 19.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.61 13.86 3.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.59 129.41 40.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.119 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 76.9 mt -120.25 117.87 28.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.983 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.789 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 7.4 t80 -93.97 105.72 17.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.467 ' CD2' HD12 ' A' ' 355' ' ' ILE . 4.4 mp -88.28 145.02 26.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.909 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.43 ' HG3' ' C ' ' A' ' 313' ' ' LEU . 16.6 mtpp -143.31 170.89 14.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 67.46 54.92 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 12.9 mt -114.77 120.9 41.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 22.6 t -57.33 143.84 72.53 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.674 0.75 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -43.94 -27.2 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.671 2.247 . . . . 0.0 112.385 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -71.16 -38.73 72.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 66.0 t -47.05 122.44 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 44.8 p -127.31 168.67 14.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.18 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -39.22 -48.79 1.83 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.913 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . 0.436 ' NH1' ' HB2' ' A' ' 323' ' ' ARG . 0.0 OUTLIER -44.52 -49.87 9.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -53.7 -50.99 64.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 76.4 mt -55.33 -51.93 65.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.965 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 330' ' ' ALA . 97.5 t -46.98 -59.54 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.094 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 2.6 t -54.0 -47.51 71.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 31.9 mt -49.62 -46.27 49.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -119.9 41.8 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -85.15 -25.16 27.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.035 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -64.79 -37.14 86.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -94.04 20.25 8.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -114.9 81.86 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 335' ' ' LYS . 5.3 pt-20 -148.6 175.23 11.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.951 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 336' ' ' LYS . 3.8 ptpt -36.9 -50.4 0.86 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 335' ' ' LYS . 23.4 mmtm -34.1 -56.24 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -118.34 138.77 14.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.489 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -46.96 153.25 1.48 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.724 2.283 . . . . 0.0 112.372 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.33 97.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.697 2.265 . . . . 0.0 112.353 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 71.1 mt -40.99 133.19 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.164 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -89.68 116.12 27.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.49 130.49 54.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -129.94 117.89 20.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.832 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.1 ttm -103.95 146.85 28.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 34.3 mtm -110.62 167.31 10.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 28.4 p -151.62 151.37 31.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.118 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 139.44 -178.24 19.77 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.513 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -42.76 -52.43 4.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 110.852 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 12.6 ttt -88.41 37.25 0.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.448 ' C ' ' OE1' ' A' ' 352' ' ' GLN . 0.0 OUTLIER -58.63 176.74 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 94.07 37.51 5.4 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.499 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.448 ' OE1' ' C ' ' A' ' 350' ' ' ARG . 27.8 mp0 -152.91 142.49 21.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 110.866 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.49 142.87 29.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.076 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.789 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 53.0 m-85 -105.45 115.79 30.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.557 HG21 ' CE1' ' A' ' 357' ' ' PHE . 64.2 mt -108.39 129.42 62.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.12 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 27.1 m -109.53 116.06 31.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.557 ' CE1' HG21 ' A' ' 355' ' ' ILE . 36.9 m-85 -94.46 159.17 34.33 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.728 0.775 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -44.85 -47.55 11.67 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.242 . . . . 0.0 112.372 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -142.67 176.47 9.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.415 ' HA ' ' C ' ' A' ' 308' ' ' ASN . 0.0 OUTLIER -74.78 -29.21 61.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . 0.411 ' N ' ' HG2' ' A' ' 360' ' ' LYS . 77.8 mt-10 -62.33 -56.95 13.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 68.5 mt -56.09 -56.39 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.077 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -49.86 -48.62 51.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -51.22 -49.12 61.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -60.96 -52.72 63.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.942 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.25 67.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.049 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.553 HD11 ' CE2' ' A' ' 384' ' ' PHE . 5.9 tt -65.02 -67.04 0.47 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . 0.465 ' N ' HD23 ' A' ' 367' ' ' LEU . 10.3 t-80 -46.35 -36.1 6.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.84 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.5 mt -71.61 -58.3 3.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.862 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . 0.458 ' O ' ' CD1' ' A' ' 382' ' ' ILE . 9.3 t -82.59 37.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.099 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -84.94 136.2 33.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 49.28 38.42 26.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.519 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.549 ' CE1' ' O ' ' A' ' 374' ' ' LYS . 33.4 t80 -78.21 130.39 36.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.951 0.405 . . . . 0.0 110.905 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.549 ' O ' ' CE1' ' A' ' 373' ' ' TYR . 17.5 tttm -71.14 129.79 39.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.881 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 19.1 tp -143.56 124.47 14.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 43.77 48.25 6.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 59.89 42.46 98.2 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.499 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -155.47 119.25 4.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.338 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 48.3 mm -61.51 107.59 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.119 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.414 ' C ' HD22 ' A' ' 380' ' ' LEU . 8.4 tt -71.33 115.63 10.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 382' ' ' ILE . 90.6 t -99.74 136.4 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.141 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.458 ' CD1' ' O ' ' A' ' 370' ' ' VAL . 57.5 mt -113.39 135.15 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -137.45 118.8 14.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.565 ' CE1' ' HA ' ' A' ' 307' ' ' PRO . 59.9 m-85 -47.97 151.54 0.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.14 169.79 1.79 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -63.81 91.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 110.874 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -37.41 107.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -110.11 173.65 6.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -90.28 41.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.97 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -99.95 99.95 10.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -115.89 140.91 48.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 1.9 t -84.41 86.89 7.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 7.9 t -166.17 143.61 5.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 117.2 98.64 2.02 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.52 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.67 164.5 33.58 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.697 2.265 . . . . 0.0 112.354 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 19.3 m -156.31 131.44 9.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.847 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 398' ' ' GLY . 5.8 m -53.99 172.38 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.872 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 397' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.247 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.507 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 1.3 t -118.21 -51.21 2.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.84 0.352 . . . . 0.0 110.846 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 69.4 m 48.9 40.87 17.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.826 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -142.3 71.83 0.4 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.404 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 82.2 p -108.67 103.61 12.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.833 0.349 . . . . 0.0 110.92 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 79.9 p -155.47 165.64 35.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.814 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . 0.437 ' HA3' ' CD1' ' A' ' 293' ' ' ILE . . . -83.65 151.08 27.45 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.442 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -67.58 -42.92 81.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.808 0.337 . . . . 0.0 110.911 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -114.79 -49.77 2.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.437 ' CD1' ' HA3' ' A' ' 290' ' ' GLY . 2.8 pp -64.05 156.9 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.134 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 295' ' ' LYS . 6.0 tpt180 -80.28 160.93 25.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 294' ' ' ARG . 34.1 mmtm -32.26 -47.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 62.8 mt -50.91 117.47 8.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.69 0.757 . . . . 0.0 111.14 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.26 -51.5 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.747 2.298 . . . . 0.0 112.292 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 7.5 mtm -51.54 -62.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.927 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 3.0 t80 54.19 43.76 30.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 6.7 t -168.1 112.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 16.5 m -58.14 -57.08 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.892 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.467 ' CE1' ' O ' ' A' ' 303' ' ' ASN . 2.6 t80 -166.76 147.92 6.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.467 ' O ' ' CE1' ' A' ' 302' ' ' TYR . 10.7 t30 -99.96 111.41 61.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.717 0.77 . . . . 0.0 110.917 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.77 -51.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.656 2.237 . . . . 0.0 112.36 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 110.77 -145.8 17.45 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.483 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -56.7 136.81 78.16 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.606 0.717 . . . . 0.0 110.852 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 384' ' ' PHE . 61.3 Cg_endo -75.27 145.66 30.8 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.696 2.264 . . . . 0.0 112.334 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -137.76 168.64 19.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 310' ' ' VAL . 13.1 ptmt -72.79 -33.61 66.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.907 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . 0.423 ' N ' ' HG3' ' A' ' 309' ' ' LYS . 55.6 t -98.22 145.92 8.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.143 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.565 HD13 ' CE1' ' A' ' 357' ' ' PHE . 56.9 mt -127.63 114.43 17.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.573 ' CZ ' ' CG ' ' A' ' 314' ' ' LYS . 6.4 t80 -89.31 105.94 18.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.933 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.462 ' N ' HD13 ' A' ' 313' ' ' LEU . 6.3 mp -93.22 148.05 22.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.573 ' CG ' ' CZ ' ' A' ' 312' ' ' TYR . 0.0 OUTLIER -144.5 177.12 8.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 378' ' ' LYS . 1.6 t30 67.49 53.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 15.6 mt -118.03 112.07 19.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.2 t -38.63 154.29 0.14 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.65 0.738 . . . . 0.0 110.855 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.62 1.96 3.3 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.679 2.253 . . . . 0.0 112.363 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -108.43 -24.83 11.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . 0.42 HG22 ' CG ' ' A' ' 376' ' ' TYR . 95.5 t -50.98 142.65 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.131 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 64.6 p -133.89 162.85 30.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 323' ' ' ARG . 6.2 tt0 -38.81 -53.76 1.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.909 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 322' ' ' GLU . 56.7 ttt180 -34.78 -42.71 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -62.66 -50.71 70.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 322' ' ' GLU . 15.6 mt -60.04 -48.51 81.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 78.9 t -49.33 -60.46 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.066 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 23.8 t -53.62 -38.58 64.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.9 mt -62.4 -41.24 98.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -119.56 46.02 2.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -92.31 -58.26 2.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.09 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -38.37 -47.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.899 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.503 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 49.0 m-85 -47.79 -48.76 30.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -68.82 76.09 0.3 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.929 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -122.38 79.18 1.58 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 5.3 mptt 50.08 38.03 15.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -121.07 126.09 48.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 44.22 -161.42 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.528 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.06 169.89 19.45 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.664 2.243 . . . . 0.0 112.399 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.16 124.61 9.17 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.633 2.222 . . . . 0.0 112.364 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.437 ' CD1' ' CE2' ' A' ' 357' ' ' PHE . 73.6 mt -56.24 125.35 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.152 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -87.65 133.56 33.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -118.62 140.16 50.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -137.97 123.51 19.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 46.6 tpp -103.26 133.3 48.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 20.0 tpp -89.4 144.67 25.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.936 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.1 p -139.66 153.39 47.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.1 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 129.39 -140.66 11.89 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.521 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . 0.441 ' HG3' ' N ' ' A' ' 349' ' ' MET . 2.4 ptp180 -47.16 -46.98 23.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.71 0.291 . . . . 0.0 110.86 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' MET . . . . . 0.441 ' N ' ' HG3' ' A' ' 348' ' ' ARG . 0.0 OUTLIER -125.93 86.68 2.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 11.1 mtp85 -68.95 -3.21 11.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.914 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -84.4 47.44 3.85 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.505 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -146.83 147.08 30.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 0.0 110.939 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -154.99 142.44 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.081 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 312' ' ' TYR . 50.8 m-85 -120.2 121.95 39.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.825 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 80.6 mt -115.22 145.15 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.11 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 25.9 m -122.22 117.75 26.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.565 ' CE1' HD13 ' A' ' 311' ' ' LEU . 63.4 m-85 -99.73 157.39 34.01 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.606 0.717 . . . . 0.0 110.88 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -42.33 -40.11 6.76 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.652 2.235 . . . . 0.0 112.372 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.52 171.04 20.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 361' ' ' GLU . 11.0 pttm -58.08 -53.99 52.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 360' ' ' LYS . 45.7 mt-10 -36.52 -64.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.45 -56.93 9.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.136 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -42.27 -60.62 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.089 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 367' ' ' LEU . 13.5 t90 -47.63 -64.61 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.938 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -37.67 -46.15 0.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -64.76 -38.13 89.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.037 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.567 HD12 ' CZ ' ' A' ' 384' ' ' PHE . 7.7 tt -62.04 -61.31 2.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.883 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -56.24 -30.12 61.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 28.9 mt -72.94 -50.94 20.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.955 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 370' ' ' VAL . 25.4 t -98.74 37.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.142 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . 0.421 ' O ' ' CG ' ' A' ' 371' ' ' ASN . 0.7 OUTLIER -88.12 87.65 7.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 111.44 42.55 1.05 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -89.27 125.99 35.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.988 0.423 . . . . 0.0 110.917 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -74.29 94.0 2.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 16.2 tp -104.3 132.0 51.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.99 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . 0.42 ' CG ' HG22 ' A' ' 320' ' ' VAL . 5.3 m-85 46.09 42.46 9.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 64.64 40.63 97.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . 0.465 ' HB3' ' ND2' ' A' ' 315' ' ' ASN . 81.4 mttt -152.57 149.25 28.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.757 0.313 . . . . 0.0 110.953 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 15.8 mm -84.26 107.41 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.116 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.466 ' CD2' HG13 ' A' ' 382' ' ' ILE . 8.2 tt -72.76 131.21 42.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.847 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.463 ' N ' HD22 ' A' ' 380' ' ' LEU . 41.0 t -113.1 114.45 46.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.087 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.466 HG13 ' CD2' ' A' ' 380' ' ' LEU . 31.6 mt -98.32 129.87 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -126.82 168.02 15.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.567 ' CZ ' HD12 ' A' ' 367' ' ' LEU . 26.3 m-85 -94.76 137.08 34.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -82.28 -168.12 41.25 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.457 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -108.72 134.55 51.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.804 0.335 . . . . 0.0 110.904 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.18 142.32 55.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -148.88 132.97 17.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.405 ' N ' ' HD3' ' A' ' 389' ' ' LYS . 0.0 OUTLIER -168.0 144.05 3.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -172.45 156.09 3.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.87 160.16 29.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.807 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 18.4 m -135.08 -54.24 0.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.3 m -167.74 129.59 1.52 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -72.14 159.43 53.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.466 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -77.05 115.56 4.03 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.733 2.289 . . . . 0.0 112.392 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 43.2 t -96.87 114.65 26.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 25.8 m -140.82 138.99 34.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.464 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 6.4 m -136.41 174.8 10.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 0.0 110.811 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 10.2 m -121.52 151.29 40.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.851 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 139.17 101.66 0.52 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.465 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.3 t -125.89 114.29 18.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.837 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 t -162.45 151.02 14.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . 0.467 ' HA3' ' CD1' ' A' ' 293' ' ' ILE . . . 79.84 96.88 0.32 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.519 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.21 -53.12 7.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.81 0.338 . . . . 0.0 110.893 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -79.72 -45.9 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.467 ' CD1' ' HA3' ' A' ' 290' ' ' GLY . 2.7 pp -73.04 164.72 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.116 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -127.08 -49.52 1.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -116.89 -54.54 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 38.9 mm -83.95 130.0 56.74 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.664 0.745 . . . . 0.0 111.089 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.47 -49.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.642 2.228 . . . . 0.0 112.327 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 4.0 mmm -82.41 42.71 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -89.9 -59.71 2.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 30.7 p -101.31 43.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 3.6 m -43.91 -57.81 3.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.839 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -150.28 158.23 43.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.951 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 303' ' ' ASN . 1.5 p30 -98.27 115.66 65.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.708 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.83 -41.01 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.635 2.224 . . . . 0.0 112.317 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 113.18 -176.11 17.15 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.439 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -73.38 133.94 80.22 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.617 0.723 . . . . 0.0 110.884 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -45.11 91.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.738 2.292 . . . . 0.0 112.272 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -107.09 175.63 5.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -85.8 -26.59 25.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.936 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 88.2 t -97.53 124.36 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.48 HD13 ' CE1' ' A' ' 357' ' ' PHE . 66.5 mt -113.05 115.06 27.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.934 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.795 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 16.4 t80 -87.85 104.06 16.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 8.3 mp -85.84 138.17 32.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.918 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -134.06 177.03 8.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . 0.436 ' ND2' ' HB3' ' A' ' 378' ' ' LYS . 1.7 t30 61.89 54.71 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.845 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.4 mt -111.0 127.71 55.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.456 ' HB2' ' CD ' ' A' ' 378' ' ' LYS . 29.4 t -61.91 143.35 94.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.648 0.737 . . . . 0.0 110.903 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -47.12 -19.47 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.604 2.203 . . . . 0.0 112.418 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -82.47 -33.29 28.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . 0.418 HG12 ' CG ' ' A' ' 324' ' ' ASP . 99.4 t -44.1 133.04 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 322' ' ' GLU . 68.8 p -129.63 151.56 50.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 321' ' ' THR . 9.3 tt0 -34.55 -38.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -48.16 -56.21 8.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . 0.418 ' CG ' HG12 ' A' ' 320' ' ' VAL . 0.3 OUTLIER -46.46 -45.05 17.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 42.3 mt -61.62 -46.22 90.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 65.8 t -56.32 -53.08 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 38.8 t -63.15 -41.67 99.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.851 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 24.0 mt -55.26 -41.48 72.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.971 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.411 ' CD1' ' HB3' ' A' ' 366' ' ' ALA . 19.0 m-85 -122.23 40.85 3.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 333' ' ' GLN . . . -79.2 -54.76 5.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.135 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -39.76 -33.34 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -75.32 -38.99 59.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 330' ' ' ALA . 6.3 tm0? -45.21 -47.6 12.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.966 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -87.46 40.96 0.95 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 336' ' ' LYS . 13.2 tptm -126.23 163.55 22.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 335' ' ' LYS . 42.2 mttt -34.03 109.61 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 119.67 139.92 6.05 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.453 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -47.48 164.25 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.776 2.317 . . . . 0.0 112.365 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.98 160.59 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.65 2.233 . . . . 0.0 112.337 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.418 HG21 ' N ' ' A' ' 341' ' ' GLN . 71.6 mt -92.37 144.75 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.074 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . 0.418 ' N ' HG21 ' A' ' 340' ' ' ILE . 60.9 mt-30 -98.52 123.38 42.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -114.4 140.26 48.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -141.23 124.31 16.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.891 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 41.2 tpp -108.63 137.58 46.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.813 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' MET . . . . . 0.471 ' HE3' ' N ' ' A' ' 345' ' ' MET . 1.4 mpp? -102.91 132.96 48.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 13.3 t -115.66 33.52 5.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.073 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 348' ' ' ARG . . . -88.69 -155.38 29.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.527 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 347' ' ' GLY . 26.5 tpt180 -34.28 -47.47 0.3 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.774 0.321 . . . . 0.0 110.846 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' MET . . . . . 0.462 ' HB3' ' NE2' ' A' ' 352' ' ' GLN . 0.7 OUTLIER -119.3 91.34 3.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -67.98 -2.49 7.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -88.87 37.14 3.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.509 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.462 ' NE2' ' HB3' ' A' ' 349' ' ' MET . 32.9 mt-30 -144.41 142.89 30.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 0.0 110.919 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.74 146.01 31.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.795 ' CE2' ' CE1' ' A' ' 312' ' ' TYR . 39.9 m-85 -111.72 124.02 51.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.502 HG23 ' CE1' ' A' ' 357' ' ' PHE . 79.0 mt -117.12 141.13 36.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.105 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.463 ' N ' HG21 ' A' ' 355' ' ' ILE . 35.8 m -119.84 118.47 30.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.502 ' CE1' HG23 ' A' ' 355' ' ' ILE . 32.5 m-85 -94.1 155.34 40.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.612 0.72 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.1 -32.23 18.2 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.241 . . . . 0.0 112.359 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -152.19 -179.42 7.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 8.6 pttm -78.07 -41.28 35.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . 0.435 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 36.1 mt-10 -54.04 -63.2 1.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 80.4 mt -47.17 -61.44 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 364' ' ' TRP . . . -44.36 -65.26 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.019 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' TRP . . . . . 0.408 ' C ' ' O ' ' A' ' 363' ' ' ALA . 6.1 t90 -36.46 -51.09 0.81 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.938 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -54.47 -53.29 56.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . 0.411 ' HB3' ' CD1' ' A' ' 329' ' ' PHE . . . -53.08 -40.66 64.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.53 HD11 ' CZ ' ' A' ' 384' ' ' PHE . 6.3 tt -59.57 -68.23 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . 0.431 ' N ' ' CD2' ' A' ' 367' ' ' LEU . 4.4 t60 -49.79 -33.79 17.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 35.3 mt -72.59 -39.14 67.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.967 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . 0.414 ' O ' ' CD1' ' A' ' 382' ' ' ILE . 31.3 t -109.81 40.57 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.74 141.58 32.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 48.37 30.36 8.01 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.451 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -70.46 108.82 4.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.933 0.397 . . . . 0.0 110.853 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -71.45 97.41 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.458 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 31.6 tp -101.46 131.6 47.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.915 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' TYR . . . . . 0.458 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 57.1 m-85 53.5 31.93 13.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 73.6 34.8 56.4 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . 0.456 ' CD ' ' HB2' ' A' ' 317' ' ' SER . 21.2 mtpp -142.77 112.37 6.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.697 0.284 . . . . 0.0 110.93 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 14.6 mm -52.83 100.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.166 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.481 ' C ' HD22 ' A' ' 380' ' ' LEU . 7.8 tt -69.35 120.57 15.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.5 t -104.04 120.46 54.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.414 ' CD1' ' O ' ' A' ' 370' ' ' VAL . 65.6 mt -99.34 138.46 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.099 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -140.32 120.54 13.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.912 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.53 ' CZ ' HD11 ' A' ' 367' ' ' LEU . 42.7 m-85 -54.69 147.45 14.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -61.69 161.32 27.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.453 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 157.6 23.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.322 . . . . 0.0 110.941 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -143.18 137.32 28.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.42 167.77 9.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -41.0 145.1 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.911 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -135.9 169.91 16.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.931 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 48.0 ttm-85 -131.62 124.81 30.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 46.6 t -56.71 94.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 30.7 t -115.53 108.85 16.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.818 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 155.14 86.48 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.462 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.65 -39.27 17.84 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.684 2.256 . . . . 0.0 112.389 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 4.1 m 37.57 42.02 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 70.8 m -134.52 112.94 11.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.473 -179.987 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--O 1.23 0.105 0 CA-C-O 120.798 0.249 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -126.15 179.18 5.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.509 ' HG3' HG23 ' A' ' 310' ' ' VAL . 3.8 ptmt -81.5 -30.86 33.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.509 HG23 ' HG3' ' A' ' 309' ' ' LYS . 86.4 t -99.18 132.89 43.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.405 HD12 ' CE1' ' A' ' 357' ' ' PHE . 79.1 mt -112.29 152.74 28.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.96 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.788 ' CD1' ' CE2' ' A' ' 354' ' ' PHE . 10.3 t80 -124.22 101.76 7.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.948 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.593 HD21 ' HE2' ' A' ' 329' ' ' PHE . 6.1 mp -90.63 139.73 30.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.939 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -137.36 -179.53 5.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 63.73 54.06 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.81 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 12.8 mt -116.26 127.09 54.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.968 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 45.1 t -65.56 143.88 98.76 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.643 0.735 . . . . 0.0 110.831 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.16 -22.14 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.7 2.266 . . . . 0.0 112.345 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.566 ' O ' HG23 ' A' ' 321' ' ' THR . 37.6 mtt-85 -77.07 -38.86 51.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 69.5 t -46.1 140.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.095 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 319' ' ' ARG . 75.1 p -140.96 168.41 19.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.199 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 325' ' ' LEU . 19.8 tt0 -41.21 -47.37 3.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -41.52 -52.24 3.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.88 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.42 -48.43 68.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 322' ' ' GLU . 18.9 mt -58.2 -47.0 84.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 86.0 t -53.26 -56.06 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.138 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 7.5 t -60.19 -43.38 95.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.829 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.7 mt -52.12 -48.59 64.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.593 ' HE2' HD21 ' A' ' 313' ' ' LEU . 42.9 m-85 -118.35 42.1 2.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -78.96 -43.55 24.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.073 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -49.48 -34.0 15.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.402 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 21.9 m-85 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 67.1 mt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.817 0.342 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -97.71 137.8 36.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -123.81 140.27 53.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -136.35 132.94 36.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.805 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 12.4 ttm -112.22 135.9 52.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 29.4 ttm . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.908 179.919 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.424 ' C ' ' OE1' ' A' ' 352' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.424 ' OE1' ' C ' ' A' ' 351' ' ' GLY . 2.9 mp0 -147.31 152.73 38.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.851 0.358 . . . . 0.0 110.862 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -158.55 167.09 30.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.788 ' CE2' ' CD1' ' A' ' 312' ' ' TYR . 14.4 m-85 -136.6 138.38 41.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.893 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.403 HD13 ' CD2' ' A' ' 329' ' ' PHE . 85.2 mt -126.68 132.88 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.469 HG23 ' CE ' ' A' ' 309' ' ' LYS . 25.7 m -108.26 118.1 35.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.097 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.543 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 47.1 m-85 -99.84 158.91 31.23 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.639 0.733 . . . . 0.0 110.903 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.88 -35.3 13.68 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.623 2.216 . . . . 0.0 112.348 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -157.83 174.8 14.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.977 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 21.5 pttp -65.89 -45.35 82.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' GLU . . . . . 0.46 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 48.1 mt-10 -46.21 -65.17 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 60.5 mt -53.28 -54.17 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -43.59 -59.32 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.081 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' TRP . . . . . 0.495 ' O ' ' N ' ' A' ' 367' ' ' LEU . 11.4 t90 -50.44 -62.87 1.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.0 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -37.25 -50.78 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ALA . . . . . 0.485 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -60.17 -37.17 79.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.12 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.803 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 6.3 tt -62.37 -62.54 1.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.976 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' HIS . . . . . 0.436 ' N ' HD23 ' A' ' 367' ' ' LEU . 47.1 t60 -53.18 -29.2 30.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.842 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 44.9 mt -76.24 -48.36 20.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.563 HG21 ' CE1' ' A' ' 329' ' ' PHE . 5.4 t -98.41 33.0 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.101 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.36 96.27 7.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 93.32 43.9 3.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.531 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -84.8 109.16 17.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 0.0 110.922 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -62.95 119.31 9.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.935 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.404 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 19.4 tp -133.54 128.68 35.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.851 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 376' ' ' TYR . . . . . 0.404 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 25.2 m-85 45.81 41.24 7.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.999 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 66.8 41.3 93.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -142.32 141.13 32.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 49.2 mm -90.56 92.73 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.182 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.475 HD23 ' N ' ' A' ' 381' ' ' VAL . 7.2 tt -61.51 129.82 43.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.475 ' N ' HD23 ' A' ' 380' ' ' LEU . 48.0 t -117.22 111.91 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.187 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.41 ' CD1' ' O ' ' A' ' 370' ' ' VAL . 29.2 mt -93.97 137.89 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -133.73 179.21 6.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.803 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 27.7 m-85 -109.11 140.79 42.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.413 -179.908 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo . . . . . 0 C--O 1.231 0.163 0 CA-C-O 120.685 0.202 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -118.29 172.67 7.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.6 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -89.91 25.98 1.95 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.949 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.6 HG23 ' HD2' ' A' ' 309' ' ' LYS . 89.2 t -143.17 123.22 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.139 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.689 HD22 HD12 ' A' ' 367' ' ' LEU . 63.0 mt -116.66 125.62 52.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.969 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.674 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 7.8 t80 -105.1 103.88 13.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 313' ' ' LEU . 3.0 mp -87.31 144.68 26.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -140.57 178.69 7.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.928 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.0 m120 59.5 46.09 12.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.855 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.2 mt -105.7 112.5 25.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 37.5 t -54.34 144.54 41.0 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.747 0.784 . . . . 0.0 110.796 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -45.02 -32.16 6.3 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.685 2.257 . . . . 0.0 112.328 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.599 ' O ' HG23 ' A' ' 321' ' ' THR . 54.1 mtt180 -66.57 -39.82 88.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 84.9 t -46.75 113.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 319' ' ' ARG . 82.1 p -108.88 165.81 11.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.136 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -42.05 -50.28 4.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 72.9 mtt85 -43.29 -50.48 6.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -49.52 -44.28 46.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.489 ' HA ' HD12 ' A' ' 328' ' ' LEU . 96.1 mt -64.61 -51.87 60.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 91.8 t -48.27 -51.94 8.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.203 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.2 t -62.9 -40.52 97.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.935 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.517 HD21 ' CE2' ' A' ' 373' ' ' TYR . 23.0 mt -55.69 -42.83 75.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.879 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -121.18 41.62 3.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -82.54 -35.7 26.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' ARG . . . . . 0.545 ' HG3' ' CE2' ' A' ' 332' ' ' PHE . 6.3 ptp180 -55.98 -23.69 34.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.855 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.693 ' O ' HD11 ' A' ' 340' ' ' ILE . 9.0 m-85 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.701 HD13 ' CE2' ' A' ' 357' ' ' PHE . 75.6 mt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.724 0.297 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -91.04 117.25 29.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -105.92 146.02 30.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -141.26 126.51 18.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 33.4 tpp -117.18 135.01 54.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' MET . . . . . 0.496 ' CE ' ' CD2' ' A' ' 354' ' ' PHE . 31.0 mtm . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.497 ' C ' ' CD ' ' A' ' 352' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 112.409 -0.276 . . . . 0.0 112.409 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.497 ' CD ' ' C ' ' A' ' 351' ' ' GLY . 23.8 mp0 -154.38 130.31 10.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.857 0.361 . . . . 0.0 110.953 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -153.76 141.89 20.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.129 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.674 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 43.4 m-85 -103.34 152.62 21.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 45.3 mt -148.79 134.75 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 309' ' ' LYS . 21.0 m -118.14 127.49 53.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.848 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 42.2 m-85 -104.41 157.8 33.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.641 0.734 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.83 -47.63 9.74 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.668 2.245 . . . . 0.0 112.31 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -141.96 138.7 32.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' LYS . . . . . 0.425 ' H ' ' CD ' ' A' ' 360' ' ' LYS . 0.0 OUTLIER -45.82 -27.5 0.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.896 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.28 -58.6 7.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' A' ' 332' ' ' PHE . 72.6 mt -57.67 -58.8 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.848 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -46.34 -46.5 18.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.12 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -54.73 -61.58 2.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.999 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -50.25 -37.35 35.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.81 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -69.24 -45.62 69.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.689 HD12 HD22 ' A' ' 311' ' ' LEU . 6.6 tt -55.94 -51.04 69.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -63.95 -36.02 82.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 39.9 mt -74.38 -28.01 60.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 366' ' ' ALA . 17.2 t -102.01 -4.47 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 371' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 367' ' ' LEU . 1.4 p-10 -55.21 127.32 28.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 63.72 49.48 68.35 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.448 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.517 ' CE2' HD21 ' A' ' 328' ' ' LEU . 82.3 t80 -93.81 112.49 24.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 110.902 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -67.81 105.96 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 37.3 tp -118.75 118.03 30.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 55.47 35.12 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 73.4 29.52 63.9 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -133.29 129.41 37.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.78 0.324 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 51.0 mm -77.51 90.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.567 HD23 ' C ' ' A' ' 380' ' ' LEU . 8.0 tt -59.6 117.56 5.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.55 HG12 ' OE1' ' A' ' 383' ' ' GLU . 97.0 t -102.68 122.99 55.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.14 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.476 HG12 HD21 ' A' ' 380' ' ' LEU . 15.3 mt -109.26 139.19 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.113 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' GLU . . . . . 0.55 ' OE1' HG12 ' A' ' 381' ' ' VAL . 4.9 mp0 -138.65 124.86 20.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.524 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 27.9 m-85 -52.45 158.11 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.894 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.439 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo . . . . . 0 C--O 1.229 0.07 0 CA-C-O 120.868 0.278 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 308' ' ' ASN . . . . . 0.408 ' HB3' ' CD1' ' A' ' 384' ' ' PHE . 8.4 t-20 -153.64 165.79 34.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.835 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.51 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -84.97 -14.6 47.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.51 HG23 ' HD2' ' A' ' 309' ' ' LYS . 54.4 t -111.32 134.43 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.135 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.801 HD12 ' HE2' ' A' ' 357' ' ' PHE . 29.0 mt -119.04 120.67 37.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.897 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.792 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 13.9 t80 -106.41 102.69 12.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.688 HD23 HD21 ' A' ' 380' ' ' LEU . 6.2 mp -88.88 149.55 23.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.557 ' HE2' ' CD2' ' A' ' 312' ' ' TYR . 22.5 mttt -137.56 -176.73 4.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 55.35 53.9 9.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.2 mt -109.32 117.68 34.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.898 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 38.6 t -61.34 139.91 94.67 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.675 0.75 . . . . 0.0 110.874 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -43.2 -27.63 1.17 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.703 2.268 . . . . 0.0 112.256 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.514 ' HB3' ' CE2' ' A' ' 376' ' ' TYR . 23.0 mmt85 -69.73 -42.85 73.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.857 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 93.5 t -44.31 136.34 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.13 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.8 p -135.88 166.54 23.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.101 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -41.64 -52.45 3.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -40.94 -41.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.69 -46.72 86.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 328' ' ' LEU . 81.3 mt -60.33 -44.8 95.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.928 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 95.0 t -55.12 -60.54 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 4.8 t -54.12 -40.63 67.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.904 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 325' ' ' LEU . 28.7 mt -56.74 -44.9 82.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.6 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 54.2 m-85 -120.54 45.76 2.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -84.06 -39.55 19.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -45.26 -37.36 4.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.785 ' O ' HD11 ' A' ' 340' ' ' ILE . 11.9 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.785 HD11 ' O ' ' A' ' 332' ' ' PHE . 59.5 mt . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.78 0.324 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -93.83 116.52 28.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -103.49 149.07 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -141.19 125.25 17.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.849 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 41.7 tpp -114.57 135.63 53.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 9.1 ttm . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.842 179.96 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.405 ' C ' ' CD ' ' A' ' 352' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.405 ' CD ' ' C ' ' A' ' 351' ' ' GLY . 3.2 mp0 -148.37 141.38 24.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 110.861 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -150.05 151.58 33.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.099 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.792 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 58.0 m-85 -116.05 143.73 45.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.825 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.475 HD12 HD11 ' A' ' 313' ' ' LEU . 77.4 mt -136.0 139.2 46.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.144 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 83.3 m -124.41 117.41 24.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.13 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.801 ' HE2' HD12 ' A' ' 311' ' ' LEU . 84.0 m-85 -96.75 158.08 34.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.649 0.738 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.7 -35.39 23.21 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.739 2.293 . . . . 0.0 112.307 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -149.71 178.68 8.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.84 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -74.58 -49.93 19.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -41.13 -63.62 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 46.6 mt -51.68 -61.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -38.86 -60.81 0.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.138 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 14.0 t90 -48.42 -56.81 7.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -50.54 -47.09 57.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ALA . . . . . 0.6 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -58.28 -32.18 68.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.079 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.685 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.2 tt -70.42 -69.94 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.916 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' HIS . . . . . 0.579 ' N ' HD23 ' A' ' 367' ' ' LEU . 21.7 t-80 -48.01 -32.68 6.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 41.7 mt -74.32 -41.53 60.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.725 ' O ' HG12 ' A' ' 370' ' ' VAL . 47.3 t -104.04 33.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.187 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -79.34 139.7 37.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 52.42 40.02 53.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.442 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.422 ' CE1' HD21 ' A' ' 328' ' ' LEU . 32.7 t80 -80.2 120.04 23.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.013 0.435 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -63.68 112.1 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 29.4 tp -121.67 127.27 50.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' TYR . . . . . 0.514 ' CE2' ' HB3' ' A' ' 319' ' ' ARG . 31.5 m-85 41.27 46.32 2.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 59.97 44.68 96.96 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.443 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -156.03 114.56 3.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.717 0.294 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 17.2 mm -50.62 111.03 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.688 HD21 HD23 ' A' ' 313' ' ' LEU . 8.3 tt -80.39 120.16 24.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.64 118.18 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.469 HD11 ' O ' ' A' ' 370' ' ' VAL . 29.4 mt -99.04 136.83 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.098 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.49 177.66 7.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.921 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.685 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 41.3 m-85 -109.98 135.23 51.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.51 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo . . . . . 0 N--CA 1.467 -0.086 0 CA-C-O 120.813 0.256 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -117.92 175.29 5.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.661 ' HG3' HG23 ' A' ' 310' ' ' VAL . 5.9 ptmm? -86.96 -36.78 18.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.661 HG23 ' HG3' ' A' ' 309' ' ' LYS . 83.9 t -96.08 125.48 48.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.105 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.446 ' CD2' ' CE1' ' A' ' 384' ' ' PHE . 34.5 mt -108.64 112.17 24.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.738 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 14.6 t80 -83.6 104.24 13.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.943 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.764 HD23 HD11 ' A' ' 380' ' ' LEU . 8.1 mp -90.66 136.71 32.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -132.24 -177.08 4.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 58.72 47.44 12.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.6 mt -106.61 111.54 24.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.4 t -45.77 142.06 3.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.701 0.762 . . . . 0.0 110.847 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.04 -19.37 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.66 2.24 . . . . 0.0 112.343 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -82.73 -37.98 23.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 60.8 t -40.77 137.17 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.176 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 4.5 p -135.77 168.25 19.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -45.99 -45.28 15.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -45.38 -59.26 2.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.876 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -44.36 -50.49 9.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 328' ' ' LEU . 28.8 mt -55.18 -41.94 72.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.979 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 98.3 t -56.69 -57.44 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.151 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 4.5 t -59.86 -24.16 64.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 325' ' ' LEU . 33.3 mt -76.07 -40.33 53.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.934 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -123.69 39.71 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -88.25 -38.71 15.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -55.61 -17.28 5.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.492 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 57.9 m-85 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 43.9 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.77 0.319 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -93.01 127.77 38.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -118.56 142.39 47.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.866 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -141.27 126.18 18.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 11.4 ttm -115.4 125.79 53.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.945 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 9.8 ptp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.886 179.998 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -129.5 150.86 50.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.329 . . . . 0.0 110.945 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -154.71 152.15 29.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.738 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 41.5 m-85 -121.14 126.43 49.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 95.6 mt -118.29 142.79 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.42 HG23 ' HZ3' ' A' ' 309' ' ' LYS . 4.8 m -123.53 121.56 35.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.682 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 37.5 m-85 -99.69 159.05 30.98 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.663 0.744 . . . . 0.0 110.864 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.48 -42.46 18.11 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.688 2.259 . . . . 0.0 112.302 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -153.89 156.44 37.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' LYS . . . . . 0.434 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 13.7 ptpt -48.6 -45.98 38.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.915 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 361' ' ' GLU . . . . . 0.434 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 20.1 mm-40 -41.24 -65.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.857 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' A' ' 363' ' ' ALA . 79.1 mt -54.08 -64.73 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.682 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -36.09 -57.6 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.062 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -49.05 -58.75 4.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -50.01 -48.19 52.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ALA . . . . . 0.492 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -57.66 -38.84 75.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.771 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 5.2 tt -64.38 -60.7 2.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' HIS . . . . . 0.556 ' N ' HD23 ' A' ' 367' ' ' LEU . 32.8 t60 -56.19 -27.55 54.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 30.2 mt -79.83 -37.11 35.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.545 ' O ' HG12 ' A' ' 370' ' ' VAL . 13.7 t -110.14 35.92 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.172 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -87.65 106.82 18.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.831 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 90.42 31.61 10.33 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.434 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.431 ' CE1' HD21 ' A' ' 328' ' ' LEU . 19.2 t80 -76.19 119.06 19.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.834 0.35 . . . . 0.0 110.991 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -66.71 107.28 2.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 15.0 tp -111.93 114.51 27.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.985 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 53.94 40.02 31.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 69.91 29.73 70.68 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.459 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -143.26 113.41 7.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.845 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 19.9 mm -53.88 128.06 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.09 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.764 HD11 HD23 ' A' ' 313' ' ' LEU . 5.5 tt -94.18 117.29 29.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 86.5 t -98.5 128.9 49.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.163 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.405 HG12 HD21 ' A' ' 380' ' ' LEU . 24.3 mt -110.58 132.22 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -134.03 124.02 25.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.922 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.771 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 39.8 m-85 -55.46 151.29 10.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.824 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.487 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.784 0.243 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -110.35 177.01 4.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.846 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -88.16 -25.17 23.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 23.5 t -97.89 128.68 49.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.088 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.696 HD12 ' CE1' ' A' ' 357' ' ' PHE . 48.7 mt -115.63 118.31 32.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.012 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.769 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 15.0 t80 -98.23 102.34 14.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.584 HD23 HD11 ' A' ' 380' ' ' LEU . 5.1 mp -88.5 146.54 25.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -138.06 -176.35 4.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 59.7 53.6 4.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.5 mt -115.65 122.84 46.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 18.0 t -64.5 143.87 98.59 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.68 0.753 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.72 -19.5 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.695 2.264 . . . . 0.0 112.386 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 -77.11 -35.16 56.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 97.6 t -48.53 146.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 12.2 p -145.24 175.33 10.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.113 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -48.38 -47.02 37.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -44.47 -54.37 6.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.24 -51.52 25.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 355' ' ' ILE . 57.2 mt -57.31 -47.53 81.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 330' ' ' ALA . 96.5 t -55.08 -61.78 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.184 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 11.6 t -53.09 -37.59 61.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.436 HD21 ' CD2' ' A' ' 373' ' ' TYR . 32.6 mt -63.23 -40.26 96.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.897 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -120.79 40.54 3.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -82.64 -21.17 35.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.08 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -69.66 -36.99 76.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 -179.87 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.607 HD13 ' CE2' ' A' ' 357' ' ' PHE . 85.4 mt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.726 0.298 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -100.88 117.77 35.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -102.34 138.8 38.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -134.35 129.29 35.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 40.5 tpp -112.87 145.14 41.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' MET . . . . . 0.452 ' HE3' ' N ' ' A' ' 345' ' ' MET . 18.6 mmt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -139.87 166.75 23.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 110.882 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -158.6 149.26 20.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.769 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 12.9 m-85 -119.39 121.82 40.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.836 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.444 HD11 HD22 ' A' ' 325' ' ' LEU . 61.9 mt -110.14 144.47 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.15 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 340' ' ' ILE . 17.2 m -120.89 117.76 28.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.132 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.696 ' CE1' HD12 ' A' ' 311' ' ' LEU . 53.6 m-85 -98.94 155.76 36.25 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.625 0.726 . . . . 0.0 110.857 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.57 -42.0 18.61 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.75 2.3 . . . . 0.0 112.324 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.75 171.55 17.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 0.9 OUTLIER -64.78 -48.94 72.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 361' ' ' GLU . . . . . 0.412 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 7.3 mm-40 -39.99 -63.17 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 363' ' ' ALA . 90.6 mt -53.27 -65.82 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -36.98 -55.49 0.92 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -48.3 -63.47 1.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -45.29 -48.89 13.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ALA . . . . . 0.442 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -60.17 -33.74 72.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.091 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.886 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.4 tt -68.01 -63.29 1.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -50.65 -34.21 25.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 24.9 mt -75.34 -57.66 3.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.961 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.527 ' O ' HD11 ' A' ' 382' ' ' ILE . 5.9 t -84.1 31.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.115 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -87.27 103.85 15.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 90.77 37.45 6.43 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.436 ' CD2' HD21 ' A' ' 328' ' ' LEU . 73.9 t80 -82.38 107.64 15.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 0.0 110.961 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -59.09 126.96 29.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.64 124.97 18.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 49.41 34.68 6.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.946 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 73.44 38.03 52.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.438 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.15 150.48 47.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.784 0.325 . . . . 0.0 110.839 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 43.1 mm -97.17 87.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.61 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.2 tt -52.07 133.63 32.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.957 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.469 ' N ' HD23 ' A' ' 380' ' ' LEU . 85.0 t -120.62 122.95 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.527 HD11 ' O ' ' A' ' 370' ' ' VAL . 21.5 mt -104.81 132.43 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.129 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -139.99 119.17 12.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.886 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 58.1 m-85 -51.33 151.59 2.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo . . . . . 0 N--CA 1.466 -0.102 0 CA-C-O 120.766 0.236 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -138.43 160.06 40.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.566 ' HG3' HG23 ' A' ' 310' ' ' VAL . 11.4 ptmt -68.94 -28.42 66.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.94 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.566 HG23 ' HG3' ' A' ' 309' ' ' LYS . 73.9 t -95.85 134.32 33.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.554 HD12 ' CE1' ' A' ' 357' ' ' PHE . 45.4 mt -123.5 121.7 36.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.696 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 10.3 t80 -96.94 113.42 24.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.505 HD12 ' N ' ' A' ' 313' ' ' LEU . 5.3 mp -103.26 145.98 29.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.401 ' HD3' ' N ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -144.68 -179.7 6.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.955 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.4 m120 60.77 51.48 4.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.5 mt -113.23 115.97 29.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 21.3 t -50.29 146.28 8.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.647 0.737 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.86 -26.37 7.12 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.656 2.237 . . . . 0.0 112.291 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.444 ' HB3' ' NH1' ' A' ' 319' ' ' ARG . 7.5 mtp-105 -72.04 -31.7 66.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.27 132.34 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.166 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 322' ' ' GLU . 41.9 p -139.25 168.36 19.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.091 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 321' ' ' THR . 26.0 tt0 -37.06 -46.72 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.924 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 324' ' ' ASP . 70.7 mtm180 -47.36 -62.24 1.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 323' ' ' ARG . 4.7 m-20 -37.8 -50.92 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.598 HD22 HD11 ' A' ' 355' ' ' ILE . 22.6 mt -59.64 -47.71 84.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.962 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.634 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 94.9 t -46.6 -52.23 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 47.0 t -64.09 -42.39 96.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.482 HD21 ' CE2' ' A' ' 373' ' ' TYR . 78.3 mt -56.28 -49.33 74.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.986 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -113.72 35.04 4.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -70.58 -42.79 70.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.095 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' ARG . . . . . 0.488 ' HG3' ' CD1' ' A' ' 332' ' ' PHE . 11.4 ptm180 -40.85 -52.53 3.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.81 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.488 ' CD1' ' HG3' ' A' ' 331' ' ' ARG . 16.2 m-85 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.936 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.705 HG22 ' CE1' ' A' ' 342' ' ' PHE . 96.2 mt . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.802 0.334 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -121.88 127.74 50.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' PHE . . . . . 0.705 ' CE1' HG22 ' A' ' 340' ' ' ILE . 2.4 m-85 -111.61 139.57 46.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 31.3 ttt85 -135.4 123.22 22.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 17.7 ttm -116.9 129.56 56.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -107.89 139.97 41.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.96 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -148.46 158.75 44.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.118 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.696 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 47.7 m-85 -132.27 130.26 40.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.598 HD11 HD22 ' A' ' 325' ' ' LEU . 85.7 mt -118.68 140.52 42.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.092 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.416 HG23 ' CE ' ' A' ' 309' ' ' LYS . 26.1 m -113.19 105.57 13.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 44.0 m-85 -90.03 158.81 43.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.672 0.749 . . . . 0.0 110.889 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -42.31 -55.52 2.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.605 2.203 . . . . 0.0 112.402 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.0 -176.49 5.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 360' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 43.7 pttt -67.57 -51.17 53.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 361' ' ' GLU . . . . . 0.406 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 10.7 mm-40 -39.16 -66.13 0.31 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.44 ' O ' ' C ' ' A' ' 363' ' ' ALA . 61.1 mt -55.27 -65.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.193 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.571 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -34.67 -56.33 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.143 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -50.63 -56.17 13.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 369' ' ' LEU . 30.4 mt-30 -50.97 -43.19 60.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -62.7 -41.48 99.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.07 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.742 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 6.5 tt -62.95 -63.55 1.17 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.972 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' HIS . . . . . 0.52 ' N ' HD23 ' A' ' 367' ' ' LEU . 46.1 t60 -55.92 -31.87 63.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.868 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.422 ' CG ' ' O ' ' A' ' 365' ' ' GLN . 37.0 mt -74.32 -33.02 63.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.651 ' O ' HG12 ' A' ' 370' ' ' VAL . 23.0 t -113.6 25.56 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 367' ' ' LEU . 1.6 p30 -69.43 138.15 53.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.883 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 46.35 49.12 15.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.493 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.482 ' CE2' HD21 ' A' ' 328' ' ' LEU . 89.3 t80 -83.29 118.44 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.03 0.443 . . . . 0.0 110.949 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -68.63 109.95 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.928 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.503 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 45.5 tp -126.42 126.07 43.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.832 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' TYR . . . . . 0.503 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 39.4 m-85 51.16 38.5 21.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 68.19 35.5 83.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.468 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -140.87 133.74 29.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.74 0.305 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 16.9 mm -79.39 88.45 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.154 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.635 HD23 ' C ' ' A' ' 380' ' ' LEU . 6.3 tt -58.87 127.49 32.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.884 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.8 t -107.74 130.58 59.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.471 HG13 ' CD2' ' A' ' 380' ' ' LEU . 55.1 mt -112.6 139.68 36.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.14 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -135.45 178.98 6.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.742 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 50.3 m-85 -111.75 129.53 56.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.946 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 -179.938 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.824 0.26 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -103.2 175.8 5.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.553 ' CD ' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -91.49 5.85 47.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.553 HG23 ' CD ' ' A' ' 309' ' ' LYS . 93.5 t -129.91 135.26 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.15 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.685 HD12 ' CE1' ' A' ' 357' ' ' PHE . 96.5 mt -116.11 120.72 39.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.658 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 9.4 t80 -101.68 101.86 12.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.93 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.573 HD23 HD11 ' A' ' 380' ' ' LEU . 5.7 mp -92.96 146.79 23.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 -176.26 4.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 61.38 49.1 5.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.6 mt -115.51 137.44 52.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 38.7 t -70.67 140.02 86.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.654 0.74 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -43.61 -21.64 0.33 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.732 2.288 . . . . 0.0 112.291 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.58 ' O ' HG23 ' A' ' 321' ' ' THR . 11.4 mtp85 -76.65 -41.29 46.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' VAL . . . . . 0.419 HG22 ' HD2' ' A' ' 376' ' ' TYR . 70.7 t -42.52 123.69 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.149 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 319' ' ' ARG . 40.7 p -123.08 171.99 8.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.174 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -44.56 -51.25 9.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.885 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -40.83 -50.25 3.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -53.67 -44.25 69.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 32.5 mt -64.7 -48.51 74.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 89.3 t -49.82 -54.51 7.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.157 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 22.8 t -59.15 -41.79 89.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.859 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 44.0 mt -57.52 -45.86 84.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.767 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 36.2 m-85 -120.49 49.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -91.41 -51.42 5.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -42.74 -49.54 5.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 40.0 m-85 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 57.4 mt . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.827 0.346 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -90.76 132.92 35.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.946 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -125.1 138.36 54.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -139.08 128.91 24.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.5 tpp -112.93 141.65 46.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' MET . . . . . 0.42 ' HE3' ' HB2' ' A' ' 345' ' ' MET . 7.3 mtm . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -132.28 152.55 51.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.871 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.55 150.06 35.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.658 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 39.2 m-85 -116.47 121.31 41.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.818 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 61.7 mt -114.4 133.29 60.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.192 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.2 m -114.58 114.2 25.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.129 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.685 ' CE1' HD12 ' A' ' 311' ' ' LEU . 37.4 m-85 -91.95 157.94 40.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.722 0.772 . . . . 0.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.4 -47.82 12.48 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.647 2.232 . . . . 0.0 112.371 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -138.83 174.42 10.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -69.92 -44.15 70.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -50.97 -58.21 6.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 97.3 mt -53.15 -52.67 28.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.13 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -45.99 -61.35 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -45.79 -55.56 6.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -43.8 -53.93 5.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ALA . . . . . 0.767 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -60.31 -28.43 68.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.13 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.772 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.2 tt -70.15 -65.99 0.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.921 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -53.75 -28.67 35.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 30.1 mt -78.44 -48.88 14.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.561 ' O ' HG12 ' A' ' 370' ' ' VAL . 12.1 t -97.37 30.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' ASN . . . . . 0.42 ' O ' ' CG ' ' A' ' 371' ' ' ASN . 2.0 t30 -82.83 85.97 7.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.956 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 108.9 52.22 0.66 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.436 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -99.51 110.06 22.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.975 0.417 . . . . 0.0 110.898 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -61.47 125.7 24.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 30.3 tp -138.27 128.37 25.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.92 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' TYR . . . . . 0.419 ' HD2' HG22 ' A' ' 320' ' ' VAL . 41.2 m-85 48.17 42.69 17.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 61.52 37.06 93.53 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.562 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -148.35 114.44 5.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 110.974 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 34.9 mm -58.4 130.51 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.099 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.592 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.6 tt -90.93 135.92 33.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.916 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.55 ' N ' HD23 ' A' ' 380' ' ' LEU . 50.8 t -121.67 125.76 73.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.457 HG12 HD21 ' A' ' 380' ' ' LEU . 12.8 mt -111.65 137.91 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.118 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -145.78 122.09 10.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.772 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 38.7 m-85 -47.15 151.74 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.507 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo . . . . . 0 N--CA 1.465 -0.154 0 CA-C-O 120.828 0.262 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -107.9 172.64 6.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 7.57 32.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 98.0 t -126.82 123.64 63.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.587 HD22 HD12 ' A' ' 367' ' ' LEU . 57.0 mt -109.69 129.2 55.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.802 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 10.3 t80 -110.32 101.62 10.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.708 HD21 ' CE1' ' A' ' 329' ' ' PHE . 5.7 mp -86.43 144.37 27.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.431 ' HG3' ' C ' ' A' ' 313' ' ' LEU . 3.2 mtpm? -142.56 179.11 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.9 m120 60.93 54.72 3.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.529 HD21 ' HG ' ' A' ' 380' ' ' LEU . 16.3 mt -119.6 109.46 15.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 42.8 t -45.71 145.37 2.26 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.708 0.766 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -46.44 -20.65 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.359 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -73.22 -37.67 66.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.971 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 84.4 t -52.55 126.06 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.08 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 37.4 p -121.36 171.72 8.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.136 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -45.07 -42.39 8.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -49.87 -46.98 52.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -52.69 -49.39 65.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.895 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 328' ' ' LEU . 30.4 mt -59.31 -54.45 46.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 99.9 t -45.89 -52.82 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 1.4 t -61.62 -43.73 98.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.747 HD21 ' CE2' ' A' ' 373' ' ' TYR . 36.9 mt -54.2 -40.37 67.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.932 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.708 ' CE1' HD21 ' A' ' 313' ' ' LEU . 6.6 m-85 -125.93 44.48 2.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -89.57 -51.25 5.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.073 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 15.9 ptm180 -44.43 -46.54 9.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.432 ' N ' ' HG3' ' A' ' 331' ' ' ARG . 24.0 m-85 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 356' ' ' THR . 74.6 mt . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 120.725 0.297 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -88.95 136.97 32.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -123.82 139.55 53.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.4 ' HG2' ' CE ' ' A' ' 345' ' ' MET . 46.0 ttp180 -141.29 135.18 30.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 12.2 ttm -112.93 140.09 48.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' MET . . . . . 0.4 ' CE ' ' HG2' ' A' ' 343' ' ' ARG . 25.4 mmt . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -99.23 158.13 15.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 0.0 110.925 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -151.23 147.57 27.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.802 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 39.0 m-85 -113.73 119.15 36.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 75.5 mt -114.14 140.89 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.124 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.626 ' O ' HG23 ' A' ' 340' ' ' ILE . 44.0 m -118.54 130.96 56.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.557 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 18.4 m-85 -109.01 155.83 40.2 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.688 0.756 . . . . 0.0 110.909 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.9 -39.56 32.1 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.711 2.274 . . . . 0.0 112.392 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -144.53 179.45 7.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.2 ptmm? -80.12 -31.89 39.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.8 -64.53 0.87 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 75.4 mt -47.69 -65.28 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.124 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -38.15 -55.92 1.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -49.08 -60.95 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -45.01 -54.67 6.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ALA . . . . . 0.698 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -57.91 -42.83 85.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.067 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.983 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 4.5 tt -58.58 -55.47 34.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 368' ' ' HIS . . . . . 0.539 ' N ' HD23 ' A' ' 367' ' ' LEU . 36.9 t-80 -58.42 -28.63 65.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.882 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 29.5 mt -79.87 -36.76 36.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 366' ' ' ALA . 19.1 t -91.26 -6.29 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.143 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 371' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 367' ' ' LEU . 1.6 p-10 -49.6 122.3 6.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.864 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 67.32 48.0 60.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.494 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.747 ' CE2' HD21 ' A' ' 328' ' ' LEU . 76.0 t80 -90.11 110.13 21.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.932 0.396 . . . . 0.0 110.891 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -68.48 114.09 6.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.685 HD13 ' HE2' ' A' ' 373' ' ' TYR . 33.2 tp -121.94 125.0 45.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.926 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 48.72 41.41 17.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 66.29 37.87 93.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.417 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -148.85 114.69 5.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.802 0.334 . . . . 0.0 110.916 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 32.9 mm -57.8 122.26 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.529 ' HG ' HD21 ' A' ' 316' ' ' LEU . 7.4 tt -85.13 129.02 34.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.455 ' N ' HD23 ' A' ' 380' ' ' LEU . 76.6 t -103.53 119.91 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 16.3 mt -109.05 130.03 62.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -139.67 131.34 27.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.983 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 81.7 m-85 -59.05 123.28 16.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.481 -179.97 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.729 0.22 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 308' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' A' ' 384' ' ' PHE . 49.1 m-20 -101.11 172.35 7.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.467 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -90.85 1.94 56.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.467 HG23 ' HD2' ' A' ' 309' ' ' LYS . 68.7 t -121.4 128.61 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.1 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.62 HD12 ' CE1' ' A' ' 357' ' ' PHE . 28.1 mt -114.29 120.34 40.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.779 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 13.0 t80 -105.62 106.05 16.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.635 HD12 ' N ' ' A' ' 313' ' ' LEU . 1.1 mp -91.43 156.19 17.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.932 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.557 ' HE2' ' CD2' ' A' ' 312' ' ' TYR . 41.1 mttt -144.22 -176.59 5.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 15.2 m120 56.76 52.61 9.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.6 mt -115.88 113.21 23.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 40.1 t -55.8 145.15 53.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.752 0.787 . . . . 0.0 110.842 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -46.07 -25.74 3.12 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.725 2.284 . . . . 0.0 112.349 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.513 ' O ' HG23 ' A' ' 321' ' ' THR . 10.9 mtp85 -69.61 -41.96 75.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.829 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 66.6 t -44.18 134.65 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.15 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 319' ' ' ARG . 35.9 p -135.66 169.06 18.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -41.15 -48.57 3.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -40.42 -54.43 2.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -48.75 -59.99 3.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.587 ' HA ' HD12 ' A' ' 328' ' ' LEU . 36.8 mt -49.25 -52.31 27.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 80.6 t -46.27 -58.23 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 2.2 t -57.75 -43.64 85.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.587 HD12 ' HA ' ' A' ' 325' ' ' LEU . 41.9 mt -56.08 -41.61 75.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -125.83 45.98 2.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -88.0 -41.87 12.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -52.05 -18.54 1.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.807 -179.867 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 60.8 mt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.831 0.348 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -100.93 116.08 31.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.938 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -103.09 142.8 33.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -141.07 129.75 22.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.3 ttm -108.88 145.44 35.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 27.9 ttm . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.853 179.955 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 29.3 mp0 -152.31 133.03 14.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.888 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -135.59 147.23 48.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.079 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.779 ' CE2' ' CE1' ' A' ' 312' ' ' TYR . 42.6 m-85 -115.32 130.14 56.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 69.7 mt -121.5 141.72 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.188 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 39.7 m -121.21 108.61 13.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.795 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 51.3 m-85 -88.5 156.67 50.59 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 0.0 110.897 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -47.03 -47.52 16.52 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.695 2.263 . . . . 0.0 112.304 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -148.78 146.3 27.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.912 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -40.42 -41.6 1.43 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -44.49 -65.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.427 HG22 ' CD2' ' A' ' 357' ' ' PHE . 75.2 mt -57.55 -57.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.078 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.795 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -40.81 -49.07 3.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -58.56 -62.57 1.76 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -47.92 -45.6 31.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.939 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.36 85.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.164 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.666 ' C ' HD23 ' A' ' 367' ' ' LEU . 5.5 tt -63.36 -65.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' HIS . . . . . 0.641 ' N ' HD23 ' A' ' 367' ' ' LEU . 2.4 t60 -46.5 -33.58 4.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 37.3 mt -69.9 -53.0 19.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.952 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.36 36.59 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -83.54 85.77 7.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 106.55 46.18 1.16 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.491 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -89.95 120.52 31.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.008 0.433 . . . . 0.0 110.898 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -70.18 135.4 49.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 28.6 tp -148.29 116.33 6.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.955 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 53.59 42.1 31.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 66.69 30.65 76.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.47 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' LYS . . . . . 0.428 ' NZ ' ' HA ' ' A' ' 378' ' ' LYS . 0.0 OUTLIER -134.26 124.24 25.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.74 0.305 . . . . 0.0 110.888 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 33.8 mm -74.55 107.76 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.607 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.3 tt -70.16 127.84 34.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.57 126.44 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.148 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.421 HG12 HD21 ' A' ' 380' ' ' LEU . 15.0 mt -106.52 137.59 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.161 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -146.39 121.45 10.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.568 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 54.2 m-85 -52.64 140.0 24.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.853 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.493 -179.937 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 307' ' ' PRO . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 384' ' ' PHE . 59.3 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 CA-C-O 120.916 0.298 . . . . 0.0 112.27 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -130.92 -179.07 5.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.647 ' HG3' HG23 ' A' ' 310' ' ' VAL . 39.7 pttt -84.91 -26.75 27.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.647 HG23 ' HG3' ' A' ' 309' ' ' LYS . 18.3 t -102.72 145.32 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.858 HD12 ' CE1' ' A' ' 357' ' ' PHE . 77.0 mt -125.92 135.23 51.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.546 ' CD1' ' HE2' ' A' ' 314' ' ' LYS . 0.7 OUTLIER -102.86 101.46 11.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.866 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.629 HD13 HG13 ' A' ' 355' ' ' ILE . 5.7 mp -91.12 140.96 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.905 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.546 ' HE2' ' CD1' ' A' ' 312' ' ' TYR . 14.6 mttm -139.38 -178.8 5.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 60.53 47.59 8.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.441 ' HB3' HG11 ' A' ' 320' ' ' VAL . 10.8 mt -105.59 99.61 9.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 316' ' ' LEU . 28.9 t -38.08 144.02 0.38 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.642 0.734 . . . . 0.0 110.924 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -44.54 -33.75 7.0 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.673 2.249 . . . . 0.0 112.382 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.58 ' O ' HG23 ' A' ' 321' ' ' THR . 16.6 mtp85 -68.5 -39.26 81.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 316' ' ' LEU . 97.5 t -41.23 138.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 319' ' ' ARG . 68.9 p -138.0 176.1 9.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -45.13 -54.23 7.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 324' ' ' ASP . 9.4 mmm180 -42.0 -64.99 0.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.94 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 323' ' ' ARG . 40.3 m-20 -35.92 -47.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 76.0 mt -65.45 -49.39 69.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.923 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 330' ' ' ALA . 55.3 t -48.7 -59.39 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 43.8 t -56.13 -42.73 77.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.671 HD21 ' CE2' ' A' ' 373' ' ' TYR . 29.3 mt -57.16 -31.41 65.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.902 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.5 ' CE1' HD21 ' A' ' 313' ' ' LEU . 64.2 m-85 -129.45 36.8 4.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -85.56 -48.69 8.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -42.54 -41.76 3.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.762 0.315 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -109.54 127.47 54.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' PHE . . . . . 0.56 ' CE2' HD13 ' A' ' 355' ' ' ILE . 91.0 m-85 -115.56 141.58 47.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.863 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -137.11 127.21 26.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 30.0 tpp -117.15 136.97 52.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 3.2 ptp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.838 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -116.61 151.47 36.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 0.0 110.965 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -163.97 157.2 18.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.094 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.481 ' CE2' ' CE2' ' A' ' 312' ' ' TYR . 8.8 m-85 -118.44 158.42 25.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.815 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.629 HG13 HD13 ' A' ' 313' ' ' LEU . 24.3 mt -144.89 117.25 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.187 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 13.3 m -97.55 131.53 44.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.1 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.858 ' CE1' HD12 ' A' ' 311' ' ' LEU . 7.7 m-85 -111.46 155.39 42.95 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.639 0.733 . . . . 0.0 110.892 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -44.26 -31.35 4.23 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.267 . . . . 0.0 112.379 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.1 177.29 11.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' LYS . . . . . 0.417 ' NZ ' ' O ' ' A' ' 307' ' ' PRO . 0.1 OUTLIER -72.33 -49.92 30.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -43.85 -63.94 0.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 79.3 mt -50.85 -59.03 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -44.54 -46.13 9.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.095 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -59.04 -67.84 0.33 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -37.5 -52.02 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ALA . . . . . 0.609 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -55.94 -43.95 77.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.05 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.586 ' C ' HD23 ' A' ' 367' ' ' LEU . 7.9 tt -58.17 -55.24 37.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.894 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -67.45 -13.19 61.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 33.5 mt -93.01 -29.57 15.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 366' ' ' ALA . 6.2 t -109.21 17.2 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' ASN . . . . . 0.414 ' O ' ' CG ' ' A' ' 371' ' ' ASN . 4.1 p30 -75.08 117.13 16.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 81.39 36.5 20.31 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.487 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.671 ' CE2' HD21 ' A' ' 328' ' ' LEU . 65.0 t80 -81.79 114.08 20.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 0.0 110.917 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -70.07 104.4 2.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.959 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 51.2 tp -121.57 125.23 46.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 57.38 27.02 13.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.959 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 78.71 25.28 60.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.514 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -132.57 139.95 48.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 36.2 mm -84.17 94.6 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.126 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.654 HD23 ' C ' ' A' ' 380' ' ' LEU . 5.2 tt -57.54 130.11 44.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 39.3 t -110.69 124.39 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.597 HG12 HD21 ' A' ' 380' ' ' LEU . 14.8 mt -109.03 143.73 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -148.26 121.32 8.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.477 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 26.1 m-85 -46.69 149.2 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.83 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.458 -179.968 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 N--CA 1.466 -0.099 0 CA-C-O 120.791 0.246 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -153.47 166.29 33.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.629 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -84.4 29.88 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.867 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.629 HG23 ' HD2' ' A' ' 309' ' ' LYS . 90.8 t -146.9 123.21 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.178 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.521 HD21 ' HB1' ' A' ' 363' ' ' ALA . 20.4 mt -116.82 126.51 53.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.785 ' CE1' ' CZ ' ' A' ' 354' ' ' PHE . 18.0 t80 -103.94 101.56 11.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.871 HD23 HD11 ' A' ' 380' ' ' LEU . 6.5 mp -89.45 140.52 29.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.958 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -131.9 -176.06 3.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.839 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 55.61 52.98 10.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.919 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.5 mt -111.53 113.04 25.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.952 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 46.6 t -54.2 139.53 55.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.651 0.739 . . . . 0.0 110.867 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -42.37 -28.11 0.89 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.714 2.276 . . . . 0.0 112.35 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.402 ' O ' HG23 ' A' ' 321' ' ' THR . 26.4 mmt-85 -68.5 -40.4 80.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.852 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 320' ' ' VAL . . . . . 0.642 HG22 ' HD2' ' A' ' 376' ' ' TYR . 40.8 t -46.16 123.7 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.106 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 319' ' ' ARG . 18.3 p -122.05 168.49 11.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -40.81 -51.75 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -43.39 -50.11 6.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -50.04 -47.41 53.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 45.7 mt -61.46 -53.04 61.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.696 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 99.7 t -48.11 -49.56 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.182 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 5.8 t -63.46 -40.42 97.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.823 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.8 mt -58.46 -40.03 81.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.856 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.664 ' HZ ' HD21 ' A' ' 313' ' ' LEU . 14.2 m-85 -123.79 40.29 3.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 330' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -86.33 -34.28 20.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.075 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 9.9 ptp85 -55.51 -39.77 70.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.435 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 23.3 m-85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.455 HG22 ' CE1' ' A' ' 342' ' ' PHE . 79.4 mt . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.764 0.316 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -82.95 139.98 33.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' PHE . . . . . 0.455 ' CE1' HG22 ' A' ' 340' ' ' ILE . 79.8 m-85 -125.37 136.18 53.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -135.69 135.35 40.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.417 ' C ' ' CE ' ' A' ' 345' ' ' MET . 10.6 ttm -116.71 144.19 44.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 345' ' ' MET . . . . . 0.417 ' CE ' ' C ' ' A' ' 344' ' ' MET . 22.5 mmt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -122.62 154.6 37.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.785 0.326 . . . . 0.0 110.978 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -149.59 144.5 26.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.055 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.785 ' CZ ' ' CE1' ' A' ' 312' ' ' TYR . 70.1 m-85 -120.23 119.0 31.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 313' ' ' LEU . 65.7 mt -108.25 142.61 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.122 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 26.4 m -122.96 103.91 8.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.803 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 26.9 m-85 -83.57 156.16 65.37 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.703 0.763 . . . . 0.0 110.858 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -45.21 -52.91 5.91 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.702 2.268 . . . . 0.0 112.287 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -133.92 162.37 32.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -61.14 -42.6 98.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -51.8 -58.23 7.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 72.2 mt -53.08 -61.03 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.803 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -42.84 -59.78 1.84 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -43.05 -60.38 1.66 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -43.57 -45.83 6.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.951 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' ALA . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -64.14 -33.66 76.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.15 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.612 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.1 tt -63.91 -61.65 2.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.923 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.05 -35.67 69.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.11 -42.95 68.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.521 ' O ' HD11 ' A' ' 382' ' ' ILE . 11.7 t -105.12 41.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -92.21 94.49 9.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 100.64 40.76 2.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.521 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -87.63 108.96 19.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.954 0.406 . . . . 0.0 110.928 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -60.38 123.25 16.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 26.0 tp -135.97 132.82 36.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' TYR . . . . . 0.642 ' HD2' HG22 ' A' ' 320' ' ' VAL . 37.0 m-85 48.35 45.75 20.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 57.51 34.19 68.52 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.51 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -150.56 114.13 4.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.339 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 45.7 mm -51.04 146.01 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.871 HD11 HD23 ' A' ' 313' ' ' LEU . 8.3 tt -104.7 140.39 38.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.647 ' N ' HD23 ' A' ' 380' ' ' LEU . 78.9 t -123.93 125.04 70.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.521 HD11 ' O ' ' A' ' 370' ' ' VAL . 11.8 mt -109.84 132.57 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.149 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -137.01 119.83 16.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.612 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 16.9 m-85 -48.67 114.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.478 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo . . . . . 0 N--CA 1.465 -0.153 0 CA-C-O 120.762 0.234 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -126.58 178.59 5.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.469 ' HG3' HG23 ' A' ' 310' ' ' VAL . 38.3 pttt -81.62 -28.09 33.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.469 HG23 ' HG3' ' A' ' 309' ' ' LYS . 81.7 t -95.0 138.68 20.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.202 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.508 HD12 ' CE1' ' A' ' 357' ' ' PHE . 77.7 mt -125.31 114.18 18.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.788 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 11.7 t80 -88.62 104.08 16.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.939 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 313' ' ' LEU . 6.4 mp -92.52 150.84 20.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.943 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -140.84 -175.0 4.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 57.75 48.31 14.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 12.1 mt -104.09 124.89 49.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.9 t -67.6 145.05 98.09 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.659 0.742 . . . . 0.0 110.828 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.55 -27.41 3.48 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.705 2.27 . . . . 0.0 112.307 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.532 ' O ' HG23 ' A' ' 321' ' ' THR . 32.5 mtp85 -74.25 -38.33 63.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 320' ' ' VAL . . . . . 0.667 HG22 HD21 ' A' ' 375' ' ' LEU . 93.2 t -41.36 146.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 319' ' ' ARG . 44.6 p -148.73 159.38 44.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.152 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.753 ' O ' HG23 ' A' ' 326' ' ' VAL . 1.2 tm-20 -41.02 -32.27 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 323' ' ' ARG . . . . . 0.426 ' NH1' ' HB2' ' A' ' 323' ' ' ARG . 17.7 ttm105 -60.66 -58.12 9.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.956 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -45.8 -48.55 15.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.873 ' HA ' HD12 ' A' ' 328' ' ' LEU . 36.1 mt -57.84 -51.64 68.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 322' ' ' GLU . 69.4 t -45.83 -47.34 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.418 ' HA ' ' HB2' ' A' ' 330' ' ' ALA . 8.8 t -67.28 -37.73 83.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.831 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.873 HD12 ' HA ' ' A' ' 325' ' ' LEU . 51.0 mt -56.52 -34.35 66.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.934 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.524 ' CE1' HG21 ' A' ' 370' ' ' VAL . 18.4 m-85 -127.9 32.85 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.853 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 327' ' ' SER . . . -71.24 -52.14 20.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.099 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -40.06 -49.77 2.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.834 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.919 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 83.9 mt . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.913 0.387 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -92.32 138.36 31.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -127.72 136.1 51.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.841 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -134.32 122.78 23.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.873 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 45.4 tpp -110.07 133.29 53.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 26.5 ttm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 179.906 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.431 ' N ' ' CD ' ' A' ' 352' ' ' GLN . 3.0 mp0 -112.18 141.74 45.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.816 0.341 . . . . 0.0 110.891 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.59 153.63 41.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.033 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.788 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 50.7 m-85 -125.24 124.19 41.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.75 137.65 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.136 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 83.4 m -113.9 128.68 56.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.689 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 69.8 m-85 -109.46 157.05 38.43 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 0.0 110.875 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -42.8 -34.97 3.91 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.62 2.213 . . . . 0.0 112.398 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -159.44 -177.34 6.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -71.96 -45.62 60.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -43.12 -66.04 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 363' ' ' ALA . 58.1 mt -51.1 -69.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.152 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.689 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -36.3 -57.36 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -48.43 -57.28 6.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -50.28 -41.86 51.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' ALA . . . . . 0.481 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -65.65 -38.95 90.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.009 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.716 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 4.8 tt -60.75 -60.65 3.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 110.932 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' HIS . . . . . 0.634 ' N ' HD23 ' A' ' 367' ' ' LEU . 19.1 t-80 -62.08 -35.18 77.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 32.2 mt -67.46 -40.48 85.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 370' ' ' VAL . 10.5 t -107.18 32.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -75.71 125.41 29.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 64.88 38.31 95.37 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.445 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -78.65 124.93 28.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.877 0.37 . . . . 0.0 110.958 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -78.41 121.21 24.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.667 HD21 HG22 ' A' ' 320' ' ' VAL . 29.8 tp -125.77 143.97 50.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 38.46 33.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 72.13 47.81 28.82 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.433 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 378' ' ' LYS . 2.4 ptmt -165.92 120.49 1.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.825 0.345 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 46.6 mm -51.49 142.6 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.138 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.628 HD23 ' C ' ' A' ' 380' ' ' LEU . 5.6 tt -110.4 143.38 40.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.594 HG12 ' OE1' ' A' ' 383' ' ' GLU . 11.7 t -112.78 142.42 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.071 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.48 HG13 ' CD2' ' A' ' 380' ' ' LEU . 27.5 mt -134.56 136.14 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.153 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 383' ' ' GLU . . . . . 0.594 ' OE1' HG12 ' A' ' 381' ' ' VAL . 4.8 mp0 -138.63 178.93 6.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.968 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.716 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 48.7 m-85 -105.04 133.93 49.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.93 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.462 -179.92 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo . . . . . 0 N--CA 1.466 -0.113 0 CA-C-O 120.808 0.254 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -130.09 -177.79 4.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.544 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -99.12 -14.13 19.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.972 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.544 HG23 ' HD2' ' A' ' 309' ' ' LYS . 69.2 t -111.79 115.07 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.051 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.521 HD21 ' CE1' ' A' ' 384' ' ' PHE . 58.8 mt -100.32 140.23 34.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.849 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.752 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 10.6 t80 -122.27 102.88 8.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.964 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.688 HD23 HD11 ' A' ' 380' ' ' LEU . 6.6 mp -86.04 150.98 24.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.567 ' HE2' ' CD2' ' A' ' 312' ' ' TYR . 41.3 mttt -139.79 -175.9 4.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.919 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 54.59 52.35 12.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.0 mt -110.21 104.6 13.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 36.2 t -47.22 143.98 4.59 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.728 0.775 . . . . 0.0 110.823 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.37 -19.01 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.69 2.26 . . . . 0.0 112.335 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 30.5 mtt180 -77.38 -36.39 53.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 321' ' ' THR . 95.9 t -44.88 152.15 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 320' ' ' VAL . 35.3 p -158.78 166.52 31.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.164 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 321' ' ' THR . 7.3 mt-10 -34.78 -55.57 0.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.79 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 322' ' ' GLU . 60.3 mtp180 -37.45 -46.49 0.81 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -56.35 -59.71 4.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.431 ' CD2' HD22 ' A' ' 313' ' ' LEU . 23.1 mt -57.05 -51.2 70.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.926 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 92.6 t -53.11 -56.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.131 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 25.4 t -58.85 -39.51 81.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.9 mt -60.37 -40.52 91.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.471 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 28.9 m-85 -124.2 48.27 1.95 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.879 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -83.73 -57.45 3.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.992 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 331' ' ' ARG . . . . . 0.43 ' HB3' ' NH1' ' A' ' 331' ' ' ARG . 3.4 ptp180 -42.73 -46.1 5.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.891 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.439 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 74.3 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.533 HD13 ' CE2' ' A' ' 357' ' ' PHE . 71.0 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.766 0.317 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -96.18 137.15 35.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -120.08 151.65 38.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -141.27 125.24 17.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 40.4 tpp -112.94 133.63 54.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 11.9 ttm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.879 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 312' ' ' TYR . 2.8 mp0 -132.75 151.37 52.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 110.87 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -153.28 150.37 28.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.089 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.752 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 46.5 m-85 -114.64 152.72 31.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 94.7 mt -139.16 142.84 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.102 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.499 HG23 ' NZ ' ' A' ' 309' ' ' LYS . 49.7 m -124.86 121.73 35.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.141 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.533 ' CE2' HD13 ' A' ' 340' ' ' ILE . 62.2 m-85 -104.57 157.2 34.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.666 0.746 . . . . 0.0 110.802 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -46.29 -37.1 18.35 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.626 2.217 . . . . 0.0 112.368 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -149.12 174.44 12.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -71.19 -28.71 64.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -60.13 -63.33 1.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 59.2 mt -50.48 -57.53 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -40.95 -61.49 0.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.082 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -48.09 -63.07 1.17 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -43.48 -41.73 4.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.928 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' ALA . . . . . 0.471 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -63.05 -42.51 99.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.064 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.656 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.0 tt -63.02 -58.41 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.902 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -55.39 -31.28 61.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 51.3 mt -78.02 -37.32 47.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.557 ' O ' HG12 ' A' ' 370' ' ' VAL . 16.4 t -111.27 37.27 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.74 124.72 29.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 63.08 43.01 99.41 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.483 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' A' ' 374' ' ' LYS . 13.9 t80 -78.61 134.79 37.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 0.0 110.952 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.434 ' O ' ' CE1' ' A' ' 373' ' ' TYR . 21.1 ttmt -86.33 119.48 26.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 18.1 tp -133.83 120.7 20.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 53.34 41.17 32.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 67.21 31.29 77.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.451 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' LYS . . . . . 0.422 ' NZ ' ' HA ' ' A' ' 378' ' ' LYS . 0.0 OUTLIER -134.83 130.05 35.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.749 0.309 . . . . 0.0 110.829 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 33.7 mm -76.92 92.19 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.688 HD11 HD23 ' A' ' 313' ' ' LEU . 8.1 tt -61.16 114.69 3.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.67 HG12 ' OE1' ' A' ' 383' ' ' GLU . 34.1 t -101.05 127.98 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.107 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 370' ' ' VAL . 32.5 mt -104.79 126.8 59.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' GLU . . . . . 0.67 ' OE1' HG12 ' A' ' 381' ' ' VAL . 3.0 mp0 -128.65 125.73 38.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.835 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.656 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 44.8 m-85 -59.25 158.51 9.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.841 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 384' ' ' PHE . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo . . . . . 0 N--CA 1.466 -0.141 0 CA-C-O 120.782 0.242 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -115.73 176.75 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.467 ' CD ' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -90.43 5.24 48.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.467 HG23 ' CD ' ' A' ' 309' ' ' LYS . 60.5 t -127.72 129.75 70.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.44 HD21 ' HB1' ' A' ' 363' ' ' ALA . 49.3 mt -116.42 121.45 41.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.795 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 17.5 t80 -105.14 104.84 14.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.933 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 313' ' ' LEU . 3.2 mp -91.31 144.02 26.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.942 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -133.44 179.46 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.3 m120 57.23 51.83 9.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.462 ' HB3' HG11 ' A' ' 320' ' ' VAL . 13.8 mt -108.96 107.57 17.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.5 t -40.48 144.7 0.56 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.702 0.763 . . . . 0.0 110.893 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -47.16 -28.35 7.61 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.66 2.24 . . . . 0.0 112.336 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 24.2 mtt85 -73.51 -30.84 63.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' VAL . . . . . 0.462 HG11 ' HB3' ' A' ' 316' ' ' LEU . 84.9 t -51.26 119.34 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.125 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 17.2 p -124.72 172.77 9.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -44.37 -44.0 7.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 64.9 mtt-85 -48.56 -54.73 13.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -49.13 -45.03 42.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 57.6 mt -62.63 -53.52 53.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 81.6 t -44.36 -49.35 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 47.2 t -65.4 -45.64 83.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.833 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 57.8 mt -52.55 -36.8 56.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.949 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.591 ' CE1' HG21 ' A' ' 370' ' ' VAL . 25.4 m-85 -132.36 44.35 2.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.857 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 330' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -80.35 -52.82 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.051 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -37.32 -32.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.84 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 330' ' ' ALA . 86.6 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 64.3 mt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.768 0.318 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -96.31 127.85 42.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -117.66 142.42 47.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.44 ' HD3' ' N ' ' A' ' 344' ' ' MET . 0.8 OUTLIER -140.9 132.12 26.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.854 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.44 ' N ' ' HD3' ' A' ' 343' ' ' ARG . 39.7 tpp -113.83 143.43 44.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 21.3 ttm . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.916 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.441 ' HB3' ' CE1' ' A' ' 312' ' ' TYR . 1.9 mp0 -142.41 143.53 32.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 0.0 110.887 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.87 152.78 40.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.795 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 82.5 m-85 -120.27 132.67 55.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 78.4 mt -124.14 138.02 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.118 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 17.1 m -117.09 117.8 30.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.19 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.411 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 50.1 m-85 -98.86 158.17 32.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.696 0.76 . . . . 0.0 110.861 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.19 -35.59 15.44 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.661 2.241 . . . . 0.0 112.355 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -158.42 166.77 31.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 361' ' ' GLU . 8.7 pttt -58.0 -49.71 75.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 361' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 360' ' ' LYS . 2.2 tt0 -36.7 -63.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.878 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 55.0 mt -56.13 -62.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.131 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.44 ' HB1' HD21 ' A' ' 311' ' ' LEU . . . -38.6 -59.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.087 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -47.38 -58.16 4.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.404 ' O ' ' CG ' ' A' ' 369' ' ' LEU . 6.6 mm100 -53.76 -35.39 61.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 366' ' ' ALA . . . . . 0.423 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -68.12 -38.42 82.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.14 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.605 ' C ' HD23 ' A' ' 367' ' ' LEU . 7.4 tt -66.54 -56.79 9.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -60.96 -38.02 84.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.776 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.404 ' CG ' ' O ' ' A' ' 365' ' ' GLN . 37.3 mt -65.72 -40.91 92.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.591 HG21 ' CE1' ' A' ' 329' ' ' PHE . 7.3 t -106.15 28.96 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 371' ' ' ASN . . . . . 0.451 ' CG ' ' O ' ' A' ' 371' ' ' ASN . 0.8 OUTLIER -76.43 116.23 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 73.46 45.94 27.71 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.501 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.431 ' CE1' ' O ' ' A' ' 374' ' ' LYS . 38.6 t80 -85.32 138.07 32.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.912 0.386 . . . . 0.0 110.901 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.431 ' O ' ' CE1' ' A' ' 373' ' ' TYR . 22.4 ttmt -89.26 124.89 34.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 376' ' ' TYR . 60.7 tp -135.88 150.42 49.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.952 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 376' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 375' ' ' LEU . 25.2 m-85 35.57 35.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.953 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 375' ' ' LEU . . . 66.73 53.06 29.71 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.51 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -171.83 126.46 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.757 0.313 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 41.9 mm -56.28 144.71 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.161 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.676 HD23 ' C ' ' A' ' 380' ' ' LEU . 3.6 tt -112.34 140.37 47.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.442 ' N ' HD23 ' A' ' 380' ' ' LEU . 23.6 t -110.51 144.48 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.496 HD11 ' O ' ' A' ' 370' ' ' VAL . 23.6 mt -131.42 151.88 36.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.086 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -148.56 175.42 11.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.531 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 29.5 m-85 -104.51 154.2 20.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.472 -179.963 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 C--O 1.23 0.124 0 CA-C-O 120.74 0.225 . . . . 0.0 112.389 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -106.52 172.09 7.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.586 ' HD3' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -84.64 9.89 12.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.824 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.586 HG23 ' HD3' ' A' ' 309' ' ' LYS . 70.5 t -130.94 128.43 62.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.657 HD21 ' HB1' ' A' ' 363' ' ' ALA . 41.5 mt -114.33 122.29 46.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.788 ' CE1' ' CZ ' ' A' ' 354' ' ' PHE . 17.2 t80 -101.77 107.02 18.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.931 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.729 HD23 HD11 ' A' ' 380' ' ' LEU . 8.8 mp -87.37 142.93 27.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -138.68 175.33 9.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 60.54 53.43 4.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.2 mt -113.42 109.97 19.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.2 t -47.49 143.92 5.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.722 0.773 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.12 -19.08 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 321' ' ' THR . 23.7 mtt180 -78.23 -39.83 39.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 87.7 t -49.78 133.83 8.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 319' ' ' ARG . 55.2 p -133.54 170.0 16.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.606 ' HA ' HD12 ' A' ' 325' ' ' LEU . 10.9 tm-20 -43.69 -47.32 7.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -45.0 -57.65 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -49.01 -43.09 40.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.606 HD12 ' HA ' ' A' ' 322' ' ' GLU . 21.3 mt -62.69 -48.56 78.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 62.4 t -51.86 -52.36 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.1 m -61.49 -37.39 83.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.794 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.587 HD21 ' CE2' ' A' ' 373' ' ' TYR . 31.0 mt -59.15 -37.65 77.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.949 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -126.27 42.15 3.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -81.2 -47.42 13.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 331' ' ' ARG . . . . . 0.48 ' CZ ' ' HB2' ' A' ' 331' ' ' ARG . 3.5 ptm85 -46.38 -34.94 5.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 -179.934 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.503 HD13 ' CE2' ' A' ' 357' ' ' PHE . 66.9 mt . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.747 0.308 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 341' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 355' ' ' ILE . 24.7 mm-40 -87.54 142.41 27.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -126.73 144.26 50.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.816 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.2 ttt-85 -141.08 132.67 27.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.2 ttm -115.4 147.34 40.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.877 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 22.2 ttm . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.894 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.436 HE21 ' HH ' ' A' ' 312' ' ' TYR . 12.8 mt-30 -137.07 142.3 42.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.892 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -148.59 153.26 38.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.09 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.788 ' CZ ' ' CE1' ' A' ' 312' ' ' TYR . 77.9 m-85 -124.78 129.65 50.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.83 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 341' ' ' GLN . 56.8 mt -123.65 140.35 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.165 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 55.8 m -114.91 129.37 56.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.503 ' CE2' HD13 ' A' ' 340' ' ' ILE . 23.7 m-85 -106.2 156.57 36.63 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.682 0.753 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -46.11 -40.66 21.31 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.755 2.303 . . . . 0.0 112.337 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -141.26 -176.62 4.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.83 -37.0 19.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.36 -56.37 20.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 60.0 mt -54.36 -56.05 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.089 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.657 ' HB1' HD21 ' A' ' 311' ' ' LEU . . . -44.95 -59.26 2.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.075 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 364' ' ' TRP . . . . . 0.409 ' O ' ' N ' ' A' ' 367' ' ' LEU . 4.8 t90 -48.42 -66.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -40.1 -41.61 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -71.66 -39.67 70.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.079 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.93 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 5.3 tt -55.88 -50.39 70.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -69.21 -35.8 76.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 31.2 mt -62.91 -47.95 81.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.454 ' HB ' ' CD1' ' A' ' 382' ' ' ILE . 25.2 t -82.71 -28.33 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.057 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 371' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 370' ' ' VAL . 0.3 OUTLIER -36.01 120.77 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.936 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 83.28 36.29 15.11 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.414 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.587 ' CE2' HD21 ' A' ' 328' ' ' LEU . 61.0 t80 -91.79 103.43 15.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.943 0.401 . . . . 0.0 110.946 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.474 ' HE2' HD11 ' A' ' 379' ' ' ILE . 9.7 ttmm -71.2 101.85 2.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 26.5 tp -114.62 125.47 53.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.952 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 49.51 38.24 14.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 70.01 37.24 73.6 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.503 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -141.03 121.61 14.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' ILE . . . . . 0.474 HD11 ' HE2' ' A' ' 374' ' ' LYS . 38.8 mm -76.02 86.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.729 HD11 HD23 ' A' ' 313' ' ' LEU . 7.5 tt -47.76 135.09 12.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.594 ' N ' HD23 ' A' ' 380' ' ' LEU . 76.4 t -117.15 111.49 35.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.079 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.485 HG13 ' CD2' ' A' ' 380' ' ' LEU . 43.1 mt -98.64 119.2 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -130.14 127.36 39.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.93 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 48.0 m-85 -54.27 140.71 32.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.928 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.544 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 307' ' ' PRO . . . . . 0.421 ' HA ' ' CE2' ' A' ' 384' ' ' PHE . 61.2 Cg_endo . . . . . 0 C--O 1.231 0.134 0 CA-C-O 120.805 0.252 . . . . 0.0 112.348 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -128.96 164.23 23.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.26 9.46 6.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 74.3 t -130.68 129.31 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.112 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.808 HD12 ' CE1' ' A' ' 357' ' ' PHE . 64.4 mt -115.96 118.61 33.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.669 ' CE1' ' CZ ' ' A' ' 354' ' ' PHE . 8.0 t80 -102.13 111.36 23.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 313' ' ' LEU . 4.8 mp -96.58 147.66 23.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.932 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -141.16 -175.52 4.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 5.0 m120 56.19 54.97 7.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.4 mt -114.78 109.66 18.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.941 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 17.8 t -50.88 144.05 14.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.661 0.743 . . . . 0.0 110.89 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -46.53 -20.73 1.07 Allowed 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.735 2.29 . . . . 0.0 112.286 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.414 ' O ' HG23 ' A' ' 321' ' ' THR . 47.1 mmt-85 -75.13 -35.34 61.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.892 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 320' ' ' VAL . . . . . 0.441 HG13 ' CG ' ' A' ' 324' ' ' ASP . 66.1 t -45.68 137.58 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 322' ' ' GLU . 39.0 p -132.12 150.77 52.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.878 ' OE1' HD12 ' A' ' 325' ' ' LEU . 5.4 tp10 -33.56 -41.34 0.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -46.72 -55.37 7.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.836 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' ASP . . . . . 0.441 ' CG ' HG13 ' A' ' 320' ' ' VAL . 0.2 OUTLIER -46.72 -44.41 18.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.878 HD12 ' OE1' ' A' ' 322' ' ' GLU . 36.2 mt -63.09 -47.45 82.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 67.5 t -57.09 -49.93 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 1.8 m -65.56 -42.44 91.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 23.2 mt -52.37 -41.17 62.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.483 ' CE1' HG21 ' A' ' 370' ' ' VAL . 21.6 m-85 -125.38 40.8 3.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 330' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -74.82 -40.8 60.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.091 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 331' ' ' ARG . . . . . 0.474 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 10.2 ptt-85 -50.47 -45.56 56.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.474 ' N ' ' HG3' ' A' ' 331' ' ' ARG . 25.5 m-85 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.596 HD13 ' CE2' ' A' ' 357' ' ' PHE . 70.2 mt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.833 0.349 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -90.2 120.27 31.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -105.85 138.99 41.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -136.87 129.81 30.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.486 ' HE2' HD11 ' A' ' 325' ' ' LEU . 35.5 tpp -111.1 146.32 37.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.871 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 20.0 ttm . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.833 179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -133.37 145.48 50.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.834 0.349 . . . . 0.0 110.952 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -147.23 145.43 29.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.669 ' CZ ' ' CE1' ' A' ' 312' ' ' TYR . 71.2 m-85 -116.76 123.95 48.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 83.8 mt -114.19 141.24 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.084 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 85.1 m -117.88 114.74 23.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.145 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.808 ' CE1' HD12 ' A' ' 311' ' ' LEU . 38.6 m-85 -97.47 158.62 32.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.636 0.732 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -43.89 -43.99 11.98 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.739 2.292 . . . . 0.0 112.337 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.13 -175.29 5.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.952 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -74.65 -39.33 62.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -47.75 -66.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 57.2 mt -55.03 -55.72 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.107 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.49 ' HB1' HD21 ' A' ' 311' ' ' LEU . . . -43.12 -60.89 1.48 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -46.74 -59.63 2.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.835 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -45.84 -43.86 13.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.972 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.1 95.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.08 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.617 ' C ' HD23 ' A' ' 367' ' ' LEU . 7.1 tt -63.82 -51.8 63.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.916 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -62.77 -33.75 75.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 25.3 mt -72.11 -42.07 66.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.971 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 370' ' ' VAL . 11.2 t -105.64 31.75 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.145 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -75.73 127.77 33.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 58.79 45.0 95.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.497 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.445 ' HE2' HD13 ' A' ' 375' ' ' LEU . 59.7 t80 -84.06 113.32 20.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.903 0.383 . . . . 0.0 110.958 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 28.0 tttt -66.25 104.31 1.16 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.445 HD13 ' HE2' ' A' ' 373' ' ' TYR . 10.6 tp -118.56 135.91 54.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 42.43 50.45 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 53.84 41.19 66.5 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.505 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -156.45 110.26 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.781 0.324 . . . . 0.0 110.854 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 31.8 mm -51.44 118.71 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.084 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.487 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.9 tt -77.52 114.9 16.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.941 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 45.4 t -94.59 118.93 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.151 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.418 HD11 ' O ' ' A' ' 370' ' ' VAL . 36.9 mt -107.53 127.8 63.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -139.32 130.55 26.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.54 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 28.0 m-85 -57.71 132.56 53.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.452 -179.946 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 307' ' ' PRO . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 384' ' ' PHE . 61.4 Cg_endo . . . . . 0 N--CA 1.466 -0.122 0 CA-C-O 120.741 0.225 . . . . 0.0 112.404 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -139.65 162.03 36.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.937 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.565 ' HG3' HG23 ' A' ' 310' ' ' VAL . 11.9 ptmt -70.87 -25.06 62.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.939 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.565 HG23 ' HG3' ' A' ' 309' ' ' LYS . 94.9 t -106.14 143.24 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.483 HD21 ' HB1' ' A' ' 363' ' ' ALA . 52.7 mt -124.35 121.42 34.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.974 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.756 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 9.4 t80 -95.4 102.61 14.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.952 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.463 HD22 HD22 ' A' ' 325' ' ' LEU . 7.5 mp -85.99 134.09 33.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -133.43 -177.07 4.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 60.22 52.17 5.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.8 mt -113.96 122.49 47.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 13.7 t -61.8 143.77 93.9 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.655 0.741 . . . . 0.0 110.821 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.44 -25.12 2.0 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.682 2.255 . . . . 0.0 112.306 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 321' ' ' THR . 41.7 mtm180 -74.34 -39.57 62.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.831 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 99.4 t -39.33 134.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 322' ' ' GLU . 35.2 p -126.89 150.5 49.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.136 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.686 ' OE1' HD12 ' A' ' 325' ' ' LEU . 7.9 tp10 -34.36 -41.54 0.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -45.33 -55.93 5.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 324' ' ' ASP . . . . . 0.489 ' CG ' ' N ' ' A' ' 325' ' ' LEU . 0.3 OUTLIER -44.12 -51.76 7.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.924 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.686 HD12 ' OE1' ' A' ' 322' ' ' GLU . 39.0 mt -56.33 -48.38 76.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.934 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 84.7 t -55.7 -53.09 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.146 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 31.2 t -64.51 -33.61 76.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.445 HD21 ' CE2' ' A' ' 373' ' ' TYR . 21.6 mt -65.65 -35.09 79.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.413 ' CZ ' HG21 ' A' ' 370' ' ' VAL . 38.6 m-85 -128.04 44.73 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.892 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -82.48 -58.69 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 331' ' ' ARG . . . . . 0.455 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 15.6 ptp180 -41.1 -42.09 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.481 ' CE2' ' HB2' ' A' ' 366' ' ' ALA . 31.4 m-85 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.716 HD13 ' CE2' ' A' ' 357' ' ' PHE . 73.0 mt . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.805 0.336 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -97.7 136.25 38.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -123.51 142.09 51.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -140.62 128.14 21.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 14.9 ttm -110.22 146.38 35.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.823 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.882 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -137.97 156.57 47.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.738 0.304 . . . . 0.0 110.92 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -157.57 155.82 30.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.756 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 46.0 m-85 -127.01 126.0 42.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' A' ' 325' ' ' LEU . 97.6 mt -119.18 145.54 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.582 ' O ' HG23 ' A' ' 340' ' ' ILE . 69.6 m -121.31 129.66 53.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.716 ' CE2' HD13 ' A' ' 340' ' ' ILE . 48.9 m-85 -109.97 158.46 34.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.694 0.759 . . . . 0.0 110.85 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.61 -52.05 7.29 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.685 2.256 . . . . 0.0 112.334 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -138.73 170.61 15.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -66.81 -38.62 86.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -49.78 -65.8 0.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 97.0 mt -51.92 -57.5 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.091 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -41.05 -53.02 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.107 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 12.9 t90 -54.68 -65.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -36.93 -46.71 0.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' ALA . . . . . 0.481 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . . . -66.58 -49.95 64.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.094 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.774 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 4.5 tt -49.66 -50.31 43.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.853 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -65.42 -36.09 82.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 31.6 mt -64.63 -60.02 3.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 371' ' ' ASN . 20.4 t -68.45 -33.02 57.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 371' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 370' ' ' VAL . 1.5 t-20 -35.14 107.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.965 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 99.18 33.14 5.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.445 ' CE2' HD21 ' A' ' 328' ' ' LEU . 31.8 t80 -96.14 108.28 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.994 0.426 . . . . 0.0 110.97 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -78.75 105.22 9.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.928 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.565 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 21.5 tp -108.76 135.38 50.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.916 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 376' ' ' TYR . . . . . 0.565 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 57.9 m-85 52.85 27.16 5.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 79.44 34.34 32.47 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.483 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -149.9 122.07 8.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.741 0.305 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 20.5 mm -63.54 136.49 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.167 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.534 HD23 ' C ' ' A' ' 380' ' ' LEU . 8.2 tt -96.73 132.96 41.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.513 ' N ' HD23 ' A' ' 380' ' ' LEU . 55.9 t -113.84 119.86 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.445 HG13 ' CD2' ' A' ' 380' ' ' LEU . 18.3 mt -103.96 139.47 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -136.86 120.08 16.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.774 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 35.8 m-85 -48.89 118.12 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.505 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 307' ' ' PRO . . . . . 0.617 ' HA ' ' CE1' ' A' ' 384' ' ' PHE . 72.6 Cg_exo . . . . . 0 C--O 1.231 0.141 0 CA-C-O 120.838 0.266 . . . . 0.0 112.335 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' ASN . . . . . 0.423 ' C ' ' HA ' ' A' ' 360' ' ' LYS . 76.0 m-20 -124.87 164.87 19.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.45 ' HD3' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -82.61 13.86 3.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.45 HG23 ' HD3' ' A' ' 309' ' ' LYS . 57.3 t -137.59 129.41 40.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.119 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.715 HD22 HD12 ' A' ' 367' ' ' LEU . 76.9 mt -120.25 117.87 28.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.983 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.789 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 7.4 t80 -93.97 105.72 17.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 313' ' ' LEU . 4.4 mp -88.28 145.02 26.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.909 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.434 ' HG3' ' C ' ' A' ' 313' ' ' LEU . 16.6 mtpp -143.31 170.89 14.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 67.46 54.92 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 12.9 mt -114.77 120.9 41.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 22.6 t -57.33 143.84 72.53 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.674 0.75 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -43.94 -27.2 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.671 2.247 . . . . 0.0 112.385 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.591 ' O ' HG23 ' A' ' 321' ' ' THR . 1.4 mmp_? -71.16 -38.73 72.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 320' ' ' VAL . . . . . 0.439 HG22 ' HD2' ' A' ' 376' ' ' TYR . 66.0 t -47.05 122.44 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.591 HG23 ' O ' ' A' ' 319' ' ' ARG . 44.8 p -127.31 168.67 14.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.18 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -39.22 -48.79 1.83 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.913 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' ARG . . . . . 0.43 ' NH1' ' HB2' ' A' ' 323' ' ' ARG . 0.0 OUTLIER -44.52 -49.87 9.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -53.7 -50.99 64.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.843 HD22 HD11 ' A' ' 355' ' ' ILE . 76.4 mt -55.33 -51.93 65.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.965 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 97.5 t -46.98 -59.54 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.094 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 2.6 t -54.0 -47.51 71.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 31.9 mt -49.62 -46.27 49.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.414 ' CZ ' HD21 ' A' ' 313' ' ' LEU . 8.4 m-85 -119.9 41.8 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 330' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -85.15 -25.16 27.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.035 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -64.79 -37.14 86.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.404 ' HZ ' HD13 ' A' ' 369' ' ' LEU . 4.2 m-85 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 71.1 mt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.767 0.317 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -89.68 116.12 27.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.49 130.49 54.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -129.94 117.89 20.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.832 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.1 ttm -103.95 146.85 28.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 345' ' ' MET . . . . . 0.42 ' HE1' ' CE2' ' A' ' 354' ' ' PHE . 34.3 mtm . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -152.91 142.49 21.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.49 142.87 29.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.076 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.789 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 53.0 m-85 -105.45 115.79 30.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.843 HD11 HD22 ' A' ' 325' ' ' LEU . 64.2 mt -108.39 129.42 62.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.12 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 27.1 m -109.53 116.06 31.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.688 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 36.9 m-85 -94.46 159.17 34.33 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.728 0.775 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 358' ' ' PRO . . . . . 0.454 ' HB2' HD12 ' A' ' 362' ' ' ILE . 72.6 Cg_exo -44.85 -47.55 11.67 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.242 . . . . 0.0 112.372 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -142.67 176.47 9.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 360' ' ' LYS . . . . . 0.423 ' HA ' ' C ' ' A' ' 308' ' ' ASN . 0.0 OUTLIER -74.78 -29.21 61.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 361' ' ' GLU . . . . . 0.406 ' N ' ' HG2' ' A' ' 360' ' ' LYS . 77.8 mt-10 -62.33 -56.95 13.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.454 HD12 ' HB2' ' A' ' 358' ' ' PRO . 68.5 mt -56.09 -56.39 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.077 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -49.86 -48.62 51.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -51.22 -49.12 61.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -60.96 -52.72 63.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.942 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -56.63 -34.25 67.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.049 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.804 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 5.9 tt -65.02 -67.04 0.47 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 368' ' ' HIS . . . . . 0.646 ' N ' HD23 ' A' ' 367' ' ' LEU . 10.3 t-80 -46.35 -36.1 6.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.84 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.404 HD13 ' HZ ' ' A' ' 332' ' ' PHE . 23.5 mt -71.61 -58.3 3.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.862 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.569 ' O ' HD11 ' A' ' 382' ' ' ILE . 9.3 t -82.59 37.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.099 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -84.94 136.2 33.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 49.28 38.42 26.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.519 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.549 ' CE1' ' O ' ' A' ' 374' ' ' LYS . 33.4 t80 -78.21 130.39 36.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.951 0.405 . . . . 0.0 110.905 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.549 ' O ' ' CE1' ' A' ' 373' ' ' TYR . 17.5 tttm -71.14 129.79 39.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.881 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 19.1 tp -143.56 124.47 14.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' TYR . . . . . 0.439 ' HD2' HG22 ' A' ' 320' ' ' VAL . 39.3 m-85 43.77 48.25 6.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 59.89 42.46 98.2 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.499 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -155.47 119.25 4.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.338 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 48.3 mm -61.51 107.59 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.119 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.494 HD23 ' C ' ' A' ' 380' ' ' LEU . 8.4 tt -71.33 115.63 10.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.6 t -99.74 136.4 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.141 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.569 HD11 ' O ' ' A' ' 370' ' ' VAL . 57.5 mt -113.39 135.15 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -137.45 118.8 14.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.804 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 59.9 m-85 -47.97 151.54 0.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.509 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 307' ' ' PRO . . . . . 0.533 ' HA ' ' CZ ' ' A' ' 384' ' ' PHE . 61.3 Cg_endo . . . . . 0 C--O 1.23 0.105 0 CA-C-O 120.783 0.243 . . . . 0.0 112.334 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -137.76 168.64 19.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.553 ' HG3' HG23 ' A' ' 310' ' ' VAL . 13.1 ptmt -72.79 -33.61 66.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.907 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.553 HG23 ' HG3' ' A' ' 309' ' ' LYS . 55.6 t -98.22 145.92 8.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.143 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.647 HD12 ' CE1' ' A' ' 357' ' ' PHE . 56.9 mt -127.63 114.43 17.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.573 ' CZ ' ' CG ' ' A' ' 314' ' ' LYS . 6.4 t80 -89.31 105.94 18.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.933 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.444 HD23 HD21 ' A' ' 380' ' ' LEU . 6.3 mp -93.22 148.05 22.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.573 ' CG ' ' CZ ' ' A' ' 312' ' ' TYR . 0.0 OUTLIER -144.5 177.12 8.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.49 53.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 15.6 mt -118.03 112.07 19.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.2 t -38.63 154.29 0.14 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.65 0.738 . . . . 0.0 110.855 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.62 1.96 3.3 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.679 2.253 . . . . 0.0 112.363 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -108.43 -24.83 11.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.98 142.65 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.131 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 64.6 p -133.89 162.85 30.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 323' ' ' ARG . 6.2 tt0 -38.81 -53.76 1.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.909 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 322' ' ' GLU . 56.7 ttt180 -34.78 -42.71 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -62.66 -50.71 70.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 322' ' ' GLU . 15.6 mt -60.04 -48.51 81.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 78.9 t -49.33 -60.46 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.066 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 23.8 t -53.62 -38.58 64.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.43 HD11 HD22 ' A' ' 375' ' ' LEU . 40.9 mt -62.4 -41.24 98.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.479 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 60.4 m-85 -119.56 46.02 2.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -92.31 -58.26 2.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.09 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 331' ' ' ARG . . . . . 0.402 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 17.7 ptp180 -38.37 -47.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.899 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 49.0 m-85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.835 HD13 ' CE2' ' A' ' 357' ' ' PHE . 73.6 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.808 0.337 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -87.65 133.56 33.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -118.62 140.16 50.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -137.97 123.51 19.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 46.6 tpp -103.26 133.3 48.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 20.0 tpp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.936 179.92 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -146.83 147.08 30.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 0.0 110.939 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -154.99 142.44 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.081 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -120.2 121.95 39.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.825 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 80.6 mt -115.22 145.15 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.11 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 25.9 m -122.22 117.75 26.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.835 ' CE2' HD13 ' A' ' 340' ' ' ILE . 63.4 m-85 -99.73 157.39 34.01 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.606 0.717 . . . . 0.0 110.88 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -42.33 -40.11 6.76 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.652 2.235 . . . . 0.0 112.372 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.52 171.04 20.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 360' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 361' ' ' GLU . 11.0 pttm -58.08 -53.99 52.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 361' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 360' ' ' LYS . 45.7 mt-10 -36.52 -64.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.45 -56.93 9.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.136 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.467 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -42.27 -60.62 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.089 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 364' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 367' ' ' LEU . 13.5 t90 -47.63 -64.61 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.938 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -37.67 -46.15 0.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -64.76 -38.13 89.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.037 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.59 ' C ' HD23 ' A' ' 367' ' ' LEU . 7.7 tt -62.04 -61.31 2.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.883 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -56.24 -30.12 61.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 28.9 mt -72.94 -50.94 20.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.955 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.636 ' O ' HG12 ' A' ' 370' ' ' VAL . 25.4 t -98.74 37.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.142 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 371' ' ' ASN . . . . . 0.421 ' O ' ' CG ' ' A' ' 371' ' ' ASN . 0.7 OUTLIER -88.12 87.65 7.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 111.44 42.55 1.05 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -89.27 125.99 35.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.988 0.423 . . . . 0.0 110.917 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -74.29 94.0 2.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.43 HD22 HD11 ' A' ' 328' ' ' LEU . 16.2 tp -104.3 132.0 51.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.99 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 46.09 42.46 9.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 64.64 40.63 97.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -152.57 149.25 28.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.757 0.313 . . . . 0.0 110.953 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 15.8 mm -84.26 107.41 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.116 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.491 HD23 ' N ' ' A' ' 381' ' ' VAL . 8.2 tt -72.76 131.21 42.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.847 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.491 ' N ' HD23 ' A' ' 380' ' ' LEU . 41.0 t -113.1 114.45 46.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.087 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.484 HG13 ' CD2' ' A' ' 380' ' ' LEU . 31.6 mt -98.32 129.87 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -126.82 168.02 15.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.533 ' CZ ' ' HA ' ' A' ' 307' ' ' PRO . 26.3 m-85 -94.76 137.08 34.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.457 -179.94 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo . . . . . 0 N--CA 1.465 -0.156 0 CA-C-O 120.81 0.254 . . . . 0.0 112.272 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -107.09 175.63 5.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.554 ' HG3' HG23 ' A' ' 310' ' ' VAL . 18.7 pttm -85.8 -26.59 25.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.936 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.554 HG23 ' HG3' ' A' ' 309' ' ' LYS . 88.2 t -97.53 124.36 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.467 ' CD2' ' CE1' ' A' ' 384' ' ' PHE . 66.5 mt -113.05 115.06 27.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.934 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.795 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 16.4 t80 -87.85 104.06 16.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.433 HD22 HD22 ' A' ' 325' ' ' LEU . 8.3 mp -85.84 138.17 32.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.918 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -134.06 177.03 8.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 61.89 54.71 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.845 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.4 mt -111.0 127.71 55.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.457 ' HB2' ' CD ' ' A' ' 378' ' ' LYS . 29.4 t -61.91 143.35 94.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.648 0.737 . . . . 0.0 110.903 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -47.12 -19.47 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.604 2.203 . . . . 0.0 112.418 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.528 ' O ' HG23 ' A' ' 321' ' ' THR . 14.3 mtp180 -82.47 -33.29 28.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 320' ' ' VAL . . . . . 0.54 HG22 ' HD2' ' A' ' 376' ' ' TYR . 99.4 t -44.1 133.04 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 319' ' ' ARG . 68.8 p -129.63 151.56 50.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 321' ' ' THR . 9.3 tt0 -34.55 -38.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -48.16 -56.21 8.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' ASP . . . . . 0.421 ' CG ' HG13 ' A' ' 320' ' ' VAL . 0.3 OUTLIER -46.46 -45.05 17.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.433 HD22 HD22 ' A' ' 313' ' ' LEU . 42.3 mt -61.62 -46.22 90.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 65.8 t -56.32 -53.08 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 38.8 t -63.15 -41.67 99.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.851 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.457 HD21 ' CE2' ' A' ' 373' ' ' TYR . 24.0 mt -55.26 -41.48 72.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.971 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.474 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 19.0 m-85 -122.23 40.85 3.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 330' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -79.2 -54.76 5.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.135 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -39.76 -33.34 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 179.996 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 71.6 mt . . . . . 0 N--CA 1.458 -0.038 0 CA-C-O 120.834 0.349 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -98.52 123.38 42.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -114.4 140.26 48.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -141.23 124.31 16.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.891 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 41.2 tpp -108.63 137.58 46.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.813 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 345' ' ' MET . . . . . 0.403 ' HE2' ' N ' ' A' ' 345' ' ' MET . 1.4 mpp? . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -144.41 142.89 30.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 0.0 110.919 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.74 146.01 31.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.795 ' CE2' ' CE1' ' A' ' 312' ' ' TYR . 39.9 m-85 -111.72 124.02 51.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 79.0 mt -117.12 141.13 36.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 35.8 m -119.84 118.47 30.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.747 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 32.5 m-85 -94.1 155.34 40.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.612 0.72 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.1 -32.23 18.2 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.241 . . . . 0.0 112.359 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -152.19 -179.42 7.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 360' ' ' LYS . . . . . 0.444 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 8.6 pttm -78.07 -41.28 35.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 361' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 36.1 mt-10 -54.04 -63.2 1.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 80.4 mt -47.17 -61.44 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.747 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -44.36 -65.26 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.019 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 364' ' ' TRP . . . . . 0.408 ' C ' ' O ' ' A' ' 363' ' ' ALA . 6.1 t90 -36.46 -51.09 0.81 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.938 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -54.47 -53.29 56.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' ALA . . . . . 0.474 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -53.08 -40.66 64.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.78 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 6.3 tt -59.57 -68.23 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 368' ' ' HIS . . . . . 0.651 ' N ' HD23 ' A' ' 367' ' ' LEU . 4.4 t60 -49.79 -33.79 17.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 35.3 mt -72.59 -39.14 67.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.967 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 370' ' ' VAL . 31.3 t -109.81 40.57 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -82.74 141.58 32.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 48.37 30.36 8.01 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.451 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.457 ' CE2' HD21 ' A' ' 328' ' ' LEU . 38.6 t80 -70.46 108.82 4.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.933 0.397 . . . . 0.0 110.853 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -71.45 97.41 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.463 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 31.6 tp -101.46 131.6 47.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.915 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 376' ' ' TYR . . . . . 0.54 ' HD2' HG22 ' A' ' 320' ' ' VAL . 57.1 m-85 53.5 31.93 13.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 73.6 34.8 56.4 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' LYS . . . . . 0.457 ' CD ' ' HB2' ' A' ' 317' ' ' SER . 21.2 mtpp -142.77 112.37 6.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.697 0.284 . . . . 0.0 110.93 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 379' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 379' ' ' ILE . 14.6 mm -52.83 100.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.166 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.41 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.8 tt -69.35 120.57 15.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.5 t -104.04 120.46 54.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.557 HD11 ' O ' ' A' ' 370' ' ' VAL . 65.6 mt -99.34 138.46 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.099 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -140.32 120.54 13.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.912 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.78 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 42.7 m-85 -54.69 147.45 14.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.453 -179.949 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 98.7 p -84.43 168.57 15.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.368 . . . . 0.0 110.828 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 20.0 m -53.51 158.16 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 166.8 -54.6 0.24 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.531 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 8.3 m -62.33 128.25 35.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 0.0 110.924 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 23.8 t -160.94 132.24 5.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.967 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 95.79 74.09 1.2 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -76.74 -48.73 17.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 0.0 110.862 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.3 -45.79 11.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 5.4 pt -72.81 123.3 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -85.98 42.66 0.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm 61.91 50.29 4.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.76 HG22 ' H ' ' A' ' 298' ' ' MET . 2.8 mp -71.5 128.97 89.32 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.56 0.695 . . . . 0.0 111.14 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -43.16 -31.89 2.76 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.709 2.272 . . . . 0.0 112.317 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.76 ' H ' HG22 ' A' ' 296' ' ' ILE . 4.5 ptt? -153.34 105.53 2.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -76.43 51.98 0.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.875 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.9 m -86.64 139.09 31.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.854 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.9 -177.17 0.32 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.834 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.783 ' CE2' HG13 ' A' ' 381' ' ' VAL . 10.1 p90 -41.3 158.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.921 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -116.03 138.75 24.34 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.583 0.706 . . . . 0.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.47 -35.66 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.679 2.252 . . . . 0.0 112.293 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 86.77 -127.27 8.31 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.528 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.474 ' CG ' ' HD2' ' A' ' 307' ' ' PRO . 27.9 tt0 -93.74 140.52 23.07 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.679 0.752 . . . . 0.0 110.856 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' PRO . . . . . 0.474 ' HD2' ' CG ' ' A' ' 306' ' ' GLU . 60.8 Cg_endo -75.33 126.87 10.04 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 0.0 112.33 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -126.15 179.18 5.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.509 ' HG3' HG23 ' A' ' 310' ' ' VAL . 3.8 ptmt -81.5 -30.86 33.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.509 HG23 ' HG3' ' A' ' 309' ' ' LYS . 86.4 t -99.18 132.89 43.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.405 HD12 ' CE1' ' A' ' 357' ' ' PHE . 79.1 mt -112.29 152.74 28.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.96 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.788 ' CD1' ' CE2' ' A' ' 354' ' ' PHE . 10.3 t80 -124.22 101.76 7.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.948 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.593 HD21 ' HE2' ' A' ' 329' ' ' PHE . 6.1 mp -90.63 139.73 30.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.939 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -137.36 -179.53 5.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 63.73 54.06 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.81 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 12.8 mt -116.26 127.09 54.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.968 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 45.1 t -65.56 143.88 98.76 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.643 0.735 . . . . 0.0 110.831 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.16 -22.14 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.7 2.266 . . . . 0.0 112.345 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.566 ' O ' HG23 ' A' ' 321' ' ' THR . 37.6 mtt-85 -77.07 -38.86 51.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 69.5 t -46.1 140.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.095 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 319' ' ' ARG . 75.1 p -140.96 168.41 19.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.199 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 325' ' ' LEU . 19.8 tt0 -41.21 -47.37 3.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -41.52 -52.24 3.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.88 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.42 -48.43 68.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 322' ' ' GLU . 18.9 mt -58.2 -47.0 84.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 86.0 t -53.26 -56.06 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.138 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 7.5 t -60.19 -43.38 95.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.829 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.7 mt -52.12 -48.59 64.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.593 ' HE2' HD21 ' A' ' 313' ' ' LEU . 42.9 m-85 -118.35 42.1 2.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -78.96 -43.55 24.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.073 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -49.48 -34.0 15.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.402 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 21.9 m-85 -73.98 -38.16 64.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' GLN . . . . . 0.422 ' CA ' HD12 ' A' ' 340' ' ' ILE . 15.3 tm0? -43.43 -64.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.933 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.29 -44.76 88.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.825 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -38.47 150.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -42.64 133.35 3.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 123.6 143.79 6.38 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.496 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -47.37 154.44 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.686 2.258 . . . . 0.0 112.402 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.03 138.2 16.25 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.637 2.224 . . . . 0.0 112.375 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.422 HD12 ' CA ' ' A' ' 333' ' ' GLN . 67.1 mt -79.6 135.07 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.134 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -97.71 137.8 36.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -123.81 140.27 53.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -136.35 132.94 36.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.805 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 12.4 ttm -112.22 135.9 52.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 29.4 ttm -99.25 130.63 45.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.908 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 40.9 p -134.15 58.52 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.098 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 349' ' ' MET . . . -95.81 -170.84 35.63 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.497 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.24 -25.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 110.879 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' MET . . . . . 0.428 ' N ' ' O ' ' A' ' 347' ' ' GLY . 13.6 tpp -130.8 99.0 4.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.796 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 33.6 mtt180 -75.97 171.28 14.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.424 ' C ' ' OE1' ' A' ' 352' ' ' GLN . . . 106.14 28.66 5.16 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.463 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.424 ' OE1' ' C ' ' A' ' 351' ' ' GLY . 2.9 mp0 -147.31 152.73 38.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.851 0.358 . . . . 0.0 110.862 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -158.55 167.09 30.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.788 ' CE2' ' CD1' ' A' ' 312' ' ' TYR . 14.4 m-85 -136.6 138.38 41.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.893 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.403 HD13 ' CD2' ' A' ' 329' ' ' PHE . 85.2 mt -126.68 132.88 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.469 HG23 ' CE ' ' A' ' 309' ' ' LYS . 25.7 m -108.26 118.1 35.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.097 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.543 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 47.1 m-85 -99.84 158.91 31.23 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.639 0.733 . . . . 0.0 110.903 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.88 -35.3 13.68 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.623 2.216 . . . . 0.0 112.348 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -157.83 174.8 14.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.977 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 21.5 pttp -65.89 -45.35 82.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' GLU . . . . . 0.46 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 48.1 mt-10 -46.21 -65.17 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 60.5 mt -53.28 -54.17 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -43.59 -59.32 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.081 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' TRP . . . . . 0.495 ' O ' ' N ' ' A' ' 367' ' ' LEU . 11.4 t90 -50.44 -62.87 1.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.0 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -37.25 -50.78 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.485 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -60.17 -37.17 79.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.12 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.803 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 6.3 tt -62.37 -62.54 1.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.976 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' HIS . . . . . 0.436 ' N ' HD23 ' A' ' 367' ' ' LEU . 47.1 t60 -53.18 -29.2 30.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.842 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 44.9 mt -76.24 -48.36 20.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.563 HG21 ' CE1' ' A' ' 329' ' ' PHE . 5.4 t -98.41 33.0 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.101 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.36 96.27 7.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 93.32 43.9 3.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.531 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -84.8 109.16 17.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 0.0 110.922 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -62.95 119.31 9.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.935 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.404 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 19.4 tp -133.54 128.68 35.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.851 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' TYR . . . . . 0.404 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 25.2 m-85 45.81 41.24 7.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.999 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 66.8 41.3 93.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -142.32 141.13 32.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 49.2 mm -90.56 92.73 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.182 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.475 HD23 ' N ' ' A' ' 381' ' ' VAL . 7.2 tt -61.51 129.82 43.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.783 HG13 ' CE2' ' A' ' 302' ' ' TYR . 48.0 t -117.22 111.91 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.187 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.41 ' CD1' ' O ' ' A' ' 370' ' ' VAL . 29.2 mt -93.97 137.89 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -133.73 179.21 6.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.803 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 27.7 m-85 -109.11 140.79 42.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -65.46 -142.94 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.413 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.83 174.74 7.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.783 0.325 . . . . 0.0 110.885 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -99.56 113.0 25.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.09 155.12 46.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.868 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 24.7 tptt 59.95 45.17 12.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.88 155.92 16.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.06 146.52 31.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 56.5 p -105.12 45.91 0.94 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.4 t -127.56 159.27 35.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.79 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -175.17 95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.527 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.83 -8.88 19.41 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.731 2.288 . . . . 0.0 112.305 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 44.4 m -40.0 156.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 1.2 t -136.44 170.43 16.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.86 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.526 -179.94 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 41.2 m -79.91 172.64 13.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.958 0.409 . . . . 0.0 110.83 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 3.5 m -159.25 129.66 5.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.847 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 142.65 115.44 1.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 4.3 t -116.65 45.94 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.866 0.365 . . . . 0.0 110.855 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 3.4 m -41.0 160.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 96.61 50.98 1.75 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.508 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.49 -49.6 75.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.783 0.325 . . . . 0.0 110.863 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -118.11 -15.03 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.661 ' H ' HD13 ' A' ' 293' ' ' ILE . 0.2 OUTLIER -113.15 160.45 12.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.093 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.05 75.55 1.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 35.1 tttm 55.88 35.77 26.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.453 HG23 ' HD2' ' A' ' 297' ' ' PRO . 14.6 mm -106.91 135.85 19.51 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.635 0.731 . . . . 0.0 111.104 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' PRO . . . . . 0.453 ' HD2' HG23 ' A' ' 296' ' ' ILE . 64.2 Cg_endo -78.66 -39.82 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.664 2.243 . . . . 0.0 112.351 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -122.88 92.93 3.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.857 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -129.14 42.38 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.8 m -97.09 -56.6 2.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 6.0 m -128.22 175.16 8.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.849 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -51.38 169.77 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.884 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -101.16 103.37 25.43 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.66 0.743 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.26 -50.54 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.695 2.264 . . . . 0.0 112.336 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 116.1 -172.55 14.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.468 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.48 ' CG ' ' HD2' ' A' ' 307' ' ' PRO . 39.0 tt0 -77.49 141.38 65.44 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.573 0.701 . . . . 0.0 110.946 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' PRO . . . . . 0.48 ' HD2' ' CG ' ' A' ' 306' ' ' GLU . 73.1 Cg_exo -47.15 103.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.701 2.268 . . . . 0.0 112.367 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -118.29 172.67 7.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.6 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -89.91 25.98 1.95 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.949 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.6 HG23 ' HD2' ' A' ' 309' ' ' LYS . 89.2 t -143.17 123.22 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.139 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.689 HD22 HD12 ' A' ' 367' ' ' LEU . 63.0 mt -116.66 125.62 52.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.969 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.674 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 7.8 t80 -105.1 103.88 13.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 313' ' ' LEU . 3.0 mp -87.31 144.68 26.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -140.57 178.69 7.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.928 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.0 m120 59.5 46.09 12.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.855 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.2 mt -105.7 112.5 25.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 37.5 t -54.34 144.54 41.0 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.747 0.784 . . . . 0.0 110.796 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -45.02 -32.16 6.3 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.685 2.257 . . . . 0.0 112.328 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.599 ' O ' HG23 ' A' ' 321' ' ' THR . 54.1 mtt180 -66.57 -39.82 88.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 84.9 t -46.75 113.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 319' ' ' ARG . 82.1 p -108.88 165.81 11.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.136 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -42.05 -50.28 4.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 72.9 mtt85 -43.29 -50.48 6.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -49.52 -44.28 46.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.489 ' HA ' HD12 ' A' ' 328' ' ' LEU . 96.1 mt -64.61 -51.87 60.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 91.8 t -48.27 -51.94 8.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.203 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.2 t -62.9 -40.52 97.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.935 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.517 HD21 ' CE2' ' A' ' 373' ' ' TYR . 23.0 mt -55.69 -42.83 75.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.879 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -121.18 41.62 3.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -82.54 -35.7 26.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.545 ' HG3' ' CE2' ' A' ' 332' ' ' PHE . 6.3 ptp180 -55.98 -23.69 34.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.855 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.693 ' O ' HD11 ' A' ' 340' ' ' ILE . 9.0 m-85 -105.93 36.64 2.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' GLN . . . . . 0.434 ' C ' ' HD2' ' A' ' 335' ' ' LYS . 5.2 tp60 -129.71 -42.11 1.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -73.4 82.78 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.434 ' HD2' ' C ' ' A' ' 333' ' ' GLN . 0.0 OUTLIER -172.89 -175.96 1.35 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.434 ' O ' ' C ' ' A' ' 337' ' ' GLY . 9.8 mptt -52.66 -55.81 19.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.941 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 336' ' ' LYS . . . -35.62 153.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.524 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.38 153.39 39.96 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.322 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.413 ' HA ' ' OE1' ' A' ' 333' ' ' GLN . 71.8 Cg_exo -46.32 125.01 8.44 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.701 HD13 ' CE2' ' A' ' 357' ' ' PHE . 75.6 mt -60.11 137.46 22.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -91.04 117.25 29.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -105.92 146.02 30.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -141.26 126.51 18.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 33.4 tpp -117.18 135.01 54.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' MET . . . . . 0.496 ' CE ' ' CD2' ' A' ' 354' ' ' PHE . 31.0 mtm -116.98 158.12 24.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 347' ' ' GLY . 34.2 p -127.81 -63.11 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.15 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 346' ' ' THR . . . 34.65 -118.85 0.29 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.491 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -76.38 -47.75 22.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 110.852 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 34.3 mtp -124.92 135.08 52.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -83.87 -1.58 54.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.497 ' C ' ' CD ' ' A' ' 352' ' ' GLN . . . -83.87 46.03 3.58 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.409 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.497 ' CD ' ' C ' ' A' ' 351' ' ' GLY . 23.8 mp0 -154.38 130.31 10.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.857 0.361 . . . . 0.0 110.953 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -153.76 141.89 20.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.129 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.674 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 43.4 m-85 -103.34 152.62 21.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 45.3 mt -148.79 134.75 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 309' ' ' LYS . 21.0 m -118.14 127.49 53.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.848 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 42.2 m-85 -104.41 157.8 33.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.641 0.734 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.83 -47.63 9.74 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.668 2.245 . . . . 0.0 112.31 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -141.96 138.7 32.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.425 ' H ' ' CD ' ' A' ' 360' ' ' LYS . 0.0 OUTLIER -45.82 -27.5 0.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.896 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.28 -58.6 7.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' A' ' 332' ' ' PHE . 72.6 mt -57.67 -58.8 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.848 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -46.34 -46.5 18.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.12 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -54.73 -61.58 2.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.999 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -50.25 -37.35 35.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.81 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -69.24 -45.62 69.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.689 HD12 HD22 ' A' ' 311' ' ' LEU . 6.6 tt -55.94 -51.04 69.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -63.95 -36.02 82.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 39.9 mt -74.38 -28.01 60.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 366' ' ' ALA . 17.2 t -102.01 -4.47 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 367' ' ' LEU . 1.4 p-10 -55.21 127.32 28.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 63.72 49.48 68.35 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.448 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.517 ' CE2' HD21 ' A' ' 328' ' ' LEU . 82.3 t80 -93.81 112.49 24.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 110.902 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -67.81 105.96 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 37.3 tp -118.75 118.03 30.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 55.47 35.12 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 73.4 29.52 63.9 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -133.29 129.41 37.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.78 0.324 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 51.0 mm -77.51 90.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.567 HD23 ' C ' ' A' ' 380' ' ' LEU . 8.0 tt -59.6 117.56 5.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.55 HG12 ' OE1' ' A' ' 383' ' ' GLU . 97.0 t -102.68 122.99 55.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.14 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.476 HG12 HD21 ' A' ' 380' ' ' LEU . 15.3 mt -109.26 139.19 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.113 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' GLU . . . . . 0.55 ' OE1' HG12 ' A' ' 381' ' ' VAL . 4.9 mp0 -138.65 124.86 20.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.524 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 27.9 m-85 -52.45 158.11 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.894 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -84.09 -178.37 51.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.439 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -109.34 149.48 29.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.757 0.313 . . . . 0.0 110.87 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -117.09 135.96 53.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -110.26 -38.43 5.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -67.96 107.38 2.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -87.05 88.1 7.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.915 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -47.01 130.45 12.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 78.5 p -85.75 136.5 33.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.876 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 30.3 t -142.87 152.56 42.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.806 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.29 97.22 0.12 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.502 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.84 157.0 43.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.724 2.283 . . . . 0.0 112.311 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 20.8 t -92.4 -63.9 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 22.6 t -99.78 159.05 15.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.5 179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 49.8 m 54.44 41.76 31.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.89 0.376 . . . . 0.0 110.863 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 39.8 m -48.7 170.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.794 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 38.1 -147.01 0.11 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.54 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 1.8 t 66.94 39.49 3.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 0.0 110.782 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 3.1 m -82.8 140.48 32.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' GLY . . . . . 0.427 ' HA3' HD11 ' A' ' 293' ' ' ILE . . . -177.74 105.61 0.2 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.515 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -67.09 -54.27 23.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.76 -48.35 77.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.804 ' O ' HD12 ' A' ' 293' ' ' ILE . 2.7 pp -83.61 33.76 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.161 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -89.22 -53.64 4.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.867 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -72.32 -59.18 2.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 32.8 mt -124.97 104.3 29.96 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.576 0.703 . . . . 0.0 111.134 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -45.5 -37.71 15.27 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.668 2.245 . . . . 0.0 112.279 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 9.1 mmt -87.97 55.11 3.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.879 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -86.11 -44.96 11.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 63.8 p -129.14 103.06 6.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.88 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.8 m -67.57 -56.27 10.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.847 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.418 ' CZ ' ' O ' ' A' ' 303' ' ' ASN . 0.8 OUTLIER -158.74 151.67 22.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.995 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.418 ' O ' ' CZ ' ' A' ' 302' ' ' TYR . 15.2 m120 -113.44 138.03 22.34 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.612 0.72 . . . . 0.0 110.912 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.92 -40.27 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.753 2.302 . . . . 0.0 112.253 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 120.49 -114.75 2.74 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.466 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -106.91 134.95 19.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 110.917 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -47.48 148.98 4.82 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.62 2.214 . . . . 0.0 112.304 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.408 ' HB3' ' CD1' ' A' ' 384' ' ' PHE . 8.4 t-20 -153.64 165.79 34.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.835 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.51 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -84.97 -14.6 47.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.51 HG23 ' HD2' ' A' ' 309' ' ' LYS . 54.4 t -111.32 134.43 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.135 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.801 HD12 ' HE2' ' A' ' 357' ' ' PHE . 29.0 mt -119.04 120.67 37.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.897 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.792 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 13.9 t80 -106.41 102.69 12.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.688 HD23 HD21 ' A' ' 380' ' ' LEU . 6.2 mp -88.88 149.55 23.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.557 ' HE2' ' CD2' ' A' ' 312' ' ' TYR . 22.5 mttt -137.56 -176.73 4.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 55.35 53.9 9.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.2 mt -109.32 117.68 34.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.898 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 38.6 t -61.34 139.91 94.67 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.675 0.75 . . . . 0.0 110.874 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -43.2 -27.63 1.17 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.703 2.268 . . . . 0.0 112.256 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.514 ' HB3' ' CE2' ' A' ' 376' ' ' TYR . 23.0 mmt85 -69.73 -42.85 73.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.857 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 93.5 t -44.31 136.34 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.13 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.8 p -135.88 166.54 23.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.101 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -41.64 -52.45 3.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -40.94 -41.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.69 -46.72 86.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 328' ' ' LEU . 81.3 mt -60.33 -44.8 95.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.928 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 95.0 t -55.12 -60.54 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 4.8 t -54.12 -40.63 67.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.904 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 325' ' ' LEU . 28.7 mt -56.74 -44.9 82.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.6 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 54.2 m-85 -120.54 45.76 2.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 333' ' ' GLN . . . -84.06 -39.55 19.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -45.26 -37.36 4.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.785 ' O ' HD11 ' A' ' 340' ' ' ILE . 11.9 m-85 -94.22 32.1 1.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 330' ' ' ALA . 8.3 tp60 -116.72 -57.83 2.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -57.89 -34.03 69.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -50.4 155.35 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -57.41 92.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -176.51 151.48 11.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.425 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -45.23 165.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.662 2.242 . . . . 0.0 112.35 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.61 102.93 1.66 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.755 2.304 . . . . 0.0 112.299 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.785 HD11 ' O ' ' A' ' 332' ' ' PHE . 59.5 mt -41.73 131.18 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.157 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -93.83 116.52 28.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -103.49 149.07 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -141.19 125.25 17.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.849 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 41.7 tpp -114.57 135.63 53.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 9.1 ttm -90.1 167.8 12.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.842 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 9.9 t -172.68 156.01 3.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.09 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 124.67 -157.75 19.03 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.484 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.441 ' HG3' ' N ' ' A' ' 349' ' ' MET . 11.4 ptm180 -46.95 -43.3 18.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 0.0 110.808 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' MET . . . . . 0.441 ' N ' ' HG3' ' A' ' 348' ' ' ARG . 3.2 ttt -111.9 106.71 15.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.419 ' C ' ' NE ' ' A' ' 350' ' ' ARG . 0.0 OUTLIER -110.16 174.27 5.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.48 ' C ' ' NE2' ' A' ' 352' ' ' GLN . . . 96.69 31.29 7.13 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.533 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.48 ' NE2' ' C ' ' A' ' 351' ' ' GLY . 22.5 mp0 -148.37 141.38 24.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 110.861 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -150.05 151.58 33.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.099 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.792 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 58.0 m-85 -116.05 143.73 45.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.825 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.475 HD12 HD11 ' A' ' 313' ' ' LEU . 77.4 mt -136.0 139.2 46.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.144 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 83.3 m -124.41 117.41 24.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.13 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.801 ' HE2' HD12 ' A' ' 311' ' ' LEU . 84.0 m-85 -96.75 158.08 34.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.649 0.738 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.7 -35.39 23.21 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.739 2.293 . . . . 0.0 112.307 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -149.71 178.68 8.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.84 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -74.58 -49.93 19.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -41.13 -63.62 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 46.6 mt -51.68 -61.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -38.86 -60.81 0.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.138 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 14.0 t90 -48.42 -56.81 7.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -50.54 -47.09 57.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.6 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -58.28 -32.18 68.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.079 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.685 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.2 tt -70.42 -69.94 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.916 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' HIS . . . . . 0.579 ' N ' HD23 ' A' ' 367' ' ' LEU . 21.7 t-80 -48.01 -32.68 6.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 41.7 mt -74.32 -41.53 60.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.725 ' O ' HG12 ' A' ' 370' ' ' VAL . 47.3 t -104.04 33.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.187 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -79.34 139.7 37.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 52.42 40.02 53.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.442 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.422 ' CE1' HD21 ' A' ' 328' ' ' LEU . 32.7 t80 -80.2 120.04 23.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.013 0.435 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -63.68 112.1 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 29.4 tp -121.67 127.27 50.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' TYR . . . . . 0.514 ' CE2' ' HB3' ' A' ' 319' ' ' ARG . 31.5 m-85 41.27 46.32 2.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 59.97 44.68 96.96 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.443 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -156.03 114.56 3.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.717 0.294 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 17.2 mm -50.62 111.03 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.688 HD21 HD23 ' A' ' 313' ' ' LEU . 8.3 tt -80.39 120.16 24.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.64 118.18 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.469 HD11 ' O ' ' A' ' 370' ' ' VAL . 29.4 mt -99.04 136.83 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.098 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.49 177.66 7.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.921 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.685 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 41.3 m-85 -109.98 135.23 51.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -53.58 145.83 22.68 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.51 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -111.58 -39.16 4.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.768 0.318 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -109.12 138.47 45.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -137.34 145.32 43.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -117.53 159.98 21.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -48.93 -59.24 3.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.007 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 57.66 43.21 22.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.846 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 4.4 m -118.73 136.26 54.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.6 m -107.34 -45.0 4.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.837 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 89.99 67.21 1.22 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.56 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.92 169.76 21.07 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.746 2.297 . . . . 0.0 112.331 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 34.4 t -66.33 156.38 34.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 46.0 t -148.36 136.75 21.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.791 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.437 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.456 -0.257 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.1 m -99.39 115.16 28.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 110.813 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 46.7 t -111.88 93.31 4.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.86 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -163.2 -95.68 0.11 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.441 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 1.7 t 48.88 42.35 20.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.358 . . . . 0.0 110.847 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 4.9 t -96.31 75.95 2.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.835 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 119.75 113.87 2.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.421 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -49.53 -64.68 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.327 . . . . 0.0 110.906 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -96.05 -39.2 9.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.707 ' HA ' HD12 ' A' ' 296' ' ' ILE . 0.2 OUTLIER -80.44 14.01 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.083 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -37.58 -68.25 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -88.06 62.77 6.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.856 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 293' ' ' ILE . 47.4 mt -152.71 105.01 2.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.625 0.726 . . . . 0.0 111.152 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.9 -34.55 3.87 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.703 2.269 . . . . 0.0 112.382 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 8.5 mmt -133.38 105.57 7.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' PHE . . . . . 0.618 ' HB3' HG21 ' A' ' 296' ' ' ILE . 25.3 p90 -120.36 104.34 9.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 5.8 t -159.18 141.77 14.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 27.1 m -168.21 159.33 10.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.758 ' CE2' HG13 ' A' ' 381' ' ' VAL . 29.1 p90 -49.3 170.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.93 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -122.74 137.99 28.8 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.62 0.724 . . . . 0.0 110.9 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -79.52 -40.68 0.24 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.737 2.291 . . . . 0.0 112.324 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 108.25 -118.86 5.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.455 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -122.36 142.06 36.18 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.659 0.742 . . . . 0.0 110.873 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.21 107.02 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.663 2.242 . . . . 0.0 112.316 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -117.92 175.29 5.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.661 ' HG3' HG23 ' A' ' 310' ' ' VAL . 5.9 ptmm? -86.96 -36.78 18.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.661 HG23 ' HG3' ' A' ' 309' ' ' LYS . 83.9 t -96.08 125.48 48.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.105 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.446 ' CD2' ' CE1' ' A' ' 384' ' ' PHE . 34.5 mt -108.64 112.17 24.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.738 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 14.6 t80 -83.6 104.24 13.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.943 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.764 HD23 HD11 ' A' ' 380' ' ' LEU . 8.1 mp -90.66 136.71 32.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -132.24 -177.08 4.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 58.72 47.44 12.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.6 mt -106.61 111.54 24.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.4 t -45.77 142.06 3.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.701 0.762 . . . . 0.0 110.847 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.04 -19.37 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.66 2.24 . . . . 0.0 112.343 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -82.73 -37.98 23.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 60.8 t -40.77 137.17 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.176 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 4.5 p -135.77 168.25 19.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -45.99 -45.28 15.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -45.38 -59.26 2.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.876 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -44.36 -50.49 9.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 328' ' ' LEU . 28.8 mt -55.18 -41.94 72.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.979 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 98.3 t -56.69 -57.44 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.151 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 4.5 t -59.86 -24.16 64.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 325' ' ' LEU . 33.3 mt -76.07 -40.33 53.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.934 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -123.69 39.71 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -88.25 -38.71 15.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -55.61 -17.28 5.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.492 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 57.9 m-85 -84.56 -56.27 3.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' GLN . . . . . 0.534 ' HB2' HD12 ' A' ' 340' ' ' ILE . 5.4 tm0? -65.66 -48.52 71.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.537 ' OE2' ' HB1' ' A' ' 330' ' ' ALA . 13.0 mt-10 -52.01 -42.92 63.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.924 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -68.95 -71.52 0.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 22.3 mmtm -145.55 174.57 11.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 82.14 134.36 1.9 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.533 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -48.08 157.58 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.628 2.218 . . . . 0.0 112.43 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.1 105.93 0.09 OUTLIER 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.664 2.242 . . . . 0.0 112.381 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 333' ' ' GLN . 43.9 mt -54.23 138.97 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.183 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -93.01 127.77 38.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -118.56 142.39 47.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.866 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -141.27 126.18 18.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 11.4 ttm -115.4 125.79 53.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.945 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 9.8 ptp -104.31 157.93 16.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 26.4 p -145.18 159.91 42.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.156 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 151.89 -164.64 30.44 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -43.81 -50.51 7.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.874 0.369 . . . . 0.0 110.923 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' MET . . . . . 0.464 ' O ' ' NE2' ' A' ' 352' ' ' GLN . 2.4 ttm -102.27 42.95 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.51 177.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.929 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 93.86 23.14 23.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.464 ' NE2' ' O ' ' A' ' 349' ' ' MET . 23.8 mt-30 -129.5 150.86 50.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.329 . . . . 0.0 110.945 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -154.71 152.15 29.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.738 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 41.5 m-85 -121.14 126.43 49.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 95.6 mt -118.29 142.79 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.42 HG23 ' HZ3' ' A' ' 309' ' ' LYS . 4.8 m -123.53 121.56 35.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.682 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 37.5 m-85 -99.69 159.05 30.98 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.663 0.744 . . . . 0.0 110.864 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.48 -42.46 18.11 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.688 2.259 . . . . 0.0 112.302 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -153.89 156.44 37.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.434 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 13.7 ptpt -48.6 -45.98 38.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.915 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' GLU . . . . . 0.434 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 20.1 mm-40 -41.24 -65.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.857 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' A' ' 363' ' ' ALA . 79.1 mt -54.08 -64.73 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.682 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -36.09 -57.6 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.062 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -49.05 -58.75 4.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -50.01 -48.19 52.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.492 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -57.66 -38.84 75.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.771 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 5.2 tt -64.38 -60.7 2.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' HIS . . . . . 0.556 ' N ' HD23 ' A' ' 367' ' ' LEU . 32.8 t60 -56.19 -27.55 54.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 30.2 mt -79.83 -37.11 35.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.545 ' O ' HG12 ' A' ' 370' ' ' VAL . 13.7 t -110.14 35.92 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.172 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -87.65 106.82 18.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.831 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 90.42 31.61 10.33 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.434 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.431 ' CE1' HD21 ' A' ' 328' ' ' LEU . 19.2 t80 -76.19 119.06 19.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.834 0.35 . . . . 0.0 110.991 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -66.71 107.28 2.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 15.0 tp -111.93 114.51 27.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.985 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 53.94 40.02 31.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 69.91 29.73 70.68 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.459 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -143.26 113.41 7.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.845 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 19.9 mm -53.88 128.06 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.09 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.764 HD11 HD23 ' A' ' 313' ' ' LEU . 5.5 tt -94.18 117.29 29.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.758 HG13 ' CE2' ' A' ' 302' ' ' TYR . 86.5 t -98.5 128.9 49.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.163 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.405 HG12 HD21 ' A' ' 380' ' ' LEU . 24.3 mt -110.58 132.22 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -134.03 124.02 25.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.922 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.771 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 39.8 m-85 -55.46 151.29 10.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.824 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -50.86 172.01 0.16 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -122.54 101.98 7.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.768 0.318 . . . . 0.0 110.811 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -126.62 100.04 6.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.946 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -103.83 59.84 0.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -121.22 94.45 4.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -82.15 110.33 17.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.961 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -65.32 149.14 50.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.902 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 7.5 t -65.69 91.43 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 7.1 t -50.94 169.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.887 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 100.97 91.87 2.12 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.446 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.0 121.61 5.89 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.753 2.302 . . . . 0.0 112.373 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 3.8 m -67.49 112.75 4.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.907 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 22.2 m -88.86 154.99 19.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.806 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.511 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 33.7 p -133.42 -62.22 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.936 0.398 . . . . 0.0 110.904 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 71.6 p -48.39 145.15 3.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.871 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -155.14 -151.49 5.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.481 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.7 p -119.41 133.52 55.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.775 0.321 . . . . 0.0 110.941 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 11.1 m -57.92 100.06 0.05 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.842 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -153.22 110.61 0.46 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.538 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -62.46 -43.74 98.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.841 0.353 . . . . 0.0 110.913 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -84.48 -47.85 10.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 6.1 pt -99.3 137.95 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ARG . . . . . 0.427 ' HD3' ' C ' ' A' ' 294' ' ' ARG . 2.6 tmt_? -133.5 -63.79 0.74 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.834 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -73.49 -64.57 0.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.652 HG23 ' HD2' ' A' ' 297' ' ' PRO . 5.2 mp -107.09 139.23 20.23 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.606 0.717 . . . . 0.0 111.174 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' PRO . . . . . 0.652 ' HD2' HG23 ' A' ' 296' ' ' ILE . 63.7 Cg_endo -78.76 151.07 24.53 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.674 2.25 . . . . 0.0 112.343 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 23.2 ttp 56.95 43.82 24.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -105.93 172.89 6.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.6 t 64.44 43.08 4.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.845 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 66.9 m -152.31 166.36 32.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.758 ' CE2' HG13 ' A' ' 381' ' ' VAL . 5.3 p90 -49.36 161.64 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.941 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -124.16 139.51 32.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.659 0.742 . . . . 0.0 110.851 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.49 -41.16 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.268 . . . . 0.0 112.355 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 98.48 -144.65 17.35 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.426 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.447 ' CD ' ' HD2' ' A' ' 307' ' ' PRO . 9.0 tp10 -96.72 138.57 21.39 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.575 0.702 . . . . 0.0 110.897 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' PRO . . . . . 0.447 ' HD2' ' CD ' ' A' ' 306' ' ' GLU . 73.5 Cg_exo -47.14 99.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.668 2.246 . . . . 0.0 112.329 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -110.35 177.01 4.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.846 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -88.16 -25.17 23.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 23.5 t -97.89 128.68 49.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.088 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.696 HD12 ' CE1' ' A' ' 357' ' ' PHE . 48.7 mt -115.63 118.31 32.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.012 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.769 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 15.0 t80 -98.23 102.34 14.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.584 HD23 HD11 ' A' ' 380' ' ' LEU . 5.1 mp -88.5 146.54 25.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -138.06 -176.35 4.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 59.7 53.6 4.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.5 mt -115.65 122.84 46.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 18.0 t -64.5 143.87 98.59 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.68 0.753 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.72 -19.5 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.695 2.264 . . . . 0.0 112.386 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 -77.11 -35.16 56.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 97.6 t -48.53 146.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 12.2 p -145.24 175.33 10.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.113 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -48.38 -47.02 37.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -44.47 -54.37 6.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.24 -51.52 25.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 355' ' ' ILE . 57.2 mt -57.31 -47.53 81.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 330' ' ' ALA . 96.5 t -55.08 -61.78 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.184 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 11.6 t -53.09 -37.59 61.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.436 HD21 ' CD2' ' A' ' 373' ' ' TYR . 32.6 mt -63.23 -40.26 96.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.897 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -120.79 40.54 3.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -82.64 -21.17 35.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.08 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -69.66 -36.99 76.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -91.85 14.57 15.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -75.55 -46.04 34.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -99.52 88.21 3.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -155.94 161.1 40.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -38.48 102.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 130.22 144.64 5.6 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.486 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.52 156.5 1.07 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.651 2.234 . . . . 0.0 112.353 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -45.92 164.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 0.0 112.392 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.607 HD13 ' CE2' ' A' ' 357' ' ' PHE . 85.4 mt -89.44 140.36 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.184 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -100.88 117.77 35.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -102.34 138.8 38.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -134.35 129.29 35.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 40.5 tpp -112.87 145.14 41.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' MET . . . . . 0.452 ' HE3' ' N ' ' A' ' 345' ' ' MET . 18.6 mmt -80.7 143.55 32.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 22.9 p -113.73 -62.59 1.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.189 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 348' ' ' ARG . . . -53.12 -170.62 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.48 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 347' ' ' GLY . 6.6 ptp85 -34.55 150.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.755 0.312 . . . . 0.0 110.892 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 4.4 mtt 54.99 50.84 14.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.02 -0.04 8.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -82.28 31.48 2.9 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.486 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -139.87 166.75 23.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 110.882 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -158.6 149.26 20.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.769 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 12.9 m-85 -119.39 121.82 40.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.836 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.444 HD11 HD22 ' A' ' 325' ' ' LEU . 61.9 mt -110.14 144.47 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.15 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 340' ' ' ILE . 17.2 m -120.89 117.76 28.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.132 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.696 ' CE1' HD12 ' A' ' 311' ' ' LEU . 53.6 m-85 -98.94 155.76 36.25 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.625 0.726 . . . . 0.0 110.857 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.57 -42.0 18.61 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.75 2.3 . . . . 0.0 112.324 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.75 171.55 17.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 0.9 OUTLIER -64.78 -48.94 72.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 361' ' ' GLU . . . . . 0.412 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 7.3 mm-40 -39.99 -63.17 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 363' ' ' ALA . 90.6 mt -53.27 -65.82 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -36.98 -55.49 0.92 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -48.3 -63.47 1.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -45.29 -48.89 13.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.442 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -60.17 -33.74 72.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.091 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.886 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.4 tt -68.01 -63.29 1.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -50.65 -34.21 25.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 24.9 mt -75.34 -57.66 3.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.961 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.527 ' O ' HD11 ' A' ' 382' ' ' ILE . 5.9 t -84.1 31.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.115 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -87.27 103.85 15.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 90.77 37.45 6.43 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.436 ' CD2' HD21 ' A' ' 328' ' ' LEU . 73.9 t80 -82.38 107.64 15.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 0.0 110.961 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -59.09 126.96 29.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.64 124.97 18.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 49.41 34.68 6.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.946 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 73.44 38.03 52.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.438 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.15 150.48 47.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.784 0.325 . . . . 0.0 110.839 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 43.1 mm -97.17 87.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.61 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.2 tt -52.07 133.63 32.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.957 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.758 HG13 ' CE2' ' A' ' 302' ' ' TYR . 85.0 t -120.62 122.95 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.527 HD11 ' O ' ' A' ' 370' ' ' VAL . 21.5 mt -104.81 132.43 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.129 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -139.99 119.17 12.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.886 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 58.1 m-85 -51.33 151.59 2.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -64.99 -161.75 0.64 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -123.97 87.49 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -107.36 93.48 4.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -130.22 95.83 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.1 149.07 22.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -106.15 100.29 9.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -170.18 159.24 7.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.836 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 16.7 t -134.52 119.07 18.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 27.9 t -152.05 119.96 6.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.941 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -167.84 104.47 0.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.463 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.25 -175.45 2.41 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.649 2.233 . . . . 0.0 112.369 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 22.0 t -104.4 131.38 51.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 66.4 m -99.26 125.95 44.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.902 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 -179.939 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 73.9 m -152.69 156.39 39.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.847 0.356 . . . . 0.0 110.861 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 44.7 m -123.26 154.33 38.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 163.51 -141.43 7.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.472 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 2.3 t 55.42 37.9 29.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.858 0.361 . . . . 0.0 110.832 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 40.1 p -114.01 148.37 37.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.816 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -48.87 145.08 7.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.499 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -64.99 -44.47 89.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.864 0.364 . . . . 0.0 110.872 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -101.93 -56.5 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.883 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 2.9 pt -75.29 78.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.218 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -91.08 -60.08 2.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -42.44 -56.91 2.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.94 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.622 HG23 ' HD2' ' A' ' 297' ' ' PRO . 48.5 mt -123.44 138.38 30.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.625 0.726 . . . . 0.0 111.13 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' PRO . . . . . 0.622 ' HD2' HG23 ' A' ' 296' ' ' ILE . 63.7 Cg_endo -77.89 -48.63 0.1 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.67 2.247 . . . . 0.0 112.392 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 23.2 mtp -88.92 84.07 6.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.92 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -119.68 117.92 29.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 36.9 t -140.46 146.61 38.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 5.3 t -87.52 -58.86 2.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -125.88 165.77 18.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.954 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -123.95 99.77 37.66 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.604 0.716 . . . . 0.0 110.916 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.18 -32.1 7.06 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.718 2.279 . . . . 0.0 112.352 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 96.9 -126.5 8.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.41 ' O ' ' CG ' ' A' ' 384' ' ' PHE . 4.6 pm0 -121.01 151.27 54.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.667 0.746 . . . . 0.0 110.906 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.15 117.56 3.23 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.711 2.274 . . . . 0.0 112.309 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -138.43 160.06 40.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.566 ' HG3' HG23 ' A' ' 310' ' ' VAL . 11.4 ptmt -68.94 -28.42 66.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.94 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.566 HG23 ' HG3' ' A' ' 309' ' ' LYS . 73.9 t -95.85 134.32 33.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.554 HD12 ' CE1' ' A' ' 357' ' ' PHE . 45.4 mt -123.5 121.7 36.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.696 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 10.3 t80 -96.94 113.42 24.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.505 HD12 ' N ' ' A' ' 313' ' ' LEU . 5.3 mp -103.26 145.98 29.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.401 ' HD3' ' N ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -144.68 -179.7 6.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.955 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.4 m120 60.77 51.48 4.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.5 mt -113.23 115.97 29.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 21.3 t -50.29 146.28 8.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.647 0.737 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.86 -26.37 7.12 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.656 2.237 . . . . 0.0 112.291 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.444 ' HB3' ' NH1' ' A' ' 319' ' ' ARG . 7.5 mtp-105 -72.04 -31.7 66.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.27 132.34 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.166 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 322' ' ' GLU . 41.9 p -139.25 168.36 19.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.091 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 321' ' ' THR . 26.0 tt0 -37.06 -46.72 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.924 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 324' ' ' ASP . 70.7 mtm180 -47.36 -62.24 1.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 323' ' ' ARG . 4.7 m-20 -37.8 -50.92 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.598 HD22 HD11 ' A' ' 355' ' ' ILE . 22.6 mt -59.64 -47.71 84.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.962 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.634 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 94.9 t -46.6 -52.23 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 47.0 t -64.09 -42.39 96.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.482 HD21 ' CE2' ' A' ' 373' ' ' TYR . 78.3 mt -56.28 -49.33 74.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.986 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -113.72 35.04 4.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -70.58 -42.79 70.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.095 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.488 ' HG3' ' CD1' ' A' ' 332' ' ' PHE . 11.4 ptm180 -40.85 -52.53 3.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.81 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.488 ' CD1' ' HG3' ' A' ' 331' ' ' ARG . 16.2 m-85 -68.96 -29.01 67.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.936 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' GLN . . . . . 0.556 ' HA ' HD12 ' A' ' 340' ' ' ILE . 9.2 tp60 -44.94 -31.08 1.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.95 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -51.56 -176.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -80.91 46.61 0.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.904 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -93.42 36.1 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 123.34 -165.24 16.1 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.541 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' PRO . . . . . 0.421 ' CG ' ' HB3' ' A' ' 358' ' ' PRO . 72.1 Cg_exo -43.79 162.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.709 2.272 . . . . 0.0 112.36 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.8 143.34 29.65 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.648 2.232 . . . . 0.0 112.347 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.705 HG22 ' CE1' ' A' ' 342' ' ' PHE . 96.2 mt -92.28 140.6 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -121.88 127.74 50.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' PHE . . . . . 0.705 ' CE1' HG22 ' A' ' 340' ' ' ILE . 2.4 m-85 -111.61 139.57 46.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 31.3 ttt85 -135.4 123.22 22.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 17.7 ttm -116.9 129.56 56.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.01 133.26 33.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.877 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 12.6 t -150.22 155.84 40.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.164 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 87.01 -37.36 3.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.462 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -123.24 -46.26 2.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.768 0.318 . . . . 0.0 110.846 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 17.6 mmt -126.36 87.82 2.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.417 ' C ' ' HD2' ' A' ' 350' ' ' ARG . 7.5 tmm_? -86.99 145.72 26.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.912 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 93.58 -17.24 58.94 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.51 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -107.89 139.97 41.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.96 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -148.46 158.75 44.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.118 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.696 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 47.7 m-85 -132.27 130.26 40.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.598 HD11 HD22 ' A' ' 325' ' ' LEU . 85.7 mt -118.68 140.52 42.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.092 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.416 HG23 ' CE ' ' A' ' 309' ' ' LYS . 26.1 m -113.19 105.57 13.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 44.0 m-85 -90.03 158.81 43.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.672 0.749 . . . . 0.0 110.889 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' PRO . . . . . 0.421 ' HB3' ' CG ' ' A' ' 338' ' ' PRO . 74.3 Cg_exo -42.31 -55.52 2.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.605 2.203 . . . . 0.0 112.402 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.0 -176.49 5.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 43.7 pttt -67.57 -51.17 53.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' GLU . . . . . 0.406 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 10.7 mm-40 -39.16 -66.13 0.31 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.44 ' O ' ' C ' ' A' ' 363' ' ' ALA . 61.1 mt -55.27 -65.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.193 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.571 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -34.67 -56.33 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.143 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -50.63 -56.17 13.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 369' ' ' LEU . 30.4 mt-30 -50.97 -43.19 60.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -62.7 -41.48 99.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.07 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.742 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 6.5 tt -62.95 -63.55 1.17 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.972 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' HIS . . . . . 0.52 ' N ' HD23 ' A' ' 367' ' ' LEU . 46.1 t60 -55.92 -31.87 63.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.868 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.422 ' CG ' ' O ' ' A' ' 365' ' ' GLN . 37.0 mt -74.32 -33.02 63.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.651 ' O ' HG12 ' A' ' 370' ' ' VAL . 23.0 t -113.6 25.56 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 367' ' ' LEU . 1.6 p30 -69.43 138.15 53.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.883 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 46.35 49.12 15.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.493 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.482 ' CE2' HD21 ' A' ' 328' ' ' LEU . 89.3 t80 -83.29 118.44 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.03 0.443 . . . . 0.0 110.949 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -68.63 109.95 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.928 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.503 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 45.5 tp -126.42 126.07 43.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.832 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' TYR . . . . . 0.503 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 39.4 m-85 51.16 38.5 21.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 68.19 35.5 83.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.468 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -140.87 133.74 29.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.74 0.305 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 16.9 mm -79.39 88.45 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.154 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.635 HD23 ' C ' ' A' ' 380' ' ' LEU . 6.3 tt -58.87 127.49 32.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.884 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.8 t -107.74 130.58 59.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.471 HG13 ' CD2' ' A' ' 380' ' ' LEU . 55.1 mt -112.6 139.68 36.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.14 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -135.45 178.98 6.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.742 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 50.3 m-85 -111.75 129.53 56.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.946 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -45.44 157.89 0.28 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -102.06 101.64 12.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 110.845 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -139.18 132.34 29.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -107.6 -53.43 2.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -60.09 136.37 58.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -92.11 -64.13 1.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.889 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 11.3 mmm-85 -141.09 178.13 7.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.442 ' O ' ' C ' ' A' ' 393' ' ' SER . 1.2 t -115.2 119.88 37.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.798 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 392' ' ' SER . 84.8 p -35.05 130.35 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.832 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -143.0 147.9 19.46 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.484 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -46.44 130.45 14.5 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.702 2.268 . . . . 0.0 112.334 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 75.4 p -38.71 -46.41 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 15.9 t -121.46 131.86 54.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.867 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.535 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 95.7 p -127.44 173.86 9.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 0.0 110.804 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 29.7 t -135.25 137.35 42.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 56.9 -117.81 10.49 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.541 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 46.8 t 59.9 43.47 14.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.878 0.37 . . . . 0.0 110.861 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 41.1 t -67.71 -61.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 82.47 175.82 50.98 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.474 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -121.68 106.93 11.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.826 0.346 . . . . 0.0 110.823 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 54.64 44.66 28.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.627 HD12 ' H ' ' A' ' 295' ' ' LYS . 2.5 pp -104.55 143.02 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -102.29 63.99 0.9 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.877 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.627 ' H ' HD12 ' A' ' 293' ' ' ILE . 5.0 tppt? 54.37 39.55 31.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.49 125.6 17.74 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.643 0.735 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.75 -55.11 3.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.595 2.197 . . . . 0.0 112.383 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 21.5 ttp -115.7 106.38 13.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -128.25 41.41 3.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 5.8 t -123.49 127.43 48.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 72.0 m -149.4 174.36 12.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.813 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.941 ' CE2' HG13 ' A' ' 381' ' ' VAL . 14.6 p90 -67.56 172.57 4.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -130.07 142.04 43.99 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.552 0.691 . . . . 0.0 110.922 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.87 -51.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.706 2.27 . . . . 0.0 112.345 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.93 -163.03 30.41 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.498 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.51 ' O ' ' CD2' ' A' ' 384' ' ' PHE . 37.2 mt-10 -51.06 143.16 16.61 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.709 0.766 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.97 110.3 3.09 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.733 2.289 . . . . 0.0 112.351 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -103.2 175.8 5.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.553 ' CD ' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -91.49 5.85 47.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.553 HG23 ' CD ' ' A' ' 309' ' ' LYS . 93.5 t -129.91 135.26 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.15 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.685 HD12 ' CE1' ' A' ' 357' ' ' PHE . 96.5 mt -116.11 120.72 39.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.658 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 9.4 t80 -101.68 101.86 12.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.93 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.573 HD23 HD11 ' A' ' 380' ' ' LEU . 5.7 mp -92.96 146.79 23.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 -176.26 4.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 61.38 49.1 5.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.6 mt -115.51 137.44 52.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 38.7 t -70.67 140.02 86.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.654 0.74 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -43.61 -21.64 0.33 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.732 2.288 . . . . 0.0 112.291 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.58 ' O ' HG23 ' A' ' 321' ' ' THR . 11.4 mtp85 -76.65 -41.29 46.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.419 HG22 ' HD2' ' A' ' 376' ' ' TYR . 70.7 t -42.52 123.69 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.149 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 319' ' ' ARG . 40.7 p -123.08 171.99 8.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.174 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -44.56 -51.25 9.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.885 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -40.83 -50.25 3.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -53.67 -44.25 69.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 32.5 mt -64.7 -48.51 74.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 89.3 t -49.82 -54.51 7.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.157 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 22.8 t -59.15 -41.79 89.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.859 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 44.0 mt -57.52 -45.86 84.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.767 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 36.2 m-85 -120.49 49.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -91.41 -51.42 5.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -42.74 -49.54 5.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 40.0 m-85 -46.13 -38.94 8.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -80.6 75.04 7.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.896 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 335' ' ' LYS . 5.7 pt-20 -122.61 89.51 3.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 334' ' ' GLU . 14.0 pttp 34.49 41.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.492 ' NZ ' HD11 ' A' ' 362' ' ' ILE . 12.9 tmtt? -106.21 -51.79 2.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.884 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -144.33 -155.0 6.29 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.489 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.28 147.26 29.11 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.736 2.29 . . . . 0.0 112.342 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -47.44 111.2 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.7 2.267 . . . . 0.0 112.315 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 57.4 mt -46.71 136.68 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.106 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -90.76 132.92 35.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.946 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -125.1 138.36 54.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -139.08 128.91 24.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.5 tpp -112.93 141.65 46.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' MET . . . . . 0.478 ' O ' HG23 ' A' ' 346' ' ' THR . 7.3 mtm -103.39 163.11 12.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 345' ' ' MET . 27.4 p -157.95 156.84 31.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.143 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 111.19 -141.55 16.55 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -55.13 130.05 40.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.808 0.337 . . . . 0.0 110.931 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 42.1 mmm 48.66 51.26 15.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -71.97 -176.63 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 101.73 21.49 11.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.482 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -132.28 152.55 51.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.871 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.55 150.06 35.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.658 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 39.2 m-85 -116.47 121.31 41.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.818 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 61.7 mt -114.4 133.29 60.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.192 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.2 m -114.58 114.2 25.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.129 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.685 ' CE1' HD12 ' A' ' 311' ' ' LEU . 37.4 m-85 -91.95 157.94 40.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.722 0.772 . . . . 0.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.4 -47.82 12.48 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.647 2.232 . . . . 0.0 112.371 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -138.83 174.42 10.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -69.92 -44.15 70.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -50.97 -58.21 6.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.492 HD11 ' NZ ' ' A' ' 336' ' ' LYS . 97.3 mt -53.15 -52.67 28.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.13 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -45.99 -61.35 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -45.79 -55.56 6.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -43.8 -53.93 5.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.767 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -60.31 -28.43 68.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.13 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.772 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.2 tt -70.15 -65.99 0.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.921 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -53.75 -28.67 35.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 30.1 mt -78.44 -48.88 14.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.561 ' O ' HG12 ' A' ' 370' ' ' VAL . 12.1 t -97.37 30.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ASN . . . . . 0.42 ' O ' ' CG ' ' A' ' 371' ' ' ASN . 2.0 t30 -82.83 85.97 7.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.956 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 108.9 52.22 0.66 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.436 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -99.51 110.06 22.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.975 0.417 . . . . 0.0 110.898 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -61.47 125.7 24.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 30.3 tp -138.27 128.37 25.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.92 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' TYR . . . . . 0.419 ' HD2' HG22 ' A' ' 320' ' ' VAL . 41.2 m-85 48.17 42.69 17.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 61.52 37.06 93.53 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.562 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -148.35 114.44 5.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 110.974 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 34.9 mm -58.4 130.51 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.099 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.592 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.6 tt -90.93 135.92 33.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.916 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.941 HG13 ' CE2' ' A' ' 302' ' ' TYR . 50.8 t -121.67 125.76 73.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.457 HG12 HD21 ' A' ' 380' ' ' LEU . 12.8 mt -111.65 137.91 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.118 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -145.78 122.09 10.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.772 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 38.7 m-85 -47.15 151.74 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -51.3 129.72 32.82 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.507 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? -80.39 -48.54 12.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.32 . . . . 0.0 110.869 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -51.77 130.14 28.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.09 111.31 16.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.939 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -67.05 142.13 57.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.942 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -61.54 -59.91 4.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.918 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -128.64 135.23 49.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 82.6 p -50.68 148.54 3.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 60.5 m -60.08 159.07 10.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.879 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 145.26 99.06 0.25 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.448 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.14 167.91 25.88 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.643 2.229 . . . . 0.0 112.366 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 94.5 p -116.11 -50.78 2.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.837 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 88.4 p -73.41 118.71 16.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.415 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.479 -0.249 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 53.3 p -156.82 152.53 26.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.878 0.37 . . . . 0.0 110.866 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 88.1 p -126.74 -44.17 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 118.67 -153.4 16.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.477 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 85.4 p -165.58 118.62 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 110.908 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 66.0 p -164.58 112.18 1.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.833 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 95.41 47.79 2.5 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.522 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -40.9 -49.07 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 0.0 110.884 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -112.65 -49.11 2.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.932 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.455 ' C ' HD12 ' A' ' 293' ' ' ILE . 2.8 pp -70.85 161.8 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.173 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -116.47 179.66 3.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.812 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -47.47 97.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.67 HG23 ' HD2' ' A' ' 297' ' ' PRO . 59.8 mt -146.21 139.15 14.23 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.63 0.729 . . . . 0.0 111.17 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' PRO . . . . . 0.67 ' HD2' HG23 ' A' ' 296' ' ' ILE . 62.4 Cg_endo -77.27 -50.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.686 2.257 . . . . 0.0 112.379 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -121.78 78.78 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -80.64 -43.82 19.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.856 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 91.6 p -87.12 90.01 8.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.88 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 3.1 m -152.62 175.19 13.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -46.43 155.03 0.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.956 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -130.11 100.13 19.09 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.623 0.725 . . . . 0.0 110.831 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -44.38 -45.34 12.68 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.631 2.22 . . . . 0.0 112.413 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 103.92 -124.0 7.93 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.455 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -110.67 134.85 20.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.689 0.757 . . . . 0.0 110.868 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.21 96.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.683 2.256 . . . . 0.0 112.347 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -107.9 172.64 6.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 7.57 32.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 98.0 t -126.82 123.64 63.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.587 HD22 HD12 ' A' ' 367' ' ' LEU . 57.0 mt -109.69 129.2 55.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.802 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 10.3 t80 -110.32 101.62 10.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.708 HD21 ' CE1' ' A' ' 329' ' ' PHE . 5.7 mp -86.43 144.37 27.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.431 ' HG3' ' C ' ' A' ' 313' ' ' LEU . 3.2 mtpm? -142.56 179.11 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.9 m120 60.93 54.72 3.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.529 HD21 ' HG ' ' A' ' 380' ' ' LEU . 16.3 mt -119.6 109.46 15.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 42.8 t -45.71 145.37 2.26 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.708 0.766 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -46.44 -20.65 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.359 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -73.22 -37.67 66.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.971 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 84.4 t -52.55 126.06 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.08 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 37.4 p -121.36 171.72 8.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.136 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -45.07 -42.39 8.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -49.87 -46.98 52.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -52.69 -49.39 65.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.895 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 328' ' ' LEU . 30.4 mt -59.31 -54.45 46.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 99.9 t -45.89 -52.82 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 1.4 t -61.62 -43.73 98.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.747 HD21 ' CE2' ' A' ' 373' ' ' TYR . 36.9 mt -54.2 -40.37 67.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.932 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.708 ' CE1' HD21 ' A' ' 313' ' ' LEU . 6.6 m-85 -125.93 44.48 2.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -89.57 -51.25 5.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.073 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 15.9 ptm180 -44.43 -46.54 9.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.432 ' N ' ' HG3' ' A' ' 331' ' ' ARG . 24.0 m-85 -59.93 -45.14 93.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -59.86 106.28 0.47 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.862 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -138.31 179.78 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.45 ' HG2' ' N ' ' A' ' 336' ' ' LYS . 0.0 OUTLIER -66.77 -28.31 68.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.45 ' N ' ' HG2' ' A' ' 335' ' ' LYS . 34.4 mmtm -46.33 -47.9 18.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.952 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -126.99 159.86 21.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.41 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -44.65 168.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.637 2.225 . . . . 0.0 112.343 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.1 114.78 3.86 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.639 2.226 . . . . 0.0 112.384 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 356' ' ' THR . 74.6 mt -52.68 131.38 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.178 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -88.95 136.97 32.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -123.82 139.55 53.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.4 ' HG2' ' CE ' ' A' ' 345' ' ' MET . 46.0 ttp180 -141.29 135.18 30.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 12.2 ttm -112.93 140.09 48.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' MET . . . . . 0.4 ' CE ' ' HG2' ' A' ' 343' ' ' ARG . 25.4 mmt -79.26 131.64 36.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.88 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 29.1 p -134.83 -44.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.121 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 348' ' ' ARG . . . -51.43 111.83 1.54 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.436 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 347' ' ' GLY . 5.9 ptm180 34.38 35.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.789 0.328 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 347' ' ' GLY . 30.3 ttp -173.82 125.92 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.71 161.74 35.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 104.45 -31.69 8.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.438 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -99.23 158.13 15.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 0.0 110.925 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -151.23 147.57 27.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.802 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 39.0 m-85 -113.73 119.15 36.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 75.5 mt -114.14 140.89 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.124 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.626 ' O ' HG23 ' A' ' 340' ' ' ILE . 44.0 m -118.54 130.96 56.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.557 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 18.4 m-85 -109.01 155.83 40.2 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.688 0.756 . . . . 0.0 110.909 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.9 -39.56 32.1 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.711 2.274 . . . . 0.0 112.392 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -144.53 179.45 7.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.2 ptmm? -80.12 -31.89 39.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.8 -64.53 0.87 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 75.4 mt -47.69 -65.28 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.124 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -38.15 -55.92 1.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -49.08 -60.95 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -45.01 -54.67 6.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.698 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -57.91 -42.83 85.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.067 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.983 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 4.5 tt -58.58 -55.47 34.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' HIS . . . . . 0.539 ' N ' HD23 ' A' ' 367' ' ' LEU . 36.9 t-80 -58.42 -28.63 65.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.882 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 29.5 mt -79.87 -36.76 36.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 366' ' ' ALA . 19.1 t -91.26 -6.29 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.143 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 367' ' ' LEU . 1.6 p-10 -49.6 122.3 6.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.864 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 67.32 48.0 60.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.494 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.747 ' CE2' HD21 ' A' ' 328' ' ' LEU . 76.0 t80 -90.11 110.13 21.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.932 0.396 . . . . 0.0 110.891 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -68.48 114.09 6.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.685 HD13 ' HE2' ' A' ' 373' ' ' TYR . 33.2 tp -121.94 125.0 45.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.926 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 48.72 41.41 17.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 66.29 37.87 93.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.417 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -148.85 114.69 5.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.802 0.334 . . . . 0.0 110.916 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 32.9 mm -57.8 122.26 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.529 ' HG ' HD21 ' A' ' 316' ' ' LEU . 7.4 tt -85.13 129.02 34.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.455 ' N ' HD23 ' A' ' 380' ' ' LEU . 76.6 t -103.53 119.91 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 16.3 mt -109.05 130.03 62.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -139.67 131.34 27.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.983 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 81.7 m-85 -59.05 123.28 16.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -50.54 166.86 0.49 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.481 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -86.01 138.11 32.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.37 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -174.92 125.6 0.27 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -72.93 -50.5 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -170.72 149.72 3.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -92.73 113.69 26.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.974 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 18.6 ptt85 -148.21 105.02 3.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 47.9 t -111.96 91.2 3.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 3.8 t -40.89 147.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 162.58 92.95 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.519 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.41 14.64 1.36 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.253 . . . . 0.0 112.33 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.2 t -44.72 139.44 2.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 26.0 p -148.35 149.68 32.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.823 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.485 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 65.3 m -159.42 126.15 4.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.808 0.337 . . . . 0.0 110.841 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 52.9 p -117.27 167.42 11.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.817 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 165.48 173.04 33.61 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.397 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 66.8 m -149.99 125.34 10.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.785 0.326 . . . . 0.0 110.847 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 67.2 p -145.42 133.14 21.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.802 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -45.4 153.33 0.67 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.455 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -70.29 -40.85 74.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.349 . . . . 0.0 110.898 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -96.11 -44.85 7.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.913 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 39.9 pt -83.73 41.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.153 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -58.66 -65.78 0.6 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -77.31 -71.93 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.864 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.449 ' CG2' ' H ' ' A' ' 299' ' ' PHE . 2.9 mp -78.8 119.07 75.93 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.644 0.735 . . . . 0.0 111.108 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.55 -51.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.694 2.262 . . . . 0.0 112.316 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 22.0 mmm -54.47 -59.37 4.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.849 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' PHE . . . . . 0.449 ' H ' ' CG2' ' A' ' 296' ' ' ILE . 6.1 t80 40.95 43.19 1.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.5 t -174.69 164.5 3.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.895 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 67.5 m -80.24 -73.32 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.607 ' CD2' HG13 ' A' ' 381' ' ' VAL . 11.9 p90 -161.46 -178.45 6.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.937 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -105.31 96.37 11.45 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.643 0.735 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.75 -44.37 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.68 2.253 . . . . 0.0 112.337 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 101.41 -177.72 27.36 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.491 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.79 140.0 97.74 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.681 0.753 . . . . 0.0 110.818 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.29 93.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.7 2.267 . . . . 0.0 112.321 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' A' ' 384' ' ' PHE . 49.1 m-20 -101.11 172.35 7.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.467 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -90.85 1.94 56.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.467 HG23 ' HD2' ' A' ' 309' ' ' LYS . 68.7 t -121.4 128.61 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.1 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.62 HD12 ' CE1' ' A' ' 357' ' ' PHE . 28.1 mt -114.29 120.34 40.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.779 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 13.0 t80 -105.62 106.05 16.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.635 HD12 ' N ' ' A' ' 313' ' ' LEU . 1.1 mp -91.43 156.19 17.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.932 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.557 ' HE2' ' CD2' ' A' ' 312' ' ' TYR . 41.1 mttt -144.22 -176.59 5.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 15.2 m120 56.76 52.61 9.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.6 mt -115.88 113.21 23.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 40.1 t -55.8 145.15 53.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.752 0.787 . . . . 0.0 110.842 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -46.07 -25.74 3.12 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.725 2.284 . . . . 0.0 112.349 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.513 ' O ' HG23 ' A' ' 321' ' ' THR . 10.9 mtp85 -69.61 -41.96 75.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.829 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 66.6 t -44.18 134.65 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.15 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 319' ' ' ARG . 35.9 p -135.66 169.06 18.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -41.15 -48.57 3.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -40.42 -54.43 2.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -48.75 -59.99 3.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.587 ' HA ' HD12 ' A' ' 328' ' ' LEU . 36.8 mt -49.25 -52.31 27.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 80.6 t -46.27 -58.23 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 2.2 t -57.75 -43.64 85.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.587 HD12 ' HA ' ' A' ' 325' ' ' LEU . 41.9 mt -56.08 -41.61 75.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -125.83 45.98 2.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -88.0 -41.87 12.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -52.05 -18.54 1.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -94.2 -45.2 7.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.807 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -50.15 -42.33 50.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -97.0 33.58 1.88 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -106.7 -68.57 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -156.73 165.45 36.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 64.0 171.98 2.39 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.498 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -46.16 170.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.627 2.218 . . . . 0.0 112.339 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 340' ' ' ILE . 62.9 Cg_endo -78.9 109.65 2.63 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.635 2.223 . . . . 0.0 112.388 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 339' ' ' PRO . 60.8 mt -34.14 137.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.113 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -100.93 116.08 31.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.938 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -103.09 142.8 33.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -141.07 129.75 22.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.3 ttm -108.88 145.44 35.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 27.9 ttm -98.22 154.46 17.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.853 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 13.9 t -154.64 156.99 37.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.206 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 116.55 -104.2 1.21 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.518 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 349' ' ' MET . 10.4 ptm180 -100.03 158.16 16.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.8 0.333 . . . . 0.0 110.849 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' MET . . . . . 0.436 ' C ' ' O ' ' A' ' 348' ' ' ARG . 21.3 mmm 35.41 45.37 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.417 ' C ' ' OE1' ' A' ' 352' ' ' GLN . 5.9 ppt_? -49.76 179.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 91.96 42.07 4.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.467 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.417 ' OE1' ' C ' ' A' ' 350' ' ' ARG . 29.3 mp0 -152.31 133.03 14.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.888 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -135.59 147.23 48.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.079 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.779 ' CE2' ' CE1' ' A' ' 312' ' ' TYR . 42.6 m-85 -115.32 130.14 56.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 69.7 mt -121.5 141.72 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.188 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 39.7 m -121.21 108.61 13.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.795 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 51.3 m-85 -88.5 156.67 50.59 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 0.0 110.897 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -47.03 -47.52 16.52 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.695 2.263 . . . . 0.0 112.304 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -148.78 146.3 27.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.912 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -40.42 -41.6 1.43 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -44.49 -65.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.427 HG22 ' CD2' ' A' ' 357' ' ' PHE . 75.2 mt -57.55 -57.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.078 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.795 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -40.81 -49.07 3.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -58.56 -62.57 1.76 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -47.92 -45.6 31.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.939 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.36 85.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.164 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.666 ' C ' HD23 ' A' ' 367' ' ' LEU . 5.5 tt -63.36 -65.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' HIS . . . . . 0.641 ' N ' HD23 ' A' ' 367' ' ' LEU . 2.4 t60 -46.5 -33.58 4.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 37.3 mt -69.9 -53.0 19.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.952 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.36 36.59 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -83.54 85.77 7.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 106.55 46.18 1.16 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.491 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -89.95 120.52 31.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.008 0.433 . . . . 0.0 110.898 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -70.18 135.4 49.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 28.6 tp -148.29 116.33 6.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.955 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 53.59 42.1 31.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 66.69 30.65 76.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.47 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' LYS . . . . . 0.428 ' NZ ' ' HA ' ' A' ' 378' ' ' LYS . 0.0 OUTLIER -134.26 124.24 25.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.74 0.305 . . . . 0.0 110.888 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 33.8 mm -74.55 107.76 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.607 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.3 tt -70.16 127.84 34.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.607 HG13 ' CD2' ' A' ' 302' ' ' TYR . 46.0 t -116.57 126.44 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.148 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.523 ' O ' ' CE1' ' A' ' 302' ' ' TYR . 15.0 mt -106.52 137.59 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.161 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -146.39 121.45 10.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.568 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 54.2 m-85 -52.64 140.0 24.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.853 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -39.59 113.13 0.31 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.493 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -77.05 -43.84 32.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.803 0.335 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -126.2 159.45 32.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -104.5 131.62 51.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.864 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -100.2 124.21 45.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -103.99 103.35 13.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -162.08 145.95 12.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.949 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 16.6 m -141.51 150.09 41.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.803 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 78.4 p -63.37 159.84 17.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.91 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 150.04 71.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.481 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.93 132.03 13.82 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.723 2.282 . . . . 0.0 112.375 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 13.6 t -80.55 105.52 11.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.931 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.7 t -57.6 -50.58 72.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.89 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.558 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.2 m -157.32 140.59 15.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.363 . . . . 0.0 110.858 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 69.5 m -83.73 169.23 15.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -105.6 44.56 1.45 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.451 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 61.5 p -174.44 120.28 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 110.794 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 17.2 p -74.48 110.18 8.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 74.9 134.65 0.37 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.492 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -84.72 -22.92 29.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.777 0.322 . . . . 0.0 110.869 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -122.72 -39.74 2.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.835 ' O ' HD12 ' A' ' 293' ' ' ILE . 2.7 pp -81.35 39.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.123 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -74.97 -44.24 49.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.823 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -132.8 72.15 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.675 HD12 ' HA ' ' A' ' 293' ' ' ILE . 71.1 mt -141.19 121.16 8.48 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.593 0.711 . . . . 0.0 111.093 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.9 -39.3 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.67 2.247 . . . . 0.0 112.356 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 11.7 mtm -123.82 89.51 3.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.82 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' PHE . . . . . 0.471 ' CE1' ' O ' ' A' ' 296' ' ' ILE . 1.2 m-85 -69.25 -45.48 69.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 30.5 t -122.39 102.58 8.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.845 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 19.2 m -76.81 -53.37 8.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.855 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -174.98 164.29 3.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.953 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -138.64 143.34 37.59 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.591 0.71 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.61 -51.9 0.08 OUTLIER 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.759 2.306 . . . . 0.0 112.329 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 99.03 -161.12 20.06 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.503 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -57.16 144.65 69.07 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.625 0.726 . . . . 0.0 110.869 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' PRO . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 384' ' ' PHE . 59.3 Cg_endo -73.36 129.73 14.24 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.7 2.267 . . . . 0.0 112.27 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -130.92 -179.07 5.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.647 ' HG3' HG23 ' A' ' 310' ' ' VAL . 39.7 pttt -84.91 -26.75 27.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.647 HG23 ' HG3' ' A' ' 309' ' ' LYS . 18.3 t -102.72 145.32 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.858 HD12 ' CE1' ' A' ' 357' ' ' PHE . 77.0 mt -125.92 135.23 51.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.546 ' CD1' ' HE2' ' A' ' 314' ' ' LYS . 0.7 OUTLIER -102.86 101.46 11.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.866 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.629 HD13 HG13 ' A' ' 355' ' ' ILE . 5.7 mp -91.12 140.96 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.905 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.546 ' HE2' ' CD1' ' A' ' 312' ' ' TYR . 14.6 mttm -139.38 -178.8 5.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 60.53 47.59 8.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.441 ' HB3' HG11 ' A' ' 320' ' ' VAL . 10.8 mt -105.59 99.61 9.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 316' ' ' LEU . 28.9 t -38.08 144.02 0.38 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.642 0.734 . . . . 0.0 110.924 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -44.54 -33.75 7.0 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.673 2.249 . . . . 0.0 112.382 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.58 ' O ' HG23 ' A' ' 321' ' ' THR . 16.6 mtp85 -68.5 -39.26 81.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 316' ' ' LEU . 97.5 t -41.23 138.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 319' ' ' ARG . 68.9 p -138.0 176.1 9.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -45.13 -54.23 7.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 324' ' ' ASP . 9.4 mmm180 -42.0 -64.99 0.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.94 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 323' ' ' ARG . 40.3 m-20 -35.92 -47.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 76.0 mt -65.45 -49.39 69.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.923 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 330' ' ' ALA . 55.3 t -48.7 -59.39 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 43.8 t -56.13 -42.73 77.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.671 HD21 ' CE2' ' A' ' 373' ' ' TYR . 29.3 mt -57.16 -31.41 65.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.902 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.5 ' CE1' HD21 ' A' ' 313' ' ' LEU . 64.2 m-85 -129.45 36.8 4.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -85.56 -48.69 8.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -42.54 -41.76 3.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -64.77 -35.58 81.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 330' ' ' ALA . 23.0 tt0 -44.26 -58.37 2.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -67.13 72.34 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.454 ' HD3' ' N ' ' A' ' 336' ' ' LYS . 1.5 tmtp? -164.86 148.51 8.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.454 ' N ' ' HD3' ' A' ' 335' ' ' LYS . 44.5 tttm -41.23 110.84 0.18 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 145.81 142.02 3.73 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 339' ' ' PRO . 75.3 Cg_exo -48.24 152.46 3.62 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.637 2.225 . . . . 0.0 112.38 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 338' ' ' PRO . 76.4 Cg_exo -49.11 137.98 28.75 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.643 2.229 . . . . 0.0 112.363 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 97.2 mt -68.44 142.91 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.129 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -109.54 127.47 54.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' PHE . . . . . 0.56 ' CE2' HD13 ' A' ' 355' ' ' ILE . 91.0 m-85 -115.56 141.58 47.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.863 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -137.11 127.21 26.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 30.0 tpp -117.15 136.97 52.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 3.2 ptp -109.3 128.55 55.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.838 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 31.9 p -124.95 118.79 27.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.083 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 168.38 -138.45 5.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.547 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 35.7 ptt85 -59.38 -42.61 92.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.755 0.312 . . . . 0.0 110.802 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' MET . . . . . 0.439 ' HG3' ' NE2' ' A' ' 352' ' ' GLN . 2.5 tpp -102.21 47.99 0.88 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -59.65 170.55 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 81.8 5.68 89.62 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.48 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.439 ' NE2' ' HG3' ' A' ' 349' ' ' MET . 80.8 mt-30 -116.61 151.47 36.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 0.0 110.965 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -163.97 157.2 18.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.094 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.481 ' CE2' ' CE2' ' A' ' 312' ' ' TYR . 8.8 m-85 -118.44 158.42 25.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.815 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.629 HG13 HD13 ' A' ' 313' ' ' LEU . 24.3 mt -144.89 117.25 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.187 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 13.3 m -97.55 131.53 44.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.1 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.858 ' CE1' HD12 ' A' ' 311' ' ' LEU . 7.7 m-85 -111.46 155.39 42.95 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.639 0.733 . . . . 0.0 110.892 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -44.26 -31.35 4.23 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.267 . . . . 0.0 112.379 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.1 177.29 11.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.417 ' NZ ' ' O ' ' A' ' 307' ' ' PRO . 0.1 OUTLIER -72.33 -49.92 30.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -43.85 -63.94 0.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 79.3 mt -50.85 -59.03 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -44.54 -46.13 9.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.095 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -59.04 -67.84 0.33 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -37.5 -52.02 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.609 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -55.94 -43.95 77.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.05 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.586 ' C ' HD23 ' A' ' 367' ' ' LEU . 7.9 tt -58.17 -55.24 37.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.894 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -67.45 -13.19 61.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 33.5 mt -93.01 -29.57 15.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 366' ' ' ALA . 6.2 t -109.21 17.2 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ASN . . . . . 0.414 ' O ' ' CG ' ' A' ' 371' ' ' ASN . 4.1 p30 -75.08 117.13 16.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 81.39 36.5 20.31 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.487 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.671 ' CE2' HD21 ' A' ' 328' ' ' LEU . 65.0 t80 -81.79 114.08 20.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 0.0 110.917 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -70.07 104.4 2.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.959 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 51.2 tp -121.57 125.23 46.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 57.38 27.02 13.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.959 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 78.71 25.28 60.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.514 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -132.57 139.95 48.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 36.2 mm -84.17 94.6 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.126 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.654 HD23 ' C ' ' A' ' 380' ' ' LEU . 5.2 tt -57.54 130.11 44.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 39.3 t -110.69 124.39 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.597 HG12 HD21 ' A' ' 380' ' ' LEU . 14.8 mt -109.03 143.73 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -148.26 121.32 8.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.477 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 26.1 m-85 -46.69 149.2 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.83 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -64.97 -163.1 0.78 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.458 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -118.75 106.38 12.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.34 . . . . 0.0 110.863 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -76.25 150.22 37.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -100.62 -68.8 0.8 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -141.47 117.45 10.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.847 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -57.34 164.18 1.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -144.68 179.19 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 6.5 t -117.79 116.79 27.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 11.5 t -116.47 155.44 28.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 164.49 160.93 12.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.457 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.06 117.9 4.58 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.707 2.271 . . . . 0.0 112.38 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 10.9 t -89.21 96.55 10.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.826 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 45.7 m -47.72 154.53 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.519 -179.947 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 4.7 m -132.2 157.16 45.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.865 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.7 t -53.22 150.77 5.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.78 120.7 0.36 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.434 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 47.7 m -92.23 -60.12 1.92 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 110.914 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 53.3 m -60.81 129.1 39.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.817 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 55.84 95.49 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.48 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.73 -35.45 79.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 0.0 110.898 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -131.86 -41.08 1.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.444 ' O ' ' CE1' ' A' ' 299' ' ' PHE . 11.9 pt -52.41 -20.92 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.106 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 51.1 ptt85 -59.98 -28.35 67.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.824 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -85.29 -51.81 6.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.674 ' H ' HD12 ' A' ' 296' ' ' ILE . 4.5 mp -56.1 109.33 1.59 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.531 0.681 . . . . 0.0 111.204 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.55 -42.12 29.35 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.702 2.268 . . . . 0.0 112.327 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.426 ' O ' ' C ' ' A' ' 299' ' ' PHE . 4.0 mpp? -118.53 77.5 1.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 293' ' ' ILE . 0.7 OUTLIER -34.48 -64.3 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 41.8 t -166.29 143.58 5.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 302' ' ' TYR . 51.2 m -154.96 165.23 37.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.894 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.56 ' CD2' HG13 ' A' ' 381' ' ' VAL . 1.6 p90 -36.03 144.09 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.17 140.07 23.16 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.655 0.74 . . . . 0.0 110.852 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -78.69 -48.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.75 2.3 . . . . 0.0 112.337 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 87.26 -168.39 38.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.493 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.439 ' CD ' ' HD2' ' A' ' 307' ' ' PRO . 7.9 tp10 -39.75 137.63 1.1 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.646 0.736 . . . . 0.0 110.919 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' PRO . . . . . 0.439 ' HD2' ' CD ' ' A' ' 306' ' ' GLU . 60.4 Cg_endo -73.78 147.36 39.58 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.727 2.285 . . . . 0.0 112.337 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -153.47 166.29 33.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.629 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -84.4 29.88 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.867 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.629 HG23 ' HD2' ' A' ' 309' ' ' LYS . 90.8 t -146.9 123.21 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.178 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.521 HD21 ' HB1' ' A' ' 363' ' ' ALA . 20.4 mt -116.82 126.51 53.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.785 ' CE1' ' CZ ' ' A' ' 354' ' ' PHE . 18.0 t80 -103.94 101.56 11.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.871 HD23 HD11 ' A' ' 380' ' ' LEU . 6.5 mp -89.45 140.52 29.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.958 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -131.9 -176.06 3.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.839 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 55.61 52.98 10.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.919 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.5 mt -111.53 113.04 25.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.952 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 46.6 t -54.2 139.53 55.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.651 0.739 . . . . 0.0 110.867 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -42.37 -28.11 0.89 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.714 2.276 . . . . 0.0 112.35 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.402 ' O ' HG23 ' A' ' 321' ' ' THR . 26.4 mmt-85 -68.5 -40.4 80.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.852 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.642 HG22 ' HD2' ' A' ' 376' ' ' TYR . 40.8 t -46.16 123.7 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.106 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 319' ' ' ARG . 18.3 p -122.05 168.49 11.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -40.81 -51.75 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -43.39 -50.11 6.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -50.04 -47.41 53.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 45.7 mt -61.46 -53.04 61.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.696 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 99.7 t -48.11 -49.56 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.182 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 5.8 t -63.46 -40.42 97.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.823 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.8 mt -58.46 -40.03 81.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.856 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.664 ' HZ ' HD21 ' A' ' 313' ' ' LEU . 14.2 m-85 -123.79 40.29 3.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 330' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -86.33 -34.28 20.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.075 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 9.9 ptp85 -55.51 -39.77 70.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.435 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 23.3 m-85 -67.72 -34.84 77.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -52.56 94.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.97 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -141.32 168.7 19.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -71.06 81.84 0.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.855 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.48 -65.72 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -138.13 -157.24 7.4 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.477 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -43.15 162.84 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.77 2.313 . . . . 0.0 112.357 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -79.13 121.56 4.93 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.712 2.274 . . . . 0.0 112.307 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.455 HG22 ' CE1' ' A' ' 342' ' ' PHE . 79.4 mt -50.74 109.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.113 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -82.95 139.98 33.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' PHE . . . . . 0.455 ' CE1' HG22 ' A' ' 340' ' ' ILE . 79.8 m-85 -125.37 136.18 53.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -135.69 135.35 40.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.417 ' C ' ' CE ' ' A' ' 345' ' ' MET . 10.6 ttm -116.71 144.19 44.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' MET . . . . . 0.417 ' CE ' ' C ' ' A' ' 344' ' ' MET . 22.5 mmt -87.93 162.75 16.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 10.2 t -174.0 143.8 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.165 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 88.11 -102.76 2.86 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.5 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -45.82 -61.82 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.313 . . . . 0.0 110.84 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 7.2 mtp -127.6 94.62 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 -84.82 163.92 18.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 82.09 10.04 84.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -122.62 154.6 37.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.785 0.326 . . . . 0.0 110.978 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -149.59 144.5 26.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.055 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.785 ' CZ ' ' CE1' ' A' ' 312' ' ' TYR . 70.1 m-85 -120.23 119.0 31.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 313' ' ' LEU . 65.7 mt -108.25 142.61 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.122 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 26.4 m -122.96 103.91 8.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.803 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 26.9 m-85 -83.57 156.16 65.37 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.703 0.763 . . . . 0.0 110.858 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -45.21 -52.91 5.91 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.702 2.268 . . . . 0.0 112.287 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -133.92 162.37 32.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -61.14 -42.6 98.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -51.8 -58.23 7.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 72.2 mt -53.08 -61.03 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.803 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -42.84 -59.78 1.84 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -43.05 -60.38 1.66 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -43.57 -45.83 6.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.951 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -64.14 -33.66 76.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.15 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.612 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.1 tt -63.91 -61.65 2.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.923 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.05 -35.67 69.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.11 -42.95 68.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.521 ' O ' HD11 ' A' ' 382' ' ' ILE . 11.7 t -105.12 41.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -92.21 94.49 9.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 100.64 40.76 2.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.521 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -87.63 108.96 19.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.954 0.406 . . . . 0.0 110.928 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -60.38 123.25 16.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 26.0 tp -135.97 132.82 36.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' TYR . . . . . 0.642 ' HD2' HG22 ' A' ' 320' ' ' VAL . 37.0 m-85 48.35 45.75 20.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 57.51 34.19 68.52 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.51 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -150.56 114.13 4.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.339 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 45.7 mm -51.04 146.01 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.871 HD11 HD23 ' A' ' 313' ' ' LEU . 8.3 tt -104.7 140.39 38.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.647 ' N ' HD23 ' A' ' 380' ' ' LEU . 78.9 t -123.93 125.04 70.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.521 HD11 ' O ' ' A' ' 370' ' ' VAL . 11.8 mt -109.84 132.57 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.149 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -137.01 119.83 16.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.612 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 16.9 m-85 -48.67 114.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 386' ' ' LYS . . . -40.22 110.11 0.16 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.478 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 385' ' ' GLY . 0.0 OUTLIER -36.06 151.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.952 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -110.63 112.04 23.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -99.05 42.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -124.72 39.56 3.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -116.04 124.52 50.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 5.3 tpp85 -171.15 133.69 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 32.1 t -84.71 -41.9 15.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 65.4 p -116.44 150.14 38.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.832 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -172.9 88.37 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.41 125.44 7.7 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.65 2.233 . . . . 0.0 112.336 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 28.4 p -109.39 145.57 35.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.9 t -127.76 -55.47 1.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.531 179.969 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.6 t -73.64 140.79 46.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.836 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 35.8 t -108.2 88.22 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.801 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -177.08 113.94 0.45 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.479 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 54.7 m -116.34 126.26 53.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 110.86 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 23.6 t -115.8 145.25 42.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 98.67 139.26 10.73 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.511 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -107.94 152.06 24.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 0.0 110.863 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 44.6 38.85 2.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.959 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 15.3 pt -90.56 40.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.106 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -52.47 -43.09 64.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -121.41 -60.9 1.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.459 HG23 ' HD2' ' A' ' 297' ' ' PRO . 47.0 mt -88.25 133.34 37.0 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.625 0.726 . . . . 0.0 111.108 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' PRO . . . . . 0.459 ' HD2' HG23 ' A' ' 296' ' ' ILE . 61.5 Cg_endo -77.03 -50.68 0.09 OUTLIER 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.698 2.265 . . . . 0.0 112.338 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 29.4 mmt -58.74 -70.05 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.855 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 4.5 t80 56.37 34.61 24.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 2.4 t -159.25 112.86 2.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.796 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 36.1 m -129.01 171.77 12.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -53.07 166.74 0.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.957 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -120.07 111.17 35.69 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.638 0.733 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.64 -39.98 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.621 2.214 . . . . 0.0 112.424 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 96.52 -129.83 10.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -107.58 134.67 19.92 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.748 0.785 . . . . 0.0 110.824 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.8 113.69 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.777 2.318 . . . . 0.0 112.317 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -126.58 178.59 5.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.469 ' HG3' HG23 ' A' ' 310' ' ' VAL . 38.3 pttt -81.62 -28.09 33.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.469 HG23 ' HG3' ' A' ' 309' ' ' LYS . 81.7 t -95.0 138.68 20.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.202 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.508 HD12 ' CE1' ' A' ' 357' ' ' PHE . 77.7 mt -125.31 114.18 18.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.788 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 11.7 t80 -88.62 104.08 16.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.939 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 313' ' ' LEU . 6.4 mp -92.52 150.84 20.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.943 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -140.84 -175.0 4.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 57.75 48.31 14.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 12.1 mt -104.09 124.89 49.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.9 t -67.6 145.05 98.09 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.659 0.742 . . . . 0.0 110.828 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.55 -27.41 3.48 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.705 2.27 . . . . 0.0 112.307 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.532 ' O ' HG23 ' A' ' 321' ' ' THR . 32.5 mtp85 -74.25 -38.33 63.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.667 HG22 HD21 ' A' ' 375' ' ' LEU . 93.2 t -41.36 146.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 319' ' ' ARG . 44.6 p -148.73 159.38 44.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.152 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.753 ' O ' HG23 ' A' ' 326' ' ' VAL . 1.2 tm-20 -41.02 -32.27 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ARG . . . . . 0.426 ' NH1' ' HB2' ' A' ' 323' ' ' ARG . 17.7 ttm105 -60.66 -58.12 9.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.956 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -45.8 -48.55 15.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.873 ' HA ' HD12 ' A' ' 328' ' ' LEU . 36.1 mt -57.84 -51.64 68.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 322' ' ' GLU . 69.4 t -45.83 -47.34 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.418 ' HA ' ' HB2' ' A' ' 330' ' ' ALA . 8.8 t -67.28 -37.73 83.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.831 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.873 HD12 ' HA ' ' A' ' 325' ' ' LEU . 51.0 mt -56.52 -34.35 66.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.934 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.524 ' CE1' HG21 ' A' ' 370' ' ' VAL . 18.4 m-85 -127.9 32.85 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.853 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 327' ' ' SER . . . -71.24 -52.14 20.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.099 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -40.06 -49.77 2.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.834 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -54.07 -57.54 10.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' GLN . . . . . 0.52 ' HB2' HD12 ' A' ' 340' ' ' ILE . 12.5 tt0 -43.48 99.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.93 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -112.15 -175.48 2.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -56.96 -46.53 82.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -69.01 174.81 4.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 57.01 156.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.98 146.42 32.72 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.726 2.284 . . . . 0.0 112.35 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 340' ' ' ILE . 71.2 Cg_exo -45.94 106.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.675 2.25 . . . . 0.0 112.352 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.52 HD12 ' HB2' ' A' ' 333' ' ' GLN . 83.9 mt -34.14 129.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -92.32 138.36 31.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -127.72 136.1 51.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.841 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -134.32 122.78 23.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.873 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 45.4 tpp -110.07 133.29 53.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 26.5 ttm -83.68 119.05 24.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 9.7 t -141.38 144.77 34.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 119.62 -83.39 0.35 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.505 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -68.97 -53.51 20.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.83 0.348 . . . . 0.0 110.858 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 8.2 ttt -155.24 118.97 4.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.923 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -87.52 175.67 7.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 107.14 -21.5 31.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.536 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.431 ' N ' ' CD ' ' A' ' 352' ' ' GLN . 3.0 mp0 -112.18 141.74 45.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.816 0.341 . . . . 0.0 110.891 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.59 153.63 41.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.033 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.788 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 50.7 m-85 -125.24 124.19 41.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.75 137.65 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.136 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 83.4 m -113.9 128.68 56.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.689 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 69.8 m-85 -109.46 157.05 38.43 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 0.0 110.875 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -42.8 -34.97 3.91 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.62 2.213 . . . . 0.0 112.398 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -159.44 -177.34 6.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -71.96 -45.62 60.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -43.12 -66.04 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 363' ' ' ALA . 58.1 mt -51.1 -69.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.152 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.689 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -36.3 -57.36 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -48.43 -57.28 6.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -50.28 -41.86 51.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.481 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -65.65 -38.95 90.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.009 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.716 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 4.8 tt -60.75 -60.65 3.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 110.932 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' HIS . . . . . 0.634 ' N ' HD23 ' A' ' 367' ' ' LEU . 19.1 t-80 -62.08 -35.18 77.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 32.2 mt -67.46 -40.48 85.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 370' ' ' VAL . 10.5 t -107.18 32.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -75.71 125.41 29.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 64.88 38.31 95.37 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.445 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -78.65 124.93 28.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.877 0.37 . . . . 0.0 110.958 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -78.41 121.21 24.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.667 HD21 HG22 ' A' ' 320' ' ' VAL . 29.8 tp -125.77 143.97 50.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 38.46 33.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 72.13 47.81 28.82 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.433 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 378' ' ' LYS . 2.4 ptmt -165.92 120.49 1.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.825 0.345 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 46.6 mm -51.49 142.6 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.138 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.628 HD23 ' C ' ' A' ' 380' ' ' LEU . 5.6 tt -110.4 143.38 40.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.594 HG12 ' OE1' ' A' ' 383' ' ' GLU . 11.7 t -112.78 142.42 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.071 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.48 HG13 ' CD2' ' A' ' 380' ' ' LEU . 27.5 mt -134.56 136.14 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.153 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' GLU . . . . . 0.594 ' OE1' HG12 ' A' ' 381' ' ' VAL . 4.8 mp0 -138.63 178.93 6.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.968 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.716 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 48.7 m-85 -105.04 133.93 49.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.93 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -110.29 143.4 16.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.462 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -127.93 154.87 45.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.907 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -110.25 -47.6 3.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -154.51 126.73 7.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -81.76 45.06 0.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.892 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -118.98 150.96 39.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -121.52 -44.82 2.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.857 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 73.1 m 46.78 44.4 14.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.892 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 83.1 p -68.77 127.28 32.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.925 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 141.53 91.66 0.18 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.487 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.84 112.68 3.49 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.636 2.224 . . . . 0.0 112.367 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 66.8 m -53.0 109.59 0.44 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.93 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 11.9 t -93.46 139.65 30.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.5 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 10.2 m -65.91 95.81 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 0.0 110.849 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 4.4 m -143.67 162.55 35.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 140.35 154.71 6.33 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.466 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 30.8 m -139.42 157.07 46.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.4 t -147.43 116.49 6.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 139.5 111.0 0.93 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.463 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -93.45 -38.01 11.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.792 0.33 . . . . 0.0 110.876 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.475 ' HG2' HG23 ' A' ' 293' ' ' ILE . 1.2 pm0 -94.05 -20.25 20.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.818 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.61 HG21 ' HA ' ' A' ' 297' ' ' PRO . 2.2 pp -103.16 161.07 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.097 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 56.9 mtp85 -111.72 -56.79 2.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 28.7 mmtt -113.95 -55.57 2.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.403 HG23 ' HD2' ' A' ' 297' ' ' PRO . 58.4 mt -97.96 132.59 24.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.594 0.711 . . . . 0.0 111.149 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' PRO . . . . . 0.61 ' HA ' HG21 ' A' ' 293' ' ' ILE . 63.0 Cg_endo -77.99 -42.05 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.266 . . . . 0.0 112.253 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 16.8 mmt -81.5 43.18 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -81.58 -51.78 7.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 75.3 m -107.67 85.65 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 22.6 m -70.91 -52.47 19.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.884 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.524 ' CE1' HG13 ' A' ' 381' ' ' VAL . 4.1 p90 -132.01 136.42 47.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -103.8 136.92 19.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.652 0.739 . . . . 0.0 110.853 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.0 -52.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.621 2.214 . . . . 0.0 112.363 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 113.82 -159.94 13.43 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.534 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -81.3 135.22 50.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.732 0.777 . . . . 0.0 110.867 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.93 122.54 6.26 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.653 2.235 . . . . 0.0 112.35 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -130.09 -177.79 4.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.544 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -99.12 -14.13 19.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.972 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.544 HG23 ' HD2' ' A' ' 309' ' ' LYS . 69.2 t -111.79 115.07 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.051 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.521 HD21 ' CE1' ' A' ' 384' ' ' PHE . 58.8 mt -100.32 140.23 34.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.849 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.752 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 10.6 t80 -122.27 102.88 8.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.964 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.688 HD23 HD11 ' A' ' 380' ' ' LEU . 6.6 mp -86.04 150.98 24.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.567 ' HE2' ' CD2' ' A' ' 312' ' ' TYR . 41.3 mttt -139.79 -175.9 4.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.919 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 54.59 52.35 12.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.0 mt -110.21 104.6 13.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 36.2 t -47.22 143.98 4.59 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.728 0.775 . . . . 0.0 110.823 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.37 -19.01 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.69 2.26 . . . . 0.0 112.335 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 30.5 mtt180 -77.38 -36.39 53.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 321' ' ' THR . 95.9 t -44.88 152.15 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 320' ' ' VAL . 35.3 p -158.78 166.52 31.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.164 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 321' ' ' THR . 7.3 mt-10 -34.78 -55.57 0.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.79 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 322' ' ' GLU . 60.3 mtp180 -37.45 -46.49 0.81 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -56.35 -59.71 4.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.431 ' CD2' HD22 ' A' ' 313' ' ' LEU . 23.1 mt -57.05 -51.2 70.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.926 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 92.6 t -53.11 -56.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.131 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 25.4 t -58.85 -39.51 81.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.9 mt -60.37 -40.52 91.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.471 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 28.9 m-85 -124.2 48.27 1.95 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.879 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -83.73 -57.45 3.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.992 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.43 ' HB3' ' NH1' ' A' ' 331' ' ' ARG . 3.4 ptp180 -42.73 -46.1 5.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.891 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.439 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 74.3 m-85 -46.21 -41.97 13.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -58.62 92.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -105.67 179.5 4.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -69.14 -51.99 32.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -52.42 -58.73 5.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.24 114.0 3.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.533 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -44.93 157.09 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.712 2.275 . . . . 0.0 112.367 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -45.44 121.56 4.01 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.669 2.246 . . . . 0.0 112.316 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.533 HD13 ' CE2' ' A' ' 357' ' ' PHE . 71.0 mt -65.35 140.48 19.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.115 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -96.18 137.15 35.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -120.08 151.65 38.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -141.27 125.24 17.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 40.4 tpp -112.94 133.63 54.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 11.9 ttm -86.76 158.72 19.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.879 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.27 140.11 8.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.207 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 142.56 -154.83 25.42 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.518 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.428 ' HG3' ' N ' ' A' ' 349' ' ' MET . 30.1 ptt180 -53.3 -54.03 42.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 110.87 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 349' ' ' MET . . . . . 0.428 ' N ' ' HG3' ' A' ' 348' ' ' ARG . 17.7 ttm -101.06 81.74 2.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.849 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -91.25 176.98 6.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 102.38 15.87 24.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.502 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 312' ' ' TYR . 2.8 mp0 -132.75 151.37 52.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 110.87 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -153.28 150.37 28.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.089 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.752 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 46.5 m-85 -114.64 152.72 31.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 94.7 mt -139.16 142.84 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.102 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.499 HG23 ' NZ ' ' A' ' 309' ' ' LYS . 49.7 m -124.86 121.73 35.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.141 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.533 ' CE2' HD13 ' A' ' 340' ' ' ILE . 62.2 m-85 -104.57 157.2 34.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.666 0.746 . . . . 0.0 110.802 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -46.29 -37.1 18.35 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.626 2.217 . . . . 0.0 112.368 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -149.12 174.44 12.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -71.19 -28.71 64.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -60.13 -63.33 1.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 59.2 mt -50.48 -57.53 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -40.95 -61.49 0.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.082 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -48.09 -63.07 1.17 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -43.48 -41.73 4.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.928 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.471 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -63.05 -42.51 99.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.064 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.656 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.0 tt -63.02 -58.41 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.902 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -55.39 -31.28 61.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 51.3 mt -78.02 -37.32 47.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.557 ' O ' HG12 ' A' ' 370' ' ' VAL . 16.4 t -111.27 37.27 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.74 124.72 29.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 63.08 43.01 99.41 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.483 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' A' ' 374' ' ' LYS . 13.9 t80 -78.61 134.79 37.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 0.0 110.952 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.434 ' O ' ' CE1' ' A' ' 373' ' ' TYR . 21.1 ttmt -86.33 119.48 26.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 18.1 tp -133.83 120.7 20.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 53.34 41.17 32.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 67.21 31.29 77.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.451 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' LYS . . . . . 0.422 ' NZ ' ' HA ' ' A' ' 378' ' ' LYS . 0.0 OUTLIER -134.83 130.05 35.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.749 0.309 . . . . 0.0 110.829 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 33.7 mm -76.92 92.19 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.688 HD11 HD23 ' A' ' 313' ' ' LEU . 8.1 tt -61.16 114.69 3.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.67 HG12 ' OE1' ' A' ' 383' ' ' GLU . 34.1 t -101.05 127.98 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.107 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 370' ' ' VAL . 32.5 mt -104.79 126.8 59.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' GLU . . . . . 0.67 ' OE1' HG12 ' A' ' 381' ' ' VAL . 3.0 mp0 -128.65 125.73 38.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.835 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.656 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 44.8 m-85 -59.25 158.51 9.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.841 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 384' ' ' PHE . . . -37.67 109.13 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -47.31 -45.36 24.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 110.899 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -110.0 148.63 31.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 389' ' ' LYS . 19.6 ptmt -120.74 -44.01 2.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 388' ' ' LYS . 12.3 tmtt? -36.35 119.09 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.955 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -149.28 143.83 26.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -115.31 132.46 56.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 79.4 p -97.54 165.39 12.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.825 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 86.4 p -120.08 131.71 55.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.837 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -86.93 158.77 30.84 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.477 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.02 123.56 6.82 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.685 2.257 . . . . 0.0 112.387 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 12.0 t -132.85 134.18 44.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 13.7 m -76.61 121.74 23.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.797 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.49 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 1.2 t -146.56 161.67 40.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.896 0.379 . . . . 0.0 110.835 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 93.1 p -116.69 152.8 33.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.811 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 169.71 75.28 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.494 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.9 p -124.43 87.99 2.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.862 0.363 . . . . 0.0 110.873 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 4.6 t -113.51 129.4 56.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.848 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' GLY . . . . . 0.514 ' HA3' HD11 ' A' ' 293' ' ' ILE . . . 82.47 108.43 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.475 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.28 -59.38 4.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 110.889 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -99.97 -47.15 5.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.675 HG21 ' HA ' ' A' ' 297' ' ' PRO . 2.7 pp -59.12 165.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 25.4 ttt-85 -124.19 -47.48 1.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -127.3 -47.42 1.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.476 HG22 ' H ' ' A' ' 298' ' ' MET . 50.9 mt -104.31 101.29 26.06 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.631 0.729 . . . . 0.0 111.126 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' PRO . . . . . 0.675 ' HA ' HG21 ' A' ' 293' ' ' ILE . 73.7 Cg_exo -44.23 -21.13 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.769 2.313 . . . . 0.0 112.27 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.476 ' H ' HG22 ' A' ' 296' ' ' ILE . 6.2 tpp -107.92 45.05 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.829 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -95.45 -43.87 7.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.813 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.1 t -112.4 90.58 3.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.85 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 54.5 m -120.14 -50.43 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.816 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.916 ' CE2' HG13 ' A' ' 381' ' ' VAL . 15.1 p90 -155.61 165.49 36.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -123.74 138.59 30.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.558 0.694 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.21 -48.44 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.624 2.216 . . . . 0.0 112.287 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 113.71 -150.67 18.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.467 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -96.49 139.0 21.45 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.592 0.71 . . . . 0.0 110.9 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.46 102.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.694 2.263 . . . . 0.0 112.313 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -115.73 176.75 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.467 ' CD ' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -90.43 5.24 48.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.467 HG23 ' CD ' ' A' ' 309' ' ' LYS . 60.5 t -127.72 129.75 70.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.44 HD21 ' HB1' ' A' ' 363' ' ' ALA . 49.3 mt -116.42 121.45 41.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.795 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 17.5 t80 -105.14 104.84 14.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.933 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 313' ' ' LEU . 3.2 mp -91.31 144.02 26.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.942 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -133.44 179.46 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.3 m120 57.23 51.83 9.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.462 ' HB3' HG11 ' A' ' 320' ' ' VAL . 13.8 mt -108.96 107.57 17.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.5 t -40.48 144.7 0.56 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.702 0.763 . . . . 0.0 110.893 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -47.16 -28.35 7.61 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.66 2.24 . . . . 0.0 112.336 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 24.2 mtt85 -73.51 -30.84 63.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.462 HG11 ' HB3' ' A' ' 316' ' ' LEU . 84.9 t -51.26 119.34 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.125 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 17.2 p -124.72 172.77 9.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -44.37 -44.0 7.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 64.9 mtt-85 -48.56 -54.73 13.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -49.13 -45.03 42.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 57.6 mt -62.63 -53.52 53.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 81.6 t -44.36 -49.35 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 47.2 t -65.4 -45.64 83.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.833 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 57.8 mt -52.55 -36.8 56.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.949 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.591 ' CE1' HG21 ' A' ' 370' ' ' VAL . 25.4 m-85 -132.36 44.35 2.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.857 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -80.35 -52.82 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.051 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -37.32 -32.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.84 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 330' ' ' ALA . 86.6 m-85 -73.97 -45.76 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.924 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 330' ' ' ALA . 57.8 tt0 -50.49 -43.98 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.905 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.76 44.6 1.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -129.33 160.53 32.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.875 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -38.02 -56.7 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.96 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -43.34 138.47 3.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.473 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -47.9 160.48 0.46 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.654 2.236 . . . . 0.0 112.372 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.25 153.58 1.03 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.688 2.259 . . . . 0.0 112.324 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 64.3 mt -100.68 137.57 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -96.31 127.85 42.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -117.66 142.42 47.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.44 ' HD3' ' N ' ' A' ' 344' ' ' MET . 0.8 OUTLIER -140.9 132.12 26.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.854 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.44 ' N ' ' HD3' ' A' ' 343' ' ' ARG . 39.7 tpp -113.83 143.43 44.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 21.3 ttm -86.65 157.89 19.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.916 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 34.4 p -142.11 151.31 42.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.138 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 348' ' ' ARG . . . 126.24 -156.71 19.87 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 347' ' ' GLY . 6.6 tpm_? -35.51 -70.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.854 0.359 . . . . 0.0 110.931 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' MET . . . . . 0.474 ' O ' ' NE2' ' A' ' 352' ' ' GLN . 11.5 mmt -112.02 91.23 3.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.16 28.04 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -90.07 32.78 4.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.475 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 349' ' ' MET . 1.9 mp0 -142.41 143.53 32.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 0.0 110.887 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.87 152.78 40.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.795 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 82.5 m-85 -120.27 132.67 55.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 78.4 mt -124.14 138.02 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.118 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 17.1 m -117.09 117.8 30.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.19 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.411 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 50.1 m-85 -98.86 158.17 32.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.696 0.76 . . . . 0.0 110.861 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.19 -35.59 15.44 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.661 2.241 . . . . 0.0 112.355 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -158.42 166.77 31.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 361' ' ' GLU . 8.7 pttt -58.0 -49.71 75.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 361' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 360' ' ' LYS . 2.2 tt0 -36.7 -63.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.878 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 55.0 mt -56.13 -62.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.131 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.44 ' HB1' HD21 ' A' ' 311' ' ' LEU . . . -38.6 -59.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.087 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -47.38 -58.16 4.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.404 ' O ' ' CG ' ' A' ' 369' ' ' LEU . 6.6 mm100 -53.76 -35.39 61.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.423 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -68.12 -38.42 82.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.14 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.605 ' C ' HD23 ' A' ' 367' ' ' LEU . 7.4 tt -66.54 -56.79 9.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -60.96 -38.02 84.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.776 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.404 ' CG ' ' O ' ' A' ' 365' ' ' GLN . 37.3 mt -65.72 -40.91 92.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.591 HG21 ' CE1' ' A' ' 329' ' ' PHE . 7.3 t -106.15 28.96 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' ASN . . . . . 0.451 ' CG ' ' O ' ' A' ' 371' ' ' ASN . 0.8 OUTLIER -76.43 116.23 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 73.46 45.94 27.71 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.501 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.431 ' CE1' ' O ' ' A' ' 374' ' ' LYS . 38.6 t80 -85.32 138.07 32.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.912 0.386 . . . . 0.0 110.901 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.431 ' O ' ' CE1' ' A' ' 373' ' ' TYR . 22.4 ttmt -89.26 124.89 34.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 376' ' ' TYR . 60.7 tp -135.88 150.42 49.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.952 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 375' ' ' LEU . 25.2 m-85 35.57 35.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.953 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 375' ' ' LEU . . . 66.73 53.06 29.71 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.51 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -171.83 126.46 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.757 0.313 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 41.9 mm -56.28 144.71 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.161 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.676 HD23 ' C ' ' A' ' 380' ' ' LEU . 3.6 tt -112.34 140.37 47.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.916 HG13 ' CE2' ' A' ' 302' ' ' TYR . 23.6 t -110.51 144.48 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.496 HD11 ' O ' ' A' ' 370' ' ' VAL . 23.6 mt -131.42 151.88 36.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.086 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -148.56 175.42 11.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.531 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 29.5 m-85 -104.51 154.2 20.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -97.41 119.92 6.56 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.472 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -70.27 173.37 6.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.761 0.315 . . . . 0.0 110.958 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -128.83 166.57 18.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.896 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 109.71 15.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.89 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -65.67 101.9 0.68 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -137.2 121.87 18.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -53.0 175.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.836 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.6 t -139.49 108.75 6.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 48.2 t -137.91 141.72 40.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.78 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 168.67 97.67 0.11 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.517 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -43.74 160.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.666 2.244 . . . . 0.0 112.354 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 21.1 t -139.47 168.86 18.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.818 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 10.6 t -171.66 177.37 3.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.839 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.468 -179.982 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 53.4 p 44.13 42.54 5.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.362 . . . . 0.0 110.858 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 20.7 t -62.51 134.18 56.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.35 134.82 1.1 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.449 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 1.4 t -109.72 151.17 27.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.952 0.406 . . . . 0.0 110.852 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 39.0 m -120.31 43.06 2.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.899 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' GLY . . . . . 0.558 ' HA3' HD11 ' A' ' 293' ' ' ILE . . . 78.94 140.67 1.9 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.488 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -100.56 -49.46 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.0 110.876 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -108.02 -32.36 7.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.802 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.788 ' O ' HD12 ' A' ' 293' ' ' ILE . 2.3 pp -62.32 146.04 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.106 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' ARG . . . . . 0.404 ' N ' ' HD2' ' A' ' 294' ' ' ARG . 0.0 OUTLIER -143.15 140.55 30.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 51.89 40.0 27.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 74.4 mt -125.44 119.62 24.76 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.623 0.725 . . . . 0.0 111.106 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.87 -43.77 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.629 2.219 . . . . 0.0 112.333 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 31.5 mtt -143.92 113.08 6.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -96.3 114.14 25.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.822 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.6 m -122.8 -52.06 1.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.899 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 41.4 p -158.72 174.64 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.842 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.583 ' CE2' HG13 ' A' ' 381' ' ' VAL . 18.5 p90 -45.19 135.39 5.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -103.78 99.81 17.46 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.636 0.731 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' PRO . . . . . 0.427 ' HB2' ' CE2' ' A' ' 384' ' ' PHE . 74.1 Cg_exo -41.93 -37.59 4.36 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.699 2.266 . . . . 0.0 112.276 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 99.64 -110.97 4.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.466 ' CG ' ' HD2' ' A' ' 307' ' ' PRO . 25.9 tt0 -99.19 140.45 21.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.695 0.759 . . . . 0.0 110.862 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' PRO . . . . . 0.466 ' HD2' ' CG ' ' A' ' 306' ' ' GLU . 59.8 Cg_endo -73.04 105.95 2.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.661 2.241 . . . . 0.0 112.389 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -106.52 172.09 7.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.586 ' HD3' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -84.64 9.89 12.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.824 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.586 HG23 ' HD3' ' A' ' 309' ' ' LYS . 70.5 t -130.94 128.43 62.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.657 HD21 ' HB1' ' A' ' 363' ' ' ALA . 41.5 mt -114.33 122.29 46.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.788 ' CE1' ' CZ ' ' A' ' 354' ' ' PHE . 17.2 t80 -101.77 107.02 18.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.931 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.729 HD23 HD11 ' A' ' 380' ' ' LEU . 8.8 mp -87.37 142.93 27.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -138.68 175.33 9.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 60.54 53.43 4.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.2 mt -113.42 109.97 19.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.2 t -47.49 143.92 5.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.722 0.773 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.12 -19.08 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 321' ' ' THR . 23.7 mtt180 -78.23 -39.83 39.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 87.7 t -49.78 133.83 8.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 319' ' ' ARG . 55.2 p -133.54 170.0 16.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.606 ' HA ' HD12 ' A' ' 325' ' ' LEU . 10.9 tm-20 -43.69 -47.32 7.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -45.0 -57.65 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -49.01 -43.09 40.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.606 HD12 ' HA ' ' A' ' 322' ' ' GLU . 21.3 mt -62.69 -48.56 78.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 62.4 t -51.86 -52.36 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.1 m -61.49 -37.39 83.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.794 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.587 HD21 ' CE2' ' A' ' 373' ' ' TYR . 31.0 mt -59.15 -37.65 77.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.949 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -126.27 42.15 3.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -81.2 -47.42 13.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.48 ' CZ ' ' HB2' ' A' ' 331' ' ' ARG . 3.5 ptm85 -46.38 -34.94 5.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -74.16 -46.29 43.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -53.75 -36.84 62.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.942 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.17 49.1 1.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -119.12 -177.85 3.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -83.62 49.33 1.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -152.11 168.35 31.32 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.84 165.11 0.07 OUTLIER 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.671 2.247 . . . . 0.0 112.348 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.95 140.43 20.3 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.614 2.209 . . . . 0.0 112.372 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.503 HD13 ' CE2' ' A' ' 357' ' ' PHE . 66.9 mt -80.84 125.53 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.133 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 355' ' ' ILE . 24.7 mm-40 -87.54 142.41 27.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -126.73 144.26 50.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.816 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.2 ttt-85 -141.08 132.67 27.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.2 ttm -115.4 147.34 40.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.877 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 22.2 ttm -95.24 163.36 13.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 39.5 p -136.89 167.91 20.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.203 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 348' ' ' ARG . . . 113.89 176.65 19.21 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.483 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 349' ' ' MET . 0.0 OUTLIER -37.61 -32.73 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.341 . . . . 0.0 110.865 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 349' ' ' MET . . . . . 0.423 ' N ' ' HD2' ' A' ' 348' ' ' ARG . 46.3 ttm -127.27 84.27 2.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.28 26.97 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -89.26 30.96 5.31 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.474 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.436 HE21 ' HH ' ' A' ' 312' ' ' TYR . 12.8 mt-30 -137.07 142.3 42.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.892 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -148.59 153.26 38.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.09 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.788 ' CZ ' ' CE1' ' A' ' 312' ' ' TYR . 77.9 m-85 -124.78 129.65 50.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.83 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 341' ' ' GLN . 56.8 mt -123.65 140.35 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.165 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 55.8 m -114.91 129.37 56.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.503 ' CE2' HD13 ' A' ' 340' ' ' ILE . 23.7 m-85 -106.2 156.57 36.63 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.682 0.753 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -46.11 -40.66 21.31 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.755 2.303 . . . . 0.0 112.337 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -141.26 -176.62 4.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.83 -37.0 19.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.36 -56.37 20.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 60.0 mt -54.36 -56.05 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.089 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.657 ' HB1' HD21 ' A' ' 311' ' ' LEU . . . -44.95 -59.26 2.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.075 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' TRP . . . . . 0.409 ' O ' ' N ' ' A' ' 367' ' ' LEU . 4.8 t90 -48.42 -66.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -40.1 -41.61 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -71.66 -39.67 70.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.079 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.93 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 5.3 tt -55.88 -50.39 70.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -69.21 -35.8 76.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 31.2 mt -62.91 -47.95 81.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.454 ' HB ' ' CD1' ' A' ' 382' ' ' ILE . 25.2 t -82.71 -28.33 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.057 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 370' ' ' VAL . 0.3 OUTLIER -36.01 120.77 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.936 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 83.28 36.29 15.11 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.414 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.587 ' CE2' HD21 ' A' ' 328' ' ' LEU . 61.0 t80 -91.79 103.43 15.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.943 0.401 . . . . 0.0 110.946 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.474 ' HE2' HD11 ' A' ' 379' ' ' ILE . 9.7 ttmm -71.2 101.85 2.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 26.5 tp -114.62 125.47 53.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.952 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 49.51 38.24 14.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 70.01 37.24 73.6 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.503 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -141.03 121.61 14.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' ILE . . . . . 0.474 HD11 ' HE2' ' A' ' 374' ' ' LYS . 38.8 mm -76.02 86.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.729 HD11 HD23 ' A' ' 313' ' ' LEU . 7.5 tt -47.76 135.09 12.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.594 ' N ' HD23 ' A' ' 380' ' ' LEU . 76.4 t -117.15 111.49 35.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.079 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.485 HG13 ' CD2' ' A' ' 380' ' ' LEU . 43.1 mt -98.64 119.2 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' GLU . . . . . 0.422 ' OE1' ' CD1' ' A' ' 302' ' ' TYR . 6.3 mm-40 -130.14 127.36 39.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.93 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 48.0 m-85 -54.27 140.71 32.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.928 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -48.96 103.5 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.544 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -66.75 -54.77 19.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -42.23 139.16 1.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -109.4 108.46 19.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -128.61 87.75 2.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -43.56 145.42 0.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.928 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -140.29 115.11 9.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 6.7 t -168.98 116.91 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 36.8 p -114.04 155.33 26.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 169.18 95.55 0.1 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -44.58 126.87 7.37 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.699 2.266 . . . . 0.0 112.334 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 39.8 m -63.14 107.91 1.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.865 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 85.5 p 41.28 42.59 1.8 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.853 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.516 179.999 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 1.4 t -133.66 139.25 46.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.359 . . . . 0.0 110.869 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 35.9 t -39.09 -53.0 1.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.841 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 93.76 144.2 15.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.52 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 23.0 t -75.48 150.59 38.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.392 . . . . 0.0 110.814 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 4.6 t -109.11 42.46 1.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.873 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' GLY . . . . . 0.613 ' HA3' HD11 ' A' ' 293' ' ' ILE . . . 167.15 138.07 2.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.454 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -92.86 -56.95 2.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.838 0.352 . . . . 0.0 110.88 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -62.11 -50.4 72.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.613 HD11 ' HA3' ' A' ' 290' ' ' GLY . 14.5 pt -57.98 144.85 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.139 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' ARG . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 294' ' ' ARG . 22.3 mtm105 -133.83 84.12 2.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 56.31 43.17 26.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 47.4 mt -90.37 112.03 50.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.626 0.727 . . . . 0.0 111.14 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -44.74 -44.97 13.92 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.696 2.264 . . . . 0.0 112.364 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.12 141.3 28.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -132.99 -43.27 0.88 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 66.0 m -71.79 111.74 7.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.853 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 3.8 m -161.33 -178.57 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -51.21 151.46 2.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -128.83 121.95 21.22 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.653 0.74 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.32 -38.32 2.08 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.583 2.189 . . . . 0.0 112.324 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 68.14 -161.7 49.76 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.463 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -41.45 142.3 1.01 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.663 0.744 . . . . 0.0 110.855 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' PRO . . . . . 0.421 ' HA ' ' CE2' ' A' ' 384' ' ' PHE . 61.2 Cg_endo -75.73 137.68 20.44 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.714 2.276 . . . . 0.0 112.348 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -128.96 164.23 23.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.26 9.46 6.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 74.3 t -130.68 129.31 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.112 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.808 HD12 ' CE1' ' A' ' 357' ' ' PHE . 64.4 mt -115.96 118.61 33.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.669 ' CE1' ' CZ ' ' A' ' 354' ' ' PHE . 8.0 t80 -102.13 111.36 23.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 313' ' ' LEU . 4.8 mp -96.58 147.66 23.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.932 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -141.16 -175.52 4.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 5.0 m120 56.19 54.97 7.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.4 mt -114.78 109.66 18.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.941 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 17.8 t -50.88 144.05 14.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.661 0.743 . . . . 0.0 110.89 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -46.53 -20.73 1.07 Allowed 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.735 2.29 . . . . 0.0 112.286 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.414 ' O ' HG23 ' A' ' 321' ' ' THR . 47.1 mmt-85 -75.13 -35.34 61.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.892 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.441 HG13 ' CG ' ' A' ' 324' ' ' ASP . 66.1 t -45.68 137.58 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 322' ' ' GLU . 39.0 p -132.12 150.77 52.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.878 ' OE1' HD12 ' A' ' 325' ' ' LEU . 5.4 tp10 -33.56 -41.34 0.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -46.72 -55.37 7.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.836 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' ASP . . . . . 0.441 ' CG ' HG13 ' A' ' 320' ' ' VAL . 0.2 OUTLIER -46.72 -44.41 18.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.878 HD12 ' OE1' ' A' ' 322' ' ' GLU . 36.2 mt -63.09 -47.45 82.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 67.5 t -57.09 -49.93 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 1.8 m -65.56 -42.44 91.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 23.2 mt -52.37 -41.17 62.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.483 ' CE1' HG21 ' A' ' 370' ' ' VAL . 21.6 m-85 -125.38 40.8 3.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 330' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -74.82 -40.8 60.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.091 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.474 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 10.2 ptt-85 -50.47 -45.56 56.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.474 ' N ' ' HG3' ' A' ' 331' ' ' ARG . 25.5 m-85 -64.46 -47.32 79.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 333' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 332' ' ' PHE . 38.6 tt0 -35.01 -40.23 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -92.85 69.01 4.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -149.49 177.0 10.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.841 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -61.53 110.92 1.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 139.69 173.97 13.45 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.465 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.01 147.57 34.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.738 2.292 . . . . 0.0 112.294 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.69 119.17 2.6 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.613 2.209 . . . . 0.0 112.403 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.596 HD13 ' CE2' ' A' ' 357' ' ' PHE . 70.2 mt -49.03 127.45 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -90.2 120.27 31.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -105.85 138.99 41.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -136.87 129.81 30.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.486 ' HE2' HD11 ' A' ' 325' ' ' LEU . 35.5 tpp -111.1 146.32 37.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.871 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 20.0 ttm -83.73 163.21 20.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.833 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 1.3 t -133.22 143.5 49.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.114 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 348' ' ' ARG . . . 128.73 164.34 11.5 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.51 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 347' ' ' GLY . 9.1 ptm180 -34.48 -37.25 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 349' ' ' MET . . . . . 0.416 ' N ' ' O ' ' A' ' 347' ' ' GLY . 7.8 mtm -110.51 61.39 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.34 30.07 0.56 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -90.08 26.83 9.11 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.453 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -133.37 145.48 50.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.834 0.349 . . . . 0.0 110.952 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -147.23 145.43 29.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.669 ' CZ ' ' CE1' ' A' ' 312' ' ' TYR . 71.2 m-85 -116.76 123.95 48.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 83.8 mt -114.19 141.24 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.084 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 85.1 m -117.88 114.74 23.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.145 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.808 ' CE1' HD12 ' A' ' 311' ' ' LEU . 38.6 m-85 -97.47 158.62 32.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.636 0.732 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -43.89 -43.99 11.98 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.739 2.292 . . . . 0.0 112.337 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.13 -175.29 5.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.952 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -74.65 -39.33 62.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -47.75 -66.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 57.2 mt -55.03 -55.72 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.107 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.49 ' HB1' HD21 ' A' ' 311' ' ' LEU . . . -43.12 -60.89 1.48 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -46.74 -59.63 2.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.835 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -45.84 -43.86 13.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.972 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.1 95.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.08 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.617 ' C ' HD23 ' A' ' 367' ' ' LEU . 7.1 tt -63.82 -51.8 63.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.916 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -62.77 -33.75 75.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 25.3 mt -72.11 -42.07 66.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.971 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 370' ' ' VAL . 11.2 t -105.64 31.75 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.145 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -75.73 127.77 33.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 58.79 45.0 95.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.497 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.445 ' HE2' HD13 ' A' ' 375' ' ' LEU . 59.7 t80 -84.06 113.32 20.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.903 0.383 . . . . 0.0 110.958 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 28.0 tttt -66.25 104.31 1.16 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.445 HD13 ' HE2' ' A' ' 373' ' ' TYR . 10.6 tp -118.56 135.91 54.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 42.43 50.45 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 53.84 41.19 66.5 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.505 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -156.45 110.26 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.781 0.324 . . . . 0.0 110.854 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 31.8 mm -51.44 118.71 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.084 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.487 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.9 tt -77.52 114.9 16.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.941 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 45.4 t -94.59 118.93 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.151 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.418 HD11 ' O ' ' A' ' 370' ' ' VAL . 36.9 mt -107.53 127.8 63.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -139.32 130.55 26.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.54 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 28.0 m-85 -57.71 132.56 53.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -41.6 107.99 0.11 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.452 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -50.18 154.43 1.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -134.43 -60.12 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.908 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 22.7 tptt -148.54 149.8 32.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.943 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 13.2 pttm -85.47 -29.21 24.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.913 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -142.75 108.4 5.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -87.86 137.52 32.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.831 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 7.7 m -76.41 165.51 24.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.3 t 57.08 42.18 26.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -150.95 144.22 11.51 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.487 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -78.4 122.58 5.66 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.691 2.26 . . . . 0.0 112.369 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 46.6 p -88.73 126.68 35.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 4.8 m -68.93 -57.98 4.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.523 -179.936 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 93.9 p -158.24 149.19 20.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 0.0 110.895 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.1 t -115.93 -58.13 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 117.72 134.84 5.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 60.0 m -68.08 85.59 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.882 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 27.7 t -120.58 153.64 36.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -45.57 147.99 1.94 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.463 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -65.26 -53.35 45.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 110.885 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -111.33 -49.8 2.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.44 ' CD1' ' O ' ' A' ' 296' ' ' ILE . 21.3 pt -48.18 -38.49 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.194 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 39.38 29.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.824 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 293' ' ' ILE . 2.8 mmmm -122.71 -45.15 2.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.44 ' O ' ' CD1' ' A' ' 293' ' ' ILE . 97.9 mt -136.14 128.87 17.71 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.605 0.716 . . . . 0.0 111.142 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.02 -36.7 3.23 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.67 2.247 . . . . 0.0 112.348 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 6.2 mmm -92.96 73.84 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -113.7 -58.53 2.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.5 t -80.77 96.24 6.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.871 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 54.0 m -77.89 -53.25 7.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.24 127.01 1.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.92 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -75.32 115.92 49.8 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.675 0.75 . . . . 0.0 110.903 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.77 -50.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.687 2.258 . . . . 0.0 112.298 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 109.24 -136.81 13.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.468 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.595 ' O ' ' CD2' ' A' ' 384' ' ' PHE . 12.0 tt0 -69.06 141.13 91.52 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.661 0.743 . . . . 0.0 110.917 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' PRO . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 384' ' ' PHE . 61.4 Cg_endo -76.1 144.96 27.31 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.693 2.262 . . . . 0.0 112.404 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -139.65 162.03 36.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.937 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.565 ' HG3' HG23 ' A' ' 310' ' ' VAL . 11.9 ptmt -70.87 -25.06 62.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.939 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.565 HG23 ' HG3' ' A' ' 309' ' ' LYS . 94.9 t -106.14 143.24 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.483 HD21 ' HB1' ' A' ' 363' ' ' ALA . 52.7 mt -124.35 121.42 34.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.974 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.756 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 9.4 t80 -95.4 102.61 14.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.952 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.463 HD22 HD22 ' A' ' 325' ' ' LEU . 7.5 mp -85.99 134.09 33.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -133.43 -177.07 4.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 60.22 52.17 5.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.8 mt -113.96 122.49 47.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 13.7 t -61.8 143.77 93.9 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.655 0.741 . . . . 0.0 110.821 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.44 -25.12 2.0 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.682 2.255 . . . . 0.0 112.306 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 321' ' ' THR . 41.7 mtm180 -74.34 -39.57 62.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.831 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 99.4 t -39.33 134.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 322' ' ' GLU . 35.2 p -126.89 150.5 49.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.136 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.686 ' OE1' HD12 ' A' ' 325' ' ' LEU . 7.9 tp10 -34.36 -41.54 0.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -45.33 -55.93 5.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' ASP . . . . . 0.489 ' CG ' ' N ' ' A' ' 325' ' ' LEU . 0.3 OUTLIER -44.12 -51.76 7.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.924 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.686 HD12 ' OE1' ' A' ' 322' ' ' GLU . 39.0 mt -56.33 -48.38 76.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.934 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 84.7 t -55.7 -53.09 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.146 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 31.2 t -64.51 -33.61 76.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.445 HD21 ' CE2' ' A' ' 373' ' ' TYR . 21.6 mt -65.65 -35.09 79.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.413 ' CZ ' HG21 ' A' ' 370' ' ' VAL . 38.6 m-85 -128.04 44.73 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.892 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 333' ' ' GLN . . . -82.48 -58.69 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.455 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 15.6 ptp180 -41.1 -42.09 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.481 ' CE2' ' HB2' ' A' ' 366' ' ' ALA . 31.4 m-85 -60.63 -38.67 85.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 330' ' ' ALA . 1.0 OUTLIER -35.56 -52.2 0.66 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.34 87.36 6.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.964 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 337' ' ' GLY . 12.1 tptp -161.54 149.38 15.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 335' ' ' LYS . 49.8 mtpt -37.09 95.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.888 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 335' ' ' LYS . . . 142.37 145.22 4.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.485 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -47.41 156.14 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.723 2.282 . . . . 0.0 112.387 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.94 158.47 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.654 2.236 . . . . 0.0 112.372 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.716 HD13 ' CE2' ' A' ' 357' ' ' PHE . 73.0 mt -88.4 138.8 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.11 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -97.7 136.25 38.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -123.51 142.09 51.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -140.62 128.14 21.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 14.9 ttm -110.22 146.38 35.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.823 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.62 169.85 10.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 5.9 t -147.65 153.67 39.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 126.6 -174.64 18.03 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.456 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -42.28 -41.08 2.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.319 . . . . 0.0 110.839 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.34 71.59 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.1 29.49 0.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -93.46 32.82 5.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.457 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -137.97 156.57 47.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.738 0.304 . . . . 0.0 110.92 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -157.57 155.82 30.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.756 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 46.0 m-85 -127.01 126.0 42.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' A' ' 325' ' ' LEU . 97.6 mt -119.18 145.54 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.582 ' O ' HG23 ' A' ' 340' ' ' ILE . 69.6 m -121.31 129.66 53.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.716 ' CE2' HD13 ' A' ' 340' ' ' ILE . 48.9 m-85 -109.97 158.46 34.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.694 0.759 . . . . 0.0 110.85 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.61 -52.05 7.29 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.685 2.256 . . . . 0.0 112.334 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -138.73 170.61 15.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -66.81 -38.62 86.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -49.78 -65.8 0.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 97.0 mt -51.92 -57.5 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.091 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -41.05 -53.02 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.107 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 12.9 t90 -54.68 -65.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -36.93 -46.71 0.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.481 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . . . -66.58 -49.95 64.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.094 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.774 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 4.5 tt -49.66 -50.31 43.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.853 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -65.42 -36.09 82.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 31.6 mt -64.63 -60.02 3.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 371' ' ' ASN . 20.4 t -68.45 -33.02 57.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 370' ' ' VAL . 1.5 t-20 -35.14 107.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.965 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 99.18 33.14 5.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.445 ' CE2' HD21 ' A' ' 328' ' ' LEU . 31.8 t80 -96.14 108.28 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.994 0.426 . . . . 0.0 110.97 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -78.75 105.22 9.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.928 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.565 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 21.5 tp -108.76 135.38 50.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.916 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' TYR . . . . . 0.565 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 57.9 m-85 52.85 27.16 5.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 79.44 34.34 32.47 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.483 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -149.9 122.07 8.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.741 0.305 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 20.5 mm -63.54 136.49 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.167 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.534 HD23 ' C ' ' A' ' 380' ' ' LEU . 8.2 tt -96.73 132.96 41.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.513 ' N ' HD23 ' A' ' 380' ' ' LEU . 55.9 t -113.84 119.86 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.445 HG13 ' CD2' ' A' ' 380' ' ' LEU . 18.3 mt -103.96 139.47 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -136.86 120.08 16.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.774 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 35.8 m-85 -48.89 118.12 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.23 140.04 40.24 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.505 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 29.5 mttp -128.59 91.7 3.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.84 0.352 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -165.31 145.81 7.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.826 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? 56.69 48.73 15.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.84 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -69.92 -43.03 72.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -89.73 114.08 25.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.965 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.431 ' HD3' ' N ' ' A' ' 392' ' ' SER . 0.4 OUTLIER -112.77 175.48 5.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.431 ' N ' ' HD3' ' A' ' 391' ' ' ARG . 1.2 t -174.72 146.27 0.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 29.2 t -140.08 147.68 40.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -174.07 139.22 4.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.519 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.44 177.1 8.92 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.644 2.229 . . . . 0.0 112.331 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 22.9 t -125.35 96.49 4.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.7 m -115.4 162.89 16.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.444 179.94 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.3 t -122.41 130.15 52.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.866 0.365 . . . . 0.0 110.879 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 3.8 m -80.62 149.23 29.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.862 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 45.72 -114.62 1.35 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.475 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 71.8 m 42.44 36.72 0.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.963 0.411 . . . . 0.0 110.868 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.1 t -81.36 145.87 30.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.899 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 152.48 81.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.465 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -103.33 135.95 44.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 110.891 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 45.41 45.07 10.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.884 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.659 HD12 ' N ' ' A' ' 294' ' ' ARG . 2.7 pp -95.7 -38.35 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.068 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' ARG . . . . . 0.659 ' N ' HD12 ' A' ' 293' ' ' ILE . 7.7 tmm_? -62.16 -47.55 84.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.579 ' HB3' HD12 ' A' ' 296' ' ' ILE . 0.2 OUTLIER -46.59 -52.45 13.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.925 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' A' ' 295' ' ' LYS . 5.4 mp -112.34 101.69 52.72 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.65 0.738 . . . . 0.0 111.12 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -44.32 -41.88 13.5 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 0.0 112.292 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.473 ' HB2' HG22 ' A' ' 296' ' ' ILE . 0.0 OUTLIER -44.19 -40.82 5.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.914 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -64.84 -41.67 95.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 86.8 p -69.66 -38.87 77.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.836 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 3.0 m -41.36 -62.0 0.94 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.848 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -173.02 152.0 2.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.971 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -112.68 102.32 54.26 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.556 0.693 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' PRO . . . . . 0.404 ' HB3' HD11 ' A' ' 367' ' ' LEU . 71.0 Cg_exo -42.35 -55.57 2.49 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.713 2.275 . . . . 0.0 112.336 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 136.82 -142.51 13.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.443 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -103.42 138.71 19.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.61 0.719 . . . . 0.0 110.895 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' PRO . . . . . 0.617 ' HA ' ' CE1' ' A' ' 384' ' ' PHE . 72.6 Cg_exo -46.38 106.85 0.1 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.662 2.241 . . . . 0.0 112.335 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.423 ' C ' ' HA ' ' A' ' 360' ' ' LYS . 76.0 m-20 -124.87 164.87 19.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.45 ' HD3' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -82.61 13.86 3.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.45 HG23 ' HD3' ' A' ' 309' ' ' LYS . 57.3 t -137.59 129.41 40.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.119 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.715 HD22 HD12 ' A' ' 367' ' ' LEU . 76.9 mt -120.25 117.87 28.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.983 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.789 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 7.4 t80 -93.97 105.72 17.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 313' ' ' LEU . 4.4 mp -88.28 145.02 26.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.909 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.434 ' HG3' ' C ' ' A' ' 313' ' ' LEU . 16.6 mtpp -143.31 170.89 14.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 67.46 54.92 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 12.9 mt -114.77 120.9 41.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 22.6 t -57.33 143.84 72.53 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.674 0.75 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -43.94 -27.2 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.671 2.247 . . . . 0.0 112.385 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.591 ' O ' HG23 ' A' ' 321' ' ' THR . 1.4 mmp_? -71.16 -38.73 72.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.439 HG22 ' HD2' ' A' ' 376' ' ' TYR . 66.0 t -47.05 122.44 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.591 HG23 ' O ' ' A' ' 319' ' ' ARG . 44.8 p -127.31 168.67 14.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.18 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -39.22 -48.79 1.83 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.913 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ARG . . . . . 0.43 ' NH1' ' HB2' ' A' ' 323' ' ' ARG . 0.0 OUTLIER -44.52 -49.87 9.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -53.7 -50.99 64.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.843 HD22 HD11 ' A' ' 355' ' ' ILE . 76.4 mt -55.33 -51.93 65.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.965 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 97.5 t -46.98 -59.54 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.094 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 2.6 t -54.0 -47.51 71.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 31.9 mt -49.62 -46.27 49.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.414 ' CZ ' HD21 ' A' ' 313' ' ' LEU . 8.4 m-85 -119.9 41.8 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 330' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -85.15 -25.16 27.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.035 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -64.79 -37.14 86.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.404 ' HZ ' HD13 ' A' ' 369' ' ' LEU . 4.2 m-85 -94.04 20.25 8.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -114.9 81.86 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 335' ' ' LYS . 5.3 pt-20 -148.6 175.23 11.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.951 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 336' ' ' LYS . 3.8 ptpt -36.9 -50.4 0.86 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 335' ' ' LYS . 23.4 mmtm -34.1 -56.24 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -118.34 138.77 14.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.489 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -46.96 153.25 1.48 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.724 2.283 . . . . 0.0 112.372 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.33 97.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.697 2.265 . . . . 0.0 112.353 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 71.1 mt -40.99 133.19 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.164 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -89.68 116.12 27.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.49 130.49 54.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -129.94 117.89 20.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.832 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.1 ttm -103.95 146.85 28.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' MET . . . . . 0.42 ' HE1' ' CE2' ' A' ' 354' ' ' PHE . 34.3 mtm -110.62 167.31 10.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 28.4 p -151.62 151.37 31.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.118 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 139.44 -178.24 19.77 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.513 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -42.76 -52.43 4.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 110.852 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 12.6 ttt -88.41 37.25 0.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.448 ' C ' ' OE1' ' A' ' 352' ' ' GLN . 0.0 OUTLIER -58.63 176.74 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -179.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 94.07 37.51 5.4 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.499 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.448 ' OE1' ' C ' ' A' ' 350' ' ' ARG . 27.8 mp0 -152.91 142.49 21.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 110.866 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.49 142.87 29.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.076 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.789 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 53.0 m-85 -105.45 115.79 30.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.843 HD11 HD22 ' A' ' 325' ' ' LEU . 64.2 mt -108.39 129.42 62.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.12 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 27.1 m -109.53 116.06 31.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.688 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 36.9 m-85 -94.46 159.17 34.33 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.728 0.775 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' PRO . . . . . 0.454 ' HB2' HD12 ' A' ' 362' ' ' ILE . 72.6 Cg_exo -44.85 -47.55 11.67 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.242 . . . . 0.0 112.372 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -142.67 176.47 9.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.423 ' HA ' ' C ' ' A' ' 308' ' ' ASN . 0.0 OUTLIER -74.78 -29.21 61.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 361' ' ' GLU . . . . . 0.406 ' N ' ' HG2' ' A' ' 360' ' ' LYS . 77.8 mt-10 -62.33 -56.95 13.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.454 HD12 ' HB2' ' A' ' 358' ' ' PRO . 68.5 mt -56.09 -56.39 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.077 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -49.86 -48.62 51.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -51.22 -49.12 61.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -60.96 -52.72 63.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.942 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -56.63 -34.25 67.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.049 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.804 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 5.9 tt -65.02 -67.04 0.47 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' HIS . . . . . 0.646 ' N ' HD23 ' A' ' 367' ' ' LEU . 10.3 t-80 -46.35 -36.1 6.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.84 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.404 HD13 ' HZ ' ' A' ' 332' ' ' PHE . 23.5 mt -71.61 -58.3 3.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.862 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.569 ' O ' HD11 ' A' ' 382' ' ' ILE . 9.3 t -82.59 37.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.099 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -84.94 136.2 33.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 49.28 38.42 26.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.519 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.549 ' CE1' ' O ' ' A' ' 374' ' ' LYS . 33.4 t80 -78.21 130.39 36.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.951 0.405 . . . . 0.0 110.905 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.549 ' O ' ' CE1' ' A' ' 373' ' ' TYR . 17.5 tttm -71.14 129.79 39.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.881 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 19.1 tp -143.56 124.47 14.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' TYR . . . . . 0.439 ' HD2' HG22 ' A' ' 320' ' ' VAL . 39.3 m-85 43.77 48.25 6.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 59.89 42.46 98.2 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.499 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -155.47 119.25 4.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.338 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 48.3 mm -61.51 107.59 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.119 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.494 HD23 ' C ' ' A' ' 380' ' ' LEU . 8.4 tt -71.33 115.63 10.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.6 t -99.74 136.4 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.141 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.569 HD11 ' O ' ' A' ' 370' ' ' VAL . 57.5 mt -113.39 135.15 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -137.45 118.8 14.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.804 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 59.9 m-85 -47.97 151.54 0.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.14 169.79 1.79 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -63.81 91.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 110.874 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -37.41 107.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -110.11 173.65 6.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -90.28 41.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.97 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -99.95 99.95 10.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -115.89 140.91 48.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 1.9 t -84.41 86.89 7.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 7.9 t -166.17 143.61 5.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 117.2 98.64 2.02 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.52 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.67 164.5 33.58 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.697 2.265 . . . . 0.0 112.354 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 19.3 m -156.31 131.44 9.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.847 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 398' ' ' GLY . 5.8 m -53.99 172.38 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.872 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 398' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 397' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.247 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.507 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 1.3 t -118.21 -51.21 2.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.84 0.352 . . . . 0.0 110.846 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 69.4 m 48.9 40.87 17.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.826 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -142.3 71.83 0.4 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.404 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 82.2 p -108.67 103.61 12.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.833 0.349 . . . . 0.0 110.92 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 79.9 p -155.47 165.64 35.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.814 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' GLY . . . . . 0.448 ' HA3' ' CD1' ' A' ' 293' ' ' ILE . . . -83.65 151.08 27.45 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.442 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -67.58 -42.92 81.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.808 0.337 . . . . 0.0 110.911 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -114.79 -49.77 2.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.448 ' CD1' ' HA3' ' A' ' 290' ' ' GLY . 2.8 pp -64.05 156.9 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.134 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 295' ' ' LYS . 6.0 tpt180 -80.28 160.93 25.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 294' ' ' ARG . 34.1 mmtm -32.26 -47.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.449 HG22 ' H ' ' A' ' 299' ' ' PHE . 62.8 mt -50.91 117.47 8.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.69 0.757 . . . . 0.0 111.14 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.26 -51.5 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.747 2.298 . . . . 0.0 112.292 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 7.5 mtm -51.54 -62.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.927 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' PHE . . . . . 0.449 ' H ' HG22 ' A' ' 296' ' ' ILE . 3.0 t80 54.19 43.76 30.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.884 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 6.7 t -168.1 112.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 16.5 m -58.14 -57.08 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.892 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.467 ' CE1' ' O ' ' A' ' 303' ' ' ASN . 2.6 t80 -166.76 147.92 6.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.467 ' O ' ' CE1' ' A' ' 302' ' ' TYR . 10.7 t30 -99.96 111.41 61.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.717 0.77 . . . . 0.0 110.917 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.77 -51.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.656 2.237 . . . . 0.0 112.36 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 110.77 -145.8 17.45 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.483 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -56.7 136.81 78.16 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.606 0.717 . . . . 0.0 110.852 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' PRO . . . . . 0.533 ' HA ' ' CZ ' ' A' ' 384' ' ' PHE . 61.3 Cg_endo -75.27 145.66 30.8 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.696 2.264 . . . . 0.0 112.334 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -137.76 168.64 19.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.553 ' HG3' HG23 ' A' ' 310' ' ' VAL . 13.1 ptmt -72.79 -33.61 66.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.907 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.553 HG23 ' HG3' ' A' ' 309' ' ' LYS . 55.6 t -98.22 145.92 8.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.143 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.647 HD12 ' CE1' ' A' ' 357' ' ' PHE . 56.9 mt -127.63 114.43 17.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.573 ' CZ ' ' CG ' ' A' ' 314' ' ' LYS . 6.4 t80 -89.31 105.94 18.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.933 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.444 HD23 HD21 ' A' ' 380' ' ' LEU . 6.3 mp -93.22 148.05 22.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.573 ' CG ' ' CZ ' ' A' ' 312' ' ' TYR . 0.0 OUTLIER -144.5 177.12 8.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.49 53.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 15.6 mt -118.03 112.07 19.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.2 t -38.63 154.29 0.14 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.65 0.738 . . . . 0.0 110.855 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.62 1.96 3.3 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.679 2.253 . . . . 0.0 112.363 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -108.43 -24.83 11.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.98 142.65 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.131 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 64.6 p -133.89 162.85 30.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 323' ' ' ARG . 6.2 tt0 -38.81 -53.76 1.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.909 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 322' ' ' GLU . 56.7 ttt180 -34.78 -42.71 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -62.66 -50.71 70.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 322' ' ' GLU . 15.6 mt -60.04 -48.51 81.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 78.9 t -49.33 -60.46 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.066 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 23.8 t -53.62 -38.58 64.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.43 HD11 HD22 ' A' ' 375' ' ' LEU . 40.9 mt -62.4 -41.24 98.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.479 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 60.4 m-85 -119.56 46.02 2.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -92.31 -58.26 2.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.09 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.402 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 17.7 ptp180 -38.37 -47.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.899 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 49.0 m-85 -47.79 -48.76 30.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -68.82 76.09 0.3 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.929 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -122.38 79.18 1.58 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 5.3 mptt 50.08 38.03 15.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -121.07 126.09 48.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 44.22 -161.42 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.528 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.06 169.89 19.45 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.664 2.243 . . . . 0.0 112.399 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.16 124.61 9.17 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.633 2.222 . . . . 0.0 112.364 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.835 HD13 ' CE2' ' A' ' 357' ' ' PHE . 73.6 mt -56.24 125.35 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.152 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -87.65 133.56 33.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -118.62 140.16 50.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -137.97 123.51 19.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 46.6 tpp -103.26 133.3 48.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 20.0 tpp -89.4 144.67 25.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.936 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.1 p -139.66 153.39 47.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.1 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 129.39 -140.66 11.89 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.521 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.45 ' HG3' ' N ' ' A' ' 349' ' ' MET . 2.4 ptp180 -47.16 -46.98 23.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.71 0.291 . . . . 0.0 110.86 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 349' ' ' MET . . . . . 0.45 ' N ' ' HG3' ' A' ' 348' ' ' ARG . 0.0 OUTLIER -125.93 86.68 2.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 11.1 mtp85 -68.95 -3.21 11.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.914 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -84.4 47.44 3.85 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.505 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -146.83 147.08 30.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 0.0 110.939 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -154.99 142.44 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.081 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -120.2 121.95 39.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.825 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 80.6 mt -115.22 145.15 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.11 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 25.9 m -122.22 117.75 26.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.835 ' CE2' HD13 ' A' ' 340' ' ' ILE . 63.4 m-85 -99.73 157.39 34.01 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.606 0.717 . . . . 0.0 110.88 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -42.33 -40.11 6.76 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.652 2.235 . . . . 0.0 112.372 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.52 171.04 20.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 361' ' ' GLU . 11.0 pttm -58.08 -53.99 52.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 361' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 360' ' ' LYS . 45.7 mt-10 -36.52 -64.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.45 -56.93 9.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.136 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.467 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -42.27 -60.62 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.089 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 364' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 367' ' ' LEU . 13.5 t90 -47.63 -64.61 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.938 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -37.67 -46.15 0.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -64.76 -38.13 89.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.037 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.59 ' C ' HD23 ' A' ' 367' ' ' LEU . 7.7 tt -62.04 -61.31 2.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.883 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -56.24 -30.12 61.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 28.9 mt -72.94 -50.94 20.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.955 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.636 ' O ' HG12 ' A' ' 370' ' ' VAL . 25.4 t -98.74 37.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.142 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' ASN . . . . . 0.421 ' O ' ' CG ' ' A' ' 371' ' ' ASN . 0.7 OUTLIER -88.12 87.65 7.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 111.44 42.55 1.05 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -89.27 125.99 35.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.988 0.423 . . . . 0.0 110.917 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -74.29 94.0 2.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.43 HD22 HD11 ' A' ' 328' ' ' LEU . 16.2 tp -104.3 132.0 51.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.99 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 46.09 42.46 9.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 64.64 40.63 97.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -152.57 149.25 28.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.757 0.313 . . . . 0.0 110.953 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 15.8 mm -84.26 107.41 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.116 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.491 HD23 ' N ' ' A' ' 381' ' ' VAL . 8.2 tt -72.76 131.21 42.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.847 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.491 ' N ' HD23 ' A' ' 380' ' ' LEU . 41.0 t -113.1 114.45 46.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.087 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.484 HG13 ' CD2' ' A' ' 380' ' ' LEU . 31.6 mt -98.32 129.87 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -126.82 168.02 15.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.533 ' CZ ' ' HA ' ' A' ' 307' ' ' PRO . 26.3 m-85 -94.76 137.08 34.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -82.28 -168.12 41.25 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.457 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -108.72 134.55 51.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.804 0.335 . . . . 0.0 110.904 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.18 142.32 55.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -148.88 132.97 17.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.405 ' N ' ' HD3' ' A' ' 389' ' ' LYS . 0.0 OUTLIER -168.0 144.05 3.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -172.45 156.09 3.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.87 160.16 29.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.807 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 18.4 m -135.08 -54.24 0.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.3 m -167.74 129.59 1.52 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -72.14 159.43 53.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.466 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -77.05 115.56 4.03 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.733 2.289 . . . . 0.0 112.392 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 43.2 t -96.87 114.65 26.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 25.8 m -140.82 138.99 34.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.464 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 6.4 m -136.41 174.8 10.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 0.0 110.811 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 10.2 m -121.52 151.29 40.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.851 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 139.17 101.66 0.52 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.465 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.3 t -125.89 114.29 18.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.837 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 t -162.45 151.02 14.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' GLY . . . . . 0.659 ' HA3' HD11 ' A' ' 293' ' ' ILE . . . 79.84 96.88 0.32 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.519 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.21 -53.12 7.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.81 0.338 . . . . 0.0 110.893 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -79.72 -45.9 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.659 HD11 ' HA3' ' A' ' 290' ' ' GLY . 2.7 pp -73.04 164.72 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.116 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -127.08 -49.52 1.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -116.89 -54.54 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 38.9 mm -83.95 130.0 56.74 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.664 0.745 . . . . 0.0 111.089 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.47 -49.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.642 2.228 . . . . 0.0 112.327 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 4.0 mmm -82.41 42.71 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -89.9 -59.71 2.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 30.7 p -101.31 43.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 3.6 m -43.91 -57.81 3.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.839 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -150.28 158.23 43.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.951 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 303' ' ' ASN . 1.5 p30 -98.27 115.66 65.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.708 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.83 -41.01 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.635 2.224 . . . . 0.0 112.317 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 113.18 -176.11 17.15 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.439 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -73.38 133.94 80.22 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.617 0.723 . . . . 0.0 110.884 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -45.11 91.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.738 2.292 . . . . 0.0 112.272 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -107.09 175.63 5.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.554 ' HG3' HG23 ' A' ' 310' ' ' VAL . 18.7 pttm -85.8 -26.59 25.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.936 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.554 HG23 ' HG3' ' A' ' 309' ' ' LYS . 88.2 t -97.53 124.36 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.467 ' CD2' ' CE1' ' A' ' 384' ' ' PHE . 66.5 mt -113.05 115.06 27.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.934 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.795 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 16.4 t80 -87.85 104.06 16.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.433 HD22 HD22 ' A' ' 325' ' ' LEU . 8.3 mp -85.84 138.17 32.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.918 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -134.06 177.03 8.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 61.89 54.71 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.845 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.4 mt -111.0 127.71 55.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.457 ' HB2' ' CD ' ' A' ' 378' ' ' LYS . 29.4 t -61.91 143.35 94.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.648 0.737 . . . . 0.0 110.903 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -47.12 -19.47 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.604 2.203 . . . . 0.0 112.418 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.528 ' O ' HG23 ' A' ' 321' ' ' THR . 14.3 mtp180 -82.47 -33.29 28.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.54 HG22 ' HD2' ' A' ' 376' ' ' TYR . 99.4 t -44.1 133.04 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 319' ' ' ARG . 68.8 p -129.63 151.56 50.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 321' ' ' THR . 9.3 tt0 -34.55 -38.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -48.16 -56.21 8.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' ASP . . . . . 0.421 ' CG ' HG13 ' A' ' 320' ' ' VAL . 0.3 OUTLIER -46.46 -45.05 17.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.433 HD22 HD22 ' A' ' 313' ' ' LEU . 42.3 mt -61.62 -46.22 90.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 65.8 t -56.32 -53.08 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 38.8 t -63.15 -41.67 99.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.851 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.457 HD21 ' CE2' ' A' ' 373' ' ' TYR . 24.0 mt -55.26 -41.48 72.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.971 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.474 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 19.0 m-85 -122.23 40.85 3.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 330' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 333' ' ' GLN . . . -79.2 -54.76 5.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.135 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -39.76 -33.34 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -75.32 -38.99 59.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 330' ' ' ALA . 6.3 tm0? -45.21 -47.6 12.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.966 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -87.46 40.96 0.95 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 336' ' ' LYS . 13.2 tptm -126.23 163.55 22.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 335' ' ' LYS . 42.2 mttt -34.03 109.61 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 119.67 139.92 6.05 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.453 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -47.48 164.25 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.776 2.317 . . . . 0.0 112.365 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.98 160.59 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.65 2.233 . . . . 0.0 112.337 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 71.6 mt -92.37 144.75 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.074 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -98.52 123.38 42.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -114.4 140.26 48.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -141.23 124.31 16.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.891 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 41.2 tpp -108.63 137.58 46.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.813 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' MET . . . . . 0.403 ' HE2' ' N ' ' A' ' 345' ' ' MET . 1.4 mpp? -102.91 132.96 48.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 13.3 t -115.66 33.52 5.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.073 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 348' ' ' ARG . . . -88.69 -155.38 29.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.527 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 347' ' ' GLY . 26.5 tpt180 -34.28 -47.47 0.3 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.774 0.321 . . . . 0.0 110.846 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 349' ' ' MET . . . . . 0.466 ' HB3' ' NE2' ' A' ' 352' ' ' GLN . 0.7 OUTLIER -119.3 91.34 3.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -67.98 -2.49 7.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -88.87 37.14 3.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.509 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.466 ' NE2' ' HB3' ' A' ' 349' ' ' MET . 32.9 mt-30 -144.41 142.89 30.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 0.0 110.919 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.74 146.01 31.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.795 ' CE2' ' CE1' ' A' ' 312' ' ' TYR . 39.9 m-85 -111.72 124.02 51.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 79.0 mt -117.12 141.13 36.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 35.8 m -119.84 118.47 30.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.747 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 32.5 m-85 -94.1 155.34 40.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.612 0.72 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.1 -32.23 18.2 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.241 . . . . 0.0 112.359 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -152.19 -179.42 7.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.444 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 8.6 pttm -78.07 -41.28 35.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 361' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 36.1 mt-10 -54.04 -63.2 1.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 80.4 mt -47.17 -61.44 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.747 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -44.36 -65.26 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.019 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 364' ' ' TRP . . . . . 0.408 ' C ' ' O ' ' A' ' 363' ' ' ALA . 6.1 t90 -36.46 -51.09 0.81 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.938 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -54.47 -53.29 56.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.474 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -53.08 -40.66 64.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.78 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 6.3 tt -59.57 -68.23 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 368' ' ' HIS . . . . . 0.651 ' N ' HD23 ' A' ' 367' ' ' LEU . 4.4 t60 -49.79 -33.79 17.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 35.3 mt -72.59 -39.14 67.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.967 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 370' ' ' VAL . 31.3 t -109.81 40.57 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -82.74 141.58 32.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 48.37 30.36 8.01 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.451 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.457 ' CE2' HD21 ' A' ' 328' ' ' LEU . 38.6 t80 -70.46 108.82 4.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.933 0.397 . . . . 0.0 110.853 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -71.45 97.41 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.463 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 31.6 tp -101.46 131.6 47.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.915 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 376' ' ' TYR . . . . . 0.54 ' HD2' HG22 ' A' ' 320' ' ' VAL . 57.1 m-85 53.5 31.93 13.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 73.6 34.8 56.4 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' LYS . . . . . 0.457 ' CD ' ' HB2' ' A' ' 317' ' ' SER . 21.2 mtpp -142.77 112.37 6.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.697 0.284 . . . . 0.0 110.93 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 379' ' ' ILE . 14.6 mm -52.83 100.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.166 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.41 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.8 tt -69.35 120.57 15.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.5 t -104.04 120.46 54.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.557 HD11 ' O ' ' A' ' 370' ' ' VAL . 65.6 mt -99.34 138.46 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.099 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -140.32 120.54 13.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.912 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.78 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 42.7 m-85 -54.69 147.45 14.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -61.69 161.32 27.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.453 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 157.6 23.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.322 . . . . 0.0 110.941 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -143.18 137.32 28.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.42 167.77 9.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -41.0 145.1 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.911 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -135.9 169.91 16.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.931 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 48.0 ttm-85 -131.62 124.81 30.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 46.6 t -56.71 94.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 30.7 t -115.53 108.85 16.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.818 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 155.14 86.48 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.462 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.65 -39.27 17.84 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.684 2.256 . . . . 0.0 112.389 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 4.1 m 37.57 42.02 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 70.8 m -134.52 112.94 11.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.473 -179.987 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--O 1.23 0.105 0 CA-C-O 120.798 0.249 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -126.15 179.18 5.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.509 ' HG3' HG23 ' A' ' 310' ' ' VAL . 3.8 ptmt -81.5 -30.86 33.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.509 HG23 ' HG3' ' A' ' 309' ' ' LYS . 86.4 t -99.18 132.89 43.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.405 HD12 ' CE1' ' A' ' 357' ' ' PHE . 79.1 mt -112.29 152.74 28.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.96 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.788 ' CD1' ' CE2' ' A' ' 354' ' ' PHE . 10.3 t80 -124.22 101.76 7.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.948 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.593 HD21 ' HE2' ' A' ' 329' ' ' PHE . 6.1 mp -90.63 139.73 30.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.939 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -137.36 -179.53 5.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 63.73 54.06 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.81 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 12.8 mt -116.26 127.09 54.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.968 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 45.1 t -65.56 143.88 98.76 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.643 0.735 . . . . 0.0 110.831 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.16 -22.14 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.7 2.266 . . . . 0.0 112.345 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.566 ' O ' HG23 ' A' ' 321' ' ' THR . 37.6 mtt-85 -77.07 -38.86 51.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 69.5 t -46.1 140.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.095 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 319' ' ' ARG . 75.1 p -140.96 168.41 19.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.199 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 325' ' ' LEU . 19.8 tt0 -41.21 -47.37 3.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -41.52 -52.24 3.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.88 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.42 -48.43 68.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 322' ' ' GLU . 18.9 mt -58.2 -47.0 84.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 86.0 t -53.26 -56.06 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.138 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 7.5 t -60.19 -43.38 95.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.829 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.7 mt -52.12 -48.59 64.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.593 ' HE2' HD21 ' A' ' 313' ' ' LEU . 42.9 m-85 -118.35 42.1 2.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -78.96 -43.55 24.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.073 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -49.48 -34.0 15.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.402 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 21.9 m-85 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 67.1 mt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.817 0.342 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -97.71 137.8 36.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -123.81 140.27 53.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -136.35 132.94 36.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.805 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 12.4 ttm -112.22 135.9 52.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 29.4 ttm . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.908 179.919 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.424 ' C ' ' OE1' ' A' ' 352' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.424 ' OE1' ' C ' ' A' ' 351' ' ' GLY . 2.9 mp0 -147.31 152.73 38.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.851 0.358 . . . . 0.0 110.862 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -158.55 167.09 30.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.788 ' CE2' ' CD1' ' A' ' 312' ' ' TYR . 14.4 m-85 -136.6 138.38 41.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.893 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.403 HD13 ' CD2' ' A' ' 329' ' ' PHE . 85.2 mt -126.68 132.88 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.469 HG23 ' CE ' ' A' ' 309' ' ' LYS . 25.7 m -108.26 118.1 35.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.097 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.543 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 47.1 m-85 -99.84 158.91 31.23 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.639 0.733 . . . . 0.0 110.903 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.88 -35.3 13.68 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.623 2.216 . . . . 0.0 112.348 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -157.83 174.8 14.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.977 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 21.5 pttp -65.89 -45.35 82.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . 0.46 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 48.1 mt-10 -46.21 -65.17 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 60.5 mt -53.28 -54.17 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -43.59 -59.32 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.081 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . 0.495 ' O ' ' N ' ' A' ' 367' ' ' LEU . 11.4 t90 -50.44 -62.87 1.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.0 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -37.25 -50.78 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . 0.485 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -60.17 -37.17 79.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.12 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.803 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 6.3 tt -62.37 -62.54 1.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.976 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . 0.436 ' N ' HD23 ' A' ' 367' ' ' LEU . 47.1 t60 -53.18 -29.2 30.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.842 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 44.9 mt -76.24 -48.36 20.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.563 HG21 ' CE1' ' A' ' 329' ' ' PHE . 5.4 t -98.41 33.0 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.101 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.36 96.27 7.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 93.32 43.9 3.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.531 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -84.8 109.16 17.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 0.0 110.922 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -62.95 119.31 9.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.935 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.404 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 19.4 tp -133.54 128.68 35.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.851 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . 0.404 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 25.2 m-85 45.81 41.24 7.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.999 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 66.8 41.3 93.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -142.32 141.13 32.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 49.2 mm -90.56 92.73 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.182 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.475 HD23 ' N ' ' A' ' 381' ' ' VAL . 7.2 tt -61.51 129.82 43.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.475 ' N ' HD23 ' A' ' 380' ' ' LEU . 48.0 t -117.22 111.91 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.187 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.41 ' CD1' ' O ' ' A' ' 370' ' ' VAL . 29.2 mt -93.97 137.89 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -133.73 179.21 6.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.803 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 27.7 m-85 -109.11 140.79 42.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.413 -179.908 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo . . . . . 0 C--O 1.231 0.163 0 CA-C-O 120.685 0.202 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -118.29 172.67 7.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.6 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -89.91 25.98 1.95 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.949 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.6 HG23 ' HD2' ' A' ' 309' ' ' LYS . 89.2 t -143.17 123.22 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.139 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.689 HD22 HD12 ' A' ' 367' ' ' LEU . 63.0 mt -116.66 125.62 52.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.969 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.674 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 7.8 t80 -105.1 103.88 13.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 313' ' ' LEU . 3.0 mp -87.31 144.68 26.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -140.57 178.69 7.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.928 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.0 m120 59.5 46.09 12.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.855 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.2 mt -105.7 112.5 25.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 37.5 t -54.34 144.54 41.0 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.747 0.784 . . . . 0.0 110.796 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -45.02 -32.16 6.3 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.685 2.257 . . . . 0.0 112.328 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.599 ' O ' HG23 ' A' ' 321' ' ' THR . 54.1 mtt180 -66.57 -39.82 88.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 84.9 t -46.75 113.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 319' ' ' ARG . 82.1 p -108.88 165.81 11.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.136 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -42.05 -50.28 4.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 72.9 mtt85 -43.29 -50.48 6.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -49.52 -44.28 46.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.489 ' HA ' HD12 ' A' ' 328' ' ' LEU . 96.1 mt -64.61 -51.87 60.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 91.8 t -48.27 -51.94 8.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.203 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.2 t -62.9 -40.52 97.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.935 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.517 HD21 ' CE2' ' A' ' 373' ' ' TYR . 23.0 mt -55.69 -42.83 75.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.879 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -121.18 41.62 3.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -82.54 -35.7 26.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . 0.545 ' HG3' ' CE2' ' A' ' 332' ' ' PHE . 6.3 ptp180 -55.98 -23.69 34.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.855 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.693 ' O ' HD11 ' A' ' 340' ' ' ILE . 9.0 m-85 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.701 HD13 ' CE2' ' A' ' 357' ' ' PHE . 75.6 mt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.724 0.297 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -91.04 117.25 29.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -105.92 146.02 30.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -141.26 126.51 18.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 33.4 tpp -117.18 135.01 54.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . 0.496 ' CE ' ' CD2' ' A' ' 354' ' ' PHE . 31.0 mtm . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.497 ' C ' ' CD ' ' A' ' 352' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 112.409 -0.276 . . . . 0.0 112.409 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.497 ' CD ' ' C ' ' A' ' 351' ' ' GLY . 23.8 mp0 -154.38 130.31 10.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.857 0.361 . . . . 0.0 110.953 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -153.76 141.89 20.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.129 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.674 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 43.4 m-85 -103.34 152.62 21.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 45.3 mt -148.79 134.75 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 309' ' ' LYS . 21.0 m -118.14 127.49 53.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.848 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 42.2 m-85 -104.41 157.8 33.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.641 0.734 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.83 -47.63 9.74 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.668 2.245 . . . . 0.0 112.31 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -141.96 138.7 32.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . 0.425 ' CD ' ' H ' ' A' ' 360' ' ' LYS . 0.0 OUTLIER -45.82 -27.5 0.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.896 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.28 -58.6 7.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' A' ' 332' ' ' PHE . 72.6 mt -57.67 -58.8 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.848 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -46.34 -46.5 18.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.12 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -54.73 -61.58 2.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.999 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -50.25 -37.35 35.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.81 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -69.24 -45.62 69.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.689 HD12 HD22 ' A' ' 311' ' ' LEU . 6.6 tt -55.94 -51.04 69.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -63.95 -36.02 82.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 39.9 mt -74.38 -28.01 60.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 366' ' ' ALA . 17.2 t -102.01 -4.47 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 367' ' ' LEU . 1.4 p-10 -55.21 127.32 28.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 63.72 49.48 68.35 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.448 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.517 ' CE2' HD21 ' A' ' 328' ' ' LEU . 82.3 t80 -93.81 112.49 24.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 110.902 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -67.81 105.96 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 37.3 tp -118.75 118.03 30.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 55.47 35.12 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 73.4 29.52 63.9 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -133.29 129.41 37.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.78 0.324 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 51.0 mm -77.51 90.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.567 HD23 ' C ' ' A' ' 380' ' ' LEU . 8.0 tt -59.6 117.56 5.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.55 HG12 ' OE1' ' A' ' 383' ' ' GLU . 97.0 t -102.68 122.99 55.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.14 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.476 HG12 HD21 ' A' ' 380' ' ' LEU . 15.3 mt -109.26 139.19 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.113 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . 0.55 ' OE1' HG12 ' A' ' 381' ' ' VAL . 4.9 mp0 -138.65 124.86 20.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.524 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 27.9 m-85 -52.45 158.11 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.894 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.439 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo . . . . . 0 C--O 1.229 0.07 0 CA-C-O 120.868 0.278 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . 0.434 ' ND2' ' H ' ' A' ' 310' ' ' VAL . 61.0 t30 -153.64 165.79 34.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.835 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.51 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -84.97 -14.6 47.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.51 HG23 ' HD2' ' A' ' 309' ' ' LYS . 54.4 t -111.32 134.43 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.135 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.801 HD12 ' HE2' ' A' ' 357' ' ' PHE . 29.0 mt -119.04 120.67 37.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.897 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.792 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 13.9 t80 -106.41 102.69 12.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.688 HD23 HD21 ' A' ' 380' ' ' LEU . 6.2 mp -88.88 149.55 23.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.557 ' HE2' ' CD2' ' A' ' 312' ' ' TYR . 22.5 mttt -137.56 -176.73 4.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 55.35 53.9 9.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.2 mt -109.32 117.68 34.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.898 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 38.6 t -61.34 139.91 94.67 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.675 0.75 . . . . 0.0 110.874 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -43.2 -27.63 1.17 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.703 2.268 . . . . 0.0 112.256 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.514 ' HB3' ' CE2' ' A' ' 376' ' ' TYR . 23.0 mmt85 -69.73 -42.85 73.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.857 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 93.5 t -44.31 136.34 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.13 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.8 p -135.88 166.54 23.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.101 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -41.64 -52.45 3.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -40.94 -41.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.69 -46.72 86.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 328' ' ' LEU . 81.3 mt -60.33 -44.8 95.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.928 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 95.0 t -55.12 -60.54 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 4.8 t -54.12 -40.63 67.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.904 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 325' ' ' LEU . 28.7 mt -56.74 -44.9 82.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.6 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 54.2 m-85 -120.54 45.76 2.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -84.06 -39.55 19.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -45.26 -37.36 4.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.785 ' O ' HD11 ' A' ' 340' ' ' ILE . 11.9 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.785 HD11 ' O ' ' A' ' 332' ' ' PHE . 59.5 mt . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.78 0.324 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -93.83 116.52 28.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -103.49 149.07 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -141.19 125.25 17.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.849 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 41.7 tpp -114.57 135.63 53.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 9.1 ttm . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.842 179.96 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.405 ' C ' ' CD ' ' A' ' 352' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.405 ' CD ' ' C ' ' A' ' 351' ' ' GLY . 3.2 mp0 -148.37 141.38 24.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 110.861 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -150.05 151.58 33.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.099 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.792 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 58.0 m-85 -116.05 143.73 45.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.825 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.475 HD12 HD11 ' A' ' 313' ' ' LEU . 77.4 mt -136.0 139.2 46.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.144 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 83.3 m -124.41 117.41 24.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.13 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.801 ' HE2' HD12 ' A' ' 311' ' ' LEU . 84.0 m-85 -96.75 158.08 34.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.649 0.738 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.7 -35.39 23.21 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.739 2.293 . . . . 0.0 112.307 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -149.71 178.68 8.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.84 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -74.58 -49.93 19.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -41.13 -63.62 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 46.6 mt -51.68 -61.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -38.86 -60.81 0.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.138 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 14.0 t90 -48.42 -56.81 7.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -50.54 -47.09 57.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . 0.6 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -58.28 -32.18 68.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.079 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.685 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.2 tt -70.42 -69.94 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.916 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . 0.579 ' N ' HD23 ' A' ' 367' ' ' LEU . 4.5 t60 -48.01 -32.68 6.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 41.7 mt -74.32 -41.53 60.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 370' ' ' VAL . 47.3 t -104.04 33.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.187 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.34 139.7 37.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.901 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 52.42 40.02 53.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.442 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.422 ' CE1' HD21 ' A' ' 328' ' ' LEU . 32.7 t80 -80.2 120.04 23.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.013 0.435 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -63.68 112.1 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 29.4 tp -121.67 127.27 50.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . 0.514 ' CE2' ' HB3' ' A' ' 319' ' ' ARG . 31.5 m-85 41.27 46.32 2.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 59.97 44.68 96.96 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.443 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -156.03 114.56 3.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.717 0.294 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 17.2 mm -50.62 111.03 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.688 HD21 HD23 ' A' ' 313' ' ' LEU . 8.3 tt -80.39 120.16 24.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.64 118.18 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.469 HD11 ' O ' ' A' ' 370' ' ' VAL . 29.4 mt -99.04 136.83 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.098 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.49 177.66 7.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.921 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.685 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 41.3 m-85 -109.98 135.23 51.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.51 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo . . . . . 0 N--CA 1.467 -0.086 0 CA-C-O 120.813 0.256 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -117.92 175.29 5.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.661 ' HG3' HG23 ' A' ' 310' ' ' VAL . 5.9 ptmm? -86.96 -36.78 18.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.661 HG23 ' HG3' ' A' ' 309' ' ' LYS . 83.9 t -96.08 125.48 48.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.105 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.446 ' CD2' ' CE1' ' A' ' 384' ' ' PHE . 34.5 mt -108.64 112.17 24.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.738 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 14.6 t80 -83.6 104.24 13.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.943 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.764 HD23 HD11 ' A' ' 380' ' ' LEU . 8.1 mp -90.66 136.71 32.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -132.24 -177.08 4.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 58.72 47.44 12.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.6 mt -106.61 111.54 24.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.4 t -45.77 142.06 3.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.701 0.762 . . . . 0.0 110.847 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.04 -19.37 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.66 2.24 . . . . 0.0 112.343 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -82.73 -37.98 23.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 60.8 t -40.77 137.17 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.176 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 4.5 p -135.77 168.25 19.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -45.99 -45.28 15.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -45.38 -59.26 2.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.876 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -44.36 -50.49 9.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 328' ' ' LEU . 28.8 mt -55.18 -41.94 72.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.979 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 98.3 t -56.69 -57.44 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.151 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 4.5 t -59.86 -24.16 64.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 325' ' ' LEU . 33.3 mt -76.07 -40.33 53.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.934 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -123.69 39.71 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -88.25 -38.71 15.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -55.61 -17.28 5.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.492 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 57.9 m-85 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 43.9 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.77 0.319 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -93.01 127.77 38.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -118.56 142.39 47.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.866 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -141.27 126.18 18.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 11.4 ttm -115.4 125.79 53.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.945 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 9.8 ptp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.886 179.998 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -129.5 150.86 50.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.329 . . . . 0.0 110.945 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -154.71 152.15 29.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.738 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 41.5 m-85 -121.14 126.43 49.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 95.6 mt -118.29 142.79 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.42 HG23 ' HZ3' ' A' ' 309' ' ' LYS . 4.8 m -123.53 121.56 35.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.682 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 37.5 m-85 -99.69 159.05 30.98 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.663 0.744 . . . . 0.0 110.864 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.48 -42.46 18.11 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.688 2.259 . . . . 0.0 112.302 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -153.89 156.44 37.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . 0.434 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 13.7 ptpt -48.6 -45.98 38.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.915 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . 0.434 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 20.1 mm-40 -41.24 -65.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.857 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' A' ' 363' ' ' ALA . 79.1 mt -54.08 -64.73 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.682 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -36.09 -57.6 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.062 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -49.05 -58.75 4.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -50.01 -48.19 52.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . 0.492 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -57.66 -38.84 75.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.771 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 5.2 tt -64.38 -60.7 2.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . 0.556 ' N ' HD23 ' A' ' 367' ' ' LEU . 32.8 t60 -56.19 -27.55 54.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 30.2 mt -79.83 -37.11 35.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 370' ' ' VAL . 13.7 t -110.14 35.92 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.172 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -87.65 106.82 18.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.831 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 90.42 31.61 10.33 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.434 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.431 ' CE1' HD21 ' A' ' 328' ' ' LEU . 19.2 t80 -76.19 119.06 19.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.834 0.35 . . . . 0.0 110.991 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -66.71 107.28 2.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 15.0 tp -111.93 114.51 27.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.985 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 53.94 40.02 31.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 69.91 29.73 70.68 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.459 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -143.26 113.41 7.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.845 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 19.9 mm -53.88 128.06 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.09 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.764 HD11 HD23 ' A' ' 313' ' ' LEU . 5.5 tt -94.18 117.29 29.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 86.5 t -98.5 128.9 49.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.163 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.405 HG12 HD21 ' A' ' 380' ' ' LEU . 24.3 mt -110.58 132.22 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -134.03 124.02 25.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.922 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.771 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 39.8 m-85 -55.46 151.29 10.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.824 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.487 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.784 0.243 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -110.35 177.01 4.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.846 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -88.16 -25.17 23.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 23.5 t -97.89 128.68 49.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.088 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.696 HD12 ' CE1' ' A' ' 357' ' ' PHE . 48.7 mt -115.63 118.31 32.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.012 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.769 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 15.0 t80 -98.23 102.34 14.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.584 HD23 HD11 ' A' ' 380' ' ' LEU . 5.1 mp -88.5 146.54 25.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -138.06 -176.35 4.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 59.7 53.6 4.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.5 mt -115.65 122.84 46.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 18.0 t -64.5 143.87 98.59 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.68 0.753 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.72 -19.5 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.695 2.264 . . . . 0.0 112.386 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 -77.11 -35.16 56.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 97.6 t -48.53 146.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 12.2 p -145.24 175.33 10.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.113 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -48.38 -47.02 37.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -44.47 -54.37 6.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.24 -51.52 25.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 355' ' ' ILE . 57.2 mt -57.31 -47.53 81.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 330' ' ' ALA . 96.5 t -55.08 -61.78 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.184 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 11.6 t -53.09 -37.59 61.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.436 HD21 ' CD2' ' A' ' 373' ' ' TYR . 32.6 mt -63.23 -40.26 96.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.897 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -120.79 40.54 3.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -82.64 -21.17 35.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.08 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -69.66 -36.99 76.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 -179.87 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.607 HD13 ' CE2' ' A' ' 357' ' ' PHE . 85.4 mt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.726 0.298 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -100.88 117.77 35.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -102.34 138.8 38.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -134.35 129.29 35.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 40.5 tpp -112.87 145.14 41.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . 0.452 ' HE3' ' N ' ' A' ' 345' ' ' MET . 18.6 mmt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -139.87 166.75 23.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 110.882 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -158.6 149.26 20.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.769 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 12.9 m-85 -119.39 121.82 40.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.836 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.444 HD11 HD22 ' A' ' 325' ' ' LEU . 61.9 mt -110.14 144.47 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.15 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 340' ' ' ILE . 17.2 m -120.89 117.76 28.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.132 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.696 ' CE1' HD12 ' A' ' 311' ' ' LEU . 53.6 m-85 -98.94 155.76 36.25 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.625 0.726 . . . . 0.0 110.857 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.57 -42.0 18.61 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.75 2.3 . . . . 0.0 112.324 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.75 171.55 17.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 0.9 OUTLIER -64.78 -48.94 72.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . 0.412 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 7.3 mm-40 -39.99 -63.17 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 363' ' ' ALA . 90.6 mt -53.27 -65.82 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -36.98 -55.49 0.92 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -48.3 -63.47 1.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -45.29 -48.89 13.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . 0.442 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -60.17 -33.74 72.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.091 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.886 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.4 tt -68.01 -63.29 1.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -50.65 -34.21 25.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 24.9 mt -75.34 -57.66 3.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.961 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.527 ' O ' HD11 ' A' ' 382' ' ' ILE . 5.9 t -84.1 31.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.115 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -87.27 103.85 15.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 90.77 37.45 6.43 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.436 ' CD2' HD21 ' A' ' 328' ' ' LEU . 73.9 t80 -82.38 107.64 15.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 0.0 110.961 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -59.09 126.96 29.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.64 124.97 18.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 49.41 34.68 6.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.946 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 73.44 38.03 52.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.438 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.15 150.48 47.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.784 0.325 . . . . 0.0 110.839 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 43.1 mm -97.17 87.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.61 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.2 tt -52.07 133.63 32.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.957 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.469 ' N ' HD23 ' A' ' 380' ' ' LEU . 85.0 t -120.62 122.95 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.527 HD11 ' O ' ' A' ' 370' ' ' VAL . 21.5 mt -104.81 132.43 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.129 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -139.99 119.17 12.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.886 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 58.1 m-85 -51.33 151.59 2.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo . . . . . 0 N--CA 1.466 -0.102 0 CA-C-O 120.766 0.236 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -138.43 160.06 40.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.566 ' HG3' HG23 ' A' ' 310' ' ' VAL . 11.4 ptmt -68.94 -28.42 66.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.94 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.566 HG23 ' HG3' ' A' ' 309' ' ' LYS . 73.9 t -95.85 134.32 33.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.554 HD12 ' CE1' ' A' ' 357' ' ' PHE . 45.4 mt -123.5 121.7 36.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.696 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 10.3 t80 -96.94 113.42 24.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.505 HD12 ' N ' ' A' ' 313' ' ' LEU . 5.3 mp -103.26 145.98 29.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.401 ' HD3' ' N ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -144.68 -179.7 6.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.955 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.4 m120 60.77 51.48 4.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.5 mt -113.23 115.97 29.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 21.3 t -50.29 146.28 8.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.647 0.737 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.86 -26.37 7.12 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.656 2.237 . . . . 0.0 112.291 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.444 ' HB3' ' NH1' ' A' ' 319' ' ' ARG . 7.5 mtp-105 -72.04 -31.7 66.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.27 132.34 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.166 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 322' ' ' GLU . 41.9 p -139.25 168.36 19.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.091 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 321' ' ' THR . 26.0 tt0 -37.06 -46.72 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.924 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 324' ' ' ASP . 70.7 mtm180 -47.36 -62.24 1.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 323' ' ' ARG . 4.7 m-20 -37.8 -50.92 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.598 HD22 HD11 ' A' ' 355' ' ' ILE . 22.6 mt -59.64 -47.71 84.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.962 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.634 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 94.9 t -46.6 -52.23 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 47.0 t -64.09 -42.39 96.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.482 HD21 ' CE2' ' A' ' 373' ' ' TYR . 78.3 mt -56.28 -49.33 74.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.986 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -113.72 35.04 4.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -70.58 -42.79 70.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.095 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . 0.488 ' HG3' ' CD1' ' A' ' 332' ' ' PHE . 11.4 ptm180 -40.85 -52.53 3.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.81 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.488 ' CD1' ' HG3' ' A' ' 331' ' ' ARG . 16.2 m-85 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.936 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.705 HG22 ' CE1' ' A' ' 342' ' ' PHE . 96.2 mt . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.802 0.334 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -121.88 127.74 50.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . 0.705 ' CE1' HG22 ' A' ' 340' ' ' ILE . 2.4 m-85 -111.61 139.57 46.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 31.3 ttt85 -135.4 123.22 22.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 17.7 ttm -116.9 129.56 56.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -107.89 139.97 41.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.96 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -148.46 158.75 44.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.118 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.696 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 47.7 m-85 -132.27 130.26 40.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.598 HD11 HD22 ' A' ' 325' ' ' LEU . 85.7 mt -118.68 140.52 42.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.092 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.416 HG23 ' CE ' ' A' ' 309' ' ' LYS . 26.1 m -113.19 105.57 13.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 44.0 m-85 -90.03 158.81 43.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.672 0.749 . . . . 0.0 110.889 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -42.31 -55.52 2.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.605 2.203 . . . . 0.0 112.402 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.0 -176.49 5.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 43.7 pttt -67.57 -51.17 53.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . 0.406 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 10.7 mm-40 -39.16 -66.13 0.31 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.44 ' O ' ' C ' ' A' ' 363' ' ' ALA . 61.1 mt -55.27 -65.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.193 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.571 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -34.67 -56.33 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.143 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -50.63 -56.17 13.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 369' ' ' LEU . 30.4 mt-30 -50.97 -43.19 60.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -62.7 -41.48 99.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.07 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.742 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 6.5 tt -62.95 -63.55 1.17 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.972 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . 0.52 ' N ' HD23 ' A' ' 367' ' ' LEU . 46.1 t60 -55.92 -31.87 63.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.868 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.422 ' CG ' ' O ' ' A' ' 365' ' ' GLN . 37.0 mt -74.32 -33.02 63.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 370' ' ' VAL . 23.0 t -113.6 25.56 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 367' ' ' LEU . 1.6 p30 -69.43 138.15 53.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.883 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 46.35 49.12 15.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.493 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.482 ' CE2' HD21 ' A' ' 328' ' ' LEU . 89.3 t80 -83.29 118.44 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.03 0.443 . . . . 0.0 110.949 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -68.63 109.95 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.928 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.503 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 45.5 tp -126.42 126.07 43.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.832 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . 0.503 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 39.4 m-85 51.16 38.5 21.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 68.19 35.5 83.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.468 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -140.87 133.74 29.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.74 0.305 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 16.9 mm -79.39 88.45 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.154 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.635 HD23 ' C ' ' A' ' 380' ' ' LEU . 6.3 tt -58.87 127.49 32.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.884 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.8 t -107.74 130.58 59.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.471 HG13 ' CD2' ' A' ' 380' ' ' LEU . 55.1 mt -112.6 139.68 36.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.14 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -135.45 178.98 6.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.742 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 50.3 m-85 -111.75 129.53 56.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.946 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 -179.938 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.824 0.26 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -103.2 175.8 5.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.553 ' CD ' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -91.49 5.85 47.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.553 HG23 ' CD ' ' A' ' 309' ' ' LYS . 93.5 t -129.91 135.26 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.15 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.685 HD12 ' CE1' ' A' ' 357' ' ' PHE . 96.5 mt -116.11 120.72 39.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.658 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 9.4 t80 -101.68 101.86 12.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.93 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.573 HD23 HD11 ' A' ' 380' ' ' LEU . 5.7 mp -92.96 146.79 23.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 -176.26 4.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 61.38 49.1 5.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.6 mt -115.51 137.44 52.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 38.7 t -70.67 140.02 86.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.654 0.74 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -43.61 -21.64 0.33 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.732 2.288 . . . . 0.0 112.291 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.58 ' O ' HG23 ' A' ' 321' ' ' THR . 11.4 mtp85 -76.65 -41.29 46.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . 0.419 HG22 ' HD2' ' A' ' 376' ' ' TYR . 70.7 t -42.52 123.69 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.149 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 319' ' ' ARG . 40.7 p -123.08 171.99 8.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.174 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -44.56 -51.25 9.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.885 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -40.83 -50.25 3.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -53.67 -44.25 69.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 32.5 mt -64.7 -48.51 74.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 89.3 t -49.82 -54.51 7.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.157 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 22.8 t -59.15 -41.79 89.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.859 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 44.0 mt -57.52 -45.86 84.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.767 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 36.2 m-85 -120.49 49.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -91.41 -51.42 5.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -42.74 -49.54 5.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 40.0 m-85 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 57.4 mt . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.827 0.346 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -90.76 132.92 35.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.946 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -125.1 138.36 54.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -139.08 128.91 24.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.5 tpp -112.93 141.65 46.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . 0.42 ' HE3' ' HB2' ' A' ' 345' ' ' MET . 7.3 mtm . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -132.28 152.55 51.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.871 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.55 150.06 35.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.658 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 39.2 m-85 -116.47 121.31 41.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.818 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 61.7 mt -114.4 133.29 60.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.192 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.2 m -114.58 114.2 25.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.129 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.685 ' CE1' HD12 ' A' ' 311' ' ' LEU . 37.4 m-85 -91.95 157.94 40.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.722 0.772 . . . . 0.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.4 -47.82 12.48 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.647 2.232 . . . . 0.0 112.371 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -138.83 174.42 10.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -69.92 -44.15 70.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -50.97 -58.21 6.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 97.3 mt -53.15 -52.67 28.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.13 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -45.99 -61.35 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -45.79 -55.56 6.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -43.8 -53.93 5.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . 0.767 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -60.31 -28.43 68.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.13 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.772 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.2 tt -70.15 -65.99 0.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.921 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -53.75 -28.67 35.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 30.1 mt -78.44 -48.88 14.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 370' ' ' VAL . 12.1 t -97.37 30.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . 0.42 ' O ' ' CG ' ' A' ' 371' ' ' ASN . 2.0 t30 -82.83 85.97 7.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.956 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 108.9 52.22 0.66 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.436 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -99.51 110.06 22.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.975 0.417 . . . . 0.0 110.898 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -61.47 125.7 24.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 30.3 tp -138.27 128.37 25.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.92 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . 0.419 ' HD2' HG22 ' A' ' 320' ' ' VAL . 41.2 m-85 48.17 42.69 17.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 61.52 37.06 93.53 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.562 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -148.35 114.44 5.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 110.974 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 34.9 mm -58.4 130.51 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.099 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.592 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.6 tt -90.93 135.92 33.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.916 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.55 ' N ' HD23 ' A' ' 380' ' ' LEU . 50.8 t -121.67 125.76 73.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.457 HG12 HD21 ' A' ' 380' ' ' LEU . 12.8 mt -111.65 137.91 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.118 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -145.78 122.09 10.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.772 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 38.7 m-85 -47.15 151.74 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.507 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo . . . . . 0 N--CA 1.465 -0.154 0 CA-C-O 120.828 0.262 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -107.9 172.64 6.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 7.57 32.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 98.0 t -126.82 123.64 63.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.587 HD22 HD12 ' A' ' 367' ' ' LEU . 57.0 mt -109.69 129.2 55.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.802 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 10.3 t80 -110.32 101.62 10.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.708 HD21 ' CE1' ' A' ' 329' ' ' PHE . 5.7 mp -86.43 144.37 27.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.431 ' HG3' ' C ' ' A' ' 313' ' ' LEU . 3.2 mtpm? -142.56 179.11 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . 0.445 HD22 ' CG2' ' A' ' 381' ' ' VAL . 20.2 m-20 60.93 54.72 3.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.529 HD21 ' HG ' ' A' ' 380' ' ' LEU . 16.3 mt -119.6 109.46 15.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 42.8 t -45.71 145.37 2.26 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.708 0.766 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -46.44 -20.65 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.359 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -73.22 -37.67 66.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.971 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 84.4 t -52.55 126.06 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.08 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 37.4 p -121.36 171.72 8.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.136 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -45.07 -42.39 8.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -49.87 -46.98 52.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -52.69 -49.39 65.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.895 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 328' ' ' LEU . 30.4 mt -59.31 -54.45 46.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 99.9 t -45.89 -52.82 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 1.4 t -61.62 -43.73 98.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.747 HD21 ' CE2' ' A' ' 373' ' ' TYR . 36.9 mt -54.2 -40.37 67.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.932 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.708 ' CE1' HD21 ' A' ' 313' ' ' LEU . 6.6 m-85 -125.93 44.48 2.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -89.57 -51.25 5.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.073 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 15.9 ptm180 -44.43 -46.54 9.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.432 ' N ' ' HG3' ' A' ' 331' ' ' ARG . 24.0 m-85 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 356' ' ' THR . 74.6 mt . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 120.725 0.297 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -88.95 136.97 32.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -123.82 139.55 53.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.4 ' HG2' ' CE ' ' A' ' 345' ' ' MET . 46.0 ttp180 -141.29 135.18 30.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 12.2 ttm -112.93 140.09 48.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . 0.4 ' CE ' ' HG2' ' A' ' 343' ' ' ARG . 25.4 mmt . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -99.23 158.13 15.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 0.0 110.925 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -151.23 147.57 27.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.802 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 39.0 m-85 -113.73 119.15 36.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 75.5 mt -114.14 140.89 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.124 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.626 ' O ' HG23 ' A' ' 340' ' ' ILE . 44.0 m -118.54 130.96 56.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.557 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 18.4 m-85 -109.01 155.83 40.2 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.688 0.756 . . . . 0.0 110.909 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.9 -39.56 32.1 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.711 2.274 . . . . 0.0 112.392 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -144.53 179.45 7.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.2 ptmm? -80.12 -31.89 39.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.8 -64.53 0.87 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 75.4 mt -47.69 -65.28 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.124 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -38.15 -55.92 1.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -49.08 -60.95 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -45.01 -54.67 6.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . 0.698 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -57.91 -42.83 85.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.067 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.983 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 4.5 tt -58.58 -55.47 34.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . 0.539 ' N ' HD23 ' A' ' 367' ' ' LEU . 14.0 t60 -58.42 -28.63 65.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.882 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 29.5 mt -79.87 -36.76 36.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 366' ' ' ALA . 19.1 t -91.26 -6.29 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.143 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 371' ' ' ASN . 0.0 OUTLIER -49.6 122.3 6.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.864 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 67.32 48.0 60.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.494 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.747 ' CE2' HD21 ' A' ' 328' ' ' LEU . 76.0 t80 -90.11 110.13 21.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.932 0.396 . . . . 0.0 110.891 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -68.48 114.09 6.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.685 HD13 ' HE2' ' A' ' 373' ' ' TYR . 33.2 tp -121.94 125.0 45.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.926 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 48.72 41.41 17.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 66.29 37.87 93.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.417 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -148.85 114.69 5.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.802 0.334 . . . . 0.0 110.916 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 32.9 mm -57.8 122.26 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.529 ' HG ' HD21 ' A' ' 316' ' ' LEU . 7.4 tt -85.13 129.02 34.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.455 ' N ' HD23 ' A' ' 380' ' ' LEU . 76.6 t -103.53 119.91 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 16.3 mt -109.05 130.03 62.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -139.67 131.34 27.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.983 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 81.7 m-85 -59.05 123.28 16.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.481 -179.97 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.729 0.22 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' A' ' 384' ' ' PHE . 49.1 m-20 -101.11 172.35 7.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.467 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -90.85 1.94 56.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.467 HG23 ' HD2' ' A' ' 309' ' ' LYS . 68.7 t -121.4 128.61 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.1 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.62 HD12 ' CE1' ' A' ' 357' ' ' PHE . 28.1 mt -114.29 120.34 40.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.779 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 13.0 t80 -105.62 106.05 16.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.635 HD12 ' N ' ' A' ' 313' ' ' LEU . 1.1 mp -91.43 156.19 17.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.932 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.557 ' HE2' ' CD2' ' A' ' 312' ' ' TYR . 41.1 mttt -144.22 -176.59 5.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 15.2 m120 56.76 52.61 9.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.6 mt -115.88 113.21 23.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 40.1 t -55.8 145.15 53.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.752 0.787 . . . . 0.0 110.842 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -46.07 -25.74 3.12 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.725 2.284 . . . . 0.0 112.349 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.513 ' O ' HG23 ' A' ' 321' ' ' THR . 10.9 mtp85 -69.61 -41.96 75.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.829 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 66.6 t -44.18 134.65 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.15 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 319' ' ' ARG . 35.9 p -135.66 169.06 18.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -41.15 -48.57 3.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -40.42 -54.43 2.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -48.75 -59.99 3.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.587 ' HA ' HD12 ' A' ' 328' ' ' LEU . 36.8 mt -49.25 -52.31 27.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 80.6 t -46.27 -58.23 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 2.2 t -57.75 -43.64 85.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.587 HD12 ' HA ' ' A' ' 325' ' ' LEU . 41.9 mt -56.08 -41.61 75.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -125.83 45.98 2.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -88.0 -41.87 12.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -52.05 -18.54 1.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.807 -179.867 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 60.8 mt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.831 0.348 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -100.93 116.08 31.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.938 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -103.09 142.8 33.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -141.07 129.75 22.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.3 ttm -108.88 145.44 35.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 27.9 ttm . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.853 179.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 29.3 mp0 -152.31 133.03 14.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.888 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -135.59 147.23 48.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.079 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.779 ' CE2' ' CE1' ' A' ' 312' ' ' TYR . 42.6 m-85 -115.32 130.14 56.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 69.7 mt -121.5 141.72 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.188 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 39.7 m -121.21 108.61 13.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.795 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 51.3 m-85 -88.5 156.67 50.59 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 0.0 110.897 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -47.03 -47.52 16.52 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.695 2.263 . . . . 0.0 112.304 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -148.78 146.3 27.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.912 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -40.42 -41.6 1.43 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -44.49 -65.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.427 HG22 ' CD2' ' A' ' 357' ' ' PHE . 75.2 mt -57.55 -57.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.078 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.795 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -40.81 -49.07 3.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -58.56 -62.57 1.76 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -47.92 -45.6 31.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.939 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.36 85.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.164 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.666 ' C ' HD23 ' A' ' 367' ' ' LEU . 5.5 tt -63.36 -65.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . 0.641 ' N ' HD23 ' A' ' 367' ' ' LEU . 2.4 t60 -46.5 -33.58 4.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 37.3 mt -69.9 -53.0 19.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.952 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.36 36.59 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -83.54 85.77 7.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 106.55 46.18 1.16 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.491 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -89.95 120.52 31.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.008 0.433 . . . . 0.0 110.898 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -70.18 135.4 49.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 28.6 tp -148.29 116.33 6.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.955 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 53.59 42.1 31.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 66.69 30.65 76.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.47 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . 0.428 ' NZ ' ' HA ' ' A' ' 378' ' ' LYS . 0.0 OUTLIER -134.26 124.24 25.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.74 0.305 . . . . 0.0 110.888 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 33.8 mm -74.55 107.76 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.607 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.3 tt -70.16 127.84 34.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.57 126.44 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.148 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.421 HG12 HD21 ' A' ' 380' ' ' LEU . 15.0 mt -106.52 137.59 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.161 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -146.39 121.45 10.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.568 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 54.2 m-85 -52.64 140.0 24.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.853 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.493 -179.937 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 384' ' ' PHE . 59.3 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 CA-C-O 120.916 0.298 . . . . 0.0 112.27 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -130.92 -179.07 5.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.647 ' HG3' HG23 ' A' ' 310' ' ' VAL . 39.7 pttt -84.91 -26.75 27.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.647 HG23 ' HG3' ' A' ' 309' ' ' LYS . 18.3 t -102.72 145.32 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.858 HD12 ' CE1' ' A' ' 357' ' ' PHE . 77.0 mt -125.92 135.23 51.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.546 ' CD1' ' HE2' ' A' ' 314' ' ' LYS . 0.7 OUTLIER -102.86 101.46 11.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.866 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.629 HD13 HG13 ' A' ' 355' ' ' ILE . 5.7 mp -91.12 140.96 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.905 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.546 ' HE2' ' CD1' ' A' ' 312' ' ' TYR . 14.6 mttm -139.38 -178.8 5.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 60.53 47.59 8.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.441 ' HB3' HG11 ' A' ' 320' ' ' VAL . 10.8 mt -105.59 99.61 9.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 316' ' ' LEU . 28.9 t -38.08 144.02 0.38 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.642 0.734 . . . . 0.0 110.924 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -44.54 -33.75 7.0 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.673 2.249 . . . . 0.0 112.382 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.58 ' O ' HG23 ' A' ' 321' ' ' THR . 16.6 mtp85 -68.5 -39.26 81.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 316' ' ' LEU . 97.5 t -41.23 138.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 319' ' ' ARG . 68.9 p -138.0 176.1 9.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -45.13 -54.23 7.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 324' ' ' ASP . 9.4 mmm180 -42.0 -64.99 0.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.94 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 323' ' ' ARG . 40.3 m-20 -35.92 -47.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 76.0 mt -65.45 -49.39 69.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.923 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 330' ' ' ALA . 55.3 t -48.7 -59.39 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 43.8 t -56.13 -42.73 77.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.671 HD21 ' CE2' ' A' ' 373' ' ' TYR . 29.3 mt -57.16 -31.41 65.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.902 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.5 ' CE1' HD21 ' A' ' 313' ' ' LEU . 64.2 m-85 -129.45 36.8 4.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -85.56 -48.69 8.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -42.54 -41.76 3.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.762 0.315 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -109.54 127.47 54.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . 0.56 ' CE2' HD13 ' A' ' 355' ' ' ILE . 91.0 m-85 -115.56 141.58 47.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.863 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -137.11 127.21 26.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 30.0 tpp -117.15 136.97 52.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 3.2 ptp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.838 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -116.61 151.47 36.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 0.0 110.965 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -163.97 157.2 18.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.094 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.481 ' CE2' ' CE2' ' A' ' 312' ' ' TYR . 8.8 m-85 -118.44 158.42 25.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.815 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.629 HG13 HD13 ' A' ' 313' ' ' LEU . 24.3 mt -144.89 117.25 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.187 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 13.3 m -97.55 131.53 44.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.1 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.858 ' CE1' HD12 ' A' ' 311' ' ' LEU . 7.7 m-85 -111.46 155.39 42.95 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.639 0.733 . . . . 0.0 110.892 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -44.26 -31.35 4.23 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.267 . . . . 0.0 112.379 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.1 177.29 11.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . 0.417 ' NZ ' ' O ' ' A' ' 307' ' ' PRO . 0.1 OUTLIER -72.33 -49.92 30.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -43.85 -63.94 0.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 79.3 mt -50.85 -59.03 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -44.54 -46.13 9.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.095 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -59.04 -67.84 0.33 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -37.5 -52.02 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . 0.609 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -55.94 -43.95 77.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.05 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.586 ' C ' HD23 ' A' ' 367' ' ' LEU . 7.9 tt -58.17 -55.24 37.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.894 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -67.45 -13.19 61.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 33.5 mt -93.01 -29.57 15.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 366' ' ' ALA . 6.2 t -109.21 17.2 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 371' ' ' ASN . 0.5 OUTLIER -75.08 117.13 16.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 81.39 36.5 20.31 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.487 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.671 ' CE2' HD21 ' A' ' 328' ' ' LEU . 65.0 t80 -81.79 114.08 20.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 0.0 110.917 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -70.07 104.4 2.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.959 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 51.2 tp -121.57 125.23 46.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 57.38 27.02 13.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.959 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 78.71 25.28 60.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.514 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -132.57 139.95 48.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 36.2 mm -84.17 94.6 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.126 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.654 HD23 ' C ' ' A' ' 380' ' ' LEU . 5.2 tt -57.54 130.11 44.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 39.3 t -110.69 124.39 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.597 HG12 HD21 ' A' ' 380' ' ' LEU . 14.8 mt -109.03 143.73 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -148.26 121.32 8.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.477 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 26.1 m-85 -46.69 149.2 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.83 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.458 -179.968 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 N--CA 1.466 -0.099 0 CA-C-O 120.791 0.246 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -153.47 166.29 33.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.629 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -84.4 29.88 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.867 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.629 HG23 ' HD2' ' A' ' 309' ' ' LYS . 90.8 t -146.9 123.21 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.178 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.521 HD21 ' HB1' ' A' ' 363' ' ' ALA . 20.4 mt -116.82 126.51 53.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.785 ' CE1' ' CZ ' ' A' ' 354' ' ' PHE . 18.0 t80 -103.94 101.56 11.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.871 HD23 HD11 ' A' ' 380' ' ' LEU . 6.5 mp -89.45 140.52 29.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.958 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -131.9 -176.06 3.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.839 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 55.61 52.98 10.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.919 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.5 mt -111.53 113.04 25.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.952 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 46.6 t -54.2 139.53 55.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.651 0.739 . . . . 0.0 110.867 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -42.37 -28.11 0.89 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.714 2.276 . . . . 0.0 112.35 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.402 ' O ' HG23 ' A' ' 321' ' ' THR . 26.4 mmt-85 -68.5 -40.4 80.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.852 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . 0.642 HG22 ' HD2' ' A' ' 376' ' ' TYR . 40.8 t -46.16 123.7 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.106 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 319' ' ' ARG . 18.3 p -122.05 168.49 11.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -40.81 -51.75 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -43.39 -50.11 6.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -50.04 -47.41 53.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 45.7 mt -61.46 -53.04 61.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.696 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 99.7 t -48.11 -49.56 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.182 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 5.8 t -63.46 -40.42 97.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.823 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.8 mt -58.46 -40.03 81.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.856 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.664 ' HZ ' HD21 ' A' ' 313' ' ' LEU . 14.2 m-85 -123.79 40.29 3.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -86.33 -34.28 20.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.075 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 9.9 ptp85 -55.51 -39.77 70.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.435 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 23.3 m-85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.455 HG22 ' CE1' ' A' ' 342' ' ' PHE . 79.4 mt . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.764 0.316 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -82.95 139.98 33.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . 0.455 ' CE1' HG22 ' A' ' 340' ' ' ILE . 79.8 m-85 -125.37 136.18 53.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -135.69 135.35 40.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.417 ' C ' ' CE ' ' A' ' 345' ' ' MET . 10.6 ttm -116.71 144.19 44.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . 0.417 ' CE ' ' C ' ' A' ' 344' ' ' MET . 22.5 mmt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -122.62 154.6 37.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.785 0.326 . . . . 0.0 110.978 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -149.59 144.5 26.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.055 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.785 ' CZ ' ' CE1' ' A' ' 312' ' ' TYR . 70.1 m-85 -120.23 119.0 31.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 313' ' ' LEU . 65.7 mt -108.25 142.61 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.122 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 26.4 m -122.96 103.91 8.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.803 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 26.9 m-85 -83.57 156.16 65.37 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.703 0.763 . . . . 0.0 110.858 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -45.21 -52.91 5.91 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.702 2.268 . . . . 0.0 112.287 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -133.92 162.37 32.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -61.14 -42.6 98.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -51.8 -58.23 7.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 72.2 mt -53.08 -61.03 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.803 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -42.84 -59.78 1.84 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -43.05 -60.38 1.66 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -43.57 -45.83 6.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.951 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -64.14 -33.66 76.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.15 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.612 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.1 tt -63.91 -61.65 2.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.923 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.05 -35.67 69.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.11 -42.95 68.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.521 ' O ' HD11 ' A' ' 382' ' ' ILE . 11.7 t -105.12 41.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -92.21 94.49 9.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 100.64 40.76 2.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.521 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -87.63 108.96 19.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.954 0.406 . . . . 0.0 110.928 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -60.38 123.25 16.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 26.0 tp -135.97 132.82 36.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . 0.642 ' HD2' HG22 ' A' ' 320' ' ' VAL . 37.0 m-85 48.35 45.75 20.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 57.51 34.19 68.52 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.51 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -150.56 114.13 4.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.339 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 45.7 mm -51.04 146.01 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.871 HD11 HD23 ' A' ' 313' ' ' LEU . 8.3 tt -104.7 140.39 38.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.647 ' N ' HD23 ' A' ' 380' ' ' LEU . 78.9 t -123.93 125.04 70.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.521 HD11 ' O ' ' A' ' 370' ' ' VAL . 11.8 mt -109.84 132.57 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.149 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -137.01 119.83 16.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.612 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 16.9 m-85 -48.67 114.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.478 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo . . . . . 0 N--CA 1.465 -0.153 0 CA-C-O 120.762 0.234 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -126.58 178.59 5.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.469 ' HG3' HG23 ' A' ' 310' ' ' VAL . 38.3 pttt -81.62 -28.09 33.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.469 HG23 ' HG3' ' A' ' 309' ' ' LYS . 81.7 t -95.0 138.68 20.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.202 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.508 HD12 ' CE1' ' A' ' 357' ' ' PHE . 77.7 mt -125.31 114.18 18.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.788 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 11.7 t80 -88.62 104.08 16.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.939 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 313' ' ' LEU . 6.4 mp -92.52 150.84 20.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.943 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -140.84 -175.0 4.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 57.75 48.31 14.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 12.1 mt -104.09 124.89 49.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.9 t -67.6 145.05 98.09 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.659 0.742 . . . . 0.0 110.828 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.55 -27.41 3.48 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.705 2.27 . . . . 0.0 112.307 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.532 ' O ' HG23 ' A' ' 321' ' ' THR . 32.5 mtp85 -74.25 -38.33 63.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . 0.667 HG22 HD21 ' A' ' 375' ' ' LEU . 93.2 t -41.36 146.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 319' ' ' ARG . 44.6 p -148.73 159.38 44.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.152 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.753 ' O ' HG23 ' A' ' 326' ' ' VAL . 1.2 tm-20 -41.02 -32.27 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . 0.426 ' NH1' ' HB2' ' A' ' 323' ' ' ARG . 17.7 ttm105 -60.66 -58.12 9.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.956 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -45.8 -48.55 15.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.873 ' HA ' HD12 ' A' ' 328' ' ' LEU . 36.1 mt -57.84 -51.64 68.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 322' ' ' GLU . 69.4 t -45.83 -47.34 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.418 ' HA ' ' HB2' ' A' ' 330' ' ' ALA . 8.8 t -67.28 -37.73 83.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.831 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.873 HD12 ' HA ' ' A' ' 325' ' ' LEU . 51.0 mt -56.52 -34.35 66.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.934 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.524 ' CE1' HG21 ' A' ' 370' ' ' VAL . 18.4 m-85 -127.9 32.85 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.853 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 327' ' ' SER . . . -71.24 -52.14 20.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.099 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -40.06 -49.77 2.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.834 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.919 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 83.9 mt . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.913 0.387 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -92.32 138.36 31.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -127.72 136.1 51.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.841 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -134.32 122.78 23.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.873 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 45.4 tpp -110.07 133.29 53.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 26.5 ttm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 179.906 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.431 ' N ' ' CD ' ' A' ' 352' ' ' GLN . 3.0 mp0 -112.18 141.74 45.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.816 0.341 . . . . 0.0 110.891 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.59 153.63 41.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.033 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.788 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 50.7 m-85 -125.24 124.19 41.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.75 137.65 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.136 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 83.4 m -113.9 128.68 56.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.689 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 69.8 m-85 -109.46 157.05 38.43 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 0.0 110.875 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -42.8 -34.97 3.91 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.62 2.213 . . . . 0.0 112.398 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . 0.481 ' ND2' ' H ' ' A' ' 362' ' ' ILE . 0.7 OUTLIER -159.44 -177.34 6.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -71.96 -45.62 60.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -43.12 -66.04 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.481 ' H ' ' ND2' ' A' ' 359' ' ' ASN . 58.1 mt -51.1 -69.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.152 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.689 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -36.3 -57.36 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -48.43 -57.28 6.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -50.28 -41.86 51.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . 0.481 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -65.65 -38.95 90.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.009 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.716 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 4.8 tt -60.75 -60.65 3.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 110.932 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . 0.634 ' N ' HD23 ' A' ' 367' ' ' LEU . 19.1 t-80 -62.08 -35.18 77.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 32.2 mt -67.46 -40.48 85.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 370' ' ' VAL . 10.5 t -107.18 32.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.71 125.41 29.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 64.88 38.31 95.37 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.445 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -78.65 124.93 28.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.877 0.37 . . . . 0.0 110.958 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -78.41 121.21 24.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.667 HD21 HG22 ' A' ' 320' ' ' VAL . 29.8 tp -125.77 143.97 50.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 38.46 33.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 72.13 47.81 28.82 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.433 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 378' ' ' LYS . 2.4 ptmt -165.92 120.49 1.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.825 0.345 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 46.6 mm -51.49 142.6 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.138 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.628 HD23 ' C ' ' A' ' 380' ' ' LEU . 5.6 tt -110.4 143.38 40.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.594 HG12 ' OE1' ' A' ' 383' ' ' GLU . 11.7 t -112.78 142.42 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.071 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.48 HG13 ' CD2' ' A' ' 380' ' ' LEU . 27.5 mt -134.56 136.14 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.153 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . 0.594 ' OE1' HG12 ' A' ' 381' ' ' VAL . 4.8 mp0 -138.63 178.93 6.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.968 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.716 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 48.7 m-85 -105.04 133.93 49.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.93 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.462 -179.92 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo . . . . . 0 N--CA 1.466 -0.113 0 CA-C-O 120.808 0.254 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -130.09 -177.79 4.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.544 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -99.12 -14.13 19.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.972 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.544 HG23 ' HD2' ' A' ' 309' ' ' LYS . 69.2 t -111.79 115.07 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.051 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.521 HD21 ' CE1' ' A' ' 384' ' ' PHE . 58.8 mt -100.32 140.23 34.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.849 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.752 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 10.6 t80 -122.27 102.88 8.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.964 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.688 HD23 HD11 ' A' ' 380' ' ' LEU . 6.6 mp -86.04 150.98 24.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.567 ' HE2' ' CD2' ' A' ' 312' ' ' TYR . 41.3 mttt -139.79 -175.9 4.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.919 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 54.59 52.35 12.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.0 mt -110.21 104.6 13.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 36.2 t -47.22 143.98 4.59 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.728 0.775 . . . . 0.0 110.823 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.37 -19.01 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.69 2.26 . . . . 0.0 112.335 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 30.5 mtt180 -77.38 -36.39 53.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 321' ' ' THR . 95.9 t -44.88 152.15 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 320' ' ' VAL . 35.3 p -158.78 166.52 31.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.164 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 321' ' ' THR . 7.3 mt-10 -34.78 -55.57 0.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.79 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 322' ' ' GLU . 60.3 mtp180 -37.45 -46.49 0.81 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -56.35 -59.71 4.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.431 ' CD2' HD22 ' A' ' 313' ' ' LEU . 23.1 mt -57.05 -51.2 70.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.926 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 92.6 t -53.11 -56.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.131 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 25.4 t -58.85 -39.51 81.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.9 mt -60.37 -40.52 91.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.471 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 28.9 m-85 -124.2 48.27 1.95 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.879 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -83.73 -57.45 3.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.992 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . 0.43 ' HB3' ' NH1' ' A' ' 331' ' ' ARG . 3.4 ptp180 -42.73 -46.1 5.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.891 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.439 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 74.3 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.533 HD13 ' CE2' ' A' ' 357' ' ' PHE . 71.0 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.766 0.317 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -96.18 137.15 35.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -120.08 151.65 38.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -141.27 125.24 17.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 40.4 tpp -112.94 133.63 54.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 11.9 ttm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.879 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 312' ' ' TYR . 2.8 mp0 -132.75 151.37 52.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 110.87 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -153.28 150.37 28.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.089 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.752 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 46.5 m-85 -114.64 152.72 31.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 94.7 mt -139.16 142.84 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.102 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.499 HG23 ' NZ ' ' A' ' 309' ' ' LYS . 49.7 m -124.86 121.73 35.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.141 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.533 ' CE2' HD13 ' A' ' 340' ' ' ILE . 62.2 m-85 -104.57 157.2 34.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.666 0.746 . . . . 0.0 110.802 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -46.29 -37.1 18.35 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.626 2.217 . . . . 0.0 112.368 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -149.12 174.44 12.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -71.19 -28.71 64.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -60.13 -63.33 1.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 59.2 mt -50.48 -57.53 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -40.95 -61.49 0.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.082 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -48.09 -63.07 1.17 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -43.48 -41.73 4.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.928 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . 0.471 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -63.05 -42.51 99.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.064 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.656 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.0 tt -63.02 -58.41 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.902 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -55.39 -31.28 61.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 51.3 mt -78.02 -37.32 47.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 370' ' ' VAL . 16.4 t -111.27 37.27 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.74 124.72 29.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 63.08 43.01 99.41 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.483 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' A' ' 374' ' ' LYS . 13.9 t80 -78.61 134.79 37.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 0.0 110.952 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.434 ' O ' ' CE1' ' A' ' 373' ' ' TYR . 21.1 ttmt -86.33 119.48 26.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 18.1 tp -133.83 120.7 20.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 53.34 41.17 32.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 67.21 31.29 77.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.451 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . 0.422 ' NZ ' ' HA ' ' A' ' 378' ' ' LYS . 0.0 OUTLIER -134.83 130.05 35.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.749 0.309 . . . . 0.0 110.829 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 33.7 mm -76.92 92.19 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.688 HD11 HD23 ' A' ' 313' ' ' LEU . 8.1 tt -61.16 114.69 3.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.67 HG12 ' OE1' ' A' ' 383' ' ' GLU . 34.1 t -101.05 127.98 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.107 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 370' ' ' VAL . 32.5 mt -104.79 126.8 59.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . 0.67 ' OE1' HG12 ' A' ' 381' ' ' VAL . 3.0 mp0 -128.65 125.73 38.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.835 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.656 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 44.8 m-85 -59.25 158.51 9.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.841 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 384' ' ' PHE . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo . . . . . 0 N--CA 1.466 -0.141 0 CA-C-O 120.782 0.242 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -115.73 176.75 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.467 ' CD ' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -90.43 5.24 48.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.467 HG23 ' CD ' ' A' ' 309' ' ' LYS . 60.5 t -127.72 129.75 70.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.44 HD21 ' HB1' ' A' ' 363' ' ' ALA . 49.3 mt -116.42 121.45 41.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.795 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 17.5 t80 -105.14 104.84 14.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.933 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 313' ' ' LEU . 3.2 mp -91.31 144.02 26.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.942 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -133.44 179.46 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.3 m120 57.23 51.83 9.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.462 ' HB3' HG11 ' A' ' 320' ' ' VAL . 13.8 mt -108.96 107.57 17.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.5 t -40.48 144.7 0.56 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.702 0.763 . . . . 0.0 110.893 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -47.16 -28.35 7.61 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.66 2.24 . . . . 0.0 112.336 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 24.2 mtt85 -73.51 -30.84 63.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . 0.462 HG11 ' HB3' ' A' ' 316' ' ' LEU . 84.9 t -51.26 119.34 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.125 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 17.2 p -124.72 172.77 9.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -44.37 -44.0 7.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 64.9 mtt-85 -48.56 -54.73 13.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -49.13 -45.03 42.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 57.6 mt -62.63 -53.52 53.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 81.6 t -44.36 -49.35 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 47.2 t -65.4 -45.64 83.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.833 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 57.8 mt -52.55 -36.8 56.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.949 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.591 ' CE1' HG21 ' A' ' 370' ' ' VAL . 25.4 m-85 -132.36 44.35 2.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.857 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -80.35 -52.82 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.051 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -37.32 -32.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.84 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 330' ' ' ALA . 86.6 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 64.3 mt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.768 0.318 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -96.31 127.85 42.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -117.66 142.42 47.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.44 ' HD3' ' N ' ' A' ' 344' ' ' MET . 0.8 OUTLIER -140.9 132.12 26.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.854 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.44 ' N ' ' HD3' ' A' ' 343' ' ' ARG . 39.7 tpp -113.83 143.43 44.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 21.3 ttm . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.916 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.404 ' C ' ' NE2' ' A' ' 352' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.441 ' HB3' ' CE1' ' A' ' 312' ' ' TYR . 10.1 mp0 -142.41 143.53 32.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 0.0 110.887 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.87 152.78 40.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.795 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 82.5 m-85 -120.27 132.67 55.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 78.4 mt -124.14 138.02 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.118 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 17.1 m -117.09 117.8 30.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.19 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.411 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 50.1 m-85 -98.86 158.17 32.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.696 0.76 . . . . 0.0 110.861 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.19 -35.59 15.44 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.661 2.241 . . . . 0.0 112.355 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -158.42 166.77 31.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 361' ' ' GLU . 8.7 pttt -58.0 -49.71 75.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 360' ' ' LYS . 2.2 tt0 -36.7 -63.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.878 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 55.0 mt -56.13 -62.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.131 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.44 ' HB1' HD21 ' A' ' 311' ' ' LEU . . . -38.6 -59.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.087 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -47.38 -58.16 4.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.404 ' O ' ' CG ' ' A' ' 369' ' ' LEU . 6.6 mm100 -53.76 -35.39 61.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . 0.423 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -68.12 -38.42 82.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.14 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.605 ' C ' HD23 ' A' ' 367' ' ' LEU . 7.4 tt -66.54 -56.79 9.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -60.96 -38.02 84.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.776 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.404 ' CG ' ' O ' ' A' ' 365' ' ' GLN . 37.3 mt -65.72 -40.91 92.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.591 HG21 ' CE1' ' A' ' 329' ' ' PHE . 7.3 t -106.15 28.96 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . 0.451 ' CG ' ' O ' ' A' ' 371' ' ' ASN . 0.8 OUTLIER -76.43 116.23 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 73.46 45.94 27.71 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.501 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.431 ' CE1' ' O ' ' A' ' 374' ' ' LYS . 38.6 t80 -85.32 138.07 32.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.912 0.386 . . . . 0.0 110.901 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.431 ' O ' ' CE1' ' A' ' 373' ' ' TYR . 22.4 ttmt -89.26 124.89 34.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 376' ' ' TYR . 60.7 tp -135.88 150.42 49.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.952 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 375' ' ' LEU . 25.2 m-85 35.57 35.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.953 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 375' ' ' LEU . . . 66.73 53.06 29.71 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.51 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -171.83 126.46 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.757 0.313 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 41.9 mm -56.28 144.71 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.161 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.676 HD23 ' C ' ' A' ' 380' ' ' LEU . 3.6 tt -112.34 140.37 47.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.442 ' N ' HD23 ' A' ' 380' ' ' LEU . 23.6 t -110.51 144.48 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.496 HD11 ' O ' ' A' ' 370' ' ' VAL . 23.6 mt -131.42 151.88 36.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.086 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -148.56 175.42 11.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.531 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 29.5 m-85 -104.51 154.2 20.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.472 -179.963 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 C--O 1.23 0.124 0 CA-C-O 120.74 0.225 . . . . 0.0 112.389 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -106.52 172.09 7.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.586 ' HD3' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -84.64 9.89 12.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.824 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.586 HG23 ' HD3' ' A' ' 309' ' ' LYS . 70.5 t -130.94 128.43 62.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.657 HD21 ' HB1' ' A' ' 363' ' ' ALA . 41.5 mt -114.33 122.29 46.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.788 ' CE1' ' CZ ' ' A' ' 354' ' ' PHE . 17.2 t80 -101.77 107.02 18.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.931 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.729 HD23 HD11 ' A' ' 380' ' ' LEU . 8.8 mp -87.37 142.93 27.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -138.68 175.33 9.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 60.54 53.43 4.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.2 mt -113.42 109.97 19.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.2 t -47.49 143.92 5.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.722 0.773 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.12 -19.08 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 321' ' ' THR . 23.7 mtt180 -78.23 -39.83 39.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 87.7 t -49.78 133.83 8.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 319' ' ' ARG . 55.2 p -133.54 170.0 16.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.606 ' HA ' HD12 ' A' ' 325' ' ' LEU . 10.9 tm-20 -43.69 -47.32 7.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -45.0 -57.65 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -49.01 -43.09 40.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.606 HD12 ' HA ' ' A' ' 322' ' ' GLU . 21.3 mt -62.69 -48.56 78.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 62.4 t -51.86 -52.36 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.1 m -61.49 -37.39 83.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.794 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.587 HD21 ' CE2' ' A' ' 373' ' ' TYR . 31.0 mt -59.15 -37.65 77.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.949 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -126.27 42.15 3.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -81.2 -47.42 13.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 331' ' ' ARG . 3.5 ptm85 -46.38 -34.94 5.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 -179.934 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.503 HD13 ' CE2' ' A' ' 357' ' ' PHE . 66.9 mt . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.747 0.308 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 355' ' ' ILE . 24.7 mm-40 -87.54 142.41 27.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -126.73 144.26 50.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.816 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.2 ttt-85 -141.08 132.67 27.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.2 ttm -115.4 147.34 40.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.877 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 22.2 ttm . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.894 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -137.07 142.3 42.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.892 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -148.59 153.26 38.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.09 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.788 ' CZ ' ' CE1' ' A' ' 312' ' ' TYR . 77.9 m-85 -124.78 129.65 50.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.83 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 341' ' ' GLN . 56.8 mt -123.65 140.35 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.165 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 55.8 m -114.91 129.37 56.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.503 ' CE2' HD13 ' A' ' 340' ' ' ILE . 23.7 m-85 -106.2 156.57 36.63 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.682 0.753 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -46.11 -40.66 21.31 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.755 2.303 . . . . 0.0 112.337 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . 0.432 HD22 HD12 ' A' ' 362' ' ' ILE . 8.4 m-80 -141.26 -176.62 4.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.83 -37.0 19.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.36 -56.37 20.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.432 HD12 HD22 ' A' ' 359' ' ' ASN . 60.0 mt -54.36 -56.05 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.089 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.657 ' HB1' HD21 ' A' ' 311' ' ' LEU . . . -44.95 -59.26 2.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.075 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . 0.409 ' O ' ' N ' ' A' ' 367' ' ' LEU . 4.8 t90 -48.42 -66.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -40.1 -41.61 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -71.66 -39.67 70.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.079 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.93 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 5.3 tt -55.88 -50.39 70.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -69.21 -35.8 76.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 31.2 mt -62.91 -47.95 81.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.454 ' HB ' ' CD1' ' A' ' 382' ' ' ILE . 25.2 t -82.71 -28.33 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.057 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 370' ' ' VAL . 0.3 OUTLIER -36.01 120.77 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.936 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 83.28 36.29 15.11 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.414 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.587 ' CE2' HD21 ' A' ' 328' ' ' LEU . 61.0 t80 -91.79 103.43 15.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.943 0.401 . . . . 0.0 110.946 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.474 ' HE2' HD11 ' A' ' 379' ' ' ILE . 9.7 ttmm -71.2 101.85 2.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 26.5 tp -114.62 125.47 53.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.952 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 49.51 38.24 14.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 70.01 37.24 73.6 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.503 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -141.03 121.61 14.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . 0.474 HD11 ' HE2' ' A' ' 374' ' ' LYS . 38.8 mm -76.02 86.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.729 HD11 HD23 ' A' ' 313' ' ' LEU . 7.5 tt -47.76 135.09 12.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.594 ' N ' HD23 ' A' ' 380' ' ' LEU . 76.4 t -117.15 111.49 35.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.079 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.485 HG13 ' CD2' ' A' ' 380' ' ' LEU . 43.1 mt -98.64 119.2 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -130.14 127.36 39.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.93 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 48.0 m-85 -54.27 140.71 32.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.928 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.544 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . 0.421 ' HA ' ' CE2' ' A' ' 384' ' ' PHE . 61.2 Cg_endo . . . . . 0 C--O 1.231 0.134 0 CA-C-O 120.805 0.252 . . . . 0.0 112.348 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -128.96 164.23 23.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.26 9.46 6.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 74.3 t -130.68 129.31 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.112 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.808 HD12 ' CE1' ' A' ' 357' ' ' PHE . 64.4 mt -115.96 118.61 33.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.669 ' CE1' ' CZ ' ' A' ' 354' ' ' PHE . 8.0 t80 -102.13 111.36 23.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 313' ' ' LEU . 4.8 mp -96.58 147.66 23.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.932 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -141.16 -175.52 4.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 5.0 m120 56.19 54.97 7.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.4 mt -114.78 109.66 18.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.941 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 17.8 t -50.88 144.05 14.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.661 0.743 . . . . 0.0 110.89 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -46.53 -20.73 1.07 Allowed 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.735 2.29 . . . . 0.0 112.286 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.414 ' O ' HG23 ' A' ' 321' ' ' THR . 47.1 mmt-85 -75.13 -35.34 61.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.892 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . 0.441 HG13 ' CG ' ' A' ' 324' ' ' ASP . 66.1 t -45.68 137.58 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 322' ' ' GLU . 39.0 p -132.12 150.77 52.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.878 ' OE1' HD12 ' A' ' 325' ' ' LEU . 5.4 tp10 -33.56 -41.34 0.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -46.72 -55.37 7.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.836 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . 0.441 ' CG ' HG13 ' A' ' 320' ' ' VAL . 0.2 OUTLIER -46.72 -44.41 18.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.878 HD12 ' OE1' ' A' ' 322' ' ' GLU . 36.2 mt -63.09 -47.45 82.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 67.5 t -57.09 -49.93 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 1.8 m -65.56 -42.44 91.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 23.2 mt -52.37 -41.17 62.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.483 ' CE1' HG21 ' A' ' 370' ' ' VAL . 21.6 m-85 -125.38 40.8 3.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -74.82 -40.8 60.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.091 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . 0.474 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 10.2 ptt-85 -50.47 -45.56 56.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.474 ' N ' ' HG3' ' A' ' 331' ' ' ARG . 25.5 m-85 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.596 HD13 ' CE2' ' A' ' 357' ' ' PHE . 70.2 mt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.833 0.349 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -90.2 120.27 31.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -105.85 138.99 41.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -136.87 129.81 30.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.486 ' HE2' HD11 ' A' ' 325' ' ' LEU . 35.5 tpp -111.1 146.32 37.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.871 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 20.0 ttm . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.833 179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -133.37 145.48 50.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.834 0.349 . . . . 0.0 110.952 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -147.23 145.43 29.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.669 ' CZ ' ' CE1' ' A' ' 312' ' ' TYR . 71.2 m-85 -116.76 123.95 48.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 83.8 mt -114.19 141.24 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.084 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 85.1 m -117.88 114.74 23.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.145 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.808 ' CE1' HD12 ' A' ' 311' ' ' LEU . 38.6 m-85 -97.47 158.62 32.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.636 0.732 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -43.89 -43.99 11.98 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.739 2.292 . . . . 0.0 112.337 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.13 -175.29 5.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.952 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -74.65 -39.33 62.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -47.75 -66.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 57.2 mt -55.03 -55.72 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.107 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.49 ' HB1' HD21 ' A' ' 311' ' ' LEU . . . -43.12 -60.89 1.48 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -46.74 -59.63 2.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.835 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -45.84 -43.86 13.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.972 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.1 95.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.08 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.617 ' C ' HD23 ' A' ' 367' ' ' LEU . 7.1 tt -63.82 -51.8 63.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.916 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -62.77 -33.75 75.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 25.3 mt -72.11 -42.07 66.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.971 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 370' ' ' VAL . 11.2 t -105.64 31.75 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.145 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.73 127.77 33.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 58.79 45.0 95.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.497 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.445 ' HE2' HD13 ' A' ' 375' ' ' LEU . 59.7 t80 -84.06 113.32 20.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.903 0.383 . . . . 0.0 110.958 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 28.0 tttt -66.25 104.31 1.16 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.445 HD13 ' HE2' ' A' ' 373' ' ' TYR . 10.6 tp -118.56 135.91 54.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 42.43 50.45 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 53.84 41.19 66.5 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.505 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -156.45 110.26 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.781 0.324 . . . . 0.0 110.854 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 31.8 mm -51.44 118.71 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.084 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.487 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.9 tt -77.52 114.9 16.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.941 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 45.4 t -94.59 118.93 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.151 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.418 HD11 ' O ' ' A' ' 370' ' ' VAL . 36.9 mt -107.53 127.8 63.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -139.32 130.55 26.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.54 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 28.0 m-85 -57.71 132.56 53.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.452 -179.946 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 384' ' ' PHE . 61.4 Cg_endo . . . . . 0 N--CA 1.466 -0.122 0 CA-C-O 120.741 0.225 . . . . 0.0 112.404 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -139.65 162.03 36.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.937 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.565 ' HG3' HG23 ' A' ' 310' ' ' VAL . 11.9 ptmt -70.87 -25.06 62.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.939 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.565 HG23 ' HG3' ' A' ' 309' ' ' LYS . 94.9 t -106.14 143.24 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.483 HD21 ' HB1' ' A' ' 363' ' ' ALA . 52.7 mt -124.35 121.42 34.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.974 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.756 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 9.4 t80 -95.4 102.61 14.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.952 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.463 HD22 HD22 ' A' ' 325' ' ' LEU . 7.5 mp -85.99 134.09 33.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -133.43 -177.07 4.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 60.22 52.17 5.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.8 mt -113.96 122.49 47.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 13.7 t -61.8 143.77 93.9 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.655 0.741 . . . . 0.0 110.821 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.44 -25.12 2.0 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.682 2.255 . . . . 0.0 112.306 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 321' ' ' THR . 41.7 mtm180 -74.34 -39.57 62.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.831 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 99.4 t -39.33 134.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 322' ' ' GLU . 35.2 p -126.89 150.5 49.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.136 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.686 ' OE1' HD12 ' A' ' 325' ' ' LEU . 7.9 tp10 -34.36 -41.54 0.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -45.33 -55.93 5.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . 0.489 ' CG ' ' N ' ' A' ' 325' ' ' LEU . 0.3 OUTLIER -44.12 -51.76 7.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.924 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.686 HD12 ' OE1' ' A' ' 322' ' ' GLU . 39.0 mt -56.33 -48.38 76.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.934 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 84.7 t -55.7 -53.09 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.146 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 31.2 t -64.51 -33.61 76.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.445 HD21 ' CE2' ' A' ' 373' ' ' TYR . 21.6 mt -65.65 -35.09 79.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.413 ' CZ ' HG21 ' A' ' 370' ' ' VAL . 38.6 m-85 -128.04 44.73 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.892 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -82.48 -58.69 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . 0.455 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 15.6 ptp180 -41.1 -42.09 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.481 ' CE2' ' HB2' ' A' ' 366' ' ' ALA . 31.4 m-85 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.716 HD13 ' CE2' ' A' ' 357' ' ' PHE . 73.0 mt . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.805 0.336 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -97.7 136.25 38.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -123.51 142.09 51.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -140.62 128.14 21.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 14.9 ttm -110.22 146.38 35.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.823 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.882 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -137.97 156.57 47.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.738 0.304 . . . . 0.0 110.92 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -157.57 155.82 30.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.756 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 46.0 m-85 -127.01 126.0 42.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' A' ' 325' ' ' LEU . 97.6 mt -119.18 145.54 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.582 ' O ' HG23 ' A' ' 340' ' ' ILE . 69.6 m -121.31 129.66 53.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.716 ' CE2' HD13 ' A' ' 340' ' ' ILE . 48.9 m-85 -109.97 158.46 34.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.694 0.759 . . . . 0.0 110.85 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.61 -52.05 7.29 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.685 2.256 . . . . 0.0 112.334 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -138.73 170.61 15.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -66.81 -38.62 86.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -49.78 -65.8 0.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 97.0 mt -51.92 -57.5 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.091 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -41.05 -53.02 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.107 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 12.9 t90 -54.68 -65.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -36.93 -46.71 0.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . 0.481 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . . . -66.58 -49.95 64.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.094 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.774 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 4.5 tt -49.66 -50.31 43.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.853 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -65.42 -36.09 82.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 31.6 mt -64.63 -60.02 3.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 371' ' ' ASN . 20.4 t -68.45 -33.02 57.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 370' ' ' VAL . 1.5 t-20 -35.14 107.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.965 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 99.18 33.14 5.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.445 ' CE2' HD21 ' A' ' 328' ' ' LEU . 31.8 t80 -96.14 108.28 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.994 0.426 . . . . 0.0 110.97 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -78.75 105.22 9.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.928 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.565 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 21.5 tp -108.76 135.38 50.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.916 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . 0.565 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 57.9 m-85 52.85 27.16 5.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 79.44 34.34 32.47 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.483 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -149.9 122.07 8.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.741 0.305 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 20.5 mm -63.54 136.49 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.167 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.534 HD23 ' C ' ' A' ' 380' ' ' LEU . 8.2 tt -96.73 132.96 41.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.513 ' N ' HD23 ' A' ' 380' ' ' LEU . 55.9 t -113.84 119.86 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.445 HG13 ' CD2' ' A' ' 380' ' ' LEU . 18.3 mt -103.96 139.47 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -136.86 120.08 16.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.774 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 35.8 m-85 -48.89 118.12 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.505 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . 0.617 ' HA ' ' CE1' ' A' ' 384' ' ' PHE . 72.6 Cg_exo . . . . . 0 C--O 1.231 0.141 0 CA-C-O 120.838 0.266 . . . . 0.0 112.335 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . 0.423 ' C ' ' HA ' ' A' ' 360' ' ' LYS . 76.0 m-20 -124.87 164.87 19.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.45 ' HD3' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -82.61 13.86 3.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.45 HG23 ' HD3' ' A' ' 309' ' ' LYS . 57.3 t -137.59 129.41 40.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.119 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.715 HD22 HD12 ' A' ' 367' ' ' LEU . 76.9 mt -120.25 117.87 28.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.983 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.789 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 7.4 t80 -93.97 105.72 17.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 313' ' ' LEU . 4.4 mp -88.28 145.02 26.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.909 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.434 ' HG3' ' C ' ' A' ' 313' ' ' LEU . 16.6 mtpp -143.31 170.89 14.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 67.46 54.92 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 12.9 mt -114.77 120.9 41.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 22.6 t -57.33 143.84 72.53 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.674 0.75 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -43.94 -27.2 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.671 2.247 . . . . 0.0 112.385 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.591 ' O ' HG23 ' A' ' 321' ' ' THR . 1.4 mmp_? -71.16 -38.73 72.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . 0.439 HG22 ' HD2' ' A' ' 376' ' ' TYR . 66.0 t -47.05 122.44 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.591 HG23 ' O ' ' A' ' 319' ' ' ARG . 44.8 p -127.31 168.67 14.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.18 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -39.22 -48.79 1.83 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.913 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . 0.43 ' NH1' ' HB2' ' A' ' 323' ' ' ARG . 0.0 OUTLIER -44.52 -49.87 9.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -53.7 -50.99 64.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.843 HD22 HD11 ' A' ' 355' ' ' ILE . 76.4 mt -55.33 -51.93 65.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.965 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 97.5 t -46.98 -59.54 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.094 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 2.6 t -54.0 -47.51 71.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 31.9 mt -49.62 -46.27 49.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.414 ' CZ ' HD21 ' A' ' 313' ' ' LEU . 8.4 m-85 -119.9 41.8 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -85.15 -25.16 27.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.035 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -64.79 -37.14 86.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.404 ' HZ ' HD13 ' A' ' 369' ' ' LEU . 4.2 m-85 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 71.1 mt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.767 0.317 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -89.68 116.12 27.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.49 130.49 54.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -129.94 117.89 20.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.832 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.1 ttm -103.95 146.85 28.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . 0.42 ' HE1' ' CE2' ' A' ' 354' ' ' PHE . 34.3 mtm . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -152.91 142.49 21.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.49 142.87 29.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.076 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.789 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 53.0 m-85 -105.45 115.79 30.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.843 HD11 HD22 ' A' ' 325' ' ' LEU . 64.2 mt -108.39 129.42 62.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.12 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 27.1 m -109.53 116.06 31.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.688 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 36.9 m-85 -94.46 159.17 34.33 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.728 0.775 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . 0.454 ' HB2' HD12 ' A' ' 362' ' ' ILE . 72.6 Cg_exo -44.85 -47.55 11.67 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.242 . . . . 0.0 112.372 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -142.67 176.47 9.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . 0.423 ' HA ' ' C ' ' A' ' 308' ' ' ASN . 0.0 OUTLIER -74.78 -29.21 61.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . 0.406 ' N ' ' HG2' ' A' ' 360' ' ' LYS . 77.8 mt-10 -62.33 -56.95 13.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.454 HD12 ' HB2' ' A' ' 358' ' ' PRO . 68.5 mt -56.09 -56.39 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.077 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -49.86 -48.62 51.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -51.22 -49.12 61.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -60.96 -52.72 63.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.942 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -56.63 -34.25 67.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.049 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.804 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 5.9 tt -65.02 -67.04 0.47 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . 0.646 ' N ' HD23 ' A' ' 367' ' ' LEU . 10.3 t-80 -46.35 -36.1 6.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.84 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.404 HD13 ' HZ ' ' A' ' 332' ' ' PHE . 23.5 mt -71.61 -58.3 3.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.862 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.569 ' O ' HD11 ' A' ' 382' ' ' ILE . 9.3 t -82.59 37.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.099 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -84.94 136.2 33.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 49.28 38.42 26.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.519 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.549 ' CE1' ' O ' ' A' ' 374' ' ' LYS . 33.4 t80 -78.21 130.39 36.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.951 0.405 . . . . 0.0 110.905 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.549 ' O ' ' CE1' ' A' ' 373' ' ' TYR . 17.5 tttm -71.14 129.79 39.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.881 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 19.1 tp -143.56 124.47 14.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . 0.439 ' HD2' HG22 ' A' ' 320' ' ' VAL . 39.3 m-85 43.77 48.25 6.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 59.89 42.46 98.2 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.499 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -155.47 119.25 4.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.338 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 48.3 mm -61.51 107.59 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.119 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.494 HD23 ' C ' ' A' ' 380' ' ' LEU . 8.4 tt -71.33 115.63 10.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.6 t -99.74 136.4 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.141 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.569 HD11 ' O ' ' A' ' 370' ' ' VAL . 57.5 mt -113.39 135.15 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -137.45 118.8 14.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.804 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 59.9 m-85 -47.97 151.54 0.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.509 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . 0.533 ' HA ' ' CZ ' ' A' ' 384' ' ' PHE . 61.3 Cg_endo . . . . . 0 C--O 1.23 0.105 0 CA-C-O 120.783 0.243 . . . . 0.0 112.334 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -137.76 168.64 19.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.553 ' HG3' HG23 ' A' ' 310' ' ' VAL . 13.1 ptmt -72.79 -33.61 66.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.907 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.553 HG23 ' HG3' ' A' ' 309' ' ' LYS . 55.6 t -98.22 145.92 8.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.143 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.647 HD12 ' CE1' ' A' ' 357' ' ' PHE . 56.9 mt -127.63 114.43 17.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.573 ' CZ ' ' CG ' ' A' ' 314' ' ' LYS . 6.4 t80 -89.31 105.94 18.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.933 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.444 HD23 HD21 ' A' ' 380' ' ' LEU . 6.3 mp -93.22 148.05 22.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.573 ' CG ' ' CZ ' ' A' ' 312' ' ' TYR . 0.0 OUTLIER -144.5 177.12 8.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . 0.475 ' ND2' ' HB3' ' A' ' 378' ' ' LYS . 1.6 t30 67.49 53.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 15.6 mt -118.03 112.07 19.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.2 t -38.63 154.29 0.14 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.65 0.738 . . . . 0.0 110.855 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.62 1.96 3.3 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.679 2.253 . . . . 0.0 112.363 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -108.43 -24.83 11.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.98 142.65 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.131 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 64.6 p -133.89 162.85 30.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 323' ' ' ARG . 6.2 tt0 -38.81 -53.76 1.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.909 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 322' ' ' GLU . 56.7 ttt180 -34.78 -42.71 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -62.66 -50.71 70.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 322' ' ' GLU . 15.6 mt -60.04 -48.51 81.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 78.9 t -49.33 -60.46 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.066 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 23.8 t -53.62 -38.58 64.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.43 HD11 HD22 ' A' ' 375' ' ' LEU . 40.9 mt -62.4 -41.24 98.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.479 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 60.4 m-85 -119.56 46.02 2.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -92.31 -58.26 2.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.09 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . 0.402 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 17.7 ptp180 -38.37 -47.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.899 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 49.0 m-85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.835 HD13 ' CE2' ' A' ' 357' ' ' PHE . 73.6 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.808 0.337 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -87.65 133.56 33.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -118.62 140.16 50.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -137.97 123.51 19.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 46.6 tpp -103.26 133.3 48.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 20.0 tpp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.936 179.92 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -146.83 147.08 30.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 0.0 110.939 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -154.99 142.44 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.081 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -120.2 121.95 39.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.825 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 80.6 mt -115.22 145.15 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.11 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 25.9 m -122.22 117.75 26.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.835 ' CE2' HD13 ' A' ' 340' ' ' ILE . 63.4 m-85 -99.73 157.39 34.01 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.606 0.717 . . . . 0.0 110.88 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -42.33 -40.11 6.76 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.652 2.235 . . . . 0.0 112.372 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.52 171.04 20.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 361' ' ' GLU . 11.0 pttm -58.08 -53.99 52.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 360' ' ' LYS . 45.7 mt-10 -36.52 -64.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.45 -56.93 9.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.136 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.467 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -42.27 -60.62 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.089 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 367' ' ' LEU . 13.5 t90 -47.63 -64.61 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.938 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -37.67 -46.15 0.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -64.76 -38.13 89.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.037 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.59 ' C ' HD23 ' A' ' 367' ' ' LEU . 7.7 tt -62.04 -61.31 2.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.883 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -56.24 -30.12 61.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 28.9 mt -72.94 -50.94 20.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.955 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 370' ' ' VAL . 25.4 t -98.74 37.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.142 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . 0.421 ' O ' ' CG ' ' A' ' 371' ' ' ASN . 0.7 OUTLIER -88.12 87.65 7.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 111.44 42.55 1.05 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -89.27 125.99 35.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.988 0.423 . . . . 0.0 110.917 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -74.29 94.0 2.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.43 HD22 HD11 ' A' ' 328' ' ' LEU . 16.2 tp -104.3 132.0 51.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.99 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 46.09 42.46 9.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 64.64 40.63 97.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . 0.475 ' HB3' ' ND2' ' A' ' 315' ' ' ASN . 81.4 mttt -152.57 149.25 28.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.757 0.313 . . . . 0.0 110.953 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 15.8 mm -84.26 107.41 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.116 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.491 HD23 ' N ' ' A' ' 381' ' ' VAL . 8.2 tt -72.76 131.21 42.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.847 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.491 ' N ' HD23 ' A' ' 380' ' ' LEU . 41.0 t -113.1 114.45 46.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.087 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.484 HG13 ' CD2' ' A' ' 380' ' ' LEU . 31.6 mt -98.32 129.87 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -126.82 168.02 15.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.533 ' CZ ' ' HA ' ' A' ' 307' ' ' PRO . 26.3 m-85 -94.76 137.08 34.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.457 -179.94 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo . . . . . 0 N--CA 1.465 -0.156 0 CA-C-O 120.81 0.254 . . . . 0.0 112.272 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -107.09 175.63 5.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.554 ' HG3' HG23 ' A' ' 310' ' ' VAL . 18.7 pttm -85.8 -26.59 25.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.936 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.554 HG23 ' HG3' ' A' ' 309' ' ' LYS . 88.2 t -97.53 124.36 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.467 ' CD2' ' CE1' ' A' ' 384' ' ' PHE . 66.5 mt -113.05 115.06 27.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.934 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.795 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 16.4 t80 -87.85 104.06 16.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.433 HD22 HD22 ' A' ' 325' ' ' LEU . 8.3 mp -85.84 138.17 32.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.918 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -134.06 177.03 8.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . 0.444 ' ND2' ' HB3' ' A' ' 378' ' ' LYS . 1.7 t30 61.89 54.71 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.845 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.4 mt -111.0 127.71 55.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.457 ' HB2' ' CD ' ' A' ' 378' ' ' LYS . 29.4 t -61.91 143.35 94.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.648 0.737 . . . . 0.0 110.903 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -47.12 -19.47 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.604 2.203 . . . . 0.0 112.418 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.528 ' O ' HG23 ' A' ' 321' ' ' THR . 14.3 mtp180 -82.47 -33.29 28.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . 0.54 HG22 ' HD2' ' A' ' 376' ' ' TYR . 99.4 t -44.1 133.04 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 319' ' ' ARG . 68.8 p -129.63 151.56 50.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 321' ' ' THR . 9.3 tt0 -34.55 -38.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -48.16 -56.21 8.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . 0.421 ' CG ' HG13 ' A' ' 320' ' ' VAL . 0.3 OUTLIER -46.46 -45.05 17.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.433 HD22 HD22 ' A' ' 313' ' ' LEU . 42.3 mt -61.62 -46.22 90.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 65.8 t -56.32 -53.08 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 38.8 t -63.15 -41.67 99.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.851 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.457 HD21 ' CE2' ' A' ' 373' ' ' TYR . 24.0 mt -55.26 -41.48 72.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.971 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.474 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 19.0 m-85 -122.23 40.85 3.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -79.2 -54.76 5.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.135 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -39.76 -33.34 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 179.996 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 71.6 mt . . . . . 0 N--CA 1.458 -0.038 0 CA-C-O 120.834 0.349 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -98.52 123.38 42.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -114.4 140.26 48.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -141.23 124.31 16.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.891 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 41.2 tpp -108.63 137.58 46.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.813 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . 0.403 ' N ' ' HE2' ' A' ' 345' ' ' MET . 1.4 mpp? . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -144.41 142.89 30.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 0.0 110.919 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.74 146.01 31.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.795 ' CE2' ' CE1' ' A' ' 312' ' ' TYR . 39.9 m-85 -111.72 124.02 51.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 79.0 mt -117.12 141.13 36.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 35.8 m -119.84 118.47 30.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.747 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 32.5 m-85 -94.1 155.34 40.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.612 0.72 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.1 -32.23 18.2 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.241 . . . . 0.0 112.359 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -152.19 -179.42 7.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . 0.444 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 8.6 pttm -78.07 -41.28 35.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 36.1 mt-10 -54.04 -63.2 1.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 80.4 mt -47.17 -61.44 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.747 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -44.36 -65.26 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.019 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' TRP . . . . . 0.408 ' C ' ' O ' ' A' ' 363' ' ' ALA . 6.1 t90 -36.46 -51.09 0.81 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.938 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -54.47 -53.29 56.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . 0.474 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -53.08 -40.66 64.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.78 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 6.3 tt -59.57 -68.23 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . 0.651 ' N ' HD23 ' A' ' 367' ' ' LEU . 4.4 t60 -49.79 -33.79 17.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 35.3 mt -72.59 -39.14 67.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.967 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 370' ' ' VAL . 31.3 t -109.81 40.57 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.74 141.58 32.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 48.37 30.36 8.01 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.451 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.457 ' CE2' HD21 ' A' ' 328' ' ' LEU . 38.6 t80 -70.46 108.82 4.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.933 0.397 . . . . 0.0 110.853 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -71.45 97.41 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.463 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 31.6 tp -101.46 131.6 47.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.915 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' TYR . . . . . 0.54 ' HD2' HG22 ' A' ' 320' ' ' VAL . 57.1 m-85 53.5 31.93 13.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 73.6 34.8 56.4 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . 0.457 ' CD ' ' HB2' ' A' ' 317' ' ' SER . 21.2 mtpp -142.77 112.37 6.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.697 0.284 . . . . 0.0 110.93 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 379' ' ' ILE . 14.6 mm -52.83 100.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.166 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.41 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.8 tt -69.35 120.57 15.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.5 t -104.04 120.46 54.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.557 HD11 ' O ' ' A' ' 370' ' ' VAL . 65.6 mt -99.34 138.46 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.099 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -140.32 120.54 13.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.912 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.78 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 42.7 m-85 -54.69 147.45 14.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.453 -179.949 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 98.7 p -84.43 168.57 15.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.368 . . . . 0.0 110.828 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 20.0 m -53.51 158.16 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 166.8 -54.6 0.24 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.531 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 8.3 m -62.33 128.25 35.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 0.0 110.924 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 23.8 t -160.94 132.24 5.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.967 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 95.79 74.09 1.2 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -76.74 -48.73 17.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 0.0 110.862 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.3 -45.79 11.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 5.4 pt -72.81 123.3 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -85.98 42.66 0.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm 61.91 50.29 4.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.76 HG22 ' H ' ' A' ' 298' ' ' MET . 2.8 mp -71.5 128.97 89.32 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.56 0.695 . . . . 0.0 111.14 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -43.16 -31.89 2.76 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.709 2.272 . . . . 0.0 112.317 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.76 ' H ' HG22 ' A' ' 296' ' ' ILE . 4.5 ptt? -153.34 105.53 2.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -76.43 51.98 0.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.875 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.9 m -86.64 139.09 31.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.854 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.9 -177.17 0.32 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.834 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.783 ' CE2' HG13 ' A' ' 381' ' ' VAL . 10.1 p90 -41.3 158.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.921 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -116.03 138.75 24.34 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.583 0.706 . . . . 0.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.47 -35.66 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.679 2.252 . . . . 0.0 112.293 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 86.77 -127.27 8.31 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.528 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.474 ' CG ' ' HD2' ' A' ' 307' ' ' PRO . 27.9 tt0 -93.74 140.52 23.07 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.679 0.752 . . . . 0.0 110.856 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . 0.474 ' HD2' ' CG ' ' A' ' 306' ' ' GLU . 60.8 Cg_endo -75.33 126.87 10.04 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 0.0 112.33 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -126.15 179.18 5.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.509 ' HG3' HG23 ' A' ' 310' ' ' VAL . 3.8 ptmt -81.5 -30.86 33.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.509 HG23 ' HG3' ' A' ' 309' ' ' LYS . 86.4 t -99.18 132.89 43.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.405 HD12 ' CE1' ' A' ' 357' ' ' PHE . 79.1 mt -112.29 152.74 28.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.96 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.788 ' CD1' ' CE2' ' A' ' 354' ' ' PHE . 10.3 t80 -124.22 101.76 7.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.948 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.593 HD21 ' HE2' ' A' ' 329' ' ' PHE . 6.1 mp -90.63 139.73 30.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.939 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -137.36 -179.53 5.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 63.73 54.06 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.81 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 12.8 mt -116.26 127.09 54.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.968 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 45.1 t -65.56 143.88 98.76 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.643 0.735 . . . . 0.0 110.831 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.16 -22.14 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.7 2.266 . . . . 0.0 112.345 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.566 ' O ' HG23 ' A' ' 321' ' ' THR . 37.6 mtt-85 -77.07 -38.86 51.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 69.5 t -46.1 140.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.095 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 319' ' ' ARG . 75.1 p -140.96 168.41 19.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.199 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 325' ' ' LEU . 19.8 tt0 -41.21 -47.37 3.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -41.52 -52.24 3.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.88 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.42 -48.43 68.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 322' ' ' GLU . 18.9 mt -58.2 -47.0 84.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 86.0 t -53.26 -56.06 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.138 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 7.5 t -60.19 -43.38 95.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.829 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.7 mt -52.12 -48.59 64.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.593 ' HE2' HD21 ' A' ' 313' ' ' LEU . 42.9 m-85 -118.35 42.1 2.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -78.96 -43.55 24.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.073 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -49.48 -34.0 15.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.402 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 21.9 m-85 -73.98 -38.16 64.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . 0.422 ' CA ' HD12 ' A' ' 340' ' ' ILE . 15.3 tm0? -43.43 -64.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.933 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.29 -44.76 88.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.825 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -38.47 150.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -42.64 133.35 3.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 123.6 143.79 6.38 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.496 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -47.37 154.44 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.686 2.258 . . . . 0.0 112.402 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.03 138.2 16.25 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.637 2.224 . . . . 0.0 112.375 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.422 HD12 ' CA ' ' A' ' 333' ' ' GLN . 67.1 mt -79.6 135.07 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.134 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -97.71 137.8 36.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -123.81 140.27 53.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -136.35 132.94 36.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.805 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 12.4 ttm -112.22 135.9 52.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 29.4 ttm -99.25 130.63 45.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.908 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 40.9 p -134.15 58.52 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.098 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 349' ' ' MET . . . -95.81 -170.84 35.63 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.497 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.24 -25.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 110.879 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . 0.428 ' N ' ' O ' ' A' ' 347' ' ' GLY . 13.6 tpp -130.8 99.0 4.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.796 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 33.6 mtt180 -75.97 171.28 14.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.424 ' C ' ' OE1' ' A' ' 352' ' ' GLN . . . 106.14 28.66 5.16 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.463 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.424 ' OE1' ' C ' ' A' ' 351' ' ' GLY . 2.9 mp0 -147.31 152.73 38.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.851 0.358 . . . . 0.0 110.862 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -158.55 167.09 30.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.788 ' CE2' ' CD1' ' A' ' 312' ' ' TYR . 14.4 m-85 -136.6 138.38 41.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.893 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.403 HD13 ' CD2' ' A' ' 329' ' ' PHE . 85.2 mt -126.68 132.88 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.469 HG23 ' CE ' ' A' ' 309' ' ' LYS . 25.7 m -108.26 118.1 35.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.097 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.543 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 47.1 m-85 -99.84 158.91 31.23 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.639 0.733 . . . . 0.0 110.903 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.88 -35.3 13.68 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.623 2.216 . . . . 0.0 112.348 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -157.83 174.8 14.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.977 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 21.5 pttp -65.89 -45.35 82.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . 0.46 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 48.1 mt-10 -46.21 -65.17 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 60.5 mt -53.28 -54.17 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -43.59 -59.32 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.081 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . 0.495 ' O ' ' N ' ' A' ' 367' ' ' LEU . 11.4 t90 -50.44 -62.87 1.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.0 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -37.25 -50.78 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.485 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -60.17 -37.17 79.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.12 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.803 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 6.3 tt -62.37 -62.54 1.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.976 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . 0.436 ' N ' HD23 ' A' ' 367' ' ' LEU . 47.1 t60 -53.18 -29.2 30.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.842 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 44.9 mt -76.24 -48.36 20.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.563 HG21 ' CE1' ' A' ' 329' ' ' PHE . 5.4 t -98.41 33.0 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.101 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.36 96.27 7.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 93.32 43.9 3.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.531 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -84.8 109.16 17.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 0.0 110.922 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -62.95 119.31 9.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.935 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.404 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 19.4 tp -133.54 128.68 35.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.851 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . 0.404 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 25.2 m-85 45.81 41.24 7.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.999 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 66.8 41.3 93.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -142.32 141.13 32.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 49.2 mm -90.56 92.73 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.182 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.475 HD23 ' N ' ' A' ' 381' ' ' VAL . 7.2 tt -61.51 129.82 43.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.783 HG13 ' CE2' ' A' ' 302' ' ' TYR . 48.0 t -117.22 111.91 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.187 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.41 ' CD1' ' O ' ' A' ' 370' ' ' VAL . 29.2 mt -93.97 137.89 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -133.73 179.21 6.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.803 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 27.7 m-85 -109.11 140.79 42.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -65.46 -142.94 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.413 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.83 174.74 7.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.783 0.325 . . . . 0.0 110.885 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -99.56 113.0 25.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.09 155.12 46.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.868 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 24.7 tptt 59.95 45.17 12.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.88 155.92 16.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.06 146.52 31.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 56.5 p -105.12 45.91 0.94 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.4 t -127.56 159.27 35.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.79 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -175.17 95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.527 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.83 -8.88 19.41 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.731 2.288 . . . . 0.0 112.305 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 44.4 m -40.0 156.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 1.2 t -136.44 170.43 16.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.86 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.526 -179.94 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 41.2 m -79.91 172.64 13.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.958 0.409 . . . . 0.0 110.83 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 3.5 m -159.25 129.66 5.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.847 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 142.65 115.44 1.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 4.3 t -116.65 45.94 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.866 0.365 . . . . 0.0 110.855 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 3.4 m -41.0 160.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 96.61 50.98 1.75 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.508 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.49 -49.6 75.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.783 0.325 . . . . 0.0 110.863 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -118.11 -15.03 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.661 HD13 ' H ' ' A' ' 293' ' ' ILE . 0.2 OUTLIER -113.15 160.45 12.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.093 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.05 75.55 1.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 35.1 tttm 55.88 35.77 26.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.453 HG23 ' HD2' ' A' ' 297' ' ' PRO . 14.6 mm -106.91 135.85 19.51 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.635 0.731 . . . . 0.0 111.104 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . 0.453 ' HD2' HG23 ' A' ' 296' ' ' ILE . 64.2 Cg_endo -78.66 -39.82 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.664 2.243 . . . . 0.0 112.351 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -122.88 92.93 3.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.857 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -129.14 42.38 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.8 m -97.09 -56.6 2.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 6.0 m -128.22 175.16 8.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.849 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -51.38 169.77 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.884 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -101.16 103.37 25.43 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.66 0.743 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.26 -50.54 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.695 2.264 . . . . 0.0 112.336 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 116.1 -172.55 14.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.468 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.48 ' CG ' ' HD2' ' A' ' 307' ' ' PRO . 39.0 tt0 -77.49 141.38 65.44 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.573 0.701 . . . . 0.0 110.946 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . 0.48 ' HD2' ' CG ' ' A' ' 306' ' ' GLU . 73.1 Cg_exo -47.15 103.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.701 2.268 . . . . 0.0 112.367 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -118.29 172.67 7.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.6 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -89.91 25.98 1.95 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.949 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.6 HG23 ' HD2' ' A' ' 309' ' ' LYS . 89.2 t -143.17 123.22 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.139 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.689 HD22 HD12 ' A' ' 367' ' ' LEU . 63.0 mt -116.66 125.62 52.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.969 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.674 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 7.8 t80 -105.1 103.88 13.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 313' ' ' LEU . 3.0 mp -87.31 144.68 26.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -140.57 178.69 7.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.928 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.0 m120 59.5 46.09 12.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.855 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.2 mt -105.7 112.5 25.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 37.5 t -54.34 144.54 41.0 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.747 0.784 . . . . 0.0 110.796 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -45.02 -32.16 6.3 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.685 2.257 . . . . 0.0 112.328 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.599 ' O ' HG23 ' A' ' 321' ' ' THR . 54.1 mtt180 -66.57 -39.82 88.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 84.9 t -46.75 113.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 319' ' ' ARG . 82.1 p -108.88 165.81 11.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.136 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -42.05 -50.28 4.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 72.9 mtt85 -43.29 -50.48 6.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -49.52 -44.28 46.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.489 ' HA ' HD12 ' A' ' 328' ' ' LEU . 96.1 mt -64.61 -51.87 60.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 91.8 t -48.27 -51.94 8.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.203 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.2 t -62.9 -40.52 97.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.935 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.517 HD21 ' CE2' ' A' ' 373' ' ' TYR . 23.0 mt -55.69 -42.83 75.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.879 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -121.18 41.62 3.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -82.54 -35.7 26.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.545 ' HG3' ' CE2' ' A' ' 332' ' ' PHE . 6.3 ptp180 -55.98 -23.69 34.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.855 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.693 ' O ' HD11 ' A' ' 340' ' ' ILE . 9.0 m-85 -105.93 36.64 2.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . 0.434 ' C ' ' HD2' ' A' ' 335' ' ' LYS . 5.2 tp60 -129.71 -42.11 1.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -73.4 82.78 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.434 ' HD2' ' C ' ' A' ' 333' ' ' GLN . 0.0 OUTLIER -172.89 -175.96 1.35 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.434 ' O ' ' C ' ' A' ' 337' ' ' GLY . 9.8 mptt -52.66 -55.81 19.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.941 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 336' ' ' LYS . . . -35.62 153.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.524 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.38 153.39 39.96 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.322 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.413 ' HA ' ' OE1' ' A' ' 333' ' ' GLN . 71.8 Cg_exo -46.32 125.01 8.44 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.701 HD13 ' CE2' ' A' ' 357' ' ' PHE . 75.6 mt -60.11 137.46 22.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -91.04 117.25 29.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -105.92 146.02 30.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -141.26 126.51 18.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 33.4 tpp -117.18 135.01 54.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . 0.496 ' CE ' ' CD2' ' A' ' 354' ' ' PHE . 31.0 mtm -116.98 158.12 24.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 347' ' ' GLY . 34.2 p -127.81 -63.11 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.15 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 346' ' ' THR . . . 34.65 -118.85 0.29 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.491 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -76.38 -47.75 22.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 110.852 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 34.3 mtp -124.92 135.08 52.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -83.87 -1.58 54.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.497 ' C ' ' CD ' ' A' ' 352' ' ' GLN . . . -83.87 46.03 3.58 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.409 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.497 ' CD ' ' C ' ' A' ' 351' ' ' GLY . 23.8 mp0 -154.38 130.31 10.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.857 0.361 . . . . 0.0 110.953 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -153.76 141.89 20.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.129 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.674 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 43.4 m-85 -103.34 152.62 21.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 45.3 mt -148.79 134.75 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 309' ' ' LYS . 21.0 m -118.14 127.49 53.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.848 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 42.2 m-85 -104.41 157.8 33.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.641 0.734 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.83 -47.63 9.74 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.668 2.245 . . . . 0.0 112.31 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -141.96 138.7 32.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.425 ' CD ' ' H ' ' A' ' 360' ' ' LYS . 0.0 OUTLIER -45.82 -27.5 0.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.896 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.28 -58.6 7.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' A' ' 332' ' ' PHE . 72.6 mt -57.67 -58.8 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.848 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -46.34 -46.5 18.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.12 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -54.73 -61.58 2.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.999 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -50.25 -37.35 35.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.81 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -69.24 -45.62 69.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.689 HD12 HD22 ' A' ' 311' ' ' LEU . 6.6 tt -55.94 -51.04 69.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -63.95 -36.02 82.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 39.9 mt -74.38 -28.01 60.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 366' ' ' ALA . 17.2 t -102.01 -4.47 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 367' ' ' LEU . 1.4 p-10 -55.21 127.32 28.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 63.72 49.48 68.35 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.448 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.517 ' CE2' HD21 ' A' ' 328' ' ' LEU . 82.3 t80 -93.81 112.49 24.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 110.902 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -67.81 105.96 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 37.3 tp -118.75 118.03 30.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 55.47 35.12 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 73.4 29.52 63.9 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -133.29 129.41 37.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.78 0.324 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 51.0 mm -77.51 90.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.567 HD23 ' C ' ' A' ' 380' ' ' LEU . 8.0 tt -59.6 117.56 5.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.55 HG12 ' OE1' ' A' ' 383' ' ' GLU . 97.0 t -102.68 122.99 55.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.14 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.476 HG12 HD21 ' A' ' 380' ' ' LEU . 15.3 mt -109.26 139.19 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.113 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . 0.55 ' OE1' HG12 ' A' ' 381' ' ' VAL . 4.9 mp0 -138.65 124.86 20.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.524 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 27.9 m-85 -52.45 158.11 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.894 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -84.09 -178.37 51.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.439 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -109.34 149.48 29.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.757 0.313 . . . . 0.0 110.87 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -117.09 135.96 53.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -110.26 -38.43 5.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -67.96 107.38 2.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -87.05 88.1 7.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.915 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -47.01 130.45 12.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 78.5 p -85.75 136.5 33.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.876 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 30.3 t -142.87 152.56 42.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.806 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 161.29 97.22 0.12 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.502 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.84 157.0 43.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.724 2.283 . . . . 0.0 112.311 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 20.8 t -92.4 -63.9 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 22.6 t -99.78 159.05 15.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.5 179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 49.8 m 54.44 41.76 31.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.89 0.376 . . . . 0.0 110.863 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 39.8 m -48.7 170.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.794 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 38.1 -147.01 0.11 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.54 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 1.8 t 66.94 39.49 3.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 0.0 110.782 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 3.1 m -82.8 140.48 32.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . 0.427 ' HA3' HD11 ' A' ' 293' ' ' ILE . . . -177.74 105.61 0.2 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.515 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -67.09 -54.27 23.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.76 -48.35 77.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.804 ' O ' HD12 ' A' ' 293' ' ' ILE . 2.7 pp -83.61 33.76 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.161 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -89.22 -53.64 4.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.867 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -72.32 -59.18 2.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 32.8 mt -124.97 104.3 29.96 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.576 0.703 . . . . 0.0 111.134 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -45.5 -37.71 15.27 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.668 2.245 . . . . 0.0 112.279 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 9.1 mmt -87.97 55.11 3.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.879 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -86.11 -44.96 11.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 63.8 p -129.14 103.06 6.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.88 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.8 m -67.57 -56.27 10.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.847 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.418 ' CZ ' ' O ' ' A' ' 303' ' ' ASN . 0.8 OUTLIER -158.74 151.67 22.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.995 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.418 ' O ' ' CZ ' ' A' ' 302' ' ' TYR . 15.2 m120 -113.44 138.03 22.34 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.612 0.72 . . . . 0.0 110.912 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.92 -40.27 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.753 2.302 . . . . 0.0 112.253 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 120.49 -114.75 2.74 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.466 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -106.91 134.95 19.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 110.917 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -47.48 148.98 4.82 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.62 2.214 . . . . 0.0 112.304 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.434 ' ND2' ' H ' ' A' ' 310' ' ' VAL . 61.0 t30 -153.64 165.79 34.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.835 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.51 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -84.97 -14.6 47.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.51 HG23 ' HD2' ' A' ' 309' ' ' LYS . 54.4 t -111.32 134.43 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.135 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.801 HD12 ' HE2' ' A' ' 357' ' ' PHE . 29.0 mt -119.04 120.67 37.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.897 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.792 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 13.9 t80 -106.41 102.69 12.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.688 HD23 HD21 ' A' ' 380' ' ' LEU . 6.2 mp -88.88 149.55 23.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.557 ' HE2' ' CD2' ' A' ' 312' ' ' TYR . 22.5 mttt -137.56 -176.73 4.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 55.35 53.9 9.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.2 mt -109.32 117.68 34.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.898 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 38.6 t -61.34 139.91 94.67 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.675 0.75 . . . . 0.0 110.874 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -43.2 -27.63 1.17 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.703 2.268 . . . . 0.0 112.256 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.514 ' HB3' ' CE2' ' A' ' 376' ' ' TYR . 23.0 mmt85 -69.73 -42.85 73.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.857 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 93.5 t -44.31 136.34 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.13 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.8 p -135.88 166.54 23.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.101 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -41.64 -52.45 3.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -40.94 -41.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.69 -46.72 86.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 328' ' ' LEU . 81.3 mt -60.33 -44.8 95.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.928 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 95.0 t -55.12 -60.54 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 4.8 t -54.12 -40.63 67.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.904 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 325' ' ' LEU . 28.7 mt -56.74 -44.9 82.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.6 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 54.2 m-85 -120.54 45.76 2.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 333' ' ' GLN . . . -84.06 -39.55 19.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -45.26 -37.36 4.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.785 ' O ' HD11 ' A' ' 340' ' ' ILE . 11.9 m-85 -94.22 32.1 1.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 330' ' ' ALA . 8.3 tp60 -116.72 -57.83 2.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -57.89 -34.03 69.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -50.4 155.35 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -57.41 92.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -176.51 151.48 11.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.425 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -45.23 165.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.662 2.242 . . . . 0.0 112.35 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.61 102.93 1.66 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.755 2.304 . . . . 0.0 112.299 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.785 HD11 ' O ' ' A' ' 332' ' ' PHE . 59.5 mt -41.73 131.18 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.157 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -93.83 116.52 28.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -103.49 149.07 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -141.19 125.25 17.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.849 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 41.7 tpp -114.57 135.63 53.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 9.1 ttm -90.1 167.8 12.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.842 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 9.9 t -172.68 156.01 3.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.09 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 124.67 -157.75 19.03 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.484 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.441 ' HG3' ' N ' ' A' ' 349' ' ' MET . 11.4 ptm180 -46.95 -43.3 18.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 0.0 110.808 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . 0.441 ' N ' ' HG3' ' A' ' 348' ' ' ARG . 3.2 ttt -111.9 106.71 15.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.419 ' NE ' ' C ' ' A' ' 350' ' ' ARG . 0.0 OUTLIER -110.16 174.27 5.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.405 ' C ' ' CD ' ' A' ' 352' ' ' GLN . . . 96.69 31.29 7.13 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.533 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.405 ' CD ' ' C ' ' A' ' 351' ' ' GLY . 3.2 mp0 -148.37 141.38 24.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 110.861 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -150.05 151.58 33.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.099 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.792 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 58.0 m-85 -116.05 143.73 45.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.825 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.475 HD12 HD11 ' A' ' 313' ' ' LEU . 77.4 mt -136.0 139.2 46.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.144 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 83.3 m -124.41 117.41 24.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.13 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.801 ' HE2' HD12 ' A' ' 311' ' ' LEU . 84.0 m-85 -96.75 158.08 34.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.649 0.738 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.7 -35.39 23.21 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.739 2.293 . . . . 0.0 112.307 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -149.71 178.68 8.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.84 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -74.58 -49.93 19.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -41.13 -63.62 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 46.6 mt -51.68 -61.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -38.86 -60.81 0.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.138 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 14.0 t90 -48.42 -56.81 7.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -50.54 -47.09 57.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.6 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -58.28 -32.18 68.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.079 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.685 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.2 tt -70.42 -69.94 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.916 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . 0.579 ' N ' HD23 ' A' ' 367' ' ' LEU . 4.5 t60 -48.01 -32.68 6.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 41.7 mt -74.32 -41.53 60.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 370' ' ' VAL . 47.3 t -104.04 33.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.187 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.34 139.7 37.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.901 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 52.42 40.02 53.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.442 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.422 ' CE1' HD21 ' A' ' 328' ' ' LEU . 32.7 t80 -80.2 120.04 23.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.013 0.435 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -63.68 112.1 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 29.4 tp -121.67 127.27 50.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . 0.514 ' CE2' ' HB3' ' A' ' 319' ' ' ARG . 31.5 m-85 41.27 46.32 2.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 59.97 44.68 96.96 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.443 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -156.03 114.56 3.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.717 0.294 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 17.2 mm -50.62 111.03 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.118 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.688 HD21 HD23 ' A' ' 313' ' ' LEU . 8.3 tt -80.39 120.16 24.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.64 118.18 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.469 HD11 ' O ' ' A' ' 370' ' ' VAL . 29.4 mt -99.04 136.83 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.098 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.49 177.66 7.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.921 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.685 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 41.3 m-85 -109.98 135.23 51.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -53.58 145.83 22.68 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.51 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -111.58 -39.16 4.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.768 0.318 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -109.12 138.47 45.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -137.34 145.32 43.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -117.53 159.98 21.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -48.93 -59.24 3.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.007 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 57.66 43.21 22.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.846 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 4.4 m -118.73 136.26 54.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.6 m -107.34 -45.0 4.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.837 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 89.99 67.21 1.22 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.56 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.92 169.76 21.07 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.746 2.297 . . . . 0.0 112.331 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 34.4 t -66.33 156.38 34.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 46.0 t -148.36 136.75 21.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.791 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.437 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.456 -0.257 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.1 m -99.39 115.16 28.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 110.813 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 46.7 t -111.88 93.31 4.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.86 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -163.2 -95.68 0.11 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.441 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 1.7 t 48.88 42.35 20.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.358 . . . . 0.0 110.847 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 4.9 t -96.31 75.95 2.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.835 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 119.75 113.87 2.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.421 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -49.53 -64.68 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.327 . . . . 0.0 110.906 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -96.05 -39.2 9.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.707 ' HA ' HD12 ' A' ' 296' ' ' ILE . 0.2 OUTLIER -80.44 14.01 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.083 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -37.58 -68.25 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -88.06 62.77 6.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.856 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 293' ' ' ILE . 47.4 mt -152.71 105.01 2.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.625 0.726 . . . . 0.0 111.152 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.9 -34.55 3.87 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.703 2.269 . . . . 0.0 112.382 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 8.5 mmt -133.38 105.57 7.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . 0.618 ' HB3' HG21 ' A' ' 296' ' ' ILE . 25.3 p90 -120.36 104.34 9.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 5.8 t -159.18 141.77 14.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 27.1 m -168.21 159.33 10.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.758 ' CE2' HG13 ' A' ' 381' ' ' VAL . 29.1 p90 -49.3 170.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.93 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -122.74 137.99 28.8 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.62 0.724 . . . . 0.0 110.9 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -79.52 -40.68 0.24 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.737 2.291 . . . . 0.0 112.324 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 108.25 -118.86 5.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.455 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -122.36 142.06 36.18 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.659 0.742 . . . . 0.0 110.873 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.21 107.02 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.663 2.242 . . . . 0.0 112.316 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -117.92 175.29 5.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.661 ' HG3' HG23 ' A' ' 310' ' ' VAL . 5.9 ptmm? -86.96 -36.78 18.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.661 HG23 ' HG3' ' A' ' 309' ' ' LYS . 83.9 t -96.08 125.48 48.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.105 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.446 ' CD2' ' CE1' ' A' ' 384' ' ' PHE . 34.5 mt -108.64 112.17 24.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.738 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 14.6 t80 -83.6 104.24 13.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.943 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.764 HD23 HD11 ' A' ' 380' ' ' LEU . 8.1 mp -90.66 136.71 32.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -132.24 -177.08 4.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 58.72 47.44 12.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.6 mt -106.61 111.54 24.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.4 t -45.77 142.06 3.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.701 0.762 . . . . 0.0 110.847 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.04 -19.37 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.66 2.24 . . . . 0.0 112.343 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -82.73 -37.98 23.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 60.8 t -40.77 137.17 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.176 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 4.5 p -135.77 168.25 19.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -45.99 -45.28 15.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -45.38 -59.26 2.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.876 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -44.36 -50.49 9.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 328' ' ' LEU . 28.8 mt -55.18 -41.94 72.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.979 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 98.3 t -56.69 -57.44 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.151 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 4.5 t -59.86 -24.16 64.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 325' ' ' LEU . 33.3 mt -76.07 -40.33 53.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.934 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -123.69 39.71 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -88.25 -38.71 15.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -55.61 -17.28 5.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.492 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 57.9 m-85 -84.56 -56.27 3.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . 0.534 ' HB2' HD12 ' A' ' 340' ' ' ILE . 5.4 tm0? -65.66 -48.52 71.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.537 ' OE2' ' HB1' ' A' ' 330' ' ' ALA . 13.0 mt-10 -52.01 -42.92 63.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.924 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -68.95 -71.52 0.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 22.3 mmtm -145.55 174.57 11.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 82.14 134.36 1.9 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.533 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -48.08 157.58 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.628 2.218 . . . . 0.0 112.43 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.1 105.93 0.09 OUTLIER 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.664 2.242 . . . . 0.0 112.381 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 333' ' ' GLN . 43.9 mt -54.23 138.97 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.183 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -93.01 127.77 38.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -118.56 142.39 47.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.866 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -141.27 126.18 18.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 11.4 ttm -115.4 125.79 53.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.945 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 9.8 ptp -104.31 157.93 16.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 26.4 p -145.18 159.91 42.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.156 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 151.89 -164.64 30.44 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -43.81 -50.51 7.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.874 0.369 . . . . 0.0 110.923 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . 0.464 ' O ' ' NE2' ' A' ' 352' ' ' GLN . 2.4 ttm -102.27 42.95 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.51 177.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.929 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 93.86 23.14 23.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.464 ' NE2' ' O ' ' A' ' 349' ' ' MET . 23.8 mt-30 -129.5 150.86 50.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.329 . . . . 0.0 110.945 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -154.71 152.15 29.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.738 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 41.5 m-85 -121.14 126.43 49.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 95.6 mt -118.29 142.79 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.42 HG23 ' HZ3' ' A' ' 309' ' ' LYS . 4.8 m -123.53 121.56 35.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.682 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 37.5 m-85 -99.69 159.05 30.98 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.663 0.744 . . . . 0.0 110.864 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.48 -42.46 18.11 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.688 2.259 . . . . 0.0 112.302 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -153.89 156.44 37.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.434 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 13.7 ptpt -48.6 -45.98 38.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.915 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . 0.434 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 20.1 mm-40 -41.24 -65.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.857 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' A' ' 363' ' ' ALA . 79.1 mt -54.08 -64.73 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.682 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -36.09 -57.6 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.062 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -49.05 -58.75 4.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -50.01 -48.19 52.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.492 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -57.66 -38.84 75.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.771 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 5.2 tt -64.38 -60.7 2.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . 0.556 ' N ' HD23 ' A' ' 367' ' ' LEU . 32.8 t60 -56.19 -27.55 54.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 30.2 mt -79.83 -37.11 35.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 370' ' ' VAL . 13.7 t -110.14 35.92 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.172 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -87.65 106.82 18.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.831 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 90.42 31.61 10.33 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.434 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.431 ' CE1' HD21 ' A' ' 328' ' ' LEU . 19.2 t80 -76.19 119.06 19.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.834 0.35 . . . . 0.0 110.991 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -66.71 107.28 2.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 15.0 tp -111.93 114.51 27.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.985 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 53.94 40.02 31.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 69.91 29.73 70.68 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.459 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -143.26 113.41 7.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.845 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 19.9 mm -53.88 128.06 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.09 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.764 HD11 HD23 ' A' ' 313' ' ' LEU . 5.5 tt -94.18 117.29 29.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.758 HG13 ' CE2' ' A' ' 302' ' ' TYR . 86.5 t -98.5 128.9 49.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.163 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.405 HG12 HD21 ' A' ' 380' ' ' LEU . 24.3 mt -110.58 132.22 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -134.03 124.02 25.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.922 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.771 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 39.8 m-85 -55.46 151.29 10.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.824 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -50.86 172.01 0.16 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -122.54 101.98 7.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.768 0.318 . . . . 0.0 110.811 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -126.62 100.04 6.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.946 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -103.83 59.84 0.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -121.22 94.45 4.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -82.15 110.33 17.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.961 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -65.32 149.14 50.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.902 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 7.5 t -65.69 91.43 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 7.1 t -50.94 169.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.887 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 100.97 91.87 2.12 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.446 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.0 121.61 5.89 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.753 2.302 . . . . 0.0 112.373 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 3.8 m -67.49 112.75 4.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.907 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 22.2 m -88.86 154.99 19.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.806 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.511 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 33.7 p -133.42 -62.22 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.936 0.398 . . . . 0.0 110.904 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 71.6 p -48.39 145.15 3.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.871 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -155.14 -151.49 5.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.481 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.7 p -119.41 133.52 55.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.775 0.321 . . . . 0.0 110.941 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 11.1 m -57.92 100.06 0.05 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.842 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -153.22 110.61 0.46 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.538 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -62.46 -43.74 98.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.841 0.353 . . . . 0.0 110.913 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -84.48 -47.85 10.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 6.1 pt -99.3 137.95 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . 0.427 ' HD3' ' C ' ' A' ' 294' ' ' ARG . 2.6 tmt_? -133.5 -63.79 0.74 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.834 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -73.49 -64.57 0.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.652 HG23 ' HD2' ' A' ' 297' ' ' PRO . 5.2 mp -107.09 139.23 20.23 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.606 0.717 . . . . 0.0 111.174 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . 0.652 ' HD2' HG23 ' A' ' 296' ' ' ILE . 63.7 Cg_endo -78.76 151.07 24.53 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.674 2.25 . . . . 0.0 112.343 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 23.2 ttp 56.95 43.82 24.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -105.93 172.89 6.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.6 t 64.44 43.08 4.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.845 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 66.9 m -152.31 166.36 32.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.758 ' CE2' HG13 ' A' ' 381' ' ' VAL . 5.3 p90 -49.36 161.64 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.941 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -124.16 139.51 32.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.659 0.742 . . . . 0.0 110.851 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.49 -41.16 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.268 . . . . 0.0 112.355 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 98.48 -144.65 17.35 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.426 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.447 ' CD ' ' HD2' ' A' ' 307' ' ' PRO . 9.0 tp10 -96.72 138.57 21.39 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.575 0.702 . . . . 0.0 110.897 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . 0.447 ' HD2' ' CD ' ' A' ' 306' ' ' GLU . 73.5 Cg_exo -47.14 99.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.668 2.246 . . . . 0.0 112.329 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -110.35 177.01 4.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.846 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -88.16 -25.17 23.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 23.5 t -97.89 128.68 49.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.088 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.696 HD12 ' CE1' ' A' ' 357' ' ' PHE . 48.7 mt -115.63 118.31 32.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.012 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.769 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 15.0 t80 -98.23 102.34 14.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.584 HD23 HD11 ' A' ' 380' ' ' LEU . 5.1 mp -88.5 146.54 25.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -138.06 -176.35 4.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 59.7 53.6 4.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.5 mt -115.65 122.84 46.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 18.0 t -64.5 143.87 98.59 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.68 0.753 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.72 -19.5 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.695 2.264 . . . . 0.0 112.386 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 -77.11 -35.16 56.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 97.6 t -48.53 146.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 12.2 p -145.24 175.33 10.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.113 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -48.38 -47.02 37.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -44.47 -54.37 6.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.24 -51.52 25.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 355' ' ' ILE . 57.2 mt -57.31 -47.53 81.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 330' ' ' ALA . 96.5 t -55.08 -61.78 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.184 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 11.6 t -53.09 -37.59 61.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.436 HD21 ' CD2' ' A' ' 373' ' ' TYR . 32.6 mt -63.23 -40.26 96.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.897 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -120.79 40.54 3.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -82.64 -21.17 35.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.08 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -69.66 -36.99 76.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -91.85 14.57 15.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . 0.454 ' NE2' ' H ' ' A' ' 340' ' ' ILE . 24.3 tp60 -75.55 -46.04 34.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.886 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -99.52 88.21 3.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -155.94 161.1 40.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -38.48 102.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 130.22 144.64 5.6 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.486 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.52 156.5 1.07 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.651 2.234 . . . . 0.0 112.353 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -45.92 164.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 0.0 112.392 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.607 HD13 ' CE2' ' A' ' 357' ' ' PHE . 85.4 mt -89.44 140.36 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.184 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -100.88 117.77 35.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -102.34 138.8 38.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -134.35 129.29 35.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 40.5 tpp -112.87 145.14 41.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . 0.452 ' HE3' ' N ' ' A' ' 345' ' ' MET . 18.6 mmt -80.7 143.55 32.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 22.9 p -113.73 -62.59 1.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.189 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 348' ' ' ARG . . . -53.12 -170.62 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.48 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 347' ' ' GLY . 6.6 ptp85 -34.55 150.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.755 0.312 . . . . 0.0 110.892 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 4.4 mtt 54.99 50.84 14.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.02 -0.04 8.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -82.28 31.48 2.9 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.486 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -139.87 166.75 23.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 110.882 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -158.6 149.26 20.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.769 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 12.9 m-85 -119.39 121.82 40.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.836 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.444 HD11 HD22 ' A' ' 325' ' ' LEU . 61.9 mt -110.14 144.47 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.15 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 340' ' ' ILE . 17.2 m -120.89 117.76 28.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.132 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.696 ' CE1' HD12 ' A' ' 311' ' ' LEU . 53.6 m-85 -98.94 155.76 36.25 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.625 0.726 . . . . 0.0 110.857 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.57 -42.0 18.61 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.75 2.3 . . . . 0.0 112.324 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.75 171.55 17.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 0.9 OUTLIER -64.78 -48.94 72.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . 0.412 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 7.3 mm-40 -39.99 -63.17 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 363' ' ' ALA . 90.6 mt -53.27 -65.82 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -36.98 -55.49 0.92 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -48.3 -63.47 1.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -45.29 -48.89 13.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.442 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -60.17 -33.74 72.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.091 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.886 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.4 tt -68.01 -63.29 1.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -50.65 -34.21 25.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 24.9 mt -75.34 -57.66 3.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.961 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.527 ' O ' HD11 ' A' ' 382' ' ' ILE . 5.9 t -84.1 31.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.115 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -87.27 103.85 15.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 90.77 37.45 6.43 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.436 ' CD2' HD21 ' A' ' 328' ' ' LEU . 73.9 t80 -82.38 107.64 15.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 0.0 110.961 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -59.09 126.96 29.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.64 124.97 18.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 49.41 34.68 6.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.946 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 73.44 38.03 52.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.438 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.15 150.48 47.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.784 0.325 . . . . 0.0 110.839 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 43.1 mm -97.17 87.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.61 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.2 tt -52.07 133.63 32.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.957 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.758 HG13 ' CE2' ' A' ' 302' ' ' TYR . 85.0 t -120.62 122.95 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.527 HD11 ' O ' ' A' ' 370' ' ' VAL . 21.5 mt -104.81 132.43 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.129 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -139.99 119.17 12.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.886 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 58.1 m-85 -51.33 151.59 2.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -64.99 -161.75 0.64 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -123.97 87.49 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -107.36 93.48 4.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -130.22 95.83 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.1 149.07 22.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -106.15 100.29 9.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -170.18 159.24 7.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.836 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 16.7 t -134.52 119.07 18.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 27.9 t -152.05 119.96 6.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.941 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -167.84 104.47 0.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.463 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.25 -175.45 2.41 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.649 2.233 . . . . 0.0 112.369 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 22.0 t -104.4 131.38 51.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 66.4 m -99.26 125.95 44.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.902 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 -179.939 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 73.9 m -152.69 156.39 39.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.847 0.356 . . . . 0.0 110.861 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 44.7 m -123.26 154.33 38.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 163.51 -141.43 7.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.472 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 2.3 t 55.42 37.9 29.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.858 0.361 . . . . 0.0 110.832 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 40.1 p -114.01 148.37 37.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.816 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -48.87 145.08 7.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.499 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -64.99 -44.47 89.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.864 0.364 . . . . 0.0 110.872 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -101.93 -56.5 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.883 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 2.9 pt -75.29 78.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.218 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -91.08 -60.08 2.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -42.44 -56.91 2.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.94 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.622 HG23 ' HD2' ' A' ' 297' ' ' PRO . 48.5 mt -123.44 138.38 30.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.625 0.726 . . . . 0.0 111.13 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . 0.622 ' HD2' HG23 ' A' ' 296' ' ' ILE . 63.7 Cg_endo -77.89 -48.63 0.1 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.67 2.247 . . . . 0.0 112.392 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 23.2 mtp -88.92 84.07 6.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.92 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -119.68 117.92 29.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 36.9 t -140.46 146.61 38.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 5.3 t -87.52 -58.86 2.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -125.88 165.77 18.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.954 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -123.95 99.77 37.66 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.604 0.716 . . . . 0.0 110.916 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.18 -32.1 7.06 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.718 2.279 . . . . 0.0 112.352 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 96.9 -126.5 8.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.41 ' O ' ' CG ' ' A' ' 384' ' ' PHE . 4.6 pm0 -121.01 151.27 54.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.667 0.746 . . . . 0.0 110.906 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.15 117.56 3.23 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.711 2.274 . . . . 0.0 112.309 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -138.43 160.06 40.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.566 ' HG3' HG23 ' A' ' 310' ' ' VAL . 11.4 ptmt -68.94 -28.42 66.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.94 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.566 HG23 ' HG3' ' A' ' 309' ' ' LYS . 73.9 t -95.85 134.32 33.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.554 HD12 ' CE1' ' A' ' 357' ' ' PHE . 45.4 mt -123.5 121.7 36.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.696 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 10.3 t80 -96.94 113.42 24.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.505 HD12 ' N ' ' A' ' 313' ' ' LEU . 5.3 mp -103.26 145.98 29.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.401 ' HD3' ' N ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -144.68 -179.7 6.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.955 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.4 m120 60.77 51.48 4.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.5 mt -113.23 115.97 29.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 21.3 t -50.29 146.28 8.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.647 0.737 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.86 -26.37 7.12 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.656 2.237 . . . . 0.0 112.291 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.444 ' HB3' ' NH1' ' A' ' 319' ' ' ARG . 7.5 mtp-105 -72.04 -31.7 66.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.27 132.34 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.166 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 322' ' ' GLU . 41.9 p -139.25 168.36 19.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.091 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 321' ' ' THR . 26.0 tt0 -37.06 -46.72 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.924 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 324' ' ' ASP . 70.7 mtm180 -47.36 -62.24 1.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 323' ' ' ARG . 4.7 m-20 -37.8 -50.92 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.598 HD22 HD11 ' A' ' 355' ' ' ILE . 22.6 mt -59.64 -47.71 84.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.962 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.634 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 94.9 t -46.6 -52.23 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 47.0 t -64.09 -42.39 96.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.482 HD21 ' CE2' ' A' ' 373' ' ' TYR . 78.3 mt -56.28 -49.33 74.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.986 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -113.72 35.04 4.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -70.58 -42.79 70.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.095 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.488 ' HG3' ' CD1' ' A' ' 332' ' ' PHE . 11.4 ptm180 -40.85 -52.53 3.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.81 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.488 ' CD1' ' HG3' ' A' ' 331' ' ' ARG . 16.2 m-85 -68.96 -29.01 67.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.936 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . 0.556 ' HA ' HD12 ' A' ' 340' ' ' ILE . 9.2 tp60 -44.94 -31.08 1.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.95 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -51.56 -176.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -80.91 46.61 0.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.904 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -93.42 36.1 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 123.34 -165.24 16.1 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.541 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . 0.421 ' CG ' ' HB3' ' A' ' 358' ' ' PRO . 72.1 Cg_exo -43.79 162.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.709 2.272 . . . . 0.0 112.36 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.8 143.34 29.65 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.648 2.232 . . . . 0.0 112.347 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.705 HG22 ' CE1' ' A' ' 342' ' ' PHE . 96.2 mt -92.28 140.6 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -121.88 127.74 50.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . 0.705 ' CE1' HG22 ' A' ' 340' ' ' ILE . 2.4 m-85 -111.61 139.57 46.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 31.3 ttt85 -135.4 123.22 22.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 17.7 ttm -116.9 129.56 56.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.01 133.26 33.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.877 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 12.6 t -150.22 155.84 40.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.164 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 87.01 -37.36 3.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.462 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -123.24 -46.26 2.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.768 0.318 . . . . 0.0 110.846 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 17.6 mmt -126.36 87.82 2.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.417 ' C ' ' HD2' ' A' ' 350' ' ' ARG . 7.5 tmm_? -86.99 145.72 26.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.912 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 93.58 -17.24 58.94 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.51 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -107.89 139.97 41.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.96 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -148.46 158.75 44.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.118 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.696 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 47.7 m-85 -132.27 130.26 40.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.598 HD11 HD22 ' A' ' 325' ' ' LEU . 85.7 mt -118.68 140.52 42.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.092 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.416 HG23 ' CE ' ' A' ' 309' ' ' LYS . 26.1 m -113.19 105.57 13.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 44.0 m-85 -90.03 158.81 43.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.672 0.749 . . . . 0.0 110.889 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . 0.421 ' HB3' ' CG ' ' A' ' 338' ' ' PRO . 74.3 Cg_exo -42.31 -55.52 2.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.605 2.203 . . . . 0.0 112.402 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.0 -176.49 5.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 43.7 pttt -67.57 -51.17 53.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . 0.406 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 10.7 mm-40 -39.16 -66.13 0.31 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.44 ' O ' ' C ' ' A' ' 363' ' ' ALA . 61.1 mt -55.27 -65.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.193 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.571 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -34.67 -56.33 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.143 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -50.63 -56.17 13.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 369' ' ' LEU . 30.4 mt-30 -50.97 -43.19 60.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -62.7 -41.48 99.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.07 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.742 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 6.5 tt -62.95 -63.55 1.17 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.972 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . 0.52 ' N ' HD23 ' A' ' 367' ' ' LEU . 46.1 t60 -55.92 -31.87 63.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.868 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.422 ' CG ' ' O ' ' A' ' 365' ' ' GLN . 37.0 mt -74.32 -33.02 63.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 370' ' ' VAL . 23.0 t -113.6 25.56 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 367' ' ' LEU . 1.6 p30 -69.43 138.15 53.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.883 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 46.35 49.12 15.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.493 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.482 ' CE2' HD21 ' A' ' 328' ' ' LEU . 89.3 t80 -83.29 118.44 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.03 0.443 . . . . 0.0 110.949 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -68.63 109.95 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.928 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.503 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 45.5 tp -126.42 126.07 43.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.832 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . 0.503 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 39.4 m-85 51.16 38.5 21.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 68.19 35.5 83.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.468 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -140.87 133.74 29.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.74 0.305 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 16.9 mm -79.39 88.45 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.154 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.635 HD23 ' C ' ' A' ' 380' ' ' LEU . 6.3 tt -58.87 127.49 32.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.884 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.8 t -107.74 130.58 59.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.471 HG13 ' CD2' ' A' ' 380' ' ' LEU . 55.1 mt -112.6 139.68 36.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.14 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -135.45 178.98 6.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.742 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 50.3 m-85 -111.75 129.53 56.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.946 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -45.44 157.89 0.28 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -102.06 101.64 12.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 110.845 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -139.18 132.34 29.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -107.6 -53.43 2.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -60.09 136.37 58.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -92.11 -64.13 1.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.889 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 11.3 mmm-85 -141.09 178.13 7.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.442 ' O ' ' C ' ' A' ' 393' ' ' SER . 1.2 t -115.2 119.88 37.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.798 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 392' ' ' SER . 84.8 p -35.05 130.35 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.832 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -143.0 147.9 19.46 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.484 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -46.44 130.45 14.5 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.702 2.268 . . . . 0.0 112.334 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 75.4 p -38.71 -46.41 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 15.9 t -121.46 131.86 54.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.867 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.535 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 95.7 p -127.44 173.86 9.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 0.0 110.804 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 29.7 t -135.25 137.35 42.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 56.9 -117.81 10.49 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.541 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 46.8 t 59.9 43.47 14.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.878 0.37 . . . . 0.0 110.861 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 41.1 t -67.71 -61.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 82.47 175.82 50.98 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.474 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -121.68 106.93 11.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.826 0.346 . . . . 0.0 110.823 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 54.64 44.66 28.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.627 HD12 ' H ' ' A' ' 295' ' ' LYS . 2.5 pp -104.55 143.02 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -102.29 63.99 0.9 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.877 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.627 ' H ' HD12 ' A' ' 293' ' ' ILE . 5.0 tppt? 54.37 39.55 31.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.49 125.6 17.74 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.643 0.735 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.75 -55.11 3.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.595 2.197 . . . . 0.0 112.383 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 21.5 ttp -115.7 106.38 13.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -128.25 41.41 3.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 5.8 t -123.49 127.43 48.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 72.0 m -149.4 174.36 12.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.813 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.941 ' CE2' HG13 ' A' ' 381' ' ' VAL . 14.6 p90 -67.56 172.57 4.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -130.07 142.04 43.99 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.552 0.691 . . . . 0.0 110.922 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.87 -51.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.706 2.27 . . . . 0.0 112.345 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.93 -163.03 30.41 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.498 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.51 ' O ' ' CD2' ' A' ' 384' ' ' PHE . 37.2 mt-10 -51.06 143.16 16.61 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.709 0.766 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.97 110.3 3.09 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.733 2.289 . . . . 0.0 112.351 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -103.2 175.8 5.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.553 ' CD ' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -91.49 5.85 47.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.553 HG23 ' CD ' ' A' ' 309' ' ' LYS . 93.5 t -129.91 135.26 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.15 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.685 HD12 ' CE1' ' A' ' 357' ' ' PHE . 96.5 mt -116.11 120.72 39.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.658 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 9.4 t80 -101.68 101.86 12.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.93 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.573 HD23 HD11 ' A' ' 380' ' ' LEU . 5.7 mp -92.96 146.79 23.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 -176.26 4.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 61.38 49.1 5.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.6 mt -115.51 137.44 52.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 38.7 t -70.67 140.02 86.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.654 0.74 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -43.61 -21.64 0.33 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.732 2.288 . . . . 0.0 112.291 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.58 ' O ' HG23 ' A' ' 321' ' ' THR . 11.4 mtp85 -76.65 -41.29 46.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.419 HG22 ' HD2' ' A' ' 376' ' ' TYR . 70.7 t -42.52 123.69 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.149 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 319' ' ' ARG . 40.7 p -123.08 171.99 8.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.174 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -44.56 -51.25 9.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.885 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -40.83 -50.25 3.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -53.67 -44.25 69.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 32.5 mt -64.7 -48.51 74.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 89.3 t -49.82 -54.51 7.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.157 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 22.8 t -59.15 -41.79 89.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.859 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 44.0 mt -57.52 -45.86 84.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.767 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 36.2 m-85 -120.49 49.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -91.41 -51.42 5.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -42.74 -49.54 5.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 40.0 m-85 -46.13 -38.94 8.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -80.6 75.04 7.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.896 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 335' ' ' LYS . 5.7 pt-20 -122.61 89.51 3.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 334' ' ' GLU . 14.0 pttp 34.49 41.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.492 ' NZ ' HD11 ' A' ' 362' ' ' ILE . 12.9 tmtt? -106.21 -51.79 2.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.884 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -144.33 -155.0 6.29 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.489 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.28 147.26 29.11 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.736 2.29 . . . . 0.0 112.342 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -47.44 111.2 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.7 2.267 . . . . 0.0 112.315 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 57.4 mt -46.71 136.68 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.106 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -90.76 132.92 35.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.946 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -125.1 138.36 54.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -139.08 128.91 24.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.5 tpp -112.93 141.65 46.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . 0.478 ' O ' HG23 ' A' ' 346' ' ' THR . 7.3 mtm -103.39 163.11 12.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 345' ' ' MET . 27.4 p -157.95 156.84 31.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.143 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 111.19 -141.55 16.55 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -55.13 130.05 40.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.808 0.337 . . . . 0.0 110.931 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 42.1 mmm 48.66 51.26 15.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -71.97 -176.63 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 101.73 21.49 11.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.482 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -132.28 152.55 51.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.871 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.55 150.06 35.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.658 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 39.2 m-85 -116.47 121.31 41.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.818 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 61.7 mt -114.4 133.29 60.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.192 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.2 m -114.58 114.2 25.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.129 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.685 ' CE1' HD12 ' A' ' 311' ' ' LEU . 37.4 m-85 -91.95 157.94 40.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.722 0.772 . . . . 0.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.4 -47.82 12.48 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.647 2.232 . . . . 0.0 112.371 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -138.83 174.42 10.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -69.92 -44.15 70.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -50.97 -58.21 6.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.492 HD11 ' NZ ' ' A' ' 336' ' ' LYS . 97.3 mt -53.15 -52.67 28.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.13 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -45.99 -61.35 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -45.79 -55.56 6.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -43.8 -53.93 5.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.767 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -60.31 -28.43 68.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.13 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.772 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.2 tt -70.15 -65.99 0.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.921 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -53.75 -28.67 35.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 30.1 mt -78.44 -48.88 14.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 370' ' ' VAL . 12.1 t -97.37 30.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . 0.42 ' O ' ' CG ' ' A' ' 371' ' ' ASN . 2.0 t30 -82.83 85.97 7.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.956 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 108.9 52.22 0.66 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.436 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -99.51 110.06 22.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.975 0.417 . . . . 0.0 110.898 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -61.47 125.7 24.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 30.3 tp -138.27 128.37 25.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.92 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . 0.419 ' HD2' HG22 ' A' ' 320' ' ' VAL . 41.2 m-85 48.17 42.69 17.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 61.52 37.06 93.53 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.562 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -148.35 114.44 5.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 110.974 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 34.9 mm -58.4 130.51 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.099 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.592 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.6 tt -90.93 135.92 33.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.916 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.941 HG13 ' CE2' ' A' ' 302' ' ' TYR . 50.8 t -121.67 125.76 73.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.457 HG12 HD21 ' A' ' 380' ' ' LEU . 12.8 mt -111.65 137.91 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.118 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -145.78 122.09 10.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.772 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 38.7 m-85 -47.15 151.74 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -51.3 129.72 32.82 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.507 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? -80.39 -48.54 12.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.32 . . . . 0.0 110.869 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -51.77 130.14 28.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.09 111.31 16.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.939 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -67.05 142.13 57.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.942 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -61.54 -59.91 4.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.918 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -128.64 135.23 49.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 82.6 p -50.68 148.54 3.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 60.5 m -60.08 159.07 10.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.879 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 145.26 99.06 0.25 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.448 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.14 167.91 25.88 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.643 2.229 . . . . 0.0 112.366 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 94.5 p -116.11 -50.78 2.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.837 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 88.4 p -73.41 118.71 16.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.415 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.479 -0.249 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 53.3 p -156.82 152.53 26.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.878 0.37 . . . . 0.0 110.866 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 88.1 p -126.74 -44.17 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 118.67 -153.4 16.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.477 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 85.4 p -165.58 118.62 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 110.908 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 66.0 p -164.58 112.18 1.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.833 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 95.41 47.79 2.5 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.522 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -40.9 -49.07 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 0.0 110.884 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -112.65 -49.11 2.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.932 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.455 ' C ' HD12 ' A' ' 293' ' ' ILE . 2.8 pp -70.85 161.8 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.173 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -116.47 179.66 3.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.812 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -47.47 97.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.67 HG23 ' HD2' ' A' ' 297' ' ' PRO . 59.8 mt -146.21 139.15 14.23 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.63 0.729 . . . . 0.0 111.17 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . 0.67 ' HD2' HG23 ' A' ' 296' ' ' ILE . 62.4 Cg_endo -77.27 -50.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.686 2.257 . . . . 0.0 112.379 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -121.78 78.78 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -80.64 -43.82 19.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.856 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 91.6 p -87.12 90.01 8.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.88 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 3.1 m -152.62 175.19 13.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -46.43 155.03 0.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.956 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -130.11 100.13 19.09 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.623 0.725 . . . . 0.0 110.831 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -44.38 -45.34 12.68 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.631 2.22 . . . . 0.0 112.413 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 103.92 -124.0 7.93 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.455 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -110.67 134.85 20.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.689 0.757 . . . . 0.0 110.868 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.21 96.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.683 2.256 . . . . 0.0 112.347 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -107.9 172.64 6.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 7.57 32.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 98.0 t -126.82 123.64 63.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.587 HD22 HD12 ' A' ' 367' ' ' LEU . 57.0 mt -109.69 129.2 55.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.802 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 10.3 t80 -110.32 101.62 10.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.708 HD21 ' CE1' ' A' ' 329' ' ' PHE . 5.7 mp -86.43 144.37 27.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.431 ' HG3' ' C ' ' A' ' 313' ' ' LEU . 3.2 mtpm? -142.56 179.11 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . 0.445 HD22 ' CG2' ' A' ' 381' ' ' VAL . 20.2 m-20 60.93 54.72 3.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.529 HD21 ' HG ' ' A' ' 380' ' ' LEU . 16.3 mt -119.6 109.46 15.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 42.8 t -45.71 145.37 2.26 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.708 0.766 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -46.44 -20.65 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.359 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -73.22 -37.67 66.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.971 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 84.4 t -52.55 126.06 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.08 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 37.4 p -121.36 171.72 8.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.136 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -45.07 -42.39 8.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -49.87 -46.98 52.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -52.69 -49.39 65.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.895 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 328' ' ' LEU . 30.4 mt -59.31 -54.45 46.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 99.9 t -45.89 -52.82 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 1.4 t -61.62 -43.73 98.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.747 HD21 ' CE2' ' A' ' 373' ' ' TYR . 36.9 mt -54.2 -40.37 67.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.932 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.708 ' CE1' HD21 ' A' ' 313' ' ' LEU . 6.6 m-85 -125.93 44.48 2.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -89.57 -51.25 5.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.073 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 15.9 ptm180 -44.43 -46.54 9.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.432 ' N ' ' HG3' ' A' ' 331' ' ' ARG . 24.0 m-85 -59.93 -45.14 93.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -59.86 106.28 0.47 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.862 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -138.31 179.78 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.45 ' HG2' ' N ' ' A' ' 336' ' ' LYS . 0.0 OUTLIER -66.77 -28.31 68.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.45 ' N ' ' HG2' ' A' ' 335' ' ' LYS . 34.4 mmtm -46.33 -47.9 18.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.952 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -126.99 159.86 21.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.41 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -44.65 168.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.637 2.225 . . . . 0.0 112.343 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.1 114.78 3.86 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.639 2.226 . . . . 0.0 112.384 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 356' ' ' THR . 74.6 mt -52.68 131.38 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.178 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -88.95 136.97 32.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -123.82 139.55 53.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.4 ' HG2' ' CE ' ' A' ' 345' ' ' MET . 46.0 ttp180 -141.29 135.18 30.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 12.2 ttm -112.93 140.09 48.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . 0.4 ' CE ' ' HG2' ' A' ' 343' ' ' ARG . 25.4 mmt -79.26 131.64 36.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.88 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 29.1 p -134.83 -44.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.121 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 348' ' ' ARG . . . -51.43 111.83 1.54 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.436 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 347' ' ' GLY . 5.9 ptm180 34.38 35.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.789 0.328 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 347' ' ' GLY . 30.3 ttp -173.82 125.92 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.71 161.74 35.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 104.45 -31.69 8.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.438 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -99.23 158.13 15.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 0.0 110.925 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -151.23 147.57 27.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.802 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 39.0 m-85 -113.73 119.15 36.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 75.5 mt -114.14 140.89 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.124 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.626 ' O ' HG23 ' A' ' 340' ' ' ILE . 44.0 m -118.54 130.96 56.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.557 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 18.4 m-85 -109.01 155.83 40.2 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.688 0.756 . . . . 0.0 110.909 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.9 -39.56 32.1 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.711 2.274 . . . . 0.0 112.392 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -144.53 179.45 7.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.2 ptmm? -80.12 -31.89 39.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.8 -64.53 0.87 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 75.4 mt -47.69 -65.28 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.124 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -38.15 -55.92 1.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -49.08 -60.95 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -45.01 -54.67 6.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.698 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -57.91 -42.83 85.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.067 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.983 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 4.5 tt -58.58 -55.47 34.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . 0.539 ' N ' HD23 ' A' ' 367' ' ' LEU . 14.0 t60 -58.42 -28.63 65.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.882 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 29.5 mt -79.87 -36.76 36.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 366' ' ' ALA . 19.1 t -91.26 -6.29 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.143 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 371' ' ' ASN . 0.0 OUTLIER -49.6 122.3 6.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.864 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 67.32 48.0 60.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.494 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.747 ' CE2' HD21 ' A' ' 328' ' ' LEU . 76.0 t80 -90.11 110.13 21.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.932 0.396 . . . . 0.0 110.891 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -68.48 114.09 6.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.685 HD13 ' HE2' ' A' ' 373' ' ' TYR . 33.2 tp -121.94 125.0 45.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.926 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 48.72 41.41 17.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 66.29 37.87 93.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.417 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -148.85 114.69 5.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.802 0.334 . . . . 0.0 110.916 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 32.9 mm -57.8 122.26 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.529 ' HG ' HD21 ' A' ' 316' ' ' LEU . 7.4 tt -85.13 129.02 34.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.455 ' N ' HD23 ' A' ' 380' ' ' LEU . 76.6 t -103.53 119.91 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 16.3 mt -109.05 130.03 62.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -139.67 131.34 27.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.983 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 81.7 m-85 -59.05 123.28 16.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -50.54 166.86 0.49 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.481 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -86.01 138.11 32.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.37 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -174.92 125.6 0.27 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -72.93 -50.5 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -170.72 149.72 3.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -92.73 113.69 26.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.974 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 18.6 ptt85 -148.21 105.02 3.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 47.9 t -111.96 91.2 3.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 3.8 t -40.89 147.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 162.58 92.95 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.519 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.41 14.64 1.36 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.253 . . . . 0.0 112.33 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.2 t -44.72 139.44 2.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 26.0 p -148.35 149.68 32.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.823 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.485 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 65.3 m -159.42 126.15 4.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.808 0.337 . . . . 0.0 110.841 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 52.9 p -117.27 167.42 11.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.817 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 165.48 173.04 33.61 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.397 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 66.8 m -149.99 125.34 10.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.785 0.326 . . . . 0.0 110.847 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 67.2 p -145.42 133.14 21.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.802 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -45.4 153.33 0.67 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.455 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -70.29 -40.85 74.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.349 . . . . 0.0 110.898 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -96.11 -44.85 7.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.913 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 39.9 pt -83.73 41.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.153 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -58.66 -65.78 0.6 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -77.31 -71.93 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.864 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.449 ' CG2' ' H ' ' A' ' 299' ' ' PHE . 2.9 mp -78.8 119.07 75.93 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.644 0.735 . . . . 0.0 111.108 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.55 -51.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.694 2.262 . . . . 0.0 112.316 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 22.0 mmm -54.47 -59.37 4.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.849 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . 0.449 ' H ' ' CG2' ' A' ' 296' ' ' ILE . 6.1 t80 40.95 43.19 1.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.5 t -174.69 164.5 3.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.895 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 67.5 m -80.24 -73.32 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.607 ' CD2' HG13 ' A' ' 381' ' ' VAL . 11.9 p90 -161.46 -178.45 6.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.937 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -105.31 96.37 11.45 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.643 0.735 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.75 -44.37 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.68 2.253 . . . . 0.0 112.337 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 101.41 -177.72 27.36 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.491 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.79 140.0 97.74 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.681 0.753 . . . . 0.0 110.818 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.29 93.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.7 2.267 . . . . 0.0 112.321 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' A' ' 384' ' ' PHE . 49.1 m-20 -101.11 172.35 7.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.467 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -90.85 1.94 56.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.467 HG23 ' HD2' ' A' ' 309' ' ' LYS . 68.7 t -121.4 128.61 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.1 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.62 HD12 ' CE1' ' A' ' 357' ' ' PHE . 28.1 mt -114.29 120.34 40.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.779 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 13.0 t80 -105.62 106.05 16.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.635 HD12 ' N ' ' A' ' 313' ' ' LEU . 1.1 mp -91.43 156.19 17.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.932 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.557 ' HE2' ' CD2' ' A' ' 312' ' ' TYR . 41.1 mttt -144.22 -176.59 5.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 15.2 m120 56.76 52.61 9.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.6 mt -115.88 113.21 23.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 40.1 t -55.8 145.15 53.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.752 0.787 . . . . 0.0 110.842 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -46.07 -25.74 3.12 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.725 2.284 . . . . 0.0 112.349 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.513 ' O ' HG23 ' A' ' 321' ' ' THR . 10.9 mtp85 -69.61 -41.96 75.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.829 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 66.6 t -44.18 134.65 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.15 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 319' ' ' ARG . 35.9 p -135.66 169.06 18.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -41.15 -48.57 3.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -40.42 -54.43 2.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -48.75 -59.99 3.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.587 ' HA ' HD12 ' A' ' 328' ' ' LEU . 36.8 mt -49.25 -52.31 27.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 80.6 t -46.27 -58.23 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 2.2 t -57.75 -43.64 85.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.587 HD12 ' HA ' ' A' ' 325' ' ' LEU . 41.9 mt -56.08 -41.61 75.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -125.83 45.98 2.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -88.0 -41.87 12.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -52.05 -18.54 1.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -94.2 -45.2 7.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.807 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -50.15 -42.33 50.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -97.0 33.58 1.88 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -106.7 -68.57 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -156.73 165.45 36.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 64.0 171.98 2.39 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.498 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -46.16 170.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.627 2.218 . . . . 0.0 112.339 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 340' ' ' ILE . 62.9 Cg_endo -78.9 109.65 2.63 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.635 2.223 . . . . 0.0 112.388 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 339' ' ' PRO . 60.8 mt -34.14 137.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.113 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -100.93 116.08 31.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.938 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -103.09 142.8 33.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -141.07 129.75 22.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.3 ttm -108.88 145.44 35.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 27.9 ttm -98.22 154.46 17.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.853 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 13.9 t -154.64 156.99 37.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.206 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 116.55 -104.2 1.21 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.518 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 349' ' ' MET . 10.4 ptm180 -100.03 158.16 16.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.8 0.333 . . . . 0.0 110.849 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . 0.436 ' C ' ' O ' ' A' ' 348' ' ' ARG . 21.3 mmm 35.41 45.37 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.417 ' C ' ' OE1' ' A' ' 352' ' ' GLN . 5.9 ppt_? -49.76 179.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 91.96 42.07 4.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.467 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.417 ' OE1' ' C ' ' A' ' 350' ' ' ARG . 29.3 mp0 -152.31 133.03 14.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.888 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -135.59 147.23 48.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.079 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.779 ' CE2' ' CE1' ' A' ' 312' ' ' TYR . 42.6 m-85 -115.32 130.14 56.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 69.7 mt -121.5 141.72 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.188 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 39.7 m -121.21 108.61 13.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.795 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 51.3 m-85 -88.5 156.67 50.59 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 0.0 110.897 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -47.03 -47.52 16.52 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.695 2.263 . . . . 0.0 112.304 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -148.78 146.3 27.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.912 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -40.42 -41.6 1.43 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -44.49 -65.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.427 HG22 ' CD2' ' A' ' 357' ' ' PHE . 75.2 mt -57.55 -57.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.078 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.795 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -40.81 -49.07 3.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -58.56 -62.57 1.76 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -47.92 -45.6 31.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.939 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.36 85.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.164 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.666 ' C ' HD23 ' A' ' 367' ' ' LEU . 5.5 tt -63.36 -65.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . 0.641 ' N ' HD23 ' A' ' 367' ' ' LEU . 2.4 t60 -46.5 -33.58 4.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 37.3 mt -69.9 -53.0 19.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.952 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.36 36.59 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -83.54 85.77 7.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 106.55 46.18 1.16 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.491 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -89.95 120.52 31.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.008 0.433 . . . . 0.0 110.898 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -70.18 135.4 49.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 28.6 tp -148.29 116.33 6.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.955 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 53.59 42.1 31.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 66.69 30.65 76.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.47 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . 0.428 ' NZ ' ' HA ' ' A' ' 378' ' ' LYS . 0.0 OUTLIER -134.26 124.24 25.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.74 0.305 . . . . 0.0 110.888 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 33.8 mm -74.55 107.76 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.607 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.3 tt -70.16 127.84 34.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.607 HG13 ' CD2' ' A' ' 302' ' ' TYR . 46.0 t -116.57 126.44 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.148 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.523 ' O ' ' CE1' ' A' ' 302' ' ' TYR . 15.0 mt -106.52 137.59 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.161 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -146.39 121.45 10.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.568 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 54.2 m-85 -52.64 140.0 24.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.853 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -39.59 113.13 0.31 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.493 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -77.05 -43.84 32.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.803 0.335 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -126.2 159.45 32.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -104.5 131.62 51.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.864 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -100.2 124.21 45.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.453 ' HA ' ' NE2' ' A' ' 390' ' ' GLN . 8.3 mm-40 -103.99 103.35 13.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.943 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -162.08 145.95 12.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.949 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 16.6 m -141.51 150.09 41.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.803 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 78.4 p -63.37 159.84 17.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.91 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 150.04 71.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.481 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.93 132.03 13.82 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.723 2.282 . . . . 0.0 112.375 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 13.6 t -80.55 105.52 11.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.931 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 3.7 t -57.6 -50.58 72.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.89 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.558 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.2 m -157.32 140.59 15.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.363 . . . . 0.0 110.858 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 69.5 m -83.73 169.23 15.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -105.6 44.56 1.45 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.451 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 61.5 p -174.44 120.28 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 110.794 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 17.2 p -74.48 110.18 8.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 74.9 134.65 0.37 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.492 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -84.72 -22.92 29.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.777 0.322 . . . . 0.0 110.869 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -122.72 -39.74 2.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.835 ' O ' HD12 ' A' ' 293' ' ' ILE . 2.7 pp -81.35 39.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.123 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -74.97 -44.24 49.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.823 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -132.8 72.15 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.675 HD12 ' HA ' ' A' ' 293' ' ' ILE . 71.1 mt -141.19 121.16 8.48 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.593 0.711 . . . . 0.0 111.093 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.9 -39.3 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.67 2.247 . . . . 0.0 112.356 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 11.7 mtm -123.82 89.51 3.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.82 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . 0.471 ' CE1' ' O ' ' A' ' 296' ' ' ILE . 1.2 m-85 -69.25 -45.48 69.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 30.5 t -122.39 102.58 8.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.845 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 19.2 m -76.81 -53.37 8.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.855 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -174.98 164.29 3.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.953 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -138.64 143.34 37.59 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.591 0.71 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.61 -51.9 0.08 OUTLIER 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.759 2.306 . . . . 0.0 112.329 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 99.03 -161.12 20.06 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.503 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -57.16 144.65 69.07 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.625 0.726 . . . . 0.0 110.869 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 384' ' ' PHE . 59.3 Cg_endo -73.36 129.73 14.24 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.7 2.267 . . . . 0.0 112.27 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -130.92 -179.07 5.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.647 ' HG3' HG23 ' A' ' 310' ' ' VAL . 39.7 pttt -84.91 -26.75 27.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.647 HG23 ' HG3' ' A' ' 309' ' ' LYS . 18.3 t -102.72 145.32 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.858 HD12 ' CE1' ' A' ' 357' ' ' PHE . 77.0 mt -125.92 135.23 51.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.546 ' CD1' ' HE2' ' A' ' 314' ' ' LYS . 0.7 OUTLIER -102.86 101.46 11.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.866 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.629 HD13 HG13 ' A' ' 355' ' ' ILE . 5.7 mp -91.12 140.96 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.905 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.546 ' HE2' ' CD1' ' A' ' 312' ' ' TYR . 14.6 mttm -139.38 -178.8 5.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 60.53 47.59 8.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.441 ' HB3' HG11 ' A' ' 320' ' ' VAL . 10.8 mt -105.59 99.61 9.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 316' ' ' LEU . 28.9 t -38.08 144.02 0.38 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.642 0.734 . . . . 0.0 110.924 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -44.54 -33.75 7.0 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.673 2.249 . . . . 0.0 112.382 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.58 ' O ' HG23 ' A' ' 321' ' ' THR . 16.6 mtp85 -68.5 -39.26 81.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 316' ' ' LEU . 97.5 t -41.23 138.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 319' ' ' ARG . 68.9 p -138.0 176.1 9.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -45.13 -54.23 7.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 324' ' ' ASP . 9.4 mmm180 -42.0 -64.99 0.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.94 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 323' ' ' ARG . 40.3 m-20 -35.92 -47.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 76.0 mt -65.45 -49.39 69.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.923 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 330' ' ' ALA . 55.3 t -48.7 -59.39 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 43.8 t -56.13 -42.73 77.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.671 HD21 ' CE2' ' A' ' 373' ' ' TYR . 29.3 mt -57.16 -31.41 65.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.902 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.5 ' CE1' HD21 ' A' ' 313' ' ' LEU . 64.2 m-85 -129.45 36.8 4.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 326' ' ' VAL . . . -85.56 -48.69 8.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -42.54 -41.76 3.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -64.77 -35.58 81.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 330' ' ' ALA . 23.0 tt0 -44.26 -58.37 2.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -67.13 72.34 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.454 ' HD3' ' N ' ' A' ' 336' ' ' LYS . 1.5 tmtp? -164.86 148.51 8.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.454 ' N ' ' HD3' ' A' ' 335' ' ' LYS . 44.5 tttm -41.23 110.84 0.18 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 145.81 142.02 3.73 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 339' ' ' PRO . 75.3 Cg_exo -48.24 152.46 3.62 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.637 2.225 . . . . 0.0 112.38 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 338' ' ' PRO . 76.4 Cg_exo -49.11 137.98 28.75 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.643 2.229 . . . . 0.0 112.363 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 97.2 mt -68.44 142.91 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.129 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -109.54 127.47 54.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . 0.56 ' CE2' HD13 ' A' ' 355' ' ' ILE . 91.0 m-85 -115.56 141.58 47.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.863 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -137.11 127.21 26.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 30.0 tpp -117.15 136.97 52.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 3.2 ptp -109.3 128.55 55.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.838 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 31.9 p -124.95 118.79 27.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.083 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 168.38 -138.45 5.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.547 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 35.7 ptt85 -59.38 -42.61 92.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.755 0.312 . . . . 0.0 110.802 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . 0.439 ' HG3' ' NE2' ' A' ' 352' ' ' GLN . 2.5 tpp -102.21 47.99 0.88 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -59.65 170.55 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 81.8 5.68 89.62 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.48 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.439 ' NE2' ' HG3' ' A' ' 349' ' ' MET . 80.8 mt-30 -116.61 151.47 36.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 0.0 110.965 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -163.97 157.2 18.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.094 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.481 ' CE2' ' CE2' ' A' ' 312' ' ' TYR . 8.8 m-85 -118.44 158.42 25.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.815 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.629 HG13 HD13 ' A' ' 313' ' ' LEU . 24.3 mt -144.89 117.25 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.187 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 13.3 m -97.55 131.53 44.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.1 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.858 ' CE1' HD12 ' A' ' 311' ' ' LEU . 7.7 m-85 -111.46 155.39 42.95 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.639 0.733 . . . . 0.0 110.892 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -44.26 -31.35 4.23 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.267 . . . . 0.0 112.379 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.1 177.29 11.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.417 ' NZ ' ' O ' ' A' ' 307' ' ' PRO . 0.1 OUTLIER -72.33 -49.92 30.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -43.85 -63.94 0.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 79.3 mt -50.85 -59.03 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -44.54 -46.13 9.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.095 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -59.04 -67.84 0.33 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -37.5 -52.02 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.609 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -55.94 -43.95 77.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.05 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.586 ' C ' HD23 ' A' ' 367' ' ' LEU . 7.9 tt -58.17 -55.24 37.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.894 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -67.45 -13.19 61.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 33.5 mt -93.01 -29.57 15.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 366' ' ' ALA . 6.2 t -109.21 17.2 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 371' ' ' ASN . 0.5 OUTLIER -75.08 117.13 16.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 81.39 36.5 20.31 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.487 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.671 ' CE2' HD21 ' A' ' 328' ' ' LEU . 65.0 t80 -81.79 114.08 20.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 0.0 110.917 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -70.07 104.4 2.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.959 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 51.2 tp -121.57 125.23 46.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 57.38 27.02 13.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.959 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 78.71 25.28 60.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.514 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -132.57 139.95 48.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 36.2 mm -84.17 94.6 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.126 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.654 HD23 ' C ' ' A' ' 380' ' ' LEU . 5.2 tt -57.54 130.11 44.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 39.3 t -110.69 124.39 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.597 HG12 HD21 ' A' ' 380' ' ' LEU . 14.8 mt -109.03 143.73 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -148.26 121.32 8.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.477 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 26.1 m-85 -46.69 149.2 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.83 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -64.97 -163.1 0.78 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.458 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -118.75 106.38 12.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.34 . . . . 0.0 110.863 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -76.25 150.22 37.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -100.62 -68.8 0.8 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -141.47 117.45 10.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.847 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -57.34 164.18 1.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -144.68 179.19 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 6.5 t -117.79 116.79 27.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 11.5 t -116.47 155.44 28.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 164.49 160.93 12.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.457 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.06 117.9 4.58 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.707 2.271 . . . . 0.0 112.38 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 10.9 t -89.21 96.55 10.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.826 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 45.7 m -47.72 154.53 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.519 -179.947 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 4.7 m -132.2 157.16 45.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.865 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.7 t -53.22 150.77 5.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.78 120.7 0.36 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.434 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 47.7 m -92.23 -60.12 1.92 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 110.914 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 53.3 m -60.81 129.1 39.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.817 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 55.84 95.49 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.48 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.73 -35.45 79.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 0.0 110.898 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -131.86 -41.08 1.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.444 ' O ' ' CE1' ' A' ' 299' ' ' PHE . 11.9 pt -52.41 -20.92 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.106 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 51.1 ptt85 -59.98 -28.35 67.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.824 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -85.29 -51.81 6.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.674 HD12 ' H ' ' A' ' 296' ' ' ILE . 4.5 mp -56.1 109.33 1.59 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.531 0.681 . . . . 0.0 111.204 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.55 -42.12 29.35 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.702 2.268 . . . . 0.0 112.327 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.426 ' O ' ' C ' ' A' ' 299' ' ' PHE . 4.0 mpp? -118.53 77.5 1.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 293' ' ' ILE . 0.7 OUTLIER -34.48 -64.3 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 41.8 t -166.29 143.58 5.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 302' ' ' TYR . 51.2 m -154.96 165.23 37.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.894 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.56 ' CD2' HG13 ' A' ' 381' ' ' VAL . 1.6 p90 -36.03 144.09 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.17 140.07 23.16 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.655 0.74 . . . . 0.0 110.852 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -78.69 -48.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.75 2.3 . . . . 0.0 112.337 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 87.26 -168.39 38.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.493 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.439 ' CD ' ' HD2' ' A' ' 307' ' ' PRO . 7.9 tp10 -39.75 137.63 1.1 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.646 0.736 . . . . 0.0 110.919 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . 0.439 ' HD2' ' CD ' ' A' ' 306' ' ' GLU . 60.4 Cg_endo -73.78 147.36 39.58 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.727 2.285 . . . . 0.0 112.337 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -153.47 166.29 33.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.629 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -84.4 29.88 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.867 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.629 HG23 ' HD2' ' A' ' 309' ' ' LYS . 90.8 t -146.9 123.21 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.178 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.521 HD21 ' HB1' ' A' ' 363' ' ' ALA . 20.4 mt -116.82 126.51 53.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.785 ' CE1' ' CZ ' ' A' ' 354' ' ' PHE . 18.0 t80 -103.94 101.56 11.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.871 HD23 HD11 ' A' ' 380' ' ' LEU . 6.5 mp -89.45 140.52 29.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.958 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -131.9 -176.06 3.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.839 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 55.61 52.98 10.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.919 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.5 mt -111.53 113.04 25.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.952 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 46.6 t -54.2 139.53 55.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.651 0.739 . . . . 0.0 110.867 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -42.37 -28.11 0.89 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.714 2.276 . . . . 0.0 112.35 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.402 ' O ' HG23 ' A' ' 321' ' ' THR . 26.4 mmt-85 -68.5 -40.4 80.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.852 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.642 HG22 ' HD2' ' A' ' 376' ' ' TYR . 40.8 t -46.16 123.7 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.106 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 319' ' ' ARG . 18.3 p -122.05 168.49 11.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -40.81 -51.75 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -43.39 -50.11 6.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -50.04 -47.41 53.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 45.7 mt -61.46 -53.04 61.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.696 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 99.7 t -48.11 -49.56 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.182 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 5.8 t -63.46 -40.42 97.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.823 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.8 mt -58.46 -40.03 81.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.856 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.664 ' HZ ' HD21 ' A' ' 313' ' ' LEU . 14.2 m-85 -123.79 40.29 3.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -86.33 -34.28 20.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.075 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 9.9 ptp85 -55.51 -39.77 70.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.435 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 23.3 m-85 -67.72 -34.84 77.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -52.56 94.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.97 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -141.32 168.7 19.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -71.06 81.84 0.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.855 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.48 -65.72 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -138.13 -157.24 7.4 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.477 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -43.15 162.84 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.77 2.313 . . . . 0.0 112.357 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -79.13 121.56 4.93 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.712 2.274 . . . . 0.0 112.307 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.455 HG22 ' CE1' ' A' ' 342' ' ' PHE . 79.4 mt -50.74 109.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.113 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -82.95 139.98 33.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . 0.455 ' CE1' HG22 ' A' ' 340' ' ' ILE . 79.8 m-85 -125.37 136.18 53.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -135.69 135.35 40.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.417 ' C ' ' CE ' ' A' ' 345' ' ' MET . 10.6 ttm -116.71 144.19 44.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . 0.417 ' CE ' ' C ' ' A' ' 344' ' ' MET . 22.5 mmt -87.93 162.75 16.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 10.2 t -174.0 143.8 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.165 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 88.11 -102.76 2.86 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.5 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -45.82 -61.82 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.313 . . . . 0.0 110.84 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 7.2 mtp -127.6 94.62 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 -84.82 163.92 18.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 82.09 10.04 84.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -122.62 154.6 37.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.785 0.326 . . . . 0.0 110.978 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -149.59 144.5 26.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.055 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.785 ' CZ ' ' CE1' ' A' ' 312' ' ' TYR . 70.1 m-85 -120.23 119.0 31.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 313' ' ' LEU . 65.7 mt -108.25 142.61 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.122 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 26.4 m -122.96 103.91 8.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.803 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 26.9 m-85 -83.57 156.16 65.37 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.703 0.763 . . . . 0.0 110.858 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -45.21 -52.91 5.91 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.702 2.268 . . . . 0.0 112.287 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -133.92 162.37 32.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -61.14 -42.6 98.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -51.8 -58.23 7.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 72.2 mt -53.08 -61.03 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.803 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -42.84 -59.78 1.84 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -43.05 -60.38 1.66 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -43.57 -45.83 6.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.951 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -64.14 -33.66 76.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.15 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.612 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.1 tt -63.91 -61.65 2.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.923 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.05 -35.67 69.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.11 -42.95 68.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.521 ' O ' HD11 ' A' ' 382' ' ' ILE . 11.7 t -105.12 41.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -92.21 94.49 9.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 100.64 40.76 2.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.521 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -87.63 108.96 19.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.954 0.406 . . . . 0.0 110.928 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -60.38 123.25 16.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 26.0 tp -135.97 132.82 36.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . 0.642 ' HD2' HG22 ' A' ' 320' ' ' VAL . 37.0 m-85 48.35 45.75 20.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 57.51 34.19 68.52 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.51 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -150.56 114.13 4.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.339 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 45.7 mm -51.04 146.01 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.871 HD11 HD23 ' A' ' 313' ' ' LEU . 8.3 tt -104.7 140.39 38.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.647 ' N ' HD23 ' A' ' 380' ' ' LEU . 78.9 t -123.93 125.04 70.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.521 HD11 ' O ' ' A' ' 370' ' ' VAL . 11.8 mt -109.84 132.57 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.149 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -137.01 119.83 16.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.612 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 16.9 m-85 -48.67 114.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 386' ' ' LYS . . . -40.22 110.11 0.16 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.478 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 385' ' ' GLY . 0.0 OUTLIER -36.06 151.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.952 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -110.63 112.04 23.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -99.05 42.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -124.72 39.56 3.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -116.04 124.52 50.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 5.3 tpp85 -171.15 133.69 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 32.1 t -84.71 -41.9 15.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 65.4 p -116.44 150.14 38.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.832 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -172.9 88.37 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.41 125.44 7.7 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.65 2.233 . . . . 0.0 112.336 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 28.4 p -109.39 145.57 35.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 5.9 t -127.76 -55.47 1.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.531 179.969 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.6 t -73.64 140.79 46.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.836 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 35.8 t -108.2 88.22 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.801 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -177.08 113.94 0.45 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.479 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 54.7 m -116.34 126.26 53.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 110.86 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 23.6 t -115.8 145.25 42.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 98.67 139.26 10.73 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.511 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -107.94 152.06 24.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 0.0 110.863 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 44.6 38.85 2.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.959 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 15.3 pt -90.56 40.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.106 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -52.47 -43.09 64.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -121.41 -60.9 1.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.459 HG23 ' HD2' ' A' ' 297' ' ' PRO . 47.0 mt -88.25 133.34 37.0 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.625 0.726 . . . . 0.0 111.108 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . 0.459 ' HD2' HG23 ' A' ' 296' ' ' ILE . 61.5 Cg_endo -77.03 -50.68 0.09 OUTLIER 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.698 2.265 . . . . 0.0 112.338 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 29.4 mmt -58.74 -70.05 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.855 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 4.5 t80 56.37 34.61 24.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 2.4 t -159.25 112.86 2.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.796 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 36.1 m -129.01 171.77 12.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -53.07 166.74 0.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.957 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -120.07 111.17 35.69 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.638 0.733 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.64 -39.98 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.621 2.214 . . . . 0.0 112.424 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 96.52 -129.83 10.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -107.58 134.67 19.92 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.748 0.785 . . . . 0.0 110.824 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.8 113.69 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.777 2.318 . . . . 0.0 112.317 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -126.58 178.59 5.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.469 ' HG3' HG23 ' A' ' 310' ' ' VAL . 38.3 pttt -81.62 -28.09 33.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.469 HG23 ' HG3' ' A' ' 309' ' ' LYS . 81.7 t -95.0 138.68 20.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.202 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.508 HD12 ' CE1' ' A' ' 357' ' ' PHE . 77.7 mt -125.31 114.18 18.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.788 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 11.7 t80 -88.62 104.08 16.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.939 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 313' ' ' LEU . 6.4 mp -92.52 150.84 20.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.943 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -140.84 -175.0 4.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 57.75 48.31 14.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 12.1 mt -104.09 124.89 49.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.9 t -67.6 145.05 98.09 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.659 0.742 . . . . 0.0 110.828 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.55 -27.41 3.48 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.705 2.27 . . . . 0.0 112.307 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.532 ' O ' HG23 ' A' ' 321' ' ' THR . 32.5 mtp85 -74.25 -38.33 63.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.667 HG22 HD21 ' A' ' 375' ' ' LEU . 93.2 t -41.36 146.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 319' ' ' ARG . 44.6 p -148.73 159.38 44.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.152 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.753 ' O ' HG23 ' A' ' 326' ' ' VAL . 1.2 tm-20 -41.02 -32.27 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . 0.426 ' NH1' ' HB2' ' A' ' 323' ' ' ARG . 17.7 ttm105 -60.66 -58.12 9.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.956 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -45.8 -48.55 15.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.873 ' HA ' HD12 ' A' ' 328' ' ' LEU . 36.1 mt -57.84 -51.64 68.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 322' ' ' GLU . 69.4 t -45.83 -47.34 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.418 ' HA ' ' HB2' ' A' ' 330' ' ' ALA . 8.8 t -67.28 -37.73 83.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.831 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.873 HD12 ' HA ' ' A' ' 325' ' ' LEU . 51.0 mt -56.52 -34.35 66.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.934 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.524 ' CE1' HG21 ' A' ' 370' ' ' VAL . 18.4 m-85 -127.9 32.85 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.853 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 327' ' ' SER . . . -71.24 -52.14 20.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.099 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -40.06 -49.77 2.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.834 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -54.07 -57.54 10.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . 0.52 ' HB2' HD12 ' A' ' 340' ' ' ILE . 12.5 tt0 -43.48 99.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.93 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -112.15 -175.48 2.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -56.96 -46.53 82.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -69.01 174.81 4.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 57.01 156.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.98 146.42 32.72 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.726 2.284 . . . . 0.0 112.35 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 340' ' ' ILE . 71.2 Cg_exo -45.94 106.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.675 2.25 . . . . 0.0 112.352 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.52 HD12 ' HB2' ' A' ' 333' ' ' GLN . 83.9 mt -34.14 129.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -92.32 138.36 31.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -127.72 136.1 51.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.841 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -134.32 122.78 23.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.873 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 45.4 tpp -110.07 133.29 53.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 26.5 ttm -83.68 119.05 24.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 9.7 t -141.38 144.77 34.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 119.62 -83.39 0.35 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.505 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -68.97 -53.51 20.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.83 0.348 . . . . 0.0 110.858 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 8.2 ttt -155.24 118.97 4.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.923 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -87.52 175.67 7.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 107.14 -21.5 31.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.536 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.431 ' N ' ' CD ' ' A' ' 352' ' ' GLN . 3.0 mp0 -112.18 141.74 45.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.816 0.341 . . . . 0.0 110.891 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.59 153.63 41.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.033 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.788 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 50.7 m-85 -125.24 124.19 41.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.75 137.65 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.136 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 83.4 m -113.9 128.68 56.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.689 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 69.8 m-85 -109.46 157.05 38.43 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 0.0 110.875 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -42.8 -34.97 3.91 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.62 2.213 . . . . 0.0 112.398 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . 0.481 ' ND2' ' H ' ' A' ' 362' ' ' ILE . 0.7 OUTLIER -159.44 -177.34 6.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -71.96 -45.62 60.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -43.12 -66.04 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.481 ' H ' ' ND2' ' A' ' 359' ' ' ASN . 58.1 mt -51.1 -69.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.152 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.689 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -36.3 -57.36 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -48.43 -57.28 6.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -50.28 -41.86 51.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.481 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -65.65 -38.95 90.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.009 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.716 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 4.8 tt -60.75 -60.65 3.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 110.932 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . 0.634 ' N ' HD23 ' A' ' 367' ' ' LEU . 19.1 t-80 -62.08 -35.18 77.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 32.2 mt -67.46 -40.48 85.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 370' ' ' VAL . 10.5 t -107.18 32.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.71 125.41 29.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 64.88 38.31 95.37 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.445 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -78.65 124.93 28.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.877 0.37 . . . . 0.0 110.958 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -78.41 121.21 24.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.667 HD21 HG22 ' A' ' 320' ' ' VAL . 29.8 tp -125.77 143.97 50.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 38.46 33.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 72.13 47.81 28.82 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.433 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 378' ' ' LYS . 2.4 ptmt -165.92 120.49 1.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.825 0.345 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 46.6 mm -51.49 142.6 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.138 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.628 HD23 ' C ' ' A' ' 380' ' ' LEU . 5.6 tt -110.4 143.38 40.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.594 HG12 ' OE1' ' A' ' 383' ' ' GLU . 11.7 t -112.78 142.42 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.071 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.48 HG13 ' CD2' ' A' ' 380' ' ' LEU . 27.5 mt -134.56 136.14 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.153 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . 0.594 ' OE1' HG12 ' A' ' 381' ' ' VAL . 4.8 mp0 -138.63 178.93 6.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.968 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.716 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 48.7 m-85 -105.04 133.93 49.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.93 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -110.29 143.4 16.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.462 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -127.93 154.87 45.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.907 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -110.25 -47.6 3.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -154.51 126.73 7.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -81.76 45.06 0.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.892 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -118.98 150.96 39.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -121.52 -44.82 2.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.857 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 73.1 m 46.78 44.4 14.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.892 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 83.1 p -68.77 127.28 32.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.925 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 141.53 91.66 0.18 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.487 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.84 112.68 3.49 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.636 2.224 . . . . 0.0 112.367 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 66.8 m -53.0 109.59 0.44 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.93 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 11.9 t -93.46 139.65 30.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.5 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 10.2 m -65.91 95.81 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 0.0 110.849 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 4.4 m -143.67 162.55 35.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 140.35 154.71 6.33 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.466 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 30.8 m -139.42 157.07 46.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.4 t -147.43 116.49 6.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 139.5 111.0 0.93 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.463 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -93.45 -38.01 11.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.792 0.33 . . . . 0.0 110.876 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.475 ' HG2' HG23 ' A' ' 293' ' ' ILE . 1.2 pm0 -94.05 -20.25 20.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.818 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.61 HG21 ' HA ' ' A' ' 297' ' ' PRO . 2.2 pp -103.16 161.07 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.097 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 56.9 mtp85 -111.72 -56.79 2.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 28.7 mmtt -113.95 -55.57 2.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.403 HG23 ' HD2' ' A' ' 297' ' ' PRO . 58.4 mt -97.96 132.59 24.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.594 0.711 . . . . 0.0 111.149 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . 0.61 ' HA ' HG21 ' A' ' 293' ' ' ILE . 63.0 Cg_endo -77.99 -42.05 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.266 . . . . 0.0 112.253 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 16.8 mmt -81.5 43.18 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -81.58 -51.78 7.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 75.3 m -107.67 85.65 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 22.6 m -70.91 -52.47 19.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.884 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.524 ' CE1' HG13 ' A' ' 381' ' ' VAL . 4.1 p90 -132.01 136.42 47.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -103.8 136.92 19.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.652 0.739 . . . . 0.0 110.853 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.0 -52.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.621 2.214 . . . . 0.0 112.363 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 113.82 -159.94 13.43 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.534 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -81.3 135.22 50.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.732 0.777 . . . . 0.0 110.867 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.93 122.54 6.26 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.653 2.235 . . . . 0.0 112.35 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -130.09 -177.79 4.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.544 ' HD2' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -99.12 -14.13 19.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.972 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.544 HG23 ' HD2' ' A' ' 309' ' ' LYS . 69.2 t -111.79 115.07 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.051 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.521 HD21 ' CE1' ' A' ' 384' ' ' PHE . 58.8 mt -100.32 140.23 34.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.849 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.752 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 10.6 t80 -122.27 102.88 8.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.964 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.688 HD23 HD11 ' A' ' 380' ' ' LEU . 6.6 mp -86.04 150.98 24.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.567 ' HE2' ' CD2' ' A' ' 312' ' ' TYR . 41.3 mttt -139.79 -175.9 4.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.919 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 54.59 52.35 12.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.0 mt -110.21 104.6 13.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 36.2 t -47.22 143.98 4.59 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.728 0.775 . . . . 0.0 110.823 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.37 -19.01 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.69 2.26 . . . . 0.0 112.335 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 30.5 mtt180 -77.38 -36.39 53.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 321' ' ' THR . 95.9 t -44.88 152.15 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 320' ' ' VAL . 35.3 p -158.78 166.52 31.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.164 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 321' ' ' THR . 7.3 mt-10 -34.78 -55.57 0.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.79 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 322' ' ' GLU . 60.3 mtp180 -37.45 -46.49 0.81 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -56.35 -59.71 4.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.431 ' CD2' HD22 ' A' ' 313' ' ' LEU . 23.1 mt -57.05 -51.2 70.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.926 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 92.6 t -53.11 -56.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.131 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 25.4 t -58.85 -39.51 81.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.9 mt -60.37 -40.52 91.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.471 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 28.9 m-85 -124.2 48.27 1.95 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.879 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -83.73 -57.45 3.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.992 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.43 ' HB3' ' NH1' ' A' ' 331' ' ' ARG . 3.4 ptp180 -42.73 -46.1 5.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.891 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.439 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 74.3 m-85 -46.21 -41.97 13.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -58.62 92.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -105.67 179.5 4.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -69.14 -51.99 32.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -52.42 -58.73 5.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.24 114.0 3.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.533 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -44.93 157.09 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.712 2.275 . . . . 0.0 112.367 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -45.44 121.56 4.01 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.669 2.246 . . . . 0.0 112.316 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.533 HD13 ' CE2' ' A' ' 357' ' ' PHE . 71.0 mt -65.35 140.48 19.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.115 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -96.18 137.15 35.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -120.08 151.65 38.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -141.27 125.24 17.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 40.4 tpp -112.94 133.63 54.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 11.9 ttm -86.76 158.72 19.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.879 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.27 140.11 8.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.207 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 142.56 -154.83 25.42 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.518 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.428 ' HG3' ' N ' ' A' ' 349' ' ' MET . 30.1 ptt180 -53.3 -54.03 42.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 110.87 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . 0.428 ' N ' ' HG3' ' A' ' 348' ' ' ARG . 17.7 ttm -101.06 81.74 2.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.849 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -91.25 176.98 6.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 102.38 15.87 24.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.502 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 312' ' ' TYR . 2.8 mp0 -132.75 151.37 52.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 110.87 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -153.28 150.37 28.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.089 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.752 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 46.5 m-85 -114.64 152.72 31.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 94.7 mt -139.16 142.84 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.102 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.499 HG23 ' NZ ' ' A' ' 309' ' ' LYS . 49.7 m -124.86 121.73 35.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.141 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.533 ' CE2' HD13 ' A' ' 340' ' ' ILE . 62.2 m-85 -104.57 157.2 34.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.666 0.746 . . . . 0.0 110.802 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -46.29 -37.1 18.35 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.626 2.217 . . . . 0.0 112.368 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -149.12 174.44 12.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -71.19 -28.71 64.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -60.13 -63.33 1.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 59.2 mt -50.48 -57.53 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -40.95 -61.49 0.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.082 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -48.09 -63.07 1.17 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -43.48 -41.73 4.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.928 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.471 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -63.05 -42.51 99.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.064 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.656 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 7.0 tt -63.02 -58.41 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.902 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -55.39 -31.28 61.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 51.3 mt -78.02 -37.32 47.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 370' ' ' VAL . 16.4 t -111.27 37.27 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.74 124.72 29.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 63.08 43.01 99.41 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.483 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' A' ' 374' ' ' LYS . 13.9 t80 -78.61 134.79 37.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 0.0 110.952 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.434 ' O ' ' CE1' ' A' ' 373' ' ' TYR . 21.1 ttmt -86.33 119.48 26.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 18.1 tp -133.83 120.7 20.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 53.34 41.17 32.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 67.21 31.29 77.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.451 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . 0.422 ' NZ ' ' HA ' ' A' ' 378' ' ' LYS . 0.0 OUTLIER -134.83 130.05 35.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.749 0.309 . . . . 0.0 110.829 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 33.7 mm -76.92 92.19 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.688 HD11 HD23 ' A' ' 313' ' ' LEU . 8.1 tt -61.16 114.69 3.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.67 HG12 ' OE1' ' A' ' 383' ' ' GLU . 34.1 t -101.05 127.98 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.107 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 370' ' ' VAL . 32.5 mt -104.79 126.8 59.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . 0.67 ' OE1' HG12 ' A' ' 381' ' ' VAL . 3.0 mp0 -128.65 125.73 38.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.835 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.656 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 44.8 m-85 -59.25 158.51 9.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.841 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 384' ' ' PHE . . . -37.67 109.13 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -47.31 -45.36 24.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 110.899 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -110.0 148.63 31.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 389' ' ' LYS . 19.6 ptmt -120.74 -44.01 2.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 388' ' ' LYS . 12.3 tmtt? -36.35 119.09 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.955 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -149.28 143.83 26.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -115.31 132.46 56.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 79.4 p -97.54 165.39 12.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.825 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 86.4 p -120.08 131.71 55.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.837 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -86.93 158.77 30.84 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.477 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.02 123.56 6.82 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.685 2.257 . . . . 0.0 112.387 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 12.0 t -132.85 134.18 44.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 13.7 m -76.61 121.74 23.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.797 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.49 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 1.2 t -146.56 161.67 40.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.896 0.379 . . . . 0.0 110.835 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 93.1 p -116.69 152.8 33.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.811 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 169.71 75.28 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.494 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.9 p -124.43 87.99 2.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.862 0.363 . . . . 0.0 110.873 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 4.6 t -113.51 129.4 56.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.848 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . 0.514 ' HA3' HD11 ' A' ' 293' ' ' ILE . . . 82.47 108.43 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.475 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.28 -59.38 4.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 110.889 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -99.97 -47.15 5.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.675 HG21 ' HA ' ' A' ' 297' ' ' PRO . 2.7 pp -59.12 165.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 25.4 ttt-85 -124.19 -47.48 1.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -127.3 -47.42 1.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.476 HG22 ' H ' ' A' ' 298' ' ' MET . 50.9 mt -104.31 101.29 26.06 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.631 0.729 . . . . 0.0 111.126 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . 0.675 ' HA ' HG21 ' A' ' 293' ' ' ILE . 73.7 Cg_exo -44.23 -21.13 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.769 2.313 . . . . 0.0 112.27 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.476 ' H ' HG22 ' A' ' 296' ' ' ILE . 6.2 tpp -107.92 45.05 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.829 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -95.45 -43.87 7.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.813 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.1 t -112.4 90.58 3.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.85 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 54.5 m -120.14 -50.43 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.816 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.916 ' CE2' HG13 ' A' ' 381' ' ' VAL . 15.1 p90 -155.61 165.49 36.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -123.74 138.59 30.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.558 0.694 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.21 -48.44 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.624 2.216 . . . . 0.0 112.287 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 113.71 -150.67 18.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.467 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -96.49 139.0 21.45 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.592 0.71 . . . . 0.0 110.9 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.46 102.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.694 2.263 . . . . 0.0 112.313 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -115.73 176.75 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.467 ' CD ' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -90.43 5.24 48.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.467 HG23 ' CD ' ' A' ' 309' ' ' LYS . 60.5 t -127.72 129.75 70.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.44 HD21 ' HB1' ' A' ' 363' ' ' ALA . 49.3 mt -116.42 121.45 41.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.795 ' CD1' ' CZ ' ' A' ' 354' ' ' PHE . 17.5 t80 -105.14 104.84 14.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.933 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 313' ' ' LEU . 3.2 mp -91.31 144.02 26.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.942 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -133.44 179.46 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.3 m120 57.23 51.83 9.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.462 ' HB3' HG11 ' A' ' 320' ' ' VAL . 13.8 mt -108.96 107.57 17.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.5 t -40.48 144.7 0.56 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.702 0.763 . . . . 0.0 110.893 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -47.16 -28.35 7.61 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.66 2.24 . . . . 0.0 112.336 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 24.2 mtt85 -73.51 -30.84 63.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.462 HG11 ' HB3' ' A' ' 316' ' ' LEU . 84.9 t -51.26 119.34 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.125 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 17.2 p -124.72 172.77 9.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -44.37 -44.0 7.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 64.9 mtt-85 -48.56 -54.73 13.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -49.13 -45.03 42.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 57.6 mt -62.63 -53.52 53.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 81.6 t -44.36 -49.35 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 47.2 t -65.4 -45.64 83.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.833 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 57.8 mt -52.55 -36.8 56.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.949 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.591 ' CE1' HG21 ' A' ' 370' ' ' VAL . 25.4 m-85 -132.36 44.35 2.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.857 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -80.35 -52.82 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.051 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -37.32 -32.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.84 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 330' ' ' ALA . 86.6 m-85 -73.97 -45.76 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.924 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 330' ' ' ALA . 57.8 tt0 -50.49 -43.98 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.905 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.76 44.6 1.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -129.33 160.53 32.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.875 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -38.02 -56.7 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.96 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -43.34 138.47 3.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.473 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -47.9 160.48 0.46 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.654 2.236 . . . . 0.0 112.372 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.25 153.58 1.03 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.688 2.259 . . . . 0.0 112.324 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 64.3 mt -100.68 137.57 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -96.31 127.85 42.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -117.66 142.42 47.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.44 ' HD3' ' N ' ' A' ' 344' ' ' MET . 0.8 OUTLIER -140.9 132.12 26.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.854 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.44 ' N ' ' HD3' ' A' ' 343' ' ' ARG . 39.7 tpp -113.83 143.43 44.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 21.3 ttm -86.65 157.89 19.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.916 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 34.4 p -142.11 151.31 42.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.138 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 348' ' ' ARG . . . 126.24 -156.71 19.87 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 347' ' ' GLY . 6.6 tpm_? -35.51 -70.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.854 0.359 . . . . 0.0 110.931 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 11.5 mmt -112.02 91.23 3.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.16 28.04 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.404 ' C ' ' NE2' ' A' ' 352' ' ' GLN . . . -90.07 32.78 4.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.475 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.441 ' HB3' ' CE1' ' A' ' 312' ' ' TYR . 10.1 mp0 -142.41 143.53 32.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 0.0 110.887 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.87 152.78 40.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.795 ' CZ ' ' CD1' ' A' ' 312' ' ' TYR . 82.5 m-85 -120.27 132.67 55.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 78.4 mt -124.14 138.02 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.118 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 17.1 m -117.09 117.8 30.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.19 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.411 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 50.1 m-85 -98.86 158.17 32.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.696 0.76 . . . . 0.0 110.861 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.19 -35.59 15.44 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.661 2.241 . . . . 0.0 112.355 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -158.42 166.77 31.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 361' ' ' GLU . 8.7 pttt -58.0 -49.71 75.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 360' ' ' LYS . 2.2 tt0 -36.7 -63.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.878 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 55.0 mt -56.13 -62.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.131 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.44 ' HB1' HD21 ' A' ' 311' ' ' LEU . . . -38.6 -59.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.087 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -47.38 -58.16 4.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.404 ' O ' ' CG ' ' A' ' 369' ' ' LEU . 6.6 mm100 -53.76 -35.39 61.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.423 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -68.12 -38.42 82.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.14 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.605 ' C ' HD23 ' A' ' 367' ' ' LEU . 7.4 tt -66.54 -56.79 9.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -60.96 -38.02 84.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.776 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.404 ' CG ' ' O ' ' A' ' 365' ' ' GLN . 37.3 mt -65.72 -40.91 92.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.591 HG21 ' CE1' ' A' ' 329' ' ' PHE . 7.3 t -106.15 28.96 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . 0.451 ' CG ' ' O ' ' A' ' 371' ' ' ASN . 0.8 OUTLIER -76.43 116.23 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 73.46 45.94 27.71 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.501 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.431 ' CE1' ' O ' ' A' ' 374' ' ' LYS . 38.6 t80 -85.32 138.07 32.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.912 0.386 . . . . 0.0 110.901 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.431 ' O ' ' CE1' ' A' ' 373' ' ' TYR . 22.4 ttmt -89.26 124.89 34.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 376' ' ' TYR . 60.7 tp -135.88 150.42 49.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.952 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 375' ' ' LEU . 25.2 m-85 35.57 35.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.953 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 375' ' ' LEU . . . 66.73 53.06 29.71 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.51 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -171.83 126.46 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.757 0.313 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 41.9 mm -56.28 144.71 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.161 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.676 HD23 ' C ' ' A' ' 380' ' ' LEU . 3.6 tt -112.34 140.37 47.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.916 HG13 ' CE2' ' A' ' 302' ' ' TYR . 23.6 t -110.51 144.48 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.496 HD11 ' O ' ' A' ' 370' ' ' VAL . 23.6 mt -131.42 151.88 36.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.086 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -148.56 175.42 11.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.531 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 29.5 m-85 -104.51 154.2 20.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -97.41 119.92 6.56 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.472 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -70.27 173.37 6.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.761 0.315 . . . . 0.0 110.958 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -128.83 166.57 18.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.896 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 109.71 15.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.89 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -65.67 101.9 0.68 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -137.2 121.87 18.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -53.0 175.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.836 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.6 t -139.49 108.75 6.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 48.2 t -137.91 141.72 40.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.78 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 168.67 97.67 0.11 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.517 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -43.74 160.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.666 2.244 . . . . 0.0 112.354 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 21.1 t -139.47 168.86 18.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.818 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 10.6 t -171.66 177.37 3.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.839 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.468 -179.982 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 53.4 p 44.13 42.54 5.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.362 . . . . 0.0 110.858 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 20.7 t -62.51 134.18 56.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.35 134.82 1.1 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.449 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 1.4 t -109.72 151.17 27.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.952 0.406 . . . . 0.0 110.852 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 39.0 m -120.31 43.06 2.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.899 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . 0.558 ' HA3' HD11 ' A' ' 293' ' ' ILE . . . 78.94 140.67 1.9 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.488 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -100.56 -49.46 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.0 110.876 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -108.02 -32.36 7.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.802 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.788 ' O ' HD12 ' A' ' 293' ' ' ILE . 2.3 pp -62.32 146.04 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.106 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . 0.404 ' HD2' ' N ' ' A' ' 294' ' ' ARG . 0.0 OUTLIER -143.15 140.55 30.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 51.89 40.0 27.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 74.4 mt -125.44 119.62 24.76 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.623 0.725 . . . . 0.0 111.106 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.87 -43.77 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.629 2.219 . . . . 0.0 112.333 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 31.5 mtt -143.92 113.08 6.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -96.3 114.14 25.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.822 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.6 m -122.8 -52.06 1.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.899 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 41.4 p -158.72 174.64 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.842 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.583 ' CE2' HG13 ' A' ' 381' ' ' VAL . 18.5 p90 -45.19 135.39 5.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -103.78 99.81 17.46 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.636 0.731 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . 0.427 ' HB2' ' CE2' ' A' ' 384' ' ' PHE . 74.1 Cg_exo -41.93 -37.59 4.36 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.699 2.266 . . . . 0.0 112.276 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 99.64 -110.97 4.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.466 ' CG ' ' HD2' ' A' ' 307' ' ' PRO . 25.9 tt0 -99.19 140.45 21.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.695 0.759 . . . . 0.0 110.862 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . 0.466 ' HD2' ' CG ' ' A' ' 306' ' ' GLU . 59.8 Cg_endo -73.04 105.95 2.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.661 2.241 . . . . 0.0 112.389 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -106.52 172.09 7.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.586 ' HD3' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -84.64 9.89 12.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.824 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.586 HG23 ' HD3' ' A' ' 309' ' ' LYS . 70.5 t -130.94 128.43 62.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.657 HD21 ' HB1' ' A' ' 363' ' ' ALA . 41.5 mt -114.33 122.29 46.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.788 ' CE1' ' CZ ' ' A' ' 354' ' ' PHE . 17.2 t80 -101.77 107.02 18.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.931 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.729 HD23 HD11 ' A' ' 380' ' ' LEU . 8.8 mp -87.37 142.93 27.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -138.68 175.33 9.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 60.54 53.43 4.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.2 mt -113.42 109.97 19.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.2 t -47.49 143.92 5.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.722 0.773 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.12 -19.08 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 321' ' ' THR . 23.7 mtt180 -78.23 -39.83 39.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 87.7 t -49.78 133.83 8.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 319' ' ' ARG . 55.2 p -133.54 170.0 16.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.606 ' HA ' HD12 ' A' ' 325' ' ' LEU . 10.9 tm-20 -43.69 -47.32 7.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -45.0 -57.65 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -49.01 -43.09 40.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.606 HD12 ' HA ' ' A' ' 322' ' ' GLU . 21.3 mt -62.69 -48.56 78.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 62.4 t -51.86 -52.36 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.1 m -61.49 -37.39 83.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.794 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.587 HD21 ' CE2' ' A' ' 373' ' ' TYR . 31.0 mt -59.15 -37.65 77.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.949 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -126.27 42.15 3.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -81.2 -47.42 13.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 331' ' ' ARG . 3.5 ptm85 -46.38 -34.94 5.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -74.16 -46.29 43.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -53.75 -36.84 62.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.942 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.17 49.1 1.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -119.12 -177.85 3.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -83.62 49.33 1.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -152.11 168.35 31.32 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.84 165.11 0.07 OUTLIER 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.671 2.247 . . . . 0.0 112.348 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.95 140.43 20.3 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.614 2.209 . . . . 0.0 112.372 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.503 HD13 ' CE2' ' A' ' 357' ' ' PHE . 66.9 mt -80.84 125.53 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.133 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 355' ' ' ILE . 24.7 mm-40 -87.54 142.41 27.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -126.73 144.26 50.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.816 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.2 ttt-85 -141.08 132.67 27.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.2 ttm -115.4 147.34 40.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.877 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 22.2 ttm -95.24 163.36 13.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 39.5 p -136.89 167.91 20.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.203 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 348' ' ' ARG . . . 113.89 176.65 19.21 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.483 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 349' ' ' MET . 0.0 OUTLIER -37.61 -32.73 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.341 . . . . 0.0 110.865 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . 0.423 ' N ' ' HD2' ' A' ' 348' ' ' ARG . 46.3 ttm -127.27 84.27 2.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.28 26.97 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -89.26 30.96 5.31 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.474 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -137.07 142.3 42.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.892 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -148.59 153.26 38.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.09 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.788 ' CZ ' ' CE1' ' A' ' 312' ' ' TYR . 77.9 m-85 -124.78 129.65 50.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.83 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 341' ' ' GLN . 56.8 mt -123.65 140.35 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.165 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 55.8 m -114.91 129.37 56.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.503 ' CE2' HD13 ' A' ' 340' ' ' ILE . 23.7 m-85 -106.2 156.57 36.63 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.682 0.753 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -46.11 -40.66 21.31 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.755 2.303 . . . . 0.0 112.337 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . 0.432 HD22 HD12 ' A' ' 362' ' ' ILE . 8.4 m-80 -141.26 -176.62 4.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.83 -37.0 19.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.36 -56.37 20.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.432 HD12 HD22 ' A' ' 359' ' ' ASN . 60.0 mt -54.36 -56.05 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.089 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.657 ' HB1' HD21 ' A' ' 311' ' ' LEU . . . -44.95 -59.26 2.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.075 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . 0.409 ' O ' ' N ' ' A' ' 367' ' ' LEU . 4.8 t90 -48.42 -66.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -40.1 -41.61 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -71.66 -39.67 70.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.079 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.93 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 5.3 tt -55.88 -50.39 70.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -69.21 -35.8 76.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 31.2 mt -62.91 -47.95 81.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.454 ' HB ' ' CD1' ' A' ' 382' ' ' ILE . 25.2 t -82.71 -28.33 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.057 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 370' ' ' VAL . 0.3 OUTLIER -36.01 120.77 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.936 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 83.28 36.29 15.11 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.414 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.587 ' CE2' HD21 ' A' ' 328' ' ' LEU . 61.0 t80 -91.79 103.43 15.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.943 0.401 . . . . 0.0 110.946 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.474 ' HE2' HD11 ' A' ' 379' ' ' ILE . 9.7 ttmm -71.2 101.85 2.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 26.5 tp -114.62 125.47 53.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.952 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 49.51 38.24 14.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 70.01 37.24 73.6 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.503 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -141.03 121.61 14.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . 0.474 HD11 ' HE2' ' A' ' 374' ' ' LYS . 38.8 mm -76.02 86.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.729 HD11 HD23 ' A' ' 313' ' ' LEU . 7.5 tt -47.76 135.09 12.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.594 ' N ' HD23 ' A' ' 380' ' ' LEU . 76.4 t -117.15 111.49 35.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.079 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.485 HG13 ' CD2' ' A' ' 380' ' ' LEU . 43.1 mt -98.64 119.2 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . 0.422 ' OE1' ' CD1' ' A' ' 302' ' ' TYR . 6.3 mm-40 -130.14 127.36 39.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.93 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 48.0 m-85 -54.27 140.71 32.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.928 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -48.96 103.5 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.544 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -66.75 -54.77 19.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -42.23 139.16 1.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -109.4 108.46 19.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -128.61 87.75 2.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -43.56 145.42 0.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.928 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -140.29 115.11 9.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 6.7 t -168.98 116.91 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 36.8 p -114.04 155.33 26.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 169.18 95.55 0.1 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -44.58 126.87 7.37 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.699 2.266 . . . . 0.0 112.334 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 39.8 m -63.14 107.91 1.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.865 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 85.5 p 41.28 42.59 1.8 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.853 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.516 179.999 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 1.4 t -133.66 139.25 46.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.359 . . . . 0.0 110.869 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 35.9 t -39.09 -53.0 1.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.841 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 93.76 144.2 15.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.52 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 23.0 t -75.48 150.59 38.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.392 . . . . 0.0 110.814 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 4.6 t -109.11 42.46 1.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.873 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . 0.613 ' HA3' HD11 ' A' ' 293' ' ' ILE . . . 167.15 138.07 2.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.454 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -92.86 -56.95 2.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.838 0.352 . . . . 0.0 110.88 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -62.11 -50.4 72.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.613 HD11 ' HA3' ' A' ' 290' ' ' GLY . 14.5 pt -57.98 144.85 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.139 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 294' ' ' ARG . 22.3 mtm105 -133.83 84.12 2.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 56.31 43.17 26.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 47.4 mt -90.37 112.03 50.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.626 0.727 . . . . 0.0 111.14 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -44.74 -44.97 13.92 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.696 2.264 . . . . 0.0 112.364 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.12 141.3 28.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -132.99 -43.27 0.88 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 66.0 m -71.79 111.74 7.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.853 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 3.8 m -161.33 -178.57 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -51.21 151.46 2.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -128.83 121.95 21.22 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.653 0.74 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.32 -38.32 2.08 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.583 2.189 . . . . 0.0 112.324 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 68.14 -161.7 49.76 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.463 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -41.45 142.3 1.01 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.663 0.744 . . . . 0.0 110.855 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . 0.421 ' HA ' ' CE2' ' A' ' 384' ' ' PHE . 61.2 Cg_endo -75.73 137.68 20.44 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.714 2.276 . . . . 0.0 112.348 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -128.96 164.23 23.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.26 9.46 6.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 74.3 t -130.68 129.31 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.112 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.808 HD12 ' CE1' ' A' ' 357' ' ' PHE . 64.4 mt -115.96 118.61 33.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.669 ' CE1' ' CZ ' ' A' ' 354' ' ' PHE . 8.0 t80 -102.13 111.36 23.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 313' ' ' LEU . 4.8 mp -96.58 147.66 23.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.932 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -141.16 -175.52 4.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 5.0 m120 56.19 54.97 7.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.4 mt -114.78 109.66 18.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.941 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 17.8 t -50.88 144.05 14.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.661 0.743 . . . . 0.0 110.89 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -46.53 -20.73 1.07 Allowed 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.735 2.29 . . . . 0.0 112.286 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.414 ' O ' HG23 ' A' ' 321' ' ' THR . 47.1 mmt-85 -75.13 -35.34 61.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.892 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.441 HG13 ' CG ' ' A' ' 324' ' ' ASP . 66.1 t -45.68 137.58 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 322' ' ' GLU . 39.0 p -132.12 150.77 52.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.878 ' OE1' HD12 ' A' ' 325' ' ' LEU . 5.4 tp10 -33.56 -41.34 0.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -46.72 -55.37 7.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.836 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . 0.441 ' CG ' HG13 ' A' ' 320' ' ' VAL . 0.2 OUTLIER -46.72 -44.41 18.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.878 HD12 ' OE1' ' A' ' 322' ' ' GLU . 36.2 mt -63.09 -47.45 82.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 67.5 t -57.09 -49.93 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 1.8 m -65.56 -42.44 91.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 23.2 mt -52.37 -41.17 62.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.483 ' CE1' HG21 ' A' ' 370' ' ' VAL . 21.6 m-85 -125.38 40.8 3.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -74.82 -40.8 60.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.091 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.474 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 10.2 ptt-85 -50.47 -45.56 56.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.474 ' N ' ' HG3' ' A' ' 331' ' ' ARG . 25.5 m-85 -64.46 -47.32 79.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 332' ' ' PHE . 38.6 tt0 -35.01 -40.23 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -92.85 69.01 4.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -149.49 177.0 10.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.841 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -61.53 110.92 1.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 139.69 173.97 13.45 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.465 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.01 147.57 34.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.738 2.292 . . . . 0.0 112.294 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.69 119.17 2.6 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.613 2.209 . . . . 0.0 112.403 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.596 HD13 ' CE2' ' A' ' 357' ' ' PHE . 70.2 mt -49.03 127.45 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -90.2 120.27 31.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -105.85 138.99 41.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -136.87 129.81 30.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.486 ' HE2' HD11 ' A' ' 325' ' ' LEU . 35.5 tpp -111.1 146.32 37.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.871 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 20.0 ttm -83.73 163.21 20.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.833 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 1.3 t -133.22 143.5 49.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.114 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 348' ' ' ARG . . . 128.73 164.34 11.5 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.51 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 347' ' ' GLY . 9.1 ptm180 -34.48 -37.25 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . 0.416 ' N ' ' O ' ' A' ' 347' ' ' GLY . 7.8 mtm -110.51 61.39 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.34 30.07 0.56 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -90.08 26.83 9.11 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.453 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -133.37 145.48 50.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.834 0.349 . . . . 0.0 110.952 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -147.23 145.43 29.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.669 ' CZ ' ' CE1' ' A' ' 312' ' ' TYR . 71.2 m-85 -116.76 123.95 48.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 83.8 mt -114.19 141.24 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.084 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 85.1 m -117.88 114.74 23.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.145 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.808 ' CE1' HD12 ' A' ' 311' ' ' LEU . 38.6 m-85 -97.47 158.62 32.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.636 0.732 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -43.89 -43.99 11.98 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.739 2.292 . . . . 0.0 112.337 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.13 -175.29 5.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.952 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -74.65 -39.33 62.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -47.75 -66.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 57.2 mt -55.03 -55.72 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.107 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.49 ' HB1' HD21 ' A' ' 311' ' ' LEU . . . -43.12 -60.89 1.48 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -46.74 -59.63 2.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.835 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -45.84 -43.86 13.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.972 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.1 95.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.08 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.617 ' C ' HD23 ' A' ' 367' ' ' LEU . 7.1 tt -63.82 -51.8 63.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.916 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -62.77 -33.75 75.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 25.3 mt -72.11 -42.07 66.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.971 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 370' ' ' VAL . 11.2 t -105.64 31.75 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.145 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.73 127.77 33.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 58.79 45.0 95.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.497 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.445 ' HE2' HD13 ' A' ' 375' ' ' LEU . 59.7 t80 -84.06 113.32 20.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.903 0.383 . . . . 0.0 110.958 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 28.0 tttt -66.25 104.31 1.16 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.445 HD13 ' HE2' ' A' ' 373' ' ' TYR . 10.6 tp -118.56 135.91 54.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 42.43 50.45 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 53.84 41.19 66.5 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.505 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -156.45 110.26 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.781 0.324 . . . . 0.0 110.854 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 31.8 mm -51.44 118.71 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.084 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.487 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.9 tt -77.52 114.9 16.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.941 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 45.4 t -94.59 118.93 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.151 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.418 HD11 ' O ' ' A' ' 370' ' ' VAL . 36.9 mt -107.53 127.8 63.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -139.32 130.55 26.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.54 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 28.0 m-85 -57.71 132.56 53.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -41.6 107.99 0.11 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.452 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -50.18 154.43 1.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -134.43 -60.12 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.908 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 22.7 tptt -148.54 149.8 32.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.943 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 13.2 pttm -85.47 -29.21 24.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.913 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -142.75 108.4 5.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -87.86 137.52 32.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.831 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 7.7 m -76.41 165.51 24.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.3 t 57.08 42.18 26.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -150.95 144.22 11.51 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.487 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -78.4 122.58 5.66 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.691 2.26 . . . . 0.0 112.369 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 46.6 p -88.73 126.68 35.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 4.8 m -68.93 -57.98 4.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.523 -179.936 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 93.9 p -158.24 149.19 20.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 0.0 110.895 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.1 t -115.93 -58.13 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 117.72 134.84 5.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 60.0 m -68.08 85.59 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.882 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 27.7 t -120.58 153.64 36.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -45.57 147.99 1.94 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.463 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -65.26 -53.35 45.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 110.885 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -111.33 -49.8 2.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.44 ' CD1' ' O ' ' A' ' 296' ' ' ILE . 21.3 pt -48.18 -38.49 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.194 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 39.38 29.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.824 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 293' ' ' ILE . 2.8 mmmm -122.71 -45.15 2.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.44 ' O ' ' CD1' ' A' ' 293' ' ' ILE . 97.9 mt -136.14 128.87 17.71 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.605 0.716 . . . . 0.0 111.142 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.02 -36.7 3.23 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.67 2.247 . . . . 0.0 112.348 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 6.2 mmm -92.96 73.84 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -113.7 -58.53 2.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.5 t -80.77 96.24 6.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.871 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 54.0 m -77.89 -53.25 7.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.24 127.01 1.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.92 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -75.32 115.92 49.8 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.675 0.75 . . . . 0.0 110.903 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.77 -50.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.687 2.258 . . . . 0.0 112.298 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 109.24 -136.81 13.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.468 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.595 ' O ' ' CD2' ' A' ' 384' ' ' PHE . 12.0 tt0 -69.06 141.13 91.52 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.661 0.743 . . . . 0.0 110.917 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 384' ' ' PHE . 61.4 Cg_endo -76.1 144.96 27.31 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.693 2.262 . . . . 0.0 112.404 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -139.65 162.03 36.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.937 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.565 ' HG3' HG23 ' A' ' 310' ' ' VAL . 11.9 ptmt -70.87 -25.06 62.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.939 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.565 HG23 ' HG3' ' A' ' 309' ' ' LYS . 94.9 t -106.14 143.24 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.483 HD21 ' HB1' ' A' ' 363' ' ' ALA . 52.7 mt -124.35 121.42 34.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.974 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.756 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 9.4 t80 -95.4 102.61 14.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.952 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.463 HD22 HD22 ' A' ' 325' ' ' LEU . 7.5 mp -85.99 134.09 33.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -133.43 -177.07 4.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 60.22 52.17 5.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.8 mt -113.96 122.49 47.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 13.7 t -61.8 143.77 93.9 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.655 0.741 . . . . 0.0 110.821 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.44 -25.12 2.0 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.682 2.255 . . . . 0.0 112.306 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 321' ' ' THR . 41.7 mtm180 -74.34 -39.57 62.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.831 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 99.4 t -39.33 134.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 322' ' ' GLU . 35.2 p -126.89 150.5 49.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.136 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.686 ' OE1' HD12 ' A' ' 325' ' ' LEU . 7.9 tp10 -34.36 -41.54 0.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -45.33 -55.93 5.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . 0.489 ' CG ' ' N ' ' A' ' 325' ' ' LEU . 0.3 OUTLIER -44.12 -51.76 7.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.924 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.686 HD12 ' OE1' ' A' ' 322' ' ' GLU . 39.0 mt -56.33 -48.38 76.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.934 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 84.7 t -55.7 -53.09 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.146 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 31.2 t -64.51 -33.61 76.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.445 HD21 ' CE2' ' A' ' 373' ' ' TYR . 21.6 mt -65.65 -35.09 79.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.413 ' CZ ' HG21 ' A' ' 370' ' ' VAL . 38.6 m-85 -128.04 44.73 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.892 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 333' ' ' GLN . . . -82.48 -58.69 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.455 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 15.6 ptp180 -41.1 -42.09 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.481 ' CE2' ' HB2' ' A' ' 366' ' ' ALA . 31.4 m-85 -60.63 -38.67 85.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 330' ' ' ALA . 1.0 OUTLIER -35.56 -52.2 0.66 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.34 87.36 6.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.964 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 337' ' ' GLY . 12.1 tptp -161.54 149.38 15.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 335' ' ' LYS . 49.8 mtpt -37.09 95.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.888 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 335' ' ' LYS . . . 142.37 145.22 4.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.485 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -47.41 156.14 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.723 2.282 . . . . 0.0 112.387 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.94 158.47 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.654 2.236 . . . . 0.0 112.372 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.716 HD13 ' CE2' ' A' ' 357' ' ' PHE . 73.0 mt -88.4 138.8 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.11 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -97.7 136.25 38.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -123.51 142.09 51.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -140.62 128.14 21.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 14.9 ttm -110.22 146.38 35.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.823 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.62 169.85 10.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 5.9 t -147.65 153.67 39.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 126.6 -174.64 18.03 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.456 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -42.28 -41.08 2.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.319 . . . . 0.0 110.839 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.34 71.59 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.1 29.49 0.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -93.46 32.82 5.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.457 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -137.97 156.57 47.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.738 0.304 . . . . 0.0 110.92 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -157.57 155.82 30.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.756 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 46.0 m-85 -127.01 126.0 42.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' A' ' 325' ' ' LEU . 97.6 mt -119.18 145.54 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.582 ' O ' HG23 ' A' ' 340' ' ' ILE . 69.6 m -121.31 129.66 53.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.716 ' CE2' HD13 ' A' ' 340' ' ' ILE . 48.9 m-85 -109.97 158.46 34.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.694 0.759 . . . . 0.0 110.85 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.61 -52.05 7.29 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.685 2.256 . . . . 0.0 112.334 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -138.73 170.61 15.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -66.81 -38.62 86.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -49.78 -65.8 0.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 97.0 mt -51.92 -57.5 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.091 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -41.05 -53.02 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.107 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 12.9 t90 -54.68 -65.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -36.93 -46.71 0.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.481 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . . . -66.58 -49.95 64.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.094 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.774 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 4.5 tt -49.66 -50.31 43.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.853 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -65.42 -36.09 82.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 31.6 mt -64.63 -60.02 3.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 371' ' ' ASN . 20.4 t -68.45 -33.02 57.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 370' ' ' VAL . 1.5 t-20 -35.14 107.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.965 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 99.18 33.14 5.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.445 ' CE2' HD21 ' A' ' 328' ' ' LEU . 31.8 t80 -96.14 108.28 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.994 0.426 . . . . 0.0 110.97 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -78.75 105.22 9.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.928 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.565 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 21.5 tp -108.76 135.38 50.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.916 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . 0.565 ' CD2' ' HG ' ' A' ' 375' ' ' LEU . 57.9 m-85 52.85 27.16 5.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 79.44 34.34 32.47 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.483 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -149.9 122.07 8.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.741 0.305 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 20.5 mm -63.54 136.49 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.167 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.534 HD23 ' C ' ' A' ' 380' ' ' LEU . 8.2 tt -96.73 132.96 41.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.513 ' N ' HD23 ' A' ' 380' ' ' LEU . 55.9 t -113.84 119.86 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.445 HG13 ' CD2' ' A' ' 380' ' ' LEU . 18.3 mt -103.96 139.47 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -136.86 120.08 16.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.774 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 35.8 m-85 -48.89 118.12 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.23 140.04 40.24 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.505 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 29.5 mttp -128.59 91.7 3.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.84 0.352 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.31 145.81 7.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.826 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? 56.69 48.73 15.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.84 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -69.92 -43.03 72.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -89.73 114.08 25.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.965 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.431 ' HD3' ' N ' ' A' ' 392' ' ' SER . 0.4 OUTLIER -112.77 175.48 5.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.431 ' N ' ' HD3' ' A' ' 391' ' ' ARG . 1.2 t -174.72 146.27 0.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 29.2 t -140.08 147.68 40.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -174.07 139.22 4.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.519 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.44 177.1 8.92 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.644 2.229 . . . . 0.0 112.331 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 22.9 t -125.35 96.49 4.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.7 m -115.4 162.89 16.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.444 179.94 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.3 t -122.41 130.15 52.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.866 0.365 . . . . 0.0 110.879 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 3.8 m -80.62 149.23 29.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.862 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 45.72 -114.62 1.35 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.475 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 71.8 m 42.44 36.72 0.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.963 0.411 . . . . 0.0 110.868 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.1 t -81.36 145.87 30.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.899 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 152.48 81.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.465 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -103.33 135.95 44.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 110.891 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 45.41 45.07 10.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.884 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.659 HD12 ' N ' ' A' ' 294' ' ' ARG . 2.7 pp -95.7 -38.35 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.068 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . 0.659 ' N ' HD12 ' A' ' 293' ' ' ILE . 7.7 tmm_? -62.16 -47.55 84.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.579 ' HB3' HD12 ' A' ' 296' ' ' ILE . 0.2 OUTLIER -46.59 -52.45 13.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.925 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' A' ' 295' ' ' LYS . 5.4 mp -112.34 101.69 52.72 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.65 0.738 . . . . 0.0 111.12 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -44.32 -41.88 13.5 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 0.0 112.292 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.473 ' HB2' HG22 ' A' ' 296' ' ' ILE . 0.0 OUTLIER -44.19 -40.82 5.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.914 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -64.84 -41.67 95.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 86.8 p -69.66 -38.87 77.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.836 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 3.0 m -41.36 -62.0 0.94 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.848 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -173.02 152.0 2.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.971 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -112.68 102.32 54.26 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.556 0.693 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . 0.404 ' HB3' HD11 ' A' ' 367' ' ' LEU . 71.0 Cg_exo -42.35 -55.57 2.49 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.713 2.275 . . . . 0.0 112.336 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 136.82 -142.51 13.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.443 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -103.42 138.71 19.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.61 0.719 . . . . 0.0 110.895 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . 0.617 ' HA ' ' CE1' ' A' ' 384' ' ' PHE . 72.6 Cg_exo -46.38 106.85 0.1 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.662 2.241 . . . . 0.0 112.335 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.423 ' C ' ' HA ' ' A' ' 360' ' ' LYS . 76.0 m-20 -124.87 164.87 19.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.45 ' HD3' HG23 ' A' ' 310' ' ' VAL . 0.0 OUTLIER -82.61 13.86 3.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.45 HG23 ' HD3' ' A' ' 309' ' ' LYS . 57.3 t -137.59 129.41 40.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.119 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.715 HD22 HD12 ' A' ' 367' ' ' LEU . 76.9 mt -120.25 117.87 28.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.983 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.789 ' CD1' ' CE1' ' A' ' 354' ' ' PHE . 7.4 t80 -93.97 105.72 17.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 313' ' ' LEU . 4.4 mp -88.28 145.02 26.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.909 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.434 ' HG3' ' C ' ' A' ' 313' ' ' LEU . 16.6 mtpp -143.31 170.89 14.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 67.46 54.92 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 12.9 mt -114.77 120.9 41.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 22.6 t -57.33 143.84 72.53 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.674 0.75 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -43.94 -27.2 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.671 2.247 . . . . 0.0 112.385 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.591 ' O ' HG23 ' A' ' 321' ' ' THR . 1.4 mmp_? -71.16 -38.73 72.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.439 HG22 ' HD2' ' A' ' 376' ' ' TYR . 66.0 t -47.05 122.44 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.591 HG23 ' O ' ' A' ' 319' ' ' ARG . 44.8 p -127.31 168.67 14.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.18 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -39.22 -48.79 1.83 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.913 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . 0.43 ' NH1' ' HB2' ' A' ' 323' ' ' ARG . 0.0 OUTLIER -44.52 -49.87 9.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -53.7 -50.99 64.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.843 HD22 HD11 ' A' ' 355' ' ' ILE . 76.4 mt -55.33 -51.93 65.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.965 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 97.5 t -46.98 -59.54 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.094 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 2.6 t -54.0 -47.51 71.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 31.9 mt -49.62 -46.27 49.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.414 ' CZ ' HD21 ' A' ' 313' ' ' LEU . 8.4 m-85 -119.9 41.8 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 326' ' ' VAL . . . -85.15 -25.16 27.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.035 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -64.79 -37.14 86.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.404 ' HZ ' HD13 ' A' ' 369' ' ' LEU . 4.2 m-85 -94.04 20.25 8.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -114.9 81.86 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 335' ' ' LYS . 5.3 pt-20 -148.6 175.23 11.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.951 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 336' ' ' LYS . 3.8 ptpt -36.9 -50.4 0.86 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 335' ' ' LYS . 23.4 mmtm -34.1 -56.24 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -118.34 138.77 14.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.489 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -46.96 153.25 1.48 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.724 2.283 . . . . 0.0 112.372 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.33 97.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.697 2.265 . . . . 0.0 112.353 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 71.1 mt -40.99 133.19 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.164 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -89.68 116.12 27.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.49 130.49 54.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -129.94 117.89 20.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.832 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.1 ttm -103.95 146.85 28.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . 0.42 ' HE1' ' CE2' ' A' ' 354' ' ' PHE . 34.3 mtm -110.62 167.31 10.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 28.4 p -151.62 151.37 31.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.118 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 139.44 -178.24 19.77 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.513 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -42.76 -52.43 4.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 110.852 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . . . . . . . . . 12.6 ttt -88.41 37.25 0.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.448 ' C ' ' OE1' ' A' ' 352' ' ' GLN . 0.0 OUTLIER -58.63 176.74 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -179.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 94.07 37.51 5.4 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.499 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.448 ' OE1' ' C ' ' A' ' 350' ' ' ARG . 27.8 mp0 -152.91 142.49 21.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 110.866 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.49 142.87 29.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.076 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.789 ' CE1' ' CD1' ' A' ' 312' ' ' TYR . 53.0 m-85 -105.45 115.79 30.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.843 HD11 HD22 ' A' ' 325' ' ' LEU . 64.2 mt -108.39 129.42 62.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.12 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 27.1 m -109.53 116.06 31.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.688 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 36.9 m-85 -94.46 159.17 34.33 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.728 0.775 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . 0.454 ' HB2' HD12 ' A' ' 362' ' ' ILE . 72.6 Cg_exo -44.85 -47.55 11.67 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.242 . . . . 0.0 112.372 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -142.67 176.47 9.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.423 ' HA ' ' C ' ' A' ' 308' ' ' ASN . 0.0 OUTLIER -74.78 -29.21 61.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . 0.406 ' N ' ' HG2' ' A' ' 360' ' ' LYS . 77.8 mt-10 -62.33 -56.95 13.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.454 HD12 ' HB2' ' A' ' 358' ' ' PRO . 68.5 mt -56.09 -56.39 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.077 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -49.86 -48.62 51.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -51.22 -49.12 61.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -60.96 -52.72 63.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.942 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 370' ' ' VAL . . . -56.63 -34.25 67.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.049 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.804 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 5.9 tt -65.02 -67.04 0.47 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . 0.646 ' N ' HD23 ' A' ' 367' ' ' LEU . 10.3 t-80 -46.35 -36.1 6.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.84 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.404 HD13 ' HZ ' ' A' ' 332' ' ' PHE . 23.5 mt -71.61 -58.3 3.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.862 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.569 ' O ' HD11 ' A' ' 382' ' ' ILE . 9.3 t -82.59 37.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.099 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -84.94 136.2 33.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 49.28 38.42 26.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.519 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.549 ' CE1' ' O ' ' A' ' 374' ' ' LYS . 33.4 t80 -78.21 130.39 36.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.951 0.405 . . . . 0.0 110.905 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.549 ' O ' ' CE1' ' A' ' 373' ' ' TYR . 17.5 tttm -71.14 129.79 39.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.881 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 19.1 tp -143.56 124.47 14.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . 0.439 ' HD2' HG22 ' A' ' 320' ' ' VAL . 39.3 m-85 43.77 48.25 6.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 59.89 42.46 98.2 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.499 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -155.47 119.25 4.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.338 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 48.3 mm -61.51 107.59 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.119 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.494 HD23 ' C ' ' A' ' 380' ' ' LEU . 8.4 tt -71.33 115.63 10.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.6 t -99.74 136.4 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.141 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.569 HD11 ' O ' ' A' ' 370' ' ' VAL . 57.5 mt -113.39 135.15 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -137.45 118.8 14.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.804 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 59.9 m-85 -47.97 151.54 0.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.14 169.79 1.79 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -63.81 91.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 110.874 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -37.41 107.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -110.11 173.65 6.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -90.28 41.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.97 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -99.95 99.95 10.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -115.89 140.91 48.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 1.9 t -84.41 86.89 7.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 7.9 t -166.17 143.61 5.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 117.2 98.64 2.02 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.52 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.67 164.5 33.58 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.697 2.265 . . . . 0.0 112.354 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 19.3 m -156.31 131.44 9.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.847 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 398' ' ' GLY . 5.8 m -53.99 172.38 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.872 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 397' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.247 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.507 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 1.3 t -118.21 -51.21 2.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.84 0.352 . . . . 0.0 110.846 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 69.4 m 48.9 40.87 17.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.826 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -142.3 71.83 0.4 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.404 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 82.2 p -108.67 103.61 12.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.833 0.349 . . . . 0.0 110.92 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 79.9 p -155.47 165.64 35.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.814 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . 0.448 ' HA3' ' CD1' ' A' ' 293' ' ' ILE . . . -83.65 151.08 27.45 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.442 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -67.58 -42.92 81.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.808 0.337 . . . . 0.0 110.911 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -114.79 -49.77 2.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.448 ' CD1' ' HA3' ' A' ' 290' ' ' GLY . 2.8 pp -64.05 156.9 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.134 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 295' ' ' LYS . 6.0 tpt180 -80.28 160.93 25.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 294' ' ' ARG . 34.1 mmtm -32.26 -47.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.449 HG22 ' H ' ' A' ' 299' ' ' PHE . 62.8 mt -50.91 117.47 8.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.69 0.757 . . . . 0.0 111.14 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.26 -51.5 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.747 2.298 . . . . 0.0 112.292 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 7.5 mtm -51.54 -62.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.927 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . 0.449 ' H ' HG22 ' A' ' 296' ' ' ILE . 3.0 t80 54.19 43.76 30.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.884 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 6.7 t -168.1 112.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 16.5 m -58.14 -57.08 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.892 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.467 ' CE1' ' O ' ' A' ' 303' ' ' ASN . 2.6 t80 -166.76 147.92 6.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.467 ' O ' ' CE1' ' A' ' 302' ' ' TYR . 10.7 t30 -99.96 111.41 61.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.717 0.77 . . . . 0.0 110.917 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.77 -51.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.656 2.237 . . . . 0.0 112.36 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 110.77 -145.8 17.45 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.483 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -56.7 136.81 78.16 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.606 0.717 . . . . 0.0 110.852 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . 0.533 ' HA ' ' CZ ' ' A' ' 384' ' ' PHE . 61.3 Cg_endo -75.27 145.66 30.8 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.696 2.264 . . . . 0.0 112.334 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -137.76 168.64 19.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.553 ' HG3' HG23 ' A' ' 310' ' ' VAL . 13.1 ptmt -72.79 -33.61 66.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.907 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.553 HG23 ' HG3' ' A' ' 309' ' ' LYS . 55.6 t -98.22 145.92 8.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.143 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.647 HD12 ' CE1' ' A' ' 357' ' ' PHE . 56.9 mt -127.63 114.43 17.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.573 ' CZ ' ' CG ' ' A' ' 314' ' ' LYS . 6.4 t80 -89.31 105.94 18.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.933 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.444 HD23 HD21 ' A' ' 380' ' ' LEU . 6.3 mp -93.22 148.05 22.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.573 ' CG ' ' CZ ' ' A' ' 312' ' ' TYR . 0.0 OUTLIER -144.5 177.12 8.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . 0.475 ' ND2' ' HB3' ' A' ' 378' ' ' LYS . 1.6 t30 67.49 53.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 15.6 mt -118.03 112.07 19.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.2 t -38.63 154.29 0.14 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.65 0.738 . . . . 0.0 110.855 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.62 1.96 3.3 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.679 2.253 . . . . 0.0 112.363 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -108.43 -24.83 11.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.98 142.65 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.131 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 64.6 p -133.89 162.85 30.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 323' ' ' ARG . 6.2 tt0 -38.81 -53.76 1.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.909 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 322' ' ' GLU . 56.7 ttt180 -34.78 -42.71 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -62.66 -50.71 70.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 322' ' ' GLU . 15.6 mt -60.04 -48.51 81.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 78.9 t -49.33 -60.46 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.066 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 23.8 t -53.62 -38.58 64.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.43 HD11 HD22 ' A' ' 375' ' ' LEU . 40.9 mt -62.4 -41.24 98.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.479 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 60.4 m-85 -119.56 46.02 2.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -92.31 -58.26 2.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.09 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.402 ' HG3' ' N ' ' A' ' 332' ' ' PHE . 17.7 ptp180 -38.37 -47.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.899 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 366' ' ' ALA . 49.0 m-85 -47.79 -48.76 30.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -68.82 76.09 0.3 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.929 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -122.38 79.18 1.58 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 5.3 mptt 50.08 38.03 15.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -121.07 126.09 48.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 44.22 -161.42 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.528 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.06 169.89 19.45 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.664 2.243 . . . . 0.0 112.399 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.16 124.61 9.17 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.633 2.222 . . . . 0.0 112.364 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.835 HD13 ' CE2' ' A' ' 357' ' ' PHE . 73.6 mt -56.24 125.35 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.152 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -87.65 133.56 33.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -118.62 140.16 50.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -137.97 123.51 19.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 46.6 tpp -103.26 133.3 48.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . . . . . . . . . 20.0 tpp -89.4 144.67 25.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.936 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.1 p -139.66 153.39 47.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.1 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 129.39 -140.66 11.89 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.521 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.45 ' HG3' ' N ' ' A' ' 349' ' ' MET . 2.4 ptp180 -47.16 -46.98 23.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.71 0.291 . . . . 0.0 110.86 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . 0.45 ' N ' ' HG3' ' A' ' 348' ' ' ARG . 0.0 OUTLIER -125.93 86.68 2.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 11.1 mtp85 -68.95 -3.21 11.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.914 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -84.4 47.44 3.85 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.505 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -146.83 147.08 30.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 0.0 110.939 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -154.99 142.44 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.081 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -120.2 121.95 39.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.825 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 80.6 mt -115.22 145.15 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.11 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 25.9 m -122.22 117.75 26.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.835 ' CE2' HD13 ' A' ' 340' ' ' ILE . 63.4 m-85 -99.73 157.39 34.01 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.606 0.717 . . . . 0.0 110.88 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -42.33 -40.11 6.76 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.652 2.235 . . . . 0.0 112.372 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.52 171.04 20.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 361' ' ' GLU . 11.0 pttm -58.08 -53.99 52.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 360' ' ' LYS . 45.7 mt-10 -36.52 -64.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.45 -56.93 9.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.136 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.467 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -42.27 -60.62 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.089 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 367' ' ' LEU . 13.5 t90 -47.63 -64.61 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.938 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -37.67 -46.15 0.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . . . -64.76 -38.13 89.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.037 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.59 ' C ' HD23 ' A' ' 367' ' ' LEU . 7.7 tt -62.04 -61.31 2.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.883 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -56.24 -30.12 61.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 28.9 mt -72.94 -50.94 20.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.955 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 370' ' ' VAL . 25.4 t -98.74 37.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.142 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . 0.421 ' O ' ' CG ' ' A' ' 371' ' ' ASN . 0.7 OUTLIER -88.12 87.65 7.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 111.44 42.55 1.05 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -89.27 125.99 35.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.988 0.423 . . . . 0.0 110.917 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -74.29 94.0 2.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.43 HD22 HD11 ' A' ' 328' ' ' LEU . 16.2 tp -104.3 132.0 51.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.99 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 46.09 42.46 9.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 64.64 40.63 97.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . 0.475 ' HB3' ' ND2' ' A' ' 315' ' ' ASN . 81.4 mttt -152.57 149.25 28.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.757 0.313 . . . . 0.0 110.953 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . . . . . . . . . 15.8 mm -84.26 107.41 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.116 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.491 HD23 ' N ' ' A' ' 381' ' ' VAL . 8.2 tt -72.76 131.21 42.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.847 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.491 ' N ' HD23 ' A' ' 380' ' ' LEU . 41.0 t -113.1 114.45 46.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.087 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.484 HG13 ' CD2' ' A' ' 380' ' ' LEU . 31.6 mt -98.32 129.87 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -126.82 168.02 15.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.533 ' CZ ' ' HA ' ' A' ' 307' ' ' PRO . 26.3 m-85 -94.76 137.08 34.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -82.28 -168.12 41.25 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.457 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -108.72 134.55 51.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.804 0.335 . . . . 0.0 110.904 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.18 142.32 55.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -148.88 132.97 17.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.405 ' N ' ' HD3' ' A' ' 389' ' ' LYS . 0.0 OUTLIER -168.0 144.05 3.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -172.45 156.09 3.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.87 160.16 29.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.807 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 18.4 m -135.08 -54.24 0.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.3 m -167.74 129.59 1.52 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -72.14 159.43 53.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.466 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -77.05 115.56 4.03 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.733 2.289 . . . . 0.0 112.392 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 43.2 t -96.87 114.65 26.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 25.8 m -140.82 138.99 34.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.464 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 6.4 m -136.41 174.8 10.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 0.0 110.811 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 10.2 m -121.52 151.29 40.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.851 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 139.17 101.66 0.52 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.465 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.3 t -125.89 114.29 18.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.837 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 t -162.45 151.02 14.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . 0.659 ' HA3' HD11 ' A' ' 293' ' ' ILE . . . 79.84 96.88 0.32 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.519 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.21 -53.12 7.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.81 0.338 . . . . 0.0 110.893 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -79.72 -45.9 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.659 HD11 ' HA3' ' A' ' 290' ' ' GLY . 2.7 pp -73.04 164.72 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.116 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -127.08 -49.52 1.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -116.89 -54.54 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 38.9 mm -83.95 130.0 56.74 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.664 0.745 . . . . 0.0 111.089 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.47 -49.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.642 2.228 . . . . 0.0 112.327 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 4.0 mmm -82.41 42.71 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -89.9 -59.71 2.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 30.7 p -101.31 43.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 3.6 m -43.91 -57.81 3.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.839 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -150.28 158.23 43.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.951 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 303' ' ' ASN . 1.5 p30 -98.27 115.66 65.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.708 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.83 -41.01 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.635 2.224 . . . . 0.0 112.317 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 113.18 -176.11 17.15 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.439 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -73.38 133.94 80.22 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.617 0.723 . . . . 0.0 110.884 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -45.11 91.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.738 2.292 . . . . 0.0 112.272 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -107.09 175.63 5.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.554 ' HG3' HG23 ' A' ' 310' ' ' VAL . 18.7 pttm -85.8 -26.59 25.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.936 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.554 HG23 ' HG3' ' A' ' 309' ' ' LYS . 88.2 t -97.53 124.36 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.467 ' CD2' ' CE1' ' A' ' 384' ' ' PHE . 66.5 mt -113.05 115.06 27.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.934 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.795 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 16.4 t80 -87.85 104.06 16.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.433 HD22 HD22 ' A' ' 325' ' ' LEU . 8.3 mp -85.84 138.17 32.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.918 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -134.06 177.03 8.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . 0.444 ' ND2' ' HB3' ' A' ' 378' ' ' LYS . 1.7 t30 61.89 54.71 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.845 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.4 mt -111.0 127.71 55.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.457 ' HB2' ' CD ' ' A' ' 378' ' ' LYS . 29.4 t -61.91 143.35 94.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.648 0.737 . . . . 0.0 110.903 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -47.12 -19.47 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.604 2.203 . . . . 0.0 112.418 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.528 ' O ' HG23 ' A' ' 321' ' ' THR . 14.3 mtp180 -82.47 -33.29 28.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.54 HG22 ' HD2' ' A' ' 376' ' ' TYR . 99.4 t -44.1 133.04 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 319' ' ' ARG . 68.8 p -129.63 151.56 50.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 321' ' ' THR . 9.3 tt0 -34.55 -38.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -48.16 -56.21 8.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . 0.421 ' CG ' HG13 ' A' ' 320' ' ' VAL . 0.3 OUTLIER -46.46 -45.05 17.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.433 HD22 HD22 ' A' ' 313' ' ' LEU . 42.3 mt -61.62 -46.22 90.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 330' ' ' ALA . 65.8 t -56.32 -53.08 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 38.8 t -63.15 -41.67 99.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.851 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.457 HD21 ' CE2' ' A' ' 373' ' ' TYR . 24.0 mt -55.26 -41.48 72.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.971 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.474 ' CD1' ' HB1' ' A' ' 366' ' ' ALA . 19.0 m-85 -122.23 40.85 3.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 333' ' ' GLN . . . -79.2 -54.76 5.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.135 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -39.76 -33.34 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -75.32 -38.99 59.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 330' ' ' ALA . 6.3 tm0? -45.21 -47.6 12.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.966 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -87.46 40.96 0.95 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 336' ' ' LYS . 13.2 tptm -126.23 163.55 22.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 335' ' ' LYS . 42.2 mttt -34.03 109.61 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 119.67 139.92 6.05 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.453 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -47.48 164.25 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.776 2.317 . . . . 0.0 112.365 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.98 160.59 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.65 2.233 . . . . 0.0 112.337 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 71.6 mt -92.37 144.75 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.074 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -98.52 123.38 42.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -114.4 140.26 48.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -141.23 124.31 16.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.891 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 41.2 tpp -108.63 137.58 46.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.813 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . 0.403 ' N ' ' HE2' ' A' ' 345' ' ' MET . 1.4 mpp? -102.91 132.96 48.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 13.3 t -115.66 33.52 5.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.073 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 348' ' ' ARG . . . -88.69 -155.38 29.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.527 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 347' ' ' GLY . 26.5 tpt180 -34.28 -47.47 0.3 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.774 0.321 . . . . 0.0 110.846 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' MET . . . . . 0.466 ' HB3' ' NE2' ' A' ' 352' ' ' GLN . 0.7 OUTLIER -119.3 91.34 3.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -67.98 -2.49 7.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -88.87 37.14 3.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.509 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.466 ' NE2' ' HB3' ' A' ' 349' ' ' MET . 32.9 mt-30 -144.41 142.89 30.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 0.0 110.919 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -145.74 146.01 31.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.795 ' CE2' ' CE1' ' A' ' 312' ' ' TYR . 39.9 m-85 -111.72 124.02 51.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 79.0 mt -117.12 141.13 36.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 35.8 m -119.84 118.47 30.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.747 ' HB2' ' HB2' ' A' ' 363' ' ' ALA . 32.5 m-85 -94.1 155.34 40.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.612 0.72 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.1 -32.23 18.2 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.241 . . . . 0.0 112.359 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -152.19 -179.42 7.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.444 ' HG3' ' N ' ' A' ' 361' ' ' GLU . 8.6 pttm -78.07 -41.28 35.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 360' ' ' LYS . 36.1 mt-10 -54.04 -63.2 1.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 80.4 mt -47.17 -61.44 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.747 ' HB2' ' HB2' ' A' ' 357' ' ' PHE . . . -44.36 -65.26 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.019 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' TRP . . . . . 0.408 ' C ' ' O ' ' A' ' 363' ' ' ALA . 6.1 t90 -36.46 -51.09 0.81 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.938 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -54.47 -53.29 56.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.474 ' HB1' ' CD1' ' A' ' 329' ' ' PHE . . . -53.08 -40.66 64.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.78 HD13 ' CZ ' ' A' ' 384' ' ' PHE . 6.3 tt -59.57 -68.23 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . 0.651 ' N ' HD23 ' A' ' 367' ' ' LEU . 4.4 t60 -49.79 -33.79 17.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 35.3 mt -72.59 -39.14 67.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.967 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 370' ' ' VAL . 31.3 t -109.81 40.57 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.74 141.58 32.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 48.37 30.36 8.01 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.451 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.457 ' CE2' HD21 ' A' ' 328' ' ' LEU . 38.6 t80 -70.46 108.82 4.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.933 0.397 . . . . 0.0 110.853 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -71.45 97.41 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.463 ' HG ' ' CD2' ' A' ' 376' ' ' TYR . 31.6 tp -101.46 131.6 47.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.915 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' TYR . . . . . 0.54 ' HD2' HG22 ' A' ' 320' ' ' VAL . 57.1 m-85 53.5 31.93 13.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 73.6 34.8 56.4 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . 0.457 ' CD ' ' HB2' ' A' ' 317' ' ' SER . 21.2 mtpp -142.77 112.37 6.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.697 0.284 . . . . 0.0 110.93 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 379' ' ' ILE . 14.6 mm -52.83 100.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.166 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.41 HD23 ' C ' ' A' ' 380' ' ' LEU . 7.8 tt -69.35 120.57 15.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.5 t -104.04 120.46 54.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.557 HD11 ' O ' ' A' ' 370' ' ' VAL . 65.6 mt -99.34 138.46 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.099 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -140.32 120.54 13.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.912 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.78 ' CZ ' HD13 ' A' ' 367' ' ' LEU . 42.7 m-85 -54.69 147.45 14.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -61.69 161.32 27.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.453 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 157.6 23.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.322 . . . . 0.0 110.941 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -143.18 137.32 28.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.42 167.77 9.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -41.0 145.1 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.911 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -135.9 169.91 16.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.931 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 48.0 ttm-85 -131.62 124.81 30.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 46.6 t -56.71 94.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 30.7 t -115.53 108.85 16.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.818 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 155.14 86.48 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.462 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.65 -39.27 17.84 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.684 2.256 . . . . 0.0 112.389 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 4.1 m 37.57 42.02 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 70.8 m -134.52 112.94 11.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.473 -179.987 . . . . . . . . 0 0 . 1 stop_ save_